{
  "metadata": {
    "market_name": "Head and Neck Cancer Drug Market",
    "market_type": "Global",
    "industry": "HC",
    "years": [
      2020,
      2021,
      2022,
      2023,
      2024,
      2025,
      2026,
      2027,
      2028,
      2029,
      2030,
      2031,
      2032
    ],
    "start_year": 2020,
    "base_year": 2024,
    "forecast_year": 2032,
    "historical_years": [
      2020,
      2021,
      2022,
      2023,
      2024
    ],
    "forecast_years": [
      2025,
      2026,
      2027,
      2028,
      2029,
      2030,
      2031,
      2032
    ],
    "currency": "USD",
    "value_unit": "Mn",
    "volume_unit": "KT",
    "has_value": true,
    "has_volume": true
  },
  "dimensions": {
    "geographies": {
      "global": [
        "Global"
      ],
      "regions": [
        "North America",
        "Latin America",
        "Europe",
        "Asia Pacific",
        "Middle East",
        "Africa"
      ],
      "countries": {
        "North America": [
          "U.S.",
          "Canada"
        ],
        "Latin America": [
          "Brazil",
          "Argentina",
          "Mexico",
          "Rest of Latin America"
        ],
        "Europe": [
          "U.K.",
          "Germany",
          "France",
          "Italy",
          "Spain",
          "Russia",
          "Rest of Europe"
        ],
        "Asia Pacific": [
          "China",
          "Japan",
          "India",
          "Australia",
          "South Korea",
          "ASEAN",
          "Rest of Asia Pacific"
        ],
        "Middle East": [
          "GCC",
          "Israel",
          "Rest of Middle East"
        ],
        "Africa": [
          "North Africa",
          "Central Africa",
          "South Africa"
        ]
      },
      "all_geographies": [
        "Global",
        "North America",
        "Latin America",
        "Europe",
        "Asia Pacific",
        "Middle East",
        "Africa",
        "U.S.",
        "Canada",
        "Brazil",
        "Argentina",
        "Mexico",
        "Rest of Latin America",
        "U.K.",
        "Germany",
        "France",
        "Italy",
        "Spain",
        "Russia",
        "Rest of Europe",
        "China",
        "Japan",
        "India",
        "Australia",
        "South Korea",
        "ASEAN",
        "Rest of Asia Pacific",
        "GCC",
        "Israel",
        "Rest of Middle East",
        "North Africa",
        "Central Africa",
        "South Africa"
      ]
    },
    "segments": {
      "By Drug Class": {
        "type": "flat",
        "items": [
          "PD-1/PD-L1 Inhibitors",
          "EGFR Inhibitors",
          "VEGF/Angiogenesis Inhibitors",
          "Multikinase Inhibitors",
          "Others (including pipeline and emerging drugs)"
        ],
        "hierarchy": {}
      },
      "By Therapy Type": {
        "type": "hierarchical",
        "items": [
          "Chemotherapy",
          "Immunotherapy",
          "Targeted Therapy",
          "Targeted Therapy 1",
          "Targeted Therapy a",
          "Targeted Therapy b",
          "Targeted Therapy 2"
        ],
        "hierarchy": {
          "Targeted Therapy 1": [
            "Targeted Therapy a",
            "Targeted Therapy b"
          ],
          "Targeted Therapy": [
            "Targeted Therapy 1",
            "Targeted Therapy 2"
          ]
        }
      },
      "By Route of Administration": {
        "type": "flat",
        "items": [
          "Intravenous (IV)",
          "Oral"
        ],
        "hierarchy": {}
      },
      "By Gender": {
        "type": "flat",
        "items": [
          "Male",
          "Female"
        ],
        "hierarchy": {}
      },
      "By End User": {
        "type": "flat",
        "items": [
          "Hospital",
          "Speciality Center",
          "Research Institute"
        ],
        "hierarchy": {}
      },
      "By Sales Channel": {
        "type": "flat",
        "items": [
          "Offline",
          "Online"
        ],
        "hierarchy": {}
      }
    }
  },
  "data": {
    "value": {
      "geography_segment_matrix": [
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 12.02,
            "2021": 13.43,
            "2022": 14.72,
            "2023": 16.03,
            "2024": 17.57,
            "2025": 19.23,
            "2026": 21.11,
            "2027": 23.69,
            "2028": 25.47,
            "2029": 28.43,
            "2030": 30.94,
            "2031": 33.36,
            "2032": 37.4
          },
          "cagr": 9.97,
          "market_share": 14.01
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 17.44,
            "2021": 19.49,
            "2022": 21.37,
            "2023": 23.26,
            "2024": 25.5,
            "2025": 27.91,
            "2026": 30.64,
            "2027": 34.39,
            "2028": 36.96,
            "2029": 41.26,
            "2030": 44.9,
            "2031": 48.42,
            "2032": 54.28
          },
          "cagr": 9.97,
          "market_share": 20.33
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 15.54,
            "2021": 17.36,
            "2022": 19.04,
            "2023": 20.73,
            "2024": 22.72,
            "2025": 24.87,
            "2026": 27.3,
            "2027": 30.64,
            "2028": 32.93,
            "2029": 36.77,
            "2030": 40.01,
            "2031": 43.15,
            "2032": 48.37
          },
          "cagr": 9.97,
          "market_share": 18.11
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 23.09,
            "2021": 25.8,
            "2022": 28.3,
            "2023": 30.8,
            "2024": 33.76,
            "2025": 36.96,
            "2026": 40.57,
            "2027": 45.54,
            "2028": 48.94,
            "2029": 54.64,
            "2030": 59.46,
            "2031": 64.11,
            "2032": 71.88
          },
          "cagr": 9.97,
          "market_share": 26.92
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 17.69,
            "2021": 19.77,
            "2022": 21.68,
            "2023": 23.6,
            "2024": 25.88,
            "2025": 28.34,
            "2026": 31.08,
            "2027": 34.9,
            "2028": 37.51,
            "2029": 41.89,
            "2030": 45.58,
            "2031": 49.14,
            "2032": 55.1
          },
          "cagr": 9.96,
          "market_share": 20.63
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 15.6,
            "2021": 17.44,
            "2022": 19.12,
            "2023": 20.81,
            "2024": 22.82,
            "2025": 24.98,
            "2026": 27.41,
            "2027": 30.77,
            "2028": 33.07,
            "2029": 36.92,
            "2030": 40.18,
            "2031": 43.33,
            "2032": 48.57
          },
          "cagr": 9.96,
          "market_share": 18.19
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.09,
            "2021": 13.51,
            "2022": 14.82,
            "2023": 16.13,
            "2024": 17.68,
            "2025": 19.36,
            "2026": 21.24,
            "2027": 23.85,
            "2028": 25.63,
            "2029": 28.62,
            "2030": 31.14,
            "2031": 33.58,
            "2032": 37.64
          },
          "cagr": 9.96,
          "market_share": 14.1
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 20.52,
            "2021": 22.93,
            "2022": 25.15,
            "2023": 27.38,
            "2024": 30.01,
            "2025": 32.85,
            "2026": 36.06,
            "2027": 40.47,
            "2028": 43.5,
            "2029": 48.57,
            "2030": 52.85,
            "2031": 56.99,
            "2032": 63.89
          },
          "cagr": 9.97,
          "market_share": 23.93
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 19.99,
            "2021": 22.34,
            "2022": 24.49,
            "2023": 26.66,
            "2024": 29.23,
            "2025": 32.0,
            "2026": 35.12,
            "2027": 39.42,
            "2028": 42.37,
            "2029": 47.3,
            "2030": 51.47,
            "2031": 55.5,
            "2032": 62.22
          },
          "cagr": 9.96,
          "market_share": 23.3
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 17.58,
            "2021": 19.63,
            "2022": 21.53,
            "2023": 23.44,
            "2024": 25.69,
            "2025": 28.12,
            "2026": 30.87,
            "2027": 34.65,
            "2028": 37.24,
            "2029": 41.58,
            "2030": 45.25,
            "2031": 48.78,
            "2032": 54.71
          },
          "cagr": 9.97,
          "market_share": 20.48
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 47.1,
            "2021": 52.63,
            "2022": 57.71,
            "2023": 62.82,
            "2024": 68.86,
            "2025": 75.39,
            "2026": 82.74,
            "2027": 92.88,
            "2028": 99.82,
            "2029": 111.45,
            "2030": 121.28,
            "2031": 130.77,
            "2032": 146.61
          },
          "cagr": 9.97,
          "market_share": 54.9
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 38.68,
            "2021": 43.22,
            "2022": 47.4,
            "2023": 51.6,
            "2024": 56.57,
            "2025": 61.92,
            "2026": 67.96,
            "2027": 76.28,
            "2028": 81.99,
            "2029": 91.54,
            "2030": 99.61,
            "2031": 107.41,
            "2032": 120.42
          },
          "cagr": 9.97,
          "market_share": 45.1
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 41.54,
            "2021": 46.42,
            "2022": 50.9,
            "2023": 55.41,
            "2024": 60.74,
            "2025": 66.49,
            "2026": 72.98,
            "2027": 81.91,
            "2028": 88.04,
            "2029": 98.29,
            "2030": 106.96,
            "2031": 115.33,
            "2032": 129.31
          },
          "cagr": 9.97,
          "market_share": 48.43
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 44.24,
            "2021": 49.43,
            "2022": 54.21,
            "2023": 59.01,
            "2024": 64.69,
            "2025": 70.82,
            "2026": 77.72,
            "2027": 87.25,
            "2028": 93.77,
            "2029": 104.7,
            "2030": 113.93,
            "2031": 122.85,
            "2032": 137.72
          },
          "cagr": 9.97,
          "market_share": 51.57
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 40.56,
            "2021": 45.32,
            "2022": 49.7,
            "2023": 54.1,
            "2024": 59.31,
            "2025": 64.93,
            "2026": 71.26,
            "2027": 79.99,
            "2028": 85.97,
            "2029": 95.98,
            "2030": 104.45,
            "2031": 112.62,
            "2032": 126.26
          },
          "cagr": 9.97,
          "market_share": 47.29
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 24.33,
            "2021": 27.18,
            "2022": 29.81,
            "2023": 32.45,
            "2024": 35.57,
            "2025": 38.94,
            "2026": 42.74,
            "2027": 47.97,
            "2028": 51.56,
            "2029": 57.57,
            "2030": 62.64,
            "2031": 67.55,
            "2032": 75.73
          },
          "cagr": 9.97,
          "market_share": 28.36
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 20.89,
            "2021": 23.35,
            "2022": 25.6,
            "2023": 27.87,
            "2024": 30.55,
            "2025": 33.44,
            "2026": 36.7,
            "2027": 41.2,
            "2028": 44.28,
            "2029": 49.44,
            "2030": 53.8,
            "2031": 58.01,
            "2032": 65.04
          },
          "cagr": 9.97,
          "market_share": 24.36
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 44.5,
            "2021": 49.73,
            "2022": 54.53,
            "2023": 59.36,
            "2024": 65.07,
            "2025": 71.24,
            "2026": 78.18,
            "2027": 87.76,
            "2028": 94.32,
            "2029": 105.31,
            "2030": 114.6,
            "2031": 123.56,
            "2032": 138.53
          },
          "cagr": 9.97,
          "market_share": 51.88
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 41.28,
            "2021": 46.12,
            "2022": 50.58,
            "2023": 55.06,
            "2024": 60.36,
            "2025": 66.07,
            "2026": 72.52,
            "2027": 81.4,
            "2028": 87.49,
            "2029": 97.68,
            "2030": 106.29,
            "2031": 114.62,
            "2032": 128.5
          },
          "cagr": 9.97,
          "market_share": 48.12
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 13.95,
            "2021": 15.5,
            "2022": 17.18,
            "2023": 19.82,
            "2024": 21.47,
            "2025": 24.04,
            "2026": 27.11,
            "2027": 31.05,
            "2028": 34.38,
            "2029": 38.6,
            "2030": 42.77,
            "2031": 47.46,
            "2032": 54.62
          },
          "cagr": 12.44,
          "market_share": 24.34
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 9.02,
            "2021": 10.02,
            "2022": 11.11,
            "2023": 12.82,
            "2024": 13.89,
            "2025": 15.55,
            "2026": 17.53,
            "2027": 20.09,
            "2028": 22.24,
            "2029": 24.97,
            "2030": 27.67,
            "2031": 30.7,
            "2032": 35.33
          },
          "cagr": 12.44,
          "market_share": 15.75
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 11.75,
            "2021": 13.06,
            "2022": 14.47,
            "2023": 16.7,
            "2024": 18.09,
            "2025": 20.26,
            "2026": 22.84,
            "2027": 26.16,
            "2028": 28.97,
            "2029": 32.52,
            "2030": 36.04,
            "2031": 39.98,
            "2032": 46.02
          },
          "cagr": 12.43,
          "market_share": 20.51
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 11.01,
            "2021": 12.22,
            "2022": 13.55,
            "2023": 15.64,
            "2024": 16.94,
            "2025": 18.97,
            "2026": 21.38,
            "2027": 24.49,
            "2028": 27.12,
            "2029": 30.45,
            "2030": 33.74,
            "2031": 37.44,
            "2032": 43.08
          },
          "cagr": 12.43,
          "market_share": 19.2
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 11.59,
            "2021": 12.86,
            "2022": 14.25,
            "2023": 16.46,
            "2024": 17.82,
            "2025": 19.95,
            "2026": 22.49,
            "2027": 25.78,
            "2028": 28.54,
            "2029": 32.03,
            "2030": 35.5,
            "2031": 39.39,
            "2032": 45.33
          },
          "cagr": 12.44,
          "market_share": 20.2
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 11.97,
            "2021": 13.29,
            "2022": 14.73,
            "2023": 17.0,
            "2024": 18.42,
            "2025": 20.62,
            "2026": 23.25,
            "2027": 26.64,
            "2028": 29.49,
            "2029": 33.11,
            "2030": 36.69,
            "2031": 40.71,
            "2032": 46.85
          },
          "cagr": 12.44,
          "market_share": 20.88
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.9,
            "2021": 14.33,
            "2022": 15.88,
            "2023": 18.33,
            "2024": 19.86,
            "2025": 22.24,
            "2026": 25.07,
            "2027": 28.72,
            "2028": 31.8,
            "2029": 35.7,
            "2030": 39.56,
            "2031": 43.9,
            "2032": 50.52
          },
          "cagr": 12.44,
          "market_share": 22.51
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 12.02,
            "2021": 13.35,
            "2022": 14.79,
            "2023": 17.07,
            "2024": 18.49,
            "2025": 20.71,
            "2026": 23.34,
            "2027": 26.74,
            "2028": 29.61,
            "2029": 33.24,
            "2030": 36.84,
            "2031": 40.87,
            "2032": 47.04
          },
          "cagr": 12.43,
          "market_share": 20.96
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 13.9,
            "2021": 15.44,
            "2022": 17.11,
            "2023": 19.75,
            "2024": 21.39,
            "2025": 23.96,
            "2026": 27.01,
            "2027": 30.94,
            "2028": 34.26,
            "2029": 38.46,
            "2030": 42.62,
            "2031": 47.29,
            "2032": 54.42
          },
          "cagr": 12.43,
          "market_share": 24.25
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 6.53,
            "2021": 7.25,
            "2022": 8.05,
            "2023": 9.29,
            "2024": 10.05,
            "2025": 11.24,
            "2026": 12.68,
            "2027": 14.53,
            "2028": 16.09,
            "2029": 18.06,
            "2030": 20.01,
            "2031": 22.2,
            "2032": 25.55
          },
          "cagr": 12.45,
          "market_share": 11.39
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 33.33,
            "2021": 37.03,
            "2022": 41.03,
            "2023": 47.36,
            "2024": 51.3,
            "2025": 57.45,
            "2026": 64.76,
            "2027": 74.19,
            "2028": 82.15,
            "2029": 92.22,
            "2030": 102.19,
            "2031": 113.39,
            "2032": 130.49
          },
          "cagr": 12.43,
          "market_share": 58.16
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 23.99,
            "2021": 26.63,
            "2022": 29.53,
            "2023": 34.08,
            "2024": 36.91,
            "2025": 41.32,
            "2026": 46.59,
            "2027": 53.38,
            "2028": 59.1,
            "2029": 66.35,
            "2030": 73.53,
            "2031": 81.58,
            "2032": 93.89
          },
          "cagr": 12.44,
          "market_share": 41.84
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 22.89,
            "2021": 25.43,
            "2022": 28.18,
            "2023": 32.53,
            "2024": 35.23,
            "2025": 39.45,
            "2026": 44.48,
            "2027": 50.95,
            "2028": 56.42,
            "2029": 63.34,
            "2030": 70.19,
            "2031": 77.88,
            "2032": 89.62
          },
          "cagr": 12.44,
          "market_share": 39.94
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 34.43,
            "2021": 38.23,
            "2022": 42.38,
            "2023": 48.91,
            "2024": 52.98,
            "2025": 59.32,
            "2026": 66.87,
            "2027": 76.62,
            "2028": 84.83,
            "2029": 95.23,
            "2030": 105.53,
            "2031": 117.09,
            "2032": 134.76
          },
          "cagr": 12.44,
          "market_share": 60.06
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 18.9,
            "2021": 20.99,
            "2022": 23.27,
            "2023": 26.86,
            "2024": 29.09,
            "2025": 32.57,
            "2026": 36.72,
            "2027": 42.07,
            "2028": 46.58,
            "2029": 52.29,
            "2030": 57.95,
            "2031": 64.3,
            "2032": 73.99
          },
          "cagr": 12.44,
          "market_share": 32.98
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 22.41,
            "2021": 24.89,
            "2022": 27.58,
            "2023": 31.84,
            "2024": 34.49,
            "2025": 38.61,
            "2026": 43.53,
            "2027": 49.87,
            "2028": 55.22,
            "2029": 61.99,
            "2030": 68.69,
            "2031": 76.22,
            "2032": 87.72
          },
          "cagr": 12.44,
          "market_share": 39.1
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 16.01,
            "2021": 17.78,
            "2022": 19.71,
            "2023": 22.74,
            "2024": 24.63,
            "2025": 27.59,
            "2026": 31.1,
            "2027": 35.63,
            "2028": 39.45,
            "2029": 44.29,
            "2030": 49.08,
            "2031": 54.45,
            "2032": 62.67
          },
          "cagr": 12.43,
          "market_share": 27.92
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 35.24,
            "2021": 39.15,
            "2022": 43.39,
            "2023": 50.08,
            "2024": 54.24,
            "2025": 60.74,
            "2026": 68.47,
            "2027": 78.44,
            "2028": 86.86,
            "2029": 97.51,
            "2030": 108.05,
            "2031": 119.89,
            "2032": 137.97
          },
          "cagr": 12.43,
          "market_share": 61.49
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 22.08,
            "2021": 24.51,
            "2022": 27.17,
            "2023": 31.36,
            "2024": 33.97,
            "2025": 38.03,
            "2026": 42.88,
            "2027": 49.13,
            "2028": 54.39,
            "2029": 61.06,
            "2030": 67.67,
            "2031": 75.08,
            "2032": 86.41
          },
          "cagr": 12.44,
          "market_share": 38.51
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 14.57,
            "2021": 16.72,
            "2022": 18.19,
            "2023": 19.95,
            "2024": 22.88,
            "2025": 25.55,
            "2026": 28.04,
            "2027": 30.88,
            "2028": 34.79,
            "2029": 37.99,
            "2030": 43.1,
            "2031": 48.17,
            "2032": 52.49
          },
          "cagr": 10.83,
          "market_share": 19.99
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 16.41,
            "2021": 18.83,
            "2022": 20.49,
            "2023": 22.48,
            "2024": 25.77,
            "2025": 28.78,
            "2026": 31.58,
            "2027": 34.79,
            "2028": 39.19,
            "2029": 42.79,
            "2030": 48.55,
            "2031": 54.26,
            "2032": 59.12
          },
          "cagr": 10.83,
          "market_share": 22.51
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 13.86,
            "2021": 15.91,
            "2022": 17.31,
            "2023": 18.98,
            "2024": 21.77,
            "2025": 24.31,
            "2026": 26.67,
            "2027": 29.38,
            "2028": 33.1,
            "2029": 36.14,
            "2030": 41.01,
            "2031": 45.83,
            "2032": 49.93
          },
          "cagr": 10.83,
          "market_share": 19.02
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 16.49,
            "2021": 18.92,
            "2022": 20.59,
            "2023": 22.58,
            "2024": 25.89,
            "2025": 28.91,
            "2026": 31.73,
            "2027": 34.94,
            "2028": 39.37,
            "2029": 42.98,
            "2030": 48.77,
            "2031": 54.5,
            "2032": 59.39
          },
          "cagr": 10.83,
          "market_share": 22.62
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 11.56,
            "2021": 13.26,
            "2022": 14.44,
            "2023": 15.83,
            "2024": 18.15,
            "2025": 20.26,
            "2026": 22.24,
            "2027": 24.5,
            "2028": 27.6,
            "2029": 30.13,
            "2030": 34.19,
            "2031": 38.21,
            "2032": 41.63
          },
          "cagr": 10.84,
          "market_share": 15.86
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 17.85,
            "2021": 20.48,
            "2022": 22.29,
            "2023": 24.44,
            "2024": 28.03,
            "2025": 31.3,
            "2026": 34.35,
            "2027": 37.83,
            "2028": 42.62,
            "2029": 46.53,
            "2030": 52.8,
            "2031": 59.0,
            "2032": 64.29
          },
          "cagr": 10.83,
          "market_share": 24.49
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.38,
            "2021": 14.21,
            "2022": 15.46,
            "2023": 16.95,
            "2024": 19.44,
            "2025": 21.71,
            "2026": 23.82,
            "2027": 26.24,
            "2028": 29.56,
            "2029": 32.28,
            "2030": 36.62,
            "2031": 40.93,
            "2032": 44.6
          },
          "cagr": 10.83,
          "market_share": 16.98
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 20.67,
            "2021": 23.72,
            "2022": 25.81,
            "2023": 28.3,
            "2024": 32.45,
            "2025": 36.24,
            "2026": 39.77,
            "2027": 43.81,
            "2028": 49.35,
            "2029": 53.88,
            "2030": 61.14,
            "2031": 68.33,
            "2032": 74.45
          },
          "cagr": 10.83,
          "market_share": 28.35
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 8.6,
            "2021": 9.87,
            "2022": 10.74,
            "2023": 11.78,
            "2024": 13.51,
            "2025": 15.09,
            "2026": 16.56,
            "2027": 18.24,
            "2028": 20.54,
            "2029": 22.43,
            "2030": 25.45,
            "2031": 28.44,
            "2032": 30.99
          },
          "cagr": 10.83,
          "market_share": 11.8
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 13.39,
            "2021": 15.36,
            "2022": 16.72,
            "2023": 18.35,
            "2024": 21.03,
            "2025": 23.47,
            "2026": 25.76,
            "2027": 28.37,
            "2028": 31.98,
            "2029": 34.91,
            "2030": 39.61,
            "2031": 44.27,
            "2032": 48.23
          },
          "cagr": 10.84,
          "market_share": 18.37
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 29.19,
            "2021": 33.49,
            "2022": 36.45,
            "2023": 39.97,
            "2024": 45.83,
            "2025": 51.18,
            "2026": 56.17,
            "2027": 61.87,
            "2028": 69.7,
            "2029": 76.1,
            "2030": 86.35,
            "2031": 96.5,
            "2032": 105.14
          },
          "cagr": 10.83,
          "market_share": 40.04
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 43.7,
            "2021": 50.15,
            "2022": 54.57,
            "2023": 59.85,
            "2024": 68.63,
            "2025": 76.63,
            "2026": 84.09,
            "2027": 92.62,
            "2028": 104.35,
            "2029": 113.93,
            "2030": 129.27,
            "2031": 144.47,
            "2032": 157.42
          },
          "cagr": 10.83,
          "market_share": 59.96
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 46.0,
            "2021": 52.79,
            "2022": 57.45,
            "2023": 63.0,
            "2024": 72.24,
            "2025": 80.67,
            "2026": 88.53,
            "2027": 97.51,
            "2028": 109.86,
            "2029": 119.94,
            "2030": 136.1,
            "2031": 152.09,
            "2032": 165.72
          },
          "cagr": 10.83,
          "market_share": 63.11
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 26.89,
            "2021": 30.85,
            "2022": 33.57,
            "2023": 36.82,
            "2024": 42.22,
            "2025": 47.14,
            "2026": 51.73,
            "2027": 56.98,
            "2028": 64.19,
            "2029": 70.09,
            "2030": 79.52,
            "2031": 88.88,
            "2032": 96.84
          },
          "cagr": 10.83,
          "market_share": 36.89
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 18.57,
            "2021": 21.31,
            "2022": 23.19,
            "2023": 25.43,
            "2024": 29.16,
            "2025": 32.56,
            "2026": 35.73,
            "2027": 39.36,
            "2028": 44.34,
            "2029": 48.41,
            "2030": 54.93,
            "2031": 61.38,
            "2032": 66.89
          },
          "cagr": 10.83,
          "market_share": 25.48
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 28.45,
            "2021": 32.64,
            "2022": 35.52,
            "2023": 38.96,
            "2024": 44.67,
            "2025": 49.88,
            "2026": 54.75,
            "2027": 60.3,
            "2028": 67.93,
            "2029": 74.17,
            "2030": 84.16,
            "2031": 94.05,
            "2032": 102.48
          },
          "cagr": 10.83,
          "market_share": 39.03
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 25.87,
            "2021": 29.69,
            "2022": 32.31,
            "2023": 35.43,
            "2024": 40.63,
            "2025": 45.37,
            "2026": 49.78,
            "2027": 54.83,
            "2028": 61.78,
            "2029": 67.45,
            "2030": 76.53,
            "2031": 85.54,
            "2032": 93.19
          },
          "cagr": 10.83,
          "market_share": 35.5
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 37.13,
            "2021": 42.6,
            "2022": 46.36,
            "2023": 50.85,
            "2024": 58.3,
            "2025": 65.1,
            "2026": 71.45,
            "2027": 78.7,
            "2028": 88.66,
            "2029": 96.8,
            "2030": 109.83,
            "2031": 122.74,
            "2032": 133.74
          },
          "cagr": 10.83,
          "market_share": 50.93
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 35.76,
            "2021": 41.04,
            "2022": 44.66,
            "2023": 48.97,
            "2024": 56.16,
            "2025": 62.71,
            "2026": 68.81,
            "2027": 75.79,
            "2028": 85.39,
            "2029": 93.23,
            "2030": 105.79,
            "2031": 118.23,
            "2032": 128.82
          },
          "cagr": 10.83,
          "market_share": 49.07
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 21.97,
            "2021": 24.31,
            "2022": 27.2,
            "2023": 30.27,
            "2024": 32.17,
            "2025": 36.29,
            "2026": 39.5,
            "2027": 43.45,
            "2028": 47.79,
            "2029": 53.74,
            "2030": 58.29,
            "2031": 64.77,
            "2032": 71.89
          },
          "cagr": 10.26,
          "market_share": 20.82
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 22.38,
            "2021": 24.78,
            "2022": 27.72,
            "2023": 30.84,
            "2024": 32.78,
            "2025": 36.98,
            "2026": 40.25,
            "2027": 44.28,
            "2028": 48.7,
            "2029": 54.76,
            "2030": 59.4,
            "2031": 66.01,
            "2032": 73.26
          },
          "cagr": 10.26,
          "market_share": 21.21
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 17.27,
            "2021": 19.11,
            "2022": 21.38,
            "2023": 23.79,
            "2024": 25.29,
            "2025": 28.53,
            "2026": 31.05,
            "2027": 34.16,
            "2028": 37.57,
            "2029": 42.25,
            "2030": 45.82,
            "2031": 50.92,
            "2032": 56.51
          },
          "cagr": 10.26,
          "market_share": 16.36
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 23.92,
            "2021": 26.48,
            "2022": 29.62,
            "2023": 32.96,
            "2024": 35.03,
            "2025": 39.52,
            "2026": 43.02,
            "2027": 47.32,
            "2028": 52.05,
            "2029": 58.53,
            "2030": 63.48,
            "2031": 70.54,
            "2032": 78.29
          },
          "cagr": 10.26,
          "market_share": 22.67
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 19.99,
            "2021": 22.12,
            "2022": 24.74,
            "2023": 27.54,
            "2024": 29.27,
            "2025": 33.03,
            "2026": 35.95,
            "2027": 39.54,
            "2028": 43.48,
            "2029": 48.9,
            "2030": 53.03,
            "2031": 58.94,
            "2032": 65.41
          },
          "cagr": 10.25,
          "market_share": 18.94
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 30.38,
            "2021": 33.63,
            "2022": 37.62,
            "2023": 41.86,
            "2024": 44.5,
            "2025": 50.2,
            "2026": 54.64,
            "2027": 60.11,
            "2028": 66.11,
            "2029": 74.34,
            "2030": 80.62,
            "2031": 89.6,
            "2032": 99.44
          },
          "cagr": 10.26,
          "market_share": 28.8
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 21.73,
            "2021": 24.06,
            "2022": 26.91,
            "2023": 29.95,
            "2024": 31.83,
            "2025": 35.91,
            "2026": 39.08,
            "2027": 43.0,
            "2028": 47.29,
            "2029": 53.17,
            "2030": 57.67,
            "2031": 64.09,
            "2032": 71.13
          },
          "cagr": 10.26,
          "market_share": 20.6
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 19.47,
            "2021": 21.55,
            "2022": 24.11,
            "2023": 26.83,
            "2024": 28.51,
            "2025": 32.17,
            "2026": 35.01,
            "2027": 38.52,
            "2028": 42.36,
            "2029": 47.63,
            "2030": 51.66,
            "2031": 57.42,
            "2032": 63.72
          },
          "cagr": 10.26,
          "market_share": 18.45
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 17.41,
            "2021": 19.27,
            "2022": 21.56,
            "2023": 23.99,
            "2024": 25.5,
            "2025": 28.77,
            "2026": 31.31,
            "2027": 34.44,
            "2028": 37.88,
            "2029": 42.6,
            "2030": 46.2,
            "2031": 51.34,
            "2032": 56.98
          },
          "cagr": 10.25,
          "market_share": 16.5
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 16.54,
            "2021": 18.29,
            "2022": 20.46,
            "2023": 22.77,
            "2024": 24.2,
            "2025": 27.3,
            "2026": 29.73,
            "2027": 32.68,
            "2028": 35.95,
            "2029": 40.44,
            "2030": 43.87,
            "2031": 48.73,
            "2032": 54.09
          },
          "cagr": 10.26,
          "market_share": 15.66
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 49.11,
            "2021": 54.36,
            "2022": 60.8,
            "2023": 67.66,
            "2024": 71.92,
            "2025": 81.13,
            "2026": 88.31,
            "2027": 97.15,
            "2028": 106.84,
            "2029": 120.14,
            "2030": 130.31,
            "2031": 144.81,
            "2032": 160.71
          },
          "cagr": 10.26,
          "market_share": 46.54
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 56.42,
            "2021": 62.44,
            "2022": 69.86,
            "2023": 77.74,
            "2024": 82.62,
            "2025": 93.22,
            "2026": 101.46,
            "2027": 111.6,
            "2028": 122.75,
            "2029": 138.04,
            "2030": 149.71,
            "2031": 166.37,
            "2032": 184.65
          },
          "cagr": 10.26,
          "market_share": 53.46
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 63.64,
            "2021": 70.44,
            "2022": 78.8,
            "2023": 87.69,
            "2024": 93.2,
            "2025": 105.15,
            "2026": 114.45,
            "2027": 125.9,
            "2028": 138.46,
            "2029": 155.7,
            "2030": 168.88,
            "2031": 187.67,
            "2032": 208.28
          },
          "cagr": 10.26,
          "market_share": 60.31
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 41.89,
            "2021": 46.36,
            "2022": 51.86,
            "2023": 57.71,
            "2024": 61.34,
            "2025": 69.2,
            "2026": 75.32,
            "2027": 82.85,
            "2028": 91.13,
            "2029": 102.48,
            "2030": 111.14,
            "2031": 123.51,
            "2032": 137.08
          },
          "cagr": 10.26,
          "market_share": 39.69
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 41.44,
            "2021": 45.87,
            "2022": 51.31,
            "2023": 57.1,
            "2024": 60.69,
            "2025": 68.47,
            "2026": 74.52,
            "2027": 81.98,
            "2028": 90.16,
            "2029": 101.39,
            "2030": 109.96,
            "2031": 122.2,
            "2032": 135.62
          },
          "cagr": 10.26,
          "market_share": 39.27
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 25.73,
            "2021": 28.48,
            "2022": 31.86,
            "2023": 35.45,
            "2024": 37.68,
            "2025": 42.51,
            "2026": 46.27,
            "2027": 50.9,
            "2028": 55.98,
            "2029": 62.95,
            "2030": 68.28,
            "2031": 75.88,
            "2032": 84.21
          },
          "cagr": 10.26,
          "market_share": 24.38
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 38.36,
            "2021": 42.45,
            "2022": 47.49,
            "2023": 52.85,
            "2024": 56.17,
            "2025": 63.37,
            "2026": 68.98,
            "2027": 75.87,
            "2028": 83.45,
            "2029": 93.84,
            "2030": 101.78,
            "2031": 113.1,
            "2032": 125.53
          },
          "cagr": 10.26,
          "market_share": 36.35
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 53.28,
            "2021": 58.97,
            "2022": 65.97,
            "2023": 73.41,
            "2024": 78.02,
            "2025": 88.02,
            "2026": 95.81,
            "2027": 105.39,
            "2028": 115.91,
            "2029": 130.34,
            "2030": 141.37,
            "2031": 157.1,
            "2032": 174.36
          },
          "cagr": 10.26,
          "market_share": 50.49
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 52.25,
            "2021": 57.83,
            "2022": 64.69,
            "2023": 71.99,
            "2024": 76.52,
            "2025": 86.33,
            "2026": 93.96,
            "2027": 103.36,
            "2028": 113.68,
            "2029": 127.84,
            "2030": 138.65,
            "2031": 154.08,
            "2032": 171.0
          },
          "cagr": 10.26,
          "market_share": 49.51
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 17.94,
            "2021": 20.05,
            "2022": 22.96,
            "2023": 25.06,
            "2024": 28.06,
            "2025": 31.73,
            "2026": 34.88,
            "2027": 39.28,
            "2028": 44.37,
            "2029": 50.51,
            "2030": 55.48,
            "2031": 63.2,
            "2032": 69.15
          },
          "cagr": 11.77,
          "market_share": 13.85
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 35.29,
            "2021": 39.45,
            "2022": 45.17,
            "2023": 49.31,
            "2024": 55.2,
            "2025": 62.43,
            "2026": 68.62,
            "2027": 77.28,
            "2028": 87.29,
            "2029": 99.37,
            "2030": 109.15,
            "2031": 124.35,
            "2032": 136.04
          },
          "cagr": 11.77,
          "market_share": 27.24
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 21.7,
            "2021": 24.26,
            "2022": 27.78,
            "2023": 30.32,
            "2024": 33.94,
            "2025": 38.39,
            "2026": 42.2,
            "2027": 47.52,
            "2028": 53.68,
            "2029": 61.1,
            "2030": 67.12,
            "2031": 76.46,
            "2032": 83.66
          },
          "cagr": 11.77,
          "market_share": 16.75
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 32.49,
            "2021": 36.32,
            "2022": 41.59,
            "2023": 45.4,
            "2024": 50.82,
            "2025": 57.48,
            "2026": 63.18,
            "2027": 71.15,
            "2028": 80.37,
            "2029": 91.49,
            "2030": 100.49,
            "2031": 114.49,
            "2032": 125.26
          },
          "cagr": 11.77,
          "market_share": 25.08
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 22.15,
            "2021": 24.76,
            "2022": 28.35,
            "2023": 30.96,
            "2024": 34.65,
            "2025": 39.18,
            "2026": 43.07,
            "2027": 48.51,
            "2028": 54.78,
            "2029": 62.36,
            "2030": 68.5,
            "2031": 78.04,
            "2032": 85.38
          },
          "cagr": 11.77,
          "market_share": 17.1
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 27.85,
            "2021": 31.14,
            "2022": 35.65,
            "2023": 38.92,
            "2024": 43.57,
            "2025": 49.27,
            "2026": 54.16,
            "2027": 61.0,
            "2028": 68.9,
            "2029": 78.43,
            "2030": 86.15,
            "2031": 98.14,
            "2032": 107.38
          },
          "cagr": 11.77,
          "market_share": 21.5
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 32.51,
            "2021": 36.34,
            "2022": 41.61,
            "2023": 45.43,
            "2024": 50.85,
            "2025": 57.51,
            "2026": 63.22,
            "2027": 71.19,
            "2028": 80.41,
            "2029": 91.54,
            "2030": 100.55,
            "2031": 114.55,
            "2032": 125.33
          },
          "cagr": 11.77,
          "market_share": 25.09
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 17.0,
            "2021": 19.01,
            "2022": 21.76,
            "2023": 23.76,
            "2024": 26.59,
            "2025": 30.08,
            "2026": 33.06,
            "2027": 37.23,
            "2028": 42.05,
            "2029": 47.87,
            "2030": 52.58,
            "2031": 59.91,
            "2032": 65.54
          },
          "cagr": 11.77,
          "market_share": 13.12
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 21.4,
            "2021": 23.92,
            "2022": 27.39,
            "2023": 29.9,
            "2024": 33.47,
            "2025": 37.85,
            "2026": 41.6,
            "2027": 46.85,
            "2028": 52.92,
            "2029": 60.25,
            "2030": 66.17,
            "2031": 75.39,
            "2032": 82.48
          },
          "cagr": 11.77,
          "market_share": 16.51
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 30.81,
            "2021": 34.43,
            "2022": 39.44,
            "2023": 43.04,
            "2024": 48.19,
            "2025": 54.5,
            "2026": 59.91,
            "2027": 67.47,
            "2028": 76.21,
            "2029": 86.74,
            "2030": 95.29,
            "2031": 108.55,
            "2032": 118.76
          },
          "cagr": 11.77,
          "market_share": 23.78
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 78.86,
            "2021": 88.16,
            "2022": 100.94,
            "2023": 110.19,
            "2024": 123.36,
            "2025": 139.51,
            "2026": 153.35,
            "2027": 172.69,
            "2028": 195.06,
            "2029": 222.05,
            "2030": 243.91,
            "2031": 277.87,
            "2032": 304.01
          },
          "cagr": 11.77,
          "market_share": 60.87
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 50.71,
            "2021": 56.68,
            "2022": 64.91,
            "2023": 70.86,
            "2024": 79.31,
            "2025": 89.7,
            "2026": 98.6,
            "2027": 111.05,
            "2028": 125.43,
            "2029": 142.78,
            "2030": 156.83,
            "2031": 178.67,
            "2032": 195.48
          },
          "cagr": 11.77,
          "market_share": 39.13
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 64.0,
            "2021": 71.55,
            "2022": 81.92,
            "2023": 89.43,
            "2024": 100.11,
            "2025": 113.22,
            "2026": 124.45,
            "2027": 140.15,
            "2028": 158.31,
            "2029": 180.21,
            "2030": 197.95,
            "2031": 225.51,
            "2032": 246.72
          },
          "cagr": 11.77,
          "market_share": 49.4
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 65.57,
            "2021": 73.29,
            "2022": 83.93,
            "2023": 91.62,
            "2024": 102.56,
            "2025": 115.99,
            "2026": 127.5,
            "2027": 143.59,
            "2028": 162.18,
            "2029": 184.62,
            "2030": 202.79,
            "2031": 231.03,
            "2032": 252.77
          },
          "cagr": 11.77,
          "market_share": 50.6
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 31.53,
            "2021": 35.25,
            "2022": 40.36,
            "2023": 44.05,
            "2024": 49.32,
            "2025": 55.77,
            "2026": 61.31,
            "2027": 69.04,
            "2028": 77.99,
            "2029": 88.78,
            "2030": 97.51,
            "2031": 111.09,
            "2032": 121.54
          },
          "cagr": 11.77,
          "market_share": 24.34
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 46.69,
            "2021": 52.19,
            "2022": 59.76,
            "2023": 65.23,
            "2024": 73.02,
            "2025": 82.59,
            "2026": 90.78,
            "2027": 102.23,
            "2028": 115.47,
            "2029": 131.45,
            "2030": 144.39,
            "2031": 164.49,
            "2032": 179.97
          },
          "cagr": 11.77,
          "market_share": 36.03
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 51.35,
            "2021": 57.4,
            "2022": 65.73,
            "2023": 71.77,
            "2024": 80.33,
            "2025": 90.85,
            "2026": 99.86,
            "2027": 112.47,
            "2028": 127.03,
            "2029": 144.6,
            "2030": 158.84,
            "2031": 180.96,
            "2032": 197.98
          },
          "cagr": 11.77,
          "market_share": 39.64
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 59.57,
            "2021": 66.59,
            "2022": 76.24,
            "2023": 83.23,
            "2024": 93.17,
            "2025": 105.37,
            "2026": 115.82,
            "2027": 130.44,
            "2028": 147.33,
            "2029": 167.72,
            "2030": 184.22,
            "2031": 209.88,
            "2032": 229.62
          },
          "cagr": 11.77,
          "market_share": 45.97
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 70.0,
            "2021": 78.25,
            "2022": 89.61,
            "2023": 97.82,
            "2024": 109.5,
            "2025": 123.84,
            "2026": 136.13,
            "2027": 153.3,
            "2028": 173.16,
            "2029": 197.11,
            "2030": 216.52,
            "2031": 246.66,
            "2032": 269.87
          },
          "cagr": 11.77,
          "market_share": 54.03
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 6.86,
            "2021": 8.03,
            "2022": 9.09,
            "2023": 10.36,
            "2024": 11.68,
            "2025": 13.17,
            "2026": 15.17,
            "2027": 17.23,
            "2028": 19.73,
            "2029": 22.27,
            "2030": 25.79,
            "2031": 29.37,
            "2032": 33.17
          },
          "cagr": 14.11,
          "market_share": 11.23
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 10.7,
            "2021": 12.52,
            "2022": 14.18,
            "2023": 16.16,
            "2024": 18.22,
            "2025": 20.53,
            "2026": 23.66,
            "2027": 26.87,
            "2028": 30.76,
            "2029": 34.72,
            "2030": 40.22,
            "2031": 45.81,
            "2032": 51.73
          },
          "cagr": 14.11,
          "market_share": 17.51
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 11.62,
            "2021": 13.59,
            "2022": 15.39,
            "2023": 17.55,
            "2024": 19.78,
            "2025": 22.29,
            "2026": 25.69,
            "2027": 29.18,
            "2028": 33.4,
            "2029": 37.7,
            "2030": 43.67,
            "2031": 49.73,
            "2032": 56.16
          },
          "cagr": 14.11,
          "market_share": 19.01
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 14.55,
            "2021": 17.03,
            "2022": 19.28,
            "2023": 21.98,
            "2024": 24.78,
            "2025": 27.93,
            "2026": 32.19,
            "2027": 36.55,
            "2028": 41.85,
            "2029": 47.23,
            "2030": 54.72,
            "2031": 62.31,
            "2032": 70.36
          },
          "cagr": 14.11,
          "market_share": 23.82
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 17.38,
            "2021": 20.34,
            "2022": 23.02,
            "2023": 26.25,
            "2024": 29.58,
            "2025": 33.34,
            "2026": 38.44,
            "2027": 43.64,
            "2028": 49.96,
            "2029": 56.39,
            "2030": 65.34,
            "2031": 74.4,
            "2032": 84.01
          },
          "cagr": 14.11,
          "market_share": 28.43
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 12.19,
            "2021": 14.26,
            "2022": 16.15,
            "2023": 18.41,
            "2024": 20.75,
            "2025": 23.39,
            "2026": 26.96,
            "2027": 30.61,
            "2028": 35.04,
            "2029": 39.55,
            "2030": 45.82,
            "2031": 52.18,
            "2032": 58.92
          },
          "cagr": 14.11,
          "market_share": 19.94
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 9.98,
            "2021": 11.68,
            "2022": 13.23,
            "2023": 15.08,
            "2024": 17.0,
            "2025": 19.16,
            "2026": 22.08,
            "2027": 25.07,
            "2028": 28.7,
            "2029": 32.4,
            "2030": 37.53,
            "2031": 42.74,
            "2032": 48.26
          },
          "cagr": 14.11,
          "market_share": 16.34
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 9.98,
            "2021": 11.68,
            "2022": 13.22,
            "2023": 15.07,
            "2024": 16.99,
            "2025": 19.15,
            "2026": 22.07,
            "2027": 25.06,
            "2028": 28.69,
            "2029": 32.39,
            "2030": 37.52,
            "2031": 42.72,
            "2032": 48.25
          },
          "cagr": 14.11,
          "market_share": 16.33
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 15.9,
            "2021": 18.61,
            "2022": 21.06,
            "2023": 24.01,
            "2024": 27.07,
            "2025": 30.51,
            "2026": 35.16,
            "2027": 39.93,
            "2028": 45.71,
            "2029": 51.6,
            "2030": 59.77,
            "2031": 68.07,
            "2032": 76.86
          },
          "cagr": 14.11,
          "market_share": 26.02
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 13.06,
            "2021": 15.28,
            "2022": 17.3,
            "2023": 19.73,
            "2024": 22.23,
            "2025": 25.05,
            "2026": 28.88,
            "2027": 32.8,
            "2028": 37.56,
            "2029": 42.37,
            "2030": 49.1,
            "2031": 55.91,
            "2032": 63.14
          },
          "cagr": 14.12,
          "market_share": 21.37
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 29.39,
            "2021": 34.4,
            "2022": 38.95,
            "2023": 44.4,
            "2024": 50.05,
            "2025": 56.41,
            "2026": 65.01,
            "2027": 73.83,
            "2028": 84.52,
            "2029": 95.4,
            "2030": 110.51,
            "2031": 125.85,
            "2032": 142.11
          },
          "cagr": 14.11,
          "market_share": 48.11
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 31.72,
            "2021": 37.11,
            "2022": 42.01,
            "2023": 47.9,
            "2024": 53.99,
            "2025": 60.85,
            "2026": 70.14,
            "2027": 79.64,
            "2028": 91.18,
            "2029": 102.91,
            "2030": 119.23,
            "2031": 135.77,
            "2032": 153.32
          },
          "cagr": 14.11,
          "market_share": 51.89
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 27.32,
            "2021": 31.97,
            "2022": 36.19,
            "2023": 41.26,
            "2024": 46.51,
            "2025": 52.42,
            "2026": 60.42,
            "2027": 68.61,
            "2028": 78.55,
            "2029": 88.66,
            "2030": 102.71,
            "2031": 116.96,
            "2032": 132.07
          },
          "cagr": 14.11,
          "market_share": 44.7
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 33.79,
            "2021": 39.54,
            "2022": 44.77,
            "2023": 51.04,
            "2024": 57.53,
            "2025": 64.84,
            "2026": 74.73,
            "2027": 84.86,
            "2028": 97.15,
            "2029": 109.65,
            "2030": 127.03,
            "2031": 144.66,
            "2032": 163.36
          },
          "cagr": 14.11,
          "market_share": 55.3
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 14.65,
            "2021": 17.15,
            "2022": 19.41,
            "2023": 22.13,
            "2024": 24.95,
            "2025": 28.12,
            "2026": 32.41,
            "2027": 36.8,
            "2028": 42.13,
            "2029": 47.55,
            "2030": 55.09,
            "2031": 62.73,
            "2032": 70.84
          },
          "cagr": 14.11,
          "market_share": 23.98
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 26.18,
            "2021": 30.64,
            "2022": 34.68,
            "2023": 39.54,
            "2024": 44.57,
            "2025": 50.23,
            "2026": 57.9,
            "2027": 65.75,
            "2028": 75.27,
            "2029": 84.96,
            "2030": 98.42,
            "2031": 112.08,
            "2032": 126.56
          },
          "cagr": 14.11,
          "market_share": 42.84
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 20.28,
            "2021": 23.72,
            "2022": 26.87,
            "2023": 30.63,
            "2024": 34.52,
            "2025": 38.91,
            "2026": 44.84,
            "2027": 50.92,
            "2028": 58.3,
            "2029": 65.8,
            "2030": 76.23,
            "2031": 86.81,
            "2032": 98.03
          },
          "cagr": 14.11,
          "market_share": 33.18
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 34.45,
            "2021": 40.32,
            "2022": 45.65,
            "2023": 52.04,
            "2024": 58.66,
            "2025": 66.11,
            "2026": 76.2,
            "2027": 86.53,
            "2028": 99.06,
            "2029": 111.81,
            "2030": 129.53,
            "2031": 147.51,
            "2032": 166.57
          },
          "cagr": 14.11,
          "market_share": 56.38
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 26.66,
            "2021": 31.19,
            "2022": 35.31,
            "2023": 40.26,
            "2024": 45.38,
            "2025": 51.15,
            "2026": 58.95,
            "2027": 66.94,
            "2028": 76.64,
            "2029": 86.5,
            "2030": 100.21,
            "2031": 114.11,
            "2032": 128.86
          },
          "cagr": 14.11,
          "market_share": 43.62
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 25.4,
            "2021": 26.91,
            "2022": 30.03,
            "2023": 32.78,
            "2024": 35.28,
            "2025": 38.72,
            "2026": 41.92,
            "2027": 46.03,
            "2028": 50.35,
            "2029": 54.43,
            "2030": 59.12,
            "2031": 63.09,
            "2032": 70.52
          },
          "cagr": 8.94,
          "market_share": 18.25
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 14.53,
            "2021": 15.4,
            "2022": 17.18,
            "2023": 18.76,
            "2024": 20.19,
            "2025": 22.16,
            "2026": 23.99,
            "2027": 26.34,
            "2028": 28.81,
            "2029": 31.15,
            "2030": 33.84,
            "2031": 36.11,
            "2032": 40.36
          },
          "cagr": 8.94,
          "market_share": 10.44
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 41.16,
            "2021": 43.61,
            "2022": 48.66,
            "2023": 53.12,
            "2024": 57.18,
            "2025": 62.75,
            "2026": 67.93,
            "2027": 74.59,
            "2028": 81.59,
            "2029": 88.2,
            "2030": 95.81,
            "2031": 102.23,
            "2032": 114.27
          },
          "cagr": 8.94,
          "market_share": 29.57
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 19.3,
            "2021": 20.45,
            "2022": 22.81,
            "2023": 24.91,
            "2024": 26.81,
            "2025": 29.42,
            "2026": 31.85,
            "2027": 34.97,
            "2028": 38.25,
            "2029": 41.35,
            "2030": 44.92,
            "2031": 47.93,
            "2032": 53.58
          },
          "cagr": 8.94,
          "market_share": 13.87
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 38.78,
            "2021": 41.11,
            "2022": 45.86,
            "2023": 50.07,
            "2024": 53.89,
            "2025": 59.14,
            "2026": 64.0,
            "2027": 70.31,
            "2028": 76.89,
            "2029": 83.11,
            "2030": 90.29,
            "2031": 96.35,
            "2032": 107.68
          },
          "cagr": 8.94,
          "market_share": 27.87
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 39.25,
            "2021": 41.59,
            "2022": 46.4,
            "2023": 50.66,
            "2024": 54.53,
            "2025": 59.84,
            "2026": 64.78,
            "2027": 71.14,
            "2028": 77.81,
            "2029": 84.11,
            "2030": 91.37,
            "2031": 97.5,
            "2032": 108.98
          },
          "cagr": 8.94,
          "market_share": 28.2
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 30.06,
            "2021": 31.86,
            "2022": 35.54,
            "2023": 38.81,
            "2024": 41.77,
            "2025": 45.84,
            "2026": 49.62,
            "2027": 54.49,
            "2028": 59.6,
            "2029": 64.42,
            "2030": 69.98,
            "2031": 74.68,
            "2032": 83.47
          },
          "cagr": 8.94,
          "market_share": 21.6
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 17.95,
            "2021": 19.02,
            "2022": 21.22,
            "2023": 23.17,
            "2024": 24.93,
            "2025": 27.36,
            "2026": 29.62,
            "2027": 32.53,
            "2028": 35.58,
            "2029": 38.46,
            "2030": 41.78,
            "2031": 44.58,
            "2032": 49.83
          },
          "cagr": 8.94,
          "market_share": 12.89
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 32.26,
            "2021": 34.18,
            "2022": 38.14,
            "2023": 41.64,
            "2024": 44.82,
            "2025": 49.18,
            "2026": 53.24,
            "2027": 58.47,
            "2028": 63.95,
            "2029": 69.13,
            "2030": 75.09,
            "2031": 80.13,
            "2032": 89.56
          },
          "cagr": 8.94,
          "market_share": 23.18
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 19.65,
            "2021": 20.83,
            "2022": 23.24,
            "2023": 25.36,
            "2024": 27.3,
            "2025": 29.97,
            "2026": 32.43,
            "2027": 35.61,
            "2028": 38.95,
            "2029": 42.12,
            "2030": 45.76,
            "2031": 48.82,
            "2032": 54.57
          },
          "cagr": 8.94,
          "market_share": 14.12
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 50.28,
            "2021": 53.28,
            "2022": 59.44,
            "2023": 64.9,
            "2024": 69.85,
            "2025": 76.66,
            "2026": 82.98,
            "2027": 91.13,
            "2028": 99.67,
            "2029": 107.74,
            "2030": 117.04,
            "2031": 124.89,
            "2032": 139.6
          },
          "cagr": 8.94,
          "market_share": 36.13
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 88.89,
            "2021": 94.2,
            "2022": 105.1,
            "2023": 114.74,
            "2024": 123.5,
            "2025": 135.53,
            "2026": 146.71,
            "2027": 161.11,
            "2028": 176.22,
            "2029": 190.5,
            "2030": 206.94,
            "2031": 220.82,
            "2032": 246.81
          },
          "cagr": 8.94,
          "market_share": 63.87
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 59.74,
            "2021": 63.31,
            "2022": 70.63,
            "2023": 77.11,
            "2024": 82.99,
            "2025": 91.08,
            "2026": 98.6,
            "2027": 108.27,
            "2028": 118.43,
            "2029": 128.02,
            "2030": 139.07,
            "2031": 148.39,
            "2032": 165.87
          },
          "cagr": 8.94,
          "market_share": 42.92
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 79.43,
            "2021": 84.17,
            "2022": 93.91,
            "2023": 102.53,
            "2024": 110.36,
            "2025": 121.11,
            "2026": 131.09,
            "2027": 143.97,
            "2028": 157.46,
            "2029": 170.22,
            "2030": 184.91,
            "2031": 197.32,
            "2032": 220.54
          },
          "cagr": 8.94,
          "market_share": 57.08
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 42.74,
            "2021": 45.29,
            "2022": 50.53,
            "2023": 55.16,
            "2024": 59.37,
            "2025": 65.16,
            "2026": 70.53,
            "2027": 77.46,
            "2028": 84.72,
            "2029": 91.58,
            "2030": 99.49,
            "2031": 106.16,
            "2032": 118.66
          },
          "cagr": 8.94,
          "market_share": 30.71
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 36.64,
            "2021": 38.83,
            "2022": 43.32,
            "2023": 47.3,
            "2024": 50.91,
            "2025": 55.87,
            "2026": 60.48,
            "2027": 66.42,
            "2028": 72.65,
            "2029": 78.53,
            "2030": 85.31,
            "2031": 91.03,
            "2032": 101.75
          },
          "cagr": 8.94,
          "market_share": 26.33
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 59.79,
            "2021": 63.36,
            "2022": 70.69,
            "2023": 77.18,
            "2024": 83.07,
            "2025": 91.16,
            "2026": 98.68,
            "2027": 108.36,
            "2028": 118.52,
            "2029": 128.13,
            "2030": 139.18,
            "2031": 148.52,
            "2032": 166.0
          },
          "cagr": 8.94,
          "market_share": 42.96
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 75.02,
            "2021": 79.5,
            "2022": 88.69,
            "2023": 96.83,
            "2024": 104.22,
            "2025": 114.38,
            "2026": 123.81,
            "2027": 135.97,
            "2028": 148.72,
            "2029": 160.76,
            "2030": 174.64,
            "2031": 186.35,
            "2032": 208.29
          },
          "cagr": 8.94,
          "market_share": 53.9
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 64.15,
            "2021": 67.98,
            "2022": 75.85,
            "2023": 82.81,
            "2024": 89.13,
            "2025": 97.81,
            "2026": 105.88,
            "2027": 116.27,
            "2028": 127.17,
            "2029": 137.48,
            "2030": 149.34,
            "2031": 159.36,
            "2032": 178.12
          },
          "cagr": 8.94,
          "market_share": 46.1
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 14.21,
            "2021": 15.5,
            "2022": 16.51,
            "2023": 18.22,
            "2024": 19.18,
            "2025": 21.01,
            "2026": 22.71,
            "2027": 24.42,
            "2028": 26.42,
            "2029": 28.33,
            "2030": 31.14,
            "2031": 33.96,
            "2032": 36.52
          },
          "cagr": 8.22,
          "market_share": 19.42
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 8.12,
            "2021": 8.86,
            "2022": 9.43,
            "2023": 10.41,
            "2024": 10.96,
            "2025": 12.01,
            "2026": 12.98,
            "2027": 13.95,
            "2028": 15.1,
            "2029": 16.19,
            "2030": 17.8,
            "2031": 19.41,
            "2032": 20.87
          },
          "cagr": 8.21,
          "market_share": 11.1
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 20.04,
            "2021": 21.86,
            "2022": 23.29,
            "2023": 25.7,
            "2024": 27.05,
            "2025": 29.64,
            "2026": 32.03,
            "2027": 34.44,
            "2028": 37.26,
            "2029": 39.96,
            "2030": 43.92,
            "2031": 47.91,
            "2032": 51.51
          },
          "cagr": 8.22,
          "market_share": 27.38
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 15.4,
            "2021": 16.8,
            "2022": 17.9,
            "2023": 19.75,
            "2024": 20.79,
            "2025": 22.78,
            "2026": 24.62,
            "2027": 26.47,
            "2028": 28.64,
            "2029": 30.71,
            "2030": 33.76,
            "2031": 36.82,
            "2032": 39.58
          },
          "cagr": 8.21,
          "market_share": 21.05
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 15.42,
            "2021": 16.82,
            "2022": 17.9,
            "2023": 19.76,
            "2024": 20.8,
            "2025": 22.78,
            "2026": 24.62,
            "2027": 26.49,
            "2028": 28.64,
            "2029": 30.74,
            "2030": 33.77,
            "2031": 36.84,
            "2032": 39.6
          },
          "cagr": 8.22,
          "market_share": 21.06
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 17.37,
            "2021": 18.95,
            "2022": 20.19,
            "2023": 22.28,
            "2024": 23.45,
            "2025": 25.69,
            "2026": 27.77,
            "2027": 29.86,
            "2028": 32.3,
            "2029": 34.64,
            "2030": 38.07,
            "2031": 41.53,
            "2032": 44.65
          },
          "cagr": 8.22,
          "market_share": 23.74
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 14.68,
            "2021": 16.02,
            "2022": 17.06,
            "2023": 18.83,
            "2024": 19.82,
            "2025": 21.71,
            "2026": 23.46,
            "2027": 25.23,
            "2028": 27.3,
            "2029": 29.28,
            "2030": 32.18,
            "2031": 35.1,
            "2032": 37.73
          },
          "cagr": 8.22,
          "market_share": 20.06
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 12.0,
            "2021": 13.09,
            "2022": 13.94,
            "2023": 15.39,
            "2024": 16.2,
            "2025": 17.75,
            "2026": 19.18,
            "2027": 20.62,
            "2028": 22.31,
            "2029": 23.93,
            "2030": 26.3,
            "2031": 28.69,
            "2032": 30.84
          },
          "cagr": 8.21,
          "market_share": 16.4
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 17.16,
            "2021": 18.71,
            "2022": 19.93,
            "2023": 22.0,
            "2024": 23.15,
            "2025": 25.37,
            "2026": 27.42,
            "2027": 29.48,
            "2028": 31.89,
            "2029": 34.21,
            "2030": 37.59,
            "2031": 41.01,
            "2032": 44.09
          },
          "cagr": 8.22,
          "market_share": 23.44
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 11.98,
            "2021": 13.07,
            "2022": 13.91,
            "2023": 15.34,
            "2024": 16.16,
            "2025": 17.7,
            "2026": 19.13,
            "2027": 20.58,
            "2028": 22.26,
            "2029": 23.87,
            "2030": 26.25,
            "2031": 28.61,
            "2032": 30.77
          },
          "cagr": 8.22,
          "market_share": 16.36
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 36.94,
            "2021": 40.3,
            "2022": 42.92,
            "2023": 47.36,
            "2024": 49.86,
            "2025": 54.62,
            "2026": 59.03,
            "2027": 63.48,
            "2028": 68.67,
            "2029": 73.66,
            "2030": 80.95,
            "2031": 88.3,
            "2032": 94.93
          },
          "cagr": 8.22,
          "market_share": 50.48
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 36.25,
            "2021": 39.54,
            "2022": 42.11,
            "2023": 46.48,
            "2024": 48.92,
            "2025": 53.6,
            "2026": 57.93,
            "2027": 62.29,
            "2028": 67.39,
            "2029": 72.27,
            "2030": 79.44,
            "2031": 86.64,
            "2032": 93.15
          },
          "cagr": 8.22,
          "market_share": 49.52
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 38.16,
            "2021": 41.63,
            "2022": 44.34,
            "2023": 48.93,
            "2024": 51.5,
            "2025": 56.43,
            "2026": 60.99,
            "2027": 65.58,
            "2028": 70.95,
            "2029": 76.09,
            "2030": 83.63,
            "2031": 91.22,
            "2032": 98.07
          },
          "cagr": 8.22,
          "market_share": 52.14
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 35.03,
            "2021": 38.21,
            "2022": 40.69,
            "2023": 44.91,
            "2024": 47.28,
            "2025": 51.79,
            "2026": 55.97,
            "2027": 60.19,
            "2028": 65.11,
            "2029": 69.84,
            "2030": 76.76,
            "2031": 83.72,
            "2032": 90.01
          },
          "cagr": 8.22,
          "market_share": 47.86
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 29.59,
            "2021": 32.27,
            "2022": 34.37,
            "2023": 37.93,
            "2024": 39.93,
            "2025": 43.75,
            "2026": 47.28,
            "2027": 50.84,
            "2028": 55.0,
            "2029": 58.99,
            "2030": 64.83,
            "2031": 70.72,
            "2032": 76.03
          },
          "cagr": 8.21,
          "market_share": 40.42
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 27.08,
            "2021": 29.54,
            "2022": 31.46,
            "2023": 34.72,
            "2024": 36.55,
            "2025": 40.04,
            "2026": 43.27,
            "2027": 46.53,
            "2028": 50.34,
            "2029": 53.99,
            "2030": 59.34,
            "2031": 64.72,
            "2032": 69.59
          },
          "cagr": 8.22,
          "market_share": 37.0
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 16.52,
            "2021": 18.03,
            "2022": 19.2,
            "2023": 21.19,
            "2024": 22.3,
            "2025": 24.43,
            "2026": 26.41,
            "2027": 28.4,
            "2028": 30.72,
            "2029": 32.95,
            "2030": 36.22,
            "2031": 39.5,
            "2032": 42.46
          },
          "cagr": 8.22,
          "market_share": 22.58
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 39.19,
            "2021": 42.76,
            "2022": 45.54,
            "2023": 50.25,
            "2024": 52.9,
            "2025": 57.96,
            "2026": 62.64,
            "2027": 67.36,
            "2028": 72.87,
            "2029": 78.15,
            "2030": 85.89,
            "2031": 93.69,
            "2032": 100.72
          },
          "cagr": 8.21,
          "market_share": 53.55
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 34.0,
            "2021": 37.08,
            "2022": 39.49,
            "2023": 43.59,
            "2024": 45.88,
            "2025": 50.26,
            "2026": 54.32,
            "2027": 58.41,
            "2028": 63.19,
            "2029": 67.78,
            "2030": 74.5,
            "2031": 81.25,
            "2032": 87.36
          },
          "cagr": 8.22,
          "market_share": 46.45
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 33.6,
            "2021": 37.6,
            "2022": 39.67,
            "2023": 45.02,
            "2024": 47.58,
            "2025": 52.53,
            "2026": 57.57,
            "2027": 64.14,
            "2028": 69.68,
            "2029": 75.75,
            "2030": 83.63,
            "2031": 91.1,
            "2032": 100.92
          },
          "cagr": 9.78,
          "market_share": 24.97
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 26.06,
            "2021": 29.17,
            "2022": 30.77,
            "2023": 34.92,
            "2024": 36.91,
            "2025": 40.75,
            "2026": 44.65,
            "2027": 49.75,
            "2028": 54.05,
            "2029": 58.76,
            "2030": 64.87,
            "2031": 70.67,
            "2032": 78.28
          },
          "cagr": 9.77,
          "market_share": 19.37
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 35.28,
            "2021": 39.48,
            "2022": 41.65,
            "2023": 47.27,
            "2024": 49.96,
            "2025": 55.16,
            "2026": 60.44,
            "2027": 67.35,
            "2028": 73.17,
            "2029": 79.54,
            "2030": 87.82,
            "2031": 95.66,
            "2032": 105.97
          },
          "cagr": 9.78,
          "market_share": 26.22
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 23.82,
            "2021": 26.66,
            "2022": 28.12,
            "2023": 31.92,
            "2024": 33.74,
            "2025": 37.24,
            "2026": 40.81,
            "2027": 45.47,
            "2028": 49.4,
            "2029": 53.7,
            "2030": 59.29,
            "2031": 64.59,
            "2032": 71.55
          },
          "cagr": 9.78,
          "market_share": 17.71
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 15.79,
            "2021": 17.67,
            "2022": 18.66,
            "2023": 21.15,
            "2024": 22.37,
            "2025": 24.69,
            "2026": 27.07,
            "2027": 30.15,
            "2028": 32.76,
            "2029": 35.61,
            "2030": 39.33,
            "2031": 42.84,
            "2032": 47.44
          },
          "cagr": 9.78,
          "market_share": 11.74
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 32.61,
            "2021": 36.5,
            "2022": 38.51,
            "2023": 43.69,
            "2024": 46.19,
            "2025": 50.99,
            "2026": 55.88,
            "2027": 62.26,
            "2028": 67.64,
            "2029": 73.53,
            "2030": 81.18,
            "2031": 88.43,
            "2032": 97.96
          },
          "cagr": 9.78,
          "market_share": 24.24
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 39.86,
            "2021": 44.61,
            "2022": 47.07,
            "2023": 53.41,
            "2024": 56.45,
            "2025": 62.32,
            "2026": 68.3,
            "2027": 76.1,
            "2028": 82.67,
            "2029": 89.87,
            "2030": 99.23,
            "2031": 108.09,
            "2032": 119.74
          },
          "cagr": 9.78,
          "market_share": 29.62
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 18.67,
            "2021": 20.9,
            "2022": 22.05,
            "2023": 25.02,
            "2024": 26.45,
            "2025": 29.19,
            "2026": 31.99,
            "2027": 35.65,
            "2028": 38.73,
            "2029": 42.1,
            "2030": 46.48,
            "2031": 50.64,
            "2032": 56.09
          },
          "cagr": 9.78,
          "market_share": 13.88
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 19.93,
            "2021": 22.3,
            "2022": 23.53,
            "2023": 26.7,
            "2024": 28.22,
            "2025": 31.16,
            "2026": 34.15,
            "2027": 38.05,
            "2028": 41.33,
            "2029": 44.93,
            "2030": 49.61,
            "2031": 54.04,
            "2032": 59.86
          },
          "cagr": 9.78,
          "market_share": 14.81
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 23.48,
            "2021": 26.27,
            "2022": 27.71,
            "2023": 31.46,
            "2024": 33.25,
            "2025": 36.71,
            "2026": 40.22,
            "2027": 44.8,
            "2028": 48.69,
            "2029": 52.93,
            "2030": 58.44,
            "2031": 63.66,
            "2032": 70.51
          },
          "cagr": 9.77,
          "market_share": 17.45
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 50.04,
            "2021": 56.0,
            "2022": 59.08,
            "2023": 67.04,
            "2024": 70.86,
            "2025": 78.23,
            "2026": 85.73,
            "2027": 95.52,
            "2028": 103.77,
            "2029": 112.81,
            "2030": 124.55,
            "2031": 135.68,
            "2032": 150.3
          },
          "cagr": 9.78,
          "market_share": 37.19
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 84.51,
            "2021": 94.58,
            "2022": 99.79,
            "2023": 113.24,
            "2024": 119.7,
            "2025": 132.14,
            "2026": 144.81,
            "2027": 161.34,
            "2028": 175.29,
            "2029": 190.55,
            "2030": 210.39,
            "2031": 229.18,
            "2032": 253.86
          },
          "cagr": 9.78,
          "market_share": 62.81
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 70.9,
            "2021": 79.34,
            "2022": 83.71,
            "2023": 94.99,
            "2024": 100.41,
            "2025": 110.84,
            "2026": 121.47,
            "2027": 135.34,
            "2028": 147.03,
            "2029": 159.84,
            "2030": 176.48,
            "2031": 192.24,
            "2032": 212.95
          },
          "cagr": 9.78,
          "market_share": 52.69
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 63.65,
            "2021": 71.24,
            "2022": 75.16,
            "2023": 85.29,
            "2024": 90.15,
            "2025": 99.53,
            "2026": 109.07,
            "2027": 121.52,
            "2028": 132.03,
            "2029": 143.52,
            "2030": 158.46,
            "2031": 172.62,
            "2032": 191.21
          },
          "cagr": 9.78,
          "market_share": 47.31
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 62.81,
            "2021": 70.29,
            "2022": 74.16,
            "2023": 84.15,
            "2024": 88.95,
            "2025": 98.2,
            "2026": 107.61,
            "2027": 119.9,
            "2028": 130.26,
            "2029": 141.6,
            "2030": 156.34,
            "2031": 170.31,
            "2032": 188.66
          },
          "cagr": 9.78,
          "market_share": 46.68
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 38.37,
            "2021": 42.94,
            "2022": 45.31,
            "2023": 51.41,
            "2024": 54.34,
            "2025": 59.99,
            "2026": 65.74,
            "2027": 73.25,
            "2028": 79.58,
            "2029": 86.51,
            "2030": 95.52,
            "2031": 104.05,
            "2032": 115.26
          },
          "cagr": 9.78,
          "market_share": 28.52
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 33.37,
            "2021": 37.35,
            "2022": 39.4,
            "2023": 44.72,
            "2024": 47.27,
            "2025": 52.18,
            "2026": 57.19,
            "2027": 63.71,
            "2028": 69.22,
            "2029": 75.25,
            "2030": 83.08,
            "2031": 90.5,
            "2032": 100.24
          },
          "cagr": 9.78,
          "market_share": 24.81
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 63.08,
            "2021": 70.6,
            "2022": 74.48,
            "2023": 84.52,
            "2024": 89.34,
            "2025": 98.62,
            "2026": 108.08,
            "2027": 120.42,
            "2028": 130.83,
            "2029": 142.22,
            "2030": 157.03,
            "2031": 171.05,
            "2032": 189.48
          },
          "cagr": 9.78,
          "market_share": 46.88
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 71.47,
            "2021": 79.98,
            "2022": 84.39,
            "2023": 95.76,
            "2024": 101.22,
            "2025": 111.75,
            "2026": 122.46,
            "2027": 136.44,
            "2028": 148.23,
            "2029": 161.14,
            "2030": 177.91,
            "2031": 193.81,
            "2032": 214.68
          },
          "cagr": 9.78,
          "market_share": 53.12
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 9.71,
            "2021": 11.2,
            "2022": 12.61,
            "2023": 14.57,
            "2024": 16.55,
            "2025": 18.81,
            "2026": 21.17,
            "2027": 24.22,
            "2028": 27.9,
            "2029": 32.16,
            "2030": 36.4,
            "2031": 40.73,
            "2032": 46.99
          },
          "cagr": 13.97,
          "market_share": 12.33
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 17.33,
            "2021": 19.98,
            "2022": 22.5,
            "2023": 26.0,
            "2024": 29.53,
            "2025": 33.56,
            "2026": 37.78,
            "2027": 43.21,
            "2028": 49.79,
            "2029": 57.38,
            "2030": 64.95,
            "2031": 72.68,
            "2032": 83.86
          },
          "cagr": 13.98,
          "market_share": 22.01
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 15.69,
            "2021": 18.08,
            "2022": 20.36,
            "2023": 23.53,
            "2024": 26.72,
            "2025": 30.37,
            "2026": 34.2,
            "2027": 39.11,
            "2028": 45.06,
            "2029": 51.93,
            "2030": 58.78,
            "2031": 65.78,
            "2032": 75.89
          },
          "cagr": 13.98,
          "market_share": 19.91
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 20.32,
            "2021": 23.43,
            "2022": 26.38,
            "2023": 30.49,
            "2024": 34.62,
            "2025": 39.35,
            "2026": 44.3,
            "2027": 50.66,
            "2028": 58.38,
            "2029": 67.28,
            "2030": 76.15,
            "2031": 85.21,
            "2032": 98.31
          },
          "cagr": 13.97,
          "market_share": 25.8
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 15.71,
            "2021": 18.11,
            "2022": 20.39,
            "2023": 23.56,
            "2024": 26.76,
            "2025": 30.41,
            "2026": 34.24,
            "2027": 39.16,
            "2028": 45.12,
            "2029": 51.99,
            "2030": 58.86,
            "2031": 65.86,
            "2032": 75.98
          },
          "cagr": 13.98,
          "market_share": 19.94
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 21.14,
            "2021": 24.37,
            "2022": 27.44,
            "2023": 31.71,
            "2024": 36.01,
            "2025": 40.93,
            "2026": 46.08,
            "2027": 52.7,
            "2028": 60.72,
            "2029": 69.98,
            "2030": 79.21,
            "2031": 88.64,
            "2032": 102.26
          },
          "cagr": 13.97,
          "market_share": 26.84
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 11.18,
            "2021": 12.89,
            "2022": 14.52,
            "2023": 16.78,
            "2024": 19.05,
            "2025": 21.65,
            "2026": 24.38,
            "2027": 27.88,
            "2028": 32.13,
            "2029": 37.02,
            "2030": 41.91,
            "2031": 46.89,
            "2032": 54.1
          },
          "cagr": 13.98,
          "market_share": 14.2
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 17.23,
            "2021": 19.86,
            "2022": 22.36,
            "2023": 25.84,
            "2024": 29.35,
            "2025": 33.36,
            "2026": 37.55,
            "2027": 42.95,
            "2028": 49.49,
            "2029": 57.03,
            "2030": 64.56,
            "2031": 72.24,
            "2032": 83.34
          },
          "cagr": 13.97,
          "market_share": 21.87
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 17.49,
            "2021": 20.16,
            "2022": 22.7,
            "2023": 26.23,
            "2024": 29.79,
            "2025": 33.86,
            "2026": 38.12,
            "2027": 43.6,
            "2028": 50.23,
            "2029": 57.89,
            "2030": 65.53,
            "2031": 73.32,
            "2032": 84.59
          },
          "cagr": 13.97,
          "market_share": 22.2
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 11.72,
            "2021": 13.52,
            "2022": 15.22,
            "2023": 17.59,
            "2024": 19.98,
            "2025": 22.7,
            "2026": 25.56,
            "2027": 29.23,
            "2028": 33.68,
            "2029": 38.82,
            "2030": 43.93,
            "2031": 49.17,
            "2032": 56.74
          },
          "cagr": 13.98,
          "market_share": 14.89
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 42.72,
            "2021": 49.25,
            "2022": 55.46,
            "2023": 64.09,
            "2024": 72.78,
            "2025": 82.72,
            "2026": 93.13,
            "2027": 106.51,
            "2028": 122.73,
            "2029": 141.44,
            "2030": 160.1,
            "2031": 179.15,
            "2032": 206.69
          },
          "cagr": 13.98,
          "market_share": 54.24
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 36.04,
            "2021": 41.55,
            "2022": 46.78,
            "2023": 54.06,
            "2024": 61.4,
            "2025": 69.78,
            "2026": 78.56,
            "2027": 89.85,
            "2028": 103.52,
            "2029": 119.3,
            "2030": 135.04,
            "2031": 151.11,
            "2032": 174.34
          },
          "cagr": 13.97,
          "market_share": 45.76
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 45.03,
            "2021": 51.91,
            "2022": 58.44,
            "2023": 67.55,
            "2024": 76.7,
            "2025": 87.18,
            "2026": 98.15,
            "2027": 112.25,
            "2028": 129.34,
            "2029": 149.06,
            "2030": 168.72,
            "2031": 188.8,
            "2032": 217.82
          },
          "cagr": 13.98,
          "market_share": 57.16
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 33.73,
            "2021": 38.89,
            "2022": 43.8,
            "2023": 50.6,
            "2024": 57.48,
            "2025": 65.32,
            "2026": 73.54,
            "2027": 84.11,
            "2028": 96.91,
            "2029": 111.68,
            "2030": 126.42,
            "2031": 141.46,
            "2032": 163.21
          },
          "cagr": 13.98,
          "market_share": 42.84
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 23.85,
            "2021": 27.5,
            "2022": 30.96,
            "2023": 35.78,
            "2024": 40.64,
            "2025": 46.19,
            "2026": 52.0,
            "2027": 59.47,
            "2028": 68.52,
            "2029": 78.97,
            "2030": 89.38,
            "2031": 100.02,
            "2032": 115.4
          },
          "cagr": 13.97,
          "market_share": 30.29
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 29.43,
            "2021": 33.93,
            "2022": 38.2,
            "2023": 44.14,
            "2024": 50.13,
            "2025": 56.98,
            "2026": 64.15,
            "2027": 73.36,
            "2028": 84.53,
            "2029": 97.42,
            "2030": 110.27,
            "2031": 123.39,
            "2032": 142.36
          },
          "cagr": 13.97,
          "market_share": 37.36
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 25.48,
            "2021": 29.37,
            "2022": 33.08,
            "2023": 38.23,
            "2024": 43.41,
            "2025": 49.33,
            "2026": 55.54,
            "2027": 63.53,
            "2028": 73.2,
            "2029": 84.35,
            "2030": 95.49,
            "2031": 106.85,
            "2032": 123.27
          },
          "cagr": 13.98,
          "market_share": 32.35
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 29.52,
            "2021": 34.04,
            "2022": 38.32,
            "2023": 44.29,
            "2024": 50.29,
            "2025": 57.16,
            "2026": 64.35,
            "2027": 73.6,
            "2028": 84.81,
            "2029": 97.73,
            "2030": 110.63,
            "2031": 123.79,
            "2032": 142.82
          },
          "cagr": 13.98,
          "market_share": 37.48
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 49.24,
            "2021": 56.76,
            "2022": 63.92,
            "2023": 73.86,
            "2024": 83.89,
            "2025": 95.34,
            "2026": 107.34,
            "2027": 122.76,
            "2028": 141.44,
            "2029": 163.01,
            "2030": 184.51,
            "2031": 206.47,
            "2032": 238.21
          },
          "cagr": 13.98,
          "market_share": 62.52
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 10.23,
            "2021": 11.55,
            "2022": 12.85,
            "2023": 14.8,
            "2024": 16.11,
            "2025": 18.56,
            "2026": 20.51,
            "2027": 23.06,
            "2028": 26.22,
            "2029": 29.28,
            "2030": 33.28,
            "2031": 37.02,
            "2032": 41.23
          },
          "cagr": 12.08,
          "market_share": 14.6
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 15.68,
            "2021": 17.71,
            "2022": 19.71,
            "2023": 22.69,
            "2024": 24.7,
            "2025": 28.46,
            "2026": 31.44,
            "2027": 35.36,
            "2028": 40.19,
            "2029": 44.89,
            "2030": 51.02,
            "2031": 56.76,
            "2032": 63.21
          },
          "cagr": 12.07,
          "market_share": 22.39
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 15.91,
            "2021": 17.96,
            "2022": 19.99,
            "2023": 23.01,
            "2024": 25.05,
            "2025": 28.87,
            "2026": 31.89,
            "2027": 35.86,
            "2028": 40.77,
            "2029": 45.54,
            "2030": 51.75,
            "2031": 57.57,
            "2032": 64.12
          },
          "cagr": 12.07,
          "market_share": 22.7
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 18.75,
            "2021": 21.18,
            "2022": 23.56,
            "2023": 27.13,
            "2024": 29.54,
            "2025": 34.03,
            "2026": 37.59,
            "2027": 42.28,
            "2028": 48.06,
            "2029": 53.68,
            "2030": 61.01,
            "2031": 67.87,
            "2032": 75.59
          },
          "cagr": 12.08,
          "market_share": 26.77
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 9.48,
            "2021": 10.71,
            "2022": 11.92,
            "2023": 13.71,
            "2024": 14.93,
            "2025": 17.21,
            "2026": 18.99,
            "2027": 21.39,
            "2028": 24.29,
            "2029": 27.15,
            "2030": 30.83,
            "2031": 34.31,
            "2032": 38.22
          },
          "cagr": 12.07,
          "market_share": 13.53
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 18.27,
            "2021": 20.64,
            "2022": 22.96,
            "2023": 26.44,
            "2024": 28.78,
            "2025": 33.16,
            "2026": 36.63,
            "2027": 41.2,
            "2028": 46.84,
            "2029": 52.32,
            "2030": 59.45,
            "2031": 66.14,
            "2032": 73.66
          },
          "cagr": 12.08,
          "market_share": 26.09
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 11.29,
            "2021": 12.74,
            "2022": 14.18,
            "2023": 16.33,
            "2024": 17.78,
            "2025": 20.48,
            "2026": 22.62,
            "2027": 25.45,
            "2028": 28.92,
            "2029": 32.31,
            "2030": 36.72,
            "2031": 40.85,
            "2032": 45.49
          },
          "cagr": 12.08,
          "market_share": 16.12
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 9.71,
            "2021": 10.97,
            "2022": 12.21,
            "2023": 14.05,
            "2024": 15.3,
            "2025": 17.63,
            "2026": 19.47,
            "2027": 21.9,
            "2028": 24.89,
            "2029": 27.81,
            "2030": 31.6,
            "2031": 35.15,
            "2032": 39.15
          },
          "cagr": 12.07,
          "market_share": 13.87
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 17.2,
            "2021": 19.42,
            "2022": 21.61,
            "2023": 24.88,
            "2024": 27.09,
            "2025": 31.21,
            "2026": 34.48,
            "2027": 38.78,
            "2028": 44.08,
            "2029": 49.24,
            "2030": 55.96,
            "2031": 62.25,
            "2032": 69.33
          },
          "cagr": 12.08,
          "market_share": 24.55
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 13.58,
            "2021": 15.34,
            "2022": 17.07,
            "2023": 19.64,
            "2024": 21.38,
            "2025": 24.65,
            "2026": 27.22,
            "2027": 30.62,
            "2028": 34.8,
            "2029": 38.86,
            "2030": 44.16,
            "2031": 49.14,
            "2032": 54.74
          },
          "cagr": 12.07,
          "market_share": 19.38
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 32.41,
            "2021": 36.6,
            "2022": 40.72,
            "2023": 46.88,
            "2024": 51.04,
            "2025": 58.81,
            "2026": 64.96,
            "2027": 73.07,
            "2028": 83.06,
            "2029": 92.78,
            "2030": 105.43,
            "2031": 117.29,
            "2032": 130.63
          },
          "cagr": 12.08,
          "market_share": 46.26
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 37.64,
            "2021": 42.51,
            "2022": 47.31,
            "2023": 54.46,
            "2024": 59.29,
            "2025": 68.32,
            "2026": 75.46,
            "2027": 84.88,
            "2028": 96.47,
            "2029": 107.76,
            "2030": 122.46,
            "2031": 136.24,
            "2032": 151.74
          },
          "cagr": 12.07,
          "market_share": 53.74
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 34.16,
            "2021": 38.57,
            "2022": 42.92,
            "2023": 49.42,
            "2024": 53.8,
            "2025": 61.99,
            "2026": 68.47,
            "2027": 77.02,
            "2028": 87.54,
            "2029": 97.78,
            "2030": 111.12,
            "2031": 123.62,
            "2032": 137.69
          },
          "cagr": 12.08,
          "market_share": 48.76
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 35.89,
            "2021": 40.54,
            "2022": 45.11,
            "2023": 51.92,
            "2024": 56.53,
            "2025": 65.14,
            "2026": 71.95,
            "2027": 80.93,
            "2028": 91.99,
            "2029": 102.76,
            "2030": 116.77,
            "2031": 129.91,
            "2032": 144.68
          },
          "cagr": 12.07,
          "market_share": 51.24
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 17.81,
            "2021": 20.12,
            "2022": 22.39,
            "2023": 25.77,
            "2024": 28.06,
            "2025": 32.33,
            "2026": 35.71,
            "2027": 40.17,
            "2028": 45.66,
            "2029": 51.0,
            "2030": 57.96,
            "2031": 64.48,
            "2032": 71.81
          },
          "cagr": 12.08,
          "market_share": 25.43
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 25.58,
            "2021": 28.89,
            "2022": 32.15,
            "2023": 37.01,
            "2024": 40.3,
            "2025": 46.43,
            "2026": 51.28,
            "2027": 57.69,
            "2028": 65.57,
            "2029": 73.24,
            "2030": 83.23,
            "2031": 92.59,
            "2032": 103.13
          },
          "cagr": 12.08,
          "market_share": 36.53
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 26.66,
            "2021": 30.1,
            "2022": 33.49,
            "2023": 38.56,
            "2024": 41.97,
            "2025": 48.37,
            "2026": 53.43,
            "2027": 60.09,
            "2028": 68.3,
            "2029": 76.3,
            "2030": 86.7,
            "2031": 96.46,
            "2032": 107.43
          },
          "cagr": 12.07,
          "market_share": 38.04
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 40.55,
            "2021": 45.79,
            "2022": 50.96,
            "2023": 58.66,
            "2024": 63.87,
            "2025": 73.59,
            "2026": 81.29,
            "2027": 91.43,
            "2028": 103.93,
            "2029": 116.09,
            "2030": 131.92,
            "2031": 146.76,
            "2032": 163.46
          },
          "cagr": 12.08,
          "market_share": 57.89
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 29.5,
            "2021": 33.32,
            "2022": 37.07,
            "2023": 42.68,
            "2024": 46.46,
            "2025": 53.54,
            "2026": 59.13,
            "2027": 66.52,
            "2028": 75.6,
            "2029": 84.45,
            "2030": 95.97,
            "2031": 106.77,
            "2032": 118.91
          },
          "cagr": 12.07,
          "market_share": 42.11
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 44.12,
            "2021": 46.83,
            "2022": 49.79,
            "2023": 53.48,
            "2024": 58.05,
            "2025": 62.62,
            "2026": 67.81,
            "2027": 72.39,
            "2028": 76.57,
            "2029": 82.21,
            "2030": 87.14,
            "2031": 94.81,
            "2032": 102.81
          },
          "cagr": 7.34,
          "market_share": 31.31
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 25.5,
            "2021": 27.07,
            "2022": 28.78,
            "2023": 30.91,
            "2024": 33.55,
            "2025": 36.19,
            "2026": 39.19,
            "2027": 41.84,
            "2028": 44.26,
            "2029": 47.52,
            "2030": 50.37,
            "2031": 54.8,
            "2032": 59.43
          },
          "cagr": 7.34,
          "market_share": 18.09
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 19.07,
            "2021": 20.25,
            "2022": 21.53,
            "2023": 23.12,
            "2024": 25.09,
            "2025": 27.07,
            "2026": 29.31,
            "2027": 31.29,
            "2028": 33.1,
            "2029": 35.54,
            "2030": 37.67,
            "2031": 40.99,
            "2032": 44.45
          },
          "cagr": 7.34,
          "market_share": 13.53
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 35.14,
            "2021": 37.31,
            "2022": 39.66,
            "2023": 42.6,
            "2024": 46.24,
            "2025": 49.88,
            "2026": 54.01,
            "2027": 57.66,
            "2028": 60.99,
            "2029": 65.48,
            "2030": 69.41,
            "2031": 75.52,
            "2032": 81.9
          },
          "cagr": 7.34,
          "market_share": 24.94
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 17.11,
            "2021": 18.15,
            "2022": 19.31,
            "2023": 20.72,
            "2024": 22.5,
            "2025": 24.28,
            "2026": 26.29,
            "2027": 28.07,
            "2028": 29.68,
            "2029": 31.87,
            "2030": 33.78,
            "2031": 36.76,
            "2032": 39.85
          },
          "cagr": 7.33,
          "market_share": 12.13
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 18.12,
            "2021": 19.24,
            "2022": 20.45,
            "2023": 21.96,
            "2024": 23.84,
            "2025": 25.72,
            "2026": 27.85,
            "2027": 29.73,
            "2028": 31.45,
            "2029": 33.77,
            "2030": 35.79,
            "2031": 38.94,
            "2032": 42.23
          },
          "cagr": 7.34,
          "market_share": 12.86
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 23.93,
            "2021": 25.41,
            "2022": 27.01,
            "2023": 29.01,
            "2024": 31.49,
            "2025": 33.97,
            "2026": 36.79,
            "2027": 39.27,
            "2028": 41.54,
            "2029": 44.6,
            "2030": 47.27,
            "2031": 51.44,
            "2032": 55.78
          },
          "cagr": 7.34,
          "market_share": 16.98
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 33.74,
            "2021": 35.82,
            "2022": 38.08,
            "2023": 40.9,
            "2024": 44.39,
            "2025": 47.89,
            "2026": 51.86,
            "2027": 55.36,
            "2028": 58.56,
            "2029": 62.87,
            "2030": 66.64,
            "2031": 72.51,
            "2032": 78.63
          },
          "cagr": 7.34,
          "market_share": 23.94
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 32.98,
            "2021": 35.01,
            "2022": 37.22,
            "2023": 39.98,
            "2024": 43.39,
            "2025": 46.81,
            "2026": 50.69,
            "2027": 54.12,
            "2028": 57.24,
            "2029": 61.46,
            "2030": 65.14,
            "2031": 70.88,
            "2032": 76.86
          },
          "cagr": 7.34,
          "market_share": 23.4
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 32.17,
            "2021": 34.13,
            "2022": 36.31,
            "2023": 38.98,
            "2024": 42.32,
            "2025": 45.65,
            "2026": 49.42,
            "2027": 52.77,
            "2028": 55.81,
            "2029": 59.92,
            "2030": 63.53,
            "2031": 69.11,
            "2032": 74.94
          },
          "cagr": 7.34,
          "market_share": 22.82
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 66.42,
            "2021": 70.5,
            "2022": 74.96,
            "2023": 80.5,
            "2024": 87.38,
            "2025": 94.27,
            "2026": 102.08,
            "2027": 108.97,
            "2028": 115.27,
            "2029": 123.76,
            "2030": 131.18,
            "2031": 142.73,
            "2032": 154.78
          },
          "cagr": 7.34,
          "market_share": 47.12
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 74.52,
            "2021": 79.11,
            "2022": 84.11,
            "2023": 90.33,
            "2024": 98.05,
            "2025": 105.77,
            "2026": 114.53,
            "2027": 122.28,
            "2028": 129.33,
            "2029": 138.86,
            "2030": 147.19,
            "2031": 160.15,
            "2032": 173.66
          },
          "cagr": 7.34,
          "market_share": 52.88
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 51.71,
            "2021": 54.89,
            "2022": 58.35,
            "2023": 62.67,
            "2024": 68.03,
            "2025": 73.39,
            "2026": 79.47,
            "2027": 84.83,
            "2028": 89.73,
            "2029": 96.34,
            "2030": 102.12,
            "2031": 111.11,
            "2032": 120.49
          },
          "cagr": 7.34,
          "market_share": 36.69
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 89.23,
            "2021": 94.72,
            "2022": 100.72,
            "2023": 108.16,
            "2024": 117.4,
            "2025": 126.65,
            "2026": 137.14,
            "2027": 146.42,
            "2028": 154.87,
            "2029": 166.28,
            "2030": 176.25,
            "2031": 191.77,
            "2032": 207.95
          },
          "cagr": 7.34,
          "market_share": 63.31
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 40.29,
            "2021": 42.77,
            "2022": 45.48,
            "2023": 48.84,
            "2024": 53.01,
            "2025": 57.19,
            "2026": 61.93,
            "2027": 66.11,
            "2028": 69.93,
            "2029": 75.08,
            "2030": 79.58,
            "2031": 86.59,
            "2032": 93.9
          },
          "cagr": 7.34,
          "market_share": 28.59
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 38.93,
            "2021": 41.33,
            "2022": 43.94,
            "2023": 47.19,
            "2024": 51.22,
            "2025": 55.26,
            "2026": 59.83,
            "2027": 63.88,
            "2028": 67.56,
            "2029": 72.54,
            "2030": 76.89,
            "2031": 83.66,
            "2032": 90.72
          },
          "cagr": 7.34,
          "market_share": 27.62
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 61.72,
            "2021": 65.51,
            "2022": 69.65,
            "2023": 74.8,
            "2024": 81.2,
            "2025": 87.59,
            "2026": 94.85,
            "2027": 101.26,
            "2028": 107.11,
            "2029": 115.0,
            "2030": 121.9,
            "2031": 132.63,
            "2032": 143.82
          },
          "cagr": 7.34,
          "market_share": 43.79
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 72.98,
            "2021": 77.47,
            "2022": 82.36,
            "2023": 88.46,
            "2024": 96.01,
            "2025": 103.58,
            "2026": 112.16,
            "2027": 119.74,
            "2028": 126.65,
            "2029": 135.98,
            "2030": 144.14,
            "2031": 156.83,
            "2032": 170.06
          },
          "cagr": 7.34,
          "market_share": 51.78
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 67.96,
            "2021": 72.14,
            "2022": 76.71,
            "2023": 82.37,
            "2024": 89.42,
            "2025": 96.46,
            "2026": 104.45,
            "2027": 111.51,
            "2028": 117.95,
            "2029": 126.64,
            "2030": 134.23,
            "2031": 146.05,
            "2032": 158.38
          },
          "cagr": 7.34,
          "market_share": 48.22
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 27.71,
            "2021": 30.77,
            "2022": 34.76,
            "2023": 39.54,
            "2024": 44.56,
            "2025": 50.73,
            "2026": 56.57,
            "2027": 63.08,
            "2028": 70.51,
            "2029": 79.68,
            "2030": 89.05,
            "2031": 99.98,
            "2032": 114.46
          },
          "cagr": 12.33,
          "market_share": 25.04
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 19.36,
            "2021": 21.49,
            "2022": 24.28,
            "2023": 27.62,
            "2024": 31.13,
            "2025": 35.43,
            "2026": 39.51,
            "2027": 44.06,
            "2028": 49.26,
            "2029": 55.66,
            "2030": 62.2,
            "2031": 69.83,
            "2032": 79.96
          },
          "cagr": 12.33,
          "market_share": 17.49
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 16.31,
            "2021": 18.1,
            "2022": 20.46,
            "2023": 23.27,
            "2024": 26.22,
            "2025": 29.85,
            "2026": 33.29,
            "2027": 37.12,
            "2028": 41.49,
            "2029": 46.88,
            "2030": 52.4,
            "2031": 58.83,
            "2032": 67.35
          },
          "cagr": 12.33,
          "market_share": 14.73
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 30.75,
            "2021": 34.14,
            "2022": 38.57,
            "2023": 43.87,
            "2024": 49.44,
            "2025": 56.28,
            "2026": 62.76,
            "2027": 69.99,
            "2028": 78.24,
            "2029": 88.4,
            "2030": 98.8,
            "2031": 110.92,
            "2032": 127.0
          },
          "cagr": 12.33,
          "market_share": 27.78
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 16.56,
            "2021": 18.38,
            "2022": 20.78,
            "2023": 23.62,
            "2024": 26.64,
            "2025": 30.32,
            "2026": 33.81,
            "2027": 37.69,
            "2028": 42.14,
            "2029": 47.62,
            "2030": 53.23,
            "2031": 59.75,
            "2032": 68.41
          },
          "cagr": 12.33,
          "market_share": 14.97
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 22.74,
            "2021": 25.25,
            "2022": 28.53,
            "2023": 32.45,
            "2024": 36.57,
            "2025": 41.63,
            "2026": 46.43,
            "2027": 51.77,
            "2028": 57.87,
            "2029": 65.39,
            "2030": 73.09,
            "2031": 82.05,
            "2032": 93.94
          },
          "cagr": 12.33,
          "market_share": 20.55
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 21.6,
            "2021": 23.98,
            "2022": 27.1,
            "2023": 30.82,
            "2024": 34.73,
            "2025": 39.54,
            "2026": 44.09,
            "2027": 49.16,
            "2028": 54.96,
            "2029": 62.1,
            "2030": 69.41,
            "2031": 77.92,
            "2032": 89.21
          },
          "cagr": 12.33,
          "market_share": 19.51
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 16.6,
            "2021": 18.42,
            "2022": 20.82,
            "2023": 23.68,
            "2024": 26.69,
            "2025": 30.38,
            "2026": 33.88,
            "2027": 37.77,
            "2028": 42.23,
            "2029": 47.72,
            "2030": 53.33,
            "2031": 59.87,
            "2032": 68.55
          },
          "cagr": 12.33,
          "market_share": 15.0
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 29.02,
            "2021": 32.22,
            "2022": 36.41,
            "2023": 41.41,
            "2024": 46.67,
            "2025": 53.13,
            "2026": 59.25,
            "2027": 66.06,
            "2028": 73.85,
            "2029": 83.45,
            "2030": 93.26,
            "2031": 104.71,
            "2032": 119.88
          },
          "cagr": 12.33,
          "market_share": 26.22
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 20.73,
            "2021": 23.01,
            "2022": 25.99,
            "2023": 29.56,
            "2024": 33.33,
            "2025": 37.93,
            "2026": 42.29,
            "2027": 47.18,
            "2028": 52.73,
            "2029": 59.58,
            "2030": 66.59,
            "2031": 74.76,
            "2032": 85.6
          },
          "cagr": 12.33,
          "market_share": 18.73
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 56.18,
            "2021": 62.37,
            "2022": 70.48,
            "2023": 80.16,
            "2024": 90.34,
            "2025": 102.84,
            "2026": 114.68,
            "2027": 127.88,
            "2028": 142.96,
            "2029": 161.53,
            "2030": 180.54,
            "2031": 202.68,
            "2032": 232.06
          },
          "cagr": 12.33,
          "market_share": 50.76
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 54.51,
            "2021": 60.51,
            "2022": 68.37,
            "2023": 77.76,
            "2024": 87.65,
            "2025": 99.77,
            "2026": 111.26,
            "2027": 124.06,
            "2028": 138.68,
            "2029": 156.71,
            "2030": 175.14,
            "2031": 196.63,
            "2032": 225.12
          },
          "cagr": 12.33,
          "market_share": 49.25
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 36.62,
            "2021": 40.66,
            "2022": 45.94,
            "2023": 52.25,
            "2024": 58.89,
            "2025": 67.03,
            "2026": 74.76,
            "2027": 83.36,
            "2028": 93.18,
            "2029": 105.29,
            "2030": 117.68,
            "2031": 132.12,
            "2032": 151.26
          },
          "cagr": 12.33,
          "market_share": 33.09
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 74.07,
            "2021": 82.22,
            "2022": 92.91,
            "2023": 105.67,
            "2024": 119.1,
            "2025": 135.58,
            "2026": 151.18,
            "2027": 168.58,
            "2028": 188.46,
            "2029": 212.95,
            "2030": 238.0,
            "2031": 267.19,
            "2032": 305.92
          },
          "cagr": 12.33,
          "market_share": 66.92
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 30.31,
            "2021": 33.65,
            "2022": 38.03,
            "2023": 43.25,
            "2024": 48.74,
            "2025": 55.49,
            "2026": 61.88,
            "2027": 69.0,
            "2028": 77.13,
            "2029": 87.15,
            "2030": 97.41,
            "2031": 109.35,
            "2032": 125.2
          },
          "cagr": 12.33,
          "market_share": 27.39
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 41.54,
            "2021": 46.12,
            "2022": 52.12,
            "2023": 59.27,
            "2024": 66.8,
            "2025": 76.04,
            "2026": 84.8,
            "2027": 94.56,
            "2028": 105.71,
            "2029": 119.44,
            "2030": 133.5,
            "2031": 149.87,
            "2032": 171.59
          },
          "cagr": 12.33,
          "market_share": 37.53
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 38.84,
            "2021": 43.11,
            "2022": 48.7,
            "2023": 55.4,
            "2024": 62.45,
            "2025": 71.08,
            "2026": 79.26,
            "2027": 88.38,
            "2028": 98.8,
            "2029": 111.65,
            "2030": 124.77,
            "2031": 140.09,
            "2032": 160.39
          },
          "cagr": 12.33,
          "market_share": 35.09
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 44.36,
            "2021": 49.24,
            "2022": 55.64,
            "2023": 63.28,
            "2024": 71.33,
            "2025": 81.19,
            "2026": 90.54,
            "2027": 100.96,
            "2028": 112.86,
            "2029": 127.53,
            "2030": 142.53,
            "2031": 160.02,
            "2032": 183.21
          },
          "cagr": 12.33,
          "market_share": 40.08
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 66.33,
            "2021": 73.64,
            "2022": 83.21,
            "2023": 94.64,
            "2024": 106.66,
            "2025": 121.42,
            "2026": 135.4,
            "2027": 150.98,
            "2028": 168.78,
            "2029": 190.71,
            "2030": 213.15,
            "2031": 239.29,
            "2032": 273.97
          },
          "cagr": 12.33,
          "market_share": 59.93
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 16.75,
            "2021": 19.19,
            "2022": 21.19,
            "2023": 24.3,
            "2024": 27.57,
            "2025": 31.31,
            "2026": 36.6,
            "2027": 40.23,
            "2028": 45.75,
            "2029": 53.81,
            "2030": 59.2,
            "2031": 69.3,
            "2032": 76.75
          },
          "cagr": 13.67,
          "market_share": 21.14
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 11.75,
            "2021": 13.46,
            "2022": 14.86,
            "2023": 17.04,
            "2024": 19.34,
            "2025": 21.97,
            "2026": 25.67,
            "2027": 28.22,
            "2028": 32.09,
            "2029": 37.75,
            "2030": 41.53,
            "2031": 48.62,
            "2032": 53.84
          },
          "cagr": 13.66,
          "market_share": 14.83
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 12.78,
            "2021": 14.64,
            "2022": 16.16,
            "2023": 18.53,
            "2024": 21.02,
            "2025": 23.88,
            "2026": 27.91,
            "2027": 30.68,
            "2028": 34.89,
            "2029": 41.04,
            "2030": 45.14,
            "2031": 52.85,
            "2032": 58.53
          },
          "cagr": 13.66,
          "market_share": 16.12
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 15.8,
            "2021": 18.1,
            "2022": 19.98,
            "2023": 22.91,
            "2024": 26.0,
            "2025": 29.53,
            "2026": 34.51,
            "2027": 37.94,
            "2028": 43.15,
            "2029": 50.75,
            "2030": 55.83,
            "2031": 65.36,
            "2032": 72.38
          },
          "cagr": 13.66,
          "market_share": 19.94
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 22.16,
            "2021": 25.39,
            "2022": 28.05,
            "2023": 32.16,
            "2024": 36.48,
            "2025": 41.42,
            "2026": 48.43,
            "2027": 53.25,
            "2028": 60.53,
            "2029": 71.2,
            "2030": 78.32,
            "2031": 91.7,
            "2032": 101.53
          },
          "cagr": 13.66,
          "market_share": 27.97
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 19.76,
            "2021": 22.63,
            "2022": 24.99,
            "2023": 28.65,
            "2024": 32.51,
            "2025": 36.93,
            "2026": 43.16,
            "2027": 47.45,
            "2028": 53.95,
            "2029": 63.46,
            "2030": 69.81,
            "2031": 81.73,
            "2032": 90.5
          },
          "cagr": 13.66,
          "market_share": 24.93
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 18.32,
            "2021": 20.98,
            "2022": 23.17,
            "2023": 26.57,
            "2024": 30.14,
            "2025": 34.24,
            "2026": 40.01,
            "2027": 43.99,
            "2028": 50.02,
            "2029": 58.84,
            "2030": 64.72,
            "2031": 75.77,
            "2032": 83.91
          },
          "cagr": 13.66,
          "market_share": 23.11
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 12.64,
            "2021": 14.48,
            "2022": 15.99,
            "2023": 18.33,
            "2024": 20.8,
            "2025": 23.62,
            "2026": 27.61,
            "2027": 30.35,
            "2028": 34.51,
            "2029": 40.6,
            "2030": 44.66,
            "2031": 52.28,
            "2032": 57.9
          },
          "cagr": 13.67,
          "market_share": 15.95
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 15.72,
            "2021": 18.01,
            "2022": 19.88,
            "2023": 22.8,
            "2024": 25.87,
            "2025": 29.38,
            "2026": 34.34,
            "2027": 37.75,
            "2028": 42.93,
            "2029": 50.5,
            "2030": 55.55,
            "2031": 65.03,
            "2032": 72.02
          },
          "cagr": 13.67,
          "market_share": 19.84
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 12.8,
            "2021": 14.68,
            "2022": 16.21,
            "2023": 18.59,
            "2024": 21.09,
            "2025": 23.94,
            "2026": 28.0,
            "2027": 30.78,
            "2028": 35.0,
            "2029": 41.15,
            "2030": 45.28,
            "2031": 53.02,
            "2032": 58.7
          },
          "cagr": 13.67,
          "market_share": 16.17
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 44.52,
            "2021": 51.0,
            "2022": 56.32,
            "2023": 64.57,
            "2024": 73.27,
            "2025": 83.21,
            "2026": 97.26,
            "2027": 106.93,
            "2028": 121.59,
            "2029": 143.01,
            "2030": 157.32,
            "2031": 184.18,
            "2032": 203.96
          },
          "cagr": 13.66,
          "market_share": 56.18
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 34.72,
            "2021": 39.78,
            "2022": 43.92,
            "2023": 50.37,
            "2024": 57.14,
            "2025": 64.9,
            "2026": 75.86,
            "2027": 83.39,
            "2028": 94.82,
            "2029": 111.54,
            "2030": 122.7,
            "2031": 143.65,
            "2032": 159.07
          },
          "cagr": 13.66,
          "market_share": 43.82
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 38.34,
            "2021": 43.92,
            "2022": 48.5,
            "2023": 55.61,
            "2024": 63.1,
            "2025": 71.66,
            "2026": 83.76,
            "2027": 92.08,
            "2028": 104.71,
            "2029": 123.16,
            "2030": 135.48,
            "2031": 158.61,
            "2032": 175.65
          },
          "cagr": 13.66,
          "market_share": 48.39
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 40.9,
            "2021": 46.86,
            "2022": 51.74,
            "2023": 59.33,
            "2024": 67.31,
            "2025": 76.45,
            "2026": 89.36,
            "2027": 98.24,
            "2028": 111.7,
            "2029": 131.39,
            "2030": 144.54,
            "2031": 169.22,
            "2032": 187.38
          },
          "cagr": 13.66,
          "market_share": 51.61
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 17.23,
            "2021": 19.73,
            "2022": 21.79,
            "2023": 24.98,
            "2024": 28.35,
            "2025": 32.2,
            "2026": 37.63,
            "2027": 41.37,
            "2028": 47.04,
            "2029": 55.33,
            "2030": 60.87,
            "2031": 71.26,
            "2032": 78.92
          },
          "cagr": 13.66,
          "market_share": 21.74
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 30.8,
            "2021": 35.29,
            "2022": 38.96,
            "2023": 44.68,
            "2024": 50.69,
            "2025": 57.57,
            "2026": 67.29,
            "2027": 73.98,
            "2028": 84.12,
            "2029": 98.95,
            "2030": 108.84,
            "2031": 127.43,
            "2032": 141.11
          },
          "cagr": 13.66,
          "market_share": 38.87
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 31.21,
            "2021": 35.76,
            "2022": 39.49,
            "2023": 45.28,
            "2024": 51.37,
            "2025": 58.34,
            "2026": 68.2,
            "2027": 74.97,
            "2028": 85.25,
            "2029": 100.27,
            "2030": 110.31,
            "2031": 129.14,
            "2032": 143.0
          },
          "cagr": 13.66,
          "market_share": 39.39
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 58.83,
            "2021": 67.4,
            "2022": 74.42,
            "2023": 85.33,
            "2024": 96.82,
            "2025": 109.96,
            "2026": 128.52,
            "2027": 141.29,
            "2028": 160.67,
            "2029": 188.98,
            "2030": 207.89,
            "2031": 243.38,
            "2032": 269.52
          },
          "cagr": 13.66,
          "market_share": 74.24
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 20.41,
            "2021": 23.38,
            "2022": 25.82,
            "2023": 29.61,
            "2024": 33.59,
            "2025": 38.15,
            "2026": 44.6,
            "2027": 49.03,
            "2028": 55.74,
            "2029": 65.57,
            "2030": 72.13,
            "2031": 84.45,
            "2032": 93.51
          },
          "cagr": 13.66,
          "market_share": 25.76
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 34.11,
            "2021": 37.96,
            "2022": 41.15,
            "2023": 44.99,
            "2024": 50.19,
            "2025": 55.64,
            "2026": 59.92,
            "2027": 65.25,
            "2028": 73.11,
            "2029": 80.93,
            "2030": 87.59,
            "2031": 95.81,
            "2032": 107.11
          },
          "cagr": 9.81,
          "market_share": 25.6
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 32.06,
            "2021": 35.67,
            "2022": 38.67,
            "2023": 42.28,
            "2024": 47.17,
            "2025": 52.29,
            "2026": 56.32,
            "2027": 61.32,
            "2028": 68.71,
            "2029": 76.06,
            "2030": 82.32,
            "2031": 90.05,
            "2032": 100.67
          },
          "cagr": 9.81,
          "market_share": 24.06
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 21.97,
            "2021": 24.45,
            "2022": 26.5,
            "2023": 28.98,
            "2024": 32.33,
            "2025": 35.84,
            "2026": 38.6,
            "2027": 42.03,
            "2028": 47.09,
            "2029": 52.13,
            "2030": 56.42,
            "2031": 61.72,
            "2032": 69.0
          },
          "cagr": 9.81,
          "market_share": 16.49
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 19.57,
            "2021": 21.78,
            "2022": 23.61,
            "2023": 25.81,
            "2024": 28.8,
            "2025": 31.92,
            "2026": 34.38,
            "2027": 37.44,
            "2028": 41.95,
            "2029": 46.44,
            "2030": 50.26,
            "2031": 54.98,
            "2032": 61.46
          },
          "cagr": 9.81,
          "market_share": 14.69
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 25.5,
            "2021": 28.38,
            "2022": 30.77,
            "2023": 33.64,
            "2024": 37.54,
            "2025": 41.61,
            "2026": 44.82,
            "2027": 48.8,
            "2028": 54.67,
            "2029": 60.54,
            "2030": 65.5,
            "2031": 71.64,
            "2032": 80.1
          },
          "cagr": 9.81,
          "market_share": 19.15
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 28.4,
            "2021": 31.61,
            "2022": 34.26,
            "2023": 37.46,
            "2024": 41.8,
            "2025": 46.33,
            "2026": 49.9,
            "2027": 54.33,
            "2028": 60.88,
            "2029": 67.4,
            "2030": 72.94,
            "2031": 79.78,
            "2032": 89.19
          },
          "cagr": 9.81,
          "market_share": 21.32
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 27.87,
            "2021": 31.02,
            "2022": 33.62,
            "2023": 36.76,
            "2024": 41.01,
            "2025": 45.46,
            "2026": 48.97,
            "2027": 53.32,
            "2028": 59.74,
            "2029": 66.13,
            "2030": 71.57,
            "2031": 78.29,
            "2032": 87.52
          },
          "cagr": 9.81,
          "market_share": 20.92
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 27.0,
            "2021": 30.05,
            "2022": 32.58,
            "2023": 35.62,
            "2024": 39.74,
            "2025": 44.05,
            "2026": 47.45,
            "2027": 51.66,
            "2028": 57.88,
            "2029": 64.08,
            "2030": 69.35,
            "2031": 75.86,
            "2032": 84.81
          },
          "cagr": 9.81,
          "market_share": 20.27
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 26.05,
            "2021": 28.99,
            "2022": 31.42,
            "2023": 34.35,
            "2024": 38.33,
            "2025": 42.49,
            "2026": 45.76,
            "2027": 49.83,
            "2028": 55.83,
            "2029": 61.81,
            "2030": 66.89,
            "2031": 73.17,
            "2032": 81.8
          },
          "cagr": 9.81,
          "market_share": 19.55
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 23.89,
            "2021": 26.57,
            "2022": 28.82,
            "2023": 31.51,
            "2024": 35.15,
            "2025": 38.97,
            "2026": 41.96,
            "2027": 45.7,
            "2028": 51.2,
            "2029": 56.68,
            "2030": 61.34,
            "2031": 67.1,
            "2032": 75.02
          },
          "cagr": 9.81,
          "market_share": 17.93
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 42.07,
            "2021": 46.82,
            "2022": 50.75,
            "2023": 55.49,
            "2024": 61.91,
            "2025": 68.63,
            "2026": 73.92,
            "2027": 80.48,
            "2028": 90.18,
            "2029": 99.83,
            "2030": 108.04,
            "2031": 118.18,
            "2032": 132.12
          },
          "cagr": 9.81,
          "market_share": 31.58
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 91.14,
            "2021": 101.42,
            "2022": 109.95,
            "2023": 120.21,
            "2024": 134.12,
            "2025": 148.67,
            "2026": 160.12,
            "2027": 174.36,
            "2028": 195.35,
            "2029": 216.27,
            "2030": 234.05,
            "2031": 256.02,
            "2032": 286.22
          },
          "cagr": 9.81,
          "market_share": 68.42
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 58.94,
            "2021": 65.59,
            "2022": 71.1,
            "2023": 77.73,
            "2024": 86.73,
            "2025": 96.14,
            "2026": 103.55,
            "2027": 112.75,
            "2028": 126.33,
            "2029": 139.86,
            "2030": 151.35,
            "2031": 165.56,
            "2032": 185.09
          },
          "cagr": 9.81,
          "market_share": 44.24
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 74.27,
            "2021": 82.65,
            "2022": 89.6,
            "2023": 97.97,
            "2024": 109.3,
            "2025": 121.16,
            "2026": 130.49,
            "2027": 142.09,
            "2028": 159.2,
            "2029": 176.24,
            "2030": 190.74,
            "2031": 208.64,
            "2032": 233.25
          },
          "cagr": 9.81,
          "market_share": 55.76
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 41.7,
            "2021": 46.4,
            "2022": 50.3,
            "2023": 55.0,
            "2024": 61.36,
            "2025": 68.02,
            "2026": 73.26,
            "2027": 79.77,
            "2028": 89.38,
            "2029": 98.95,
            "2030": 107.08,
            "2031": 117.14,
            "2032": 130.95
          },
          "cagr": 9.81,
          "market_share": 31.3
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 43.45,
            "2021": 48.35,
            "2022": 52.42,
            "2023": 57.31,
            "2024": 63.94,
            "2025": 70.88,
            "2026": 76.34,
            "2027": 83.12,
            "2028": 93.14,
            "2029": 103.11,
            "2030": 111.58,
            "2031": 122.06,
            "2032": 136.46
          },
          "cagr": 9.81,
          "market_share": 32.62
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 48.06,
            "2021": 53.49,
            "2022": 57.98,
            "2023": 63.39,
            "2024": 70.73,
            "2025": 78.4,
            "2026": 84.44,
            "2027": 91.95,
            "2028": 103.01,
            "2029": 114.04,
            "2030": 123.43,
            "2031": 135.0,
            "2032": 150.93
          },
          "cagr": 9.81,
          "market_share": 36.08
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 55.52,
            "2021": 61.79,
            "2022": 66.98,
            "2023": 73.23,
            "2024": 81.71,
            "2025": 90.57,
            "2026": 97.55,
            "2027": 106.22,
            "2028": 119.01,
            "2029": 131.75,
            "2030": 142.59,
            "2031": 155.97,
            "2032": 174.37
          },
          "cagr": 9.81,
          "market_share": 41.68
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 77.69,
            "2021": 86.45,
            "2022": 93.72,
            "2023": 102.47,
            "2024": 114.32,
            "2025": 126.73,
            "2026": 136.49,
            "2027": 148.62,
            "2028": 166.52,
            "2029": 184.35,
            "2030": 199.5,
            "2031": 218.23,
            "2032": 243.97
          },
          "cagr": 9.81,
          "market_share": 58.32
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 24.58,
            "2021": 28.45,
            "2022": 32.57,
            "2023": 37.1,
            "2024": 42.11,
            "2025": 49.44,
            "2026": 56.28,
            "2027": 64.55,
            "2028": 73.9,
            "2029": 83.86,
            "2030": 97.66,
            "2031": 108.66,
            "2032": 126.66
          },
          "cagr": 14.38,
          "market_share": 23.65
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 18.37,
            "2021": 21.26,
            "2022": 24.34,
            "2023": 27.73,
            "2024": 31.47,
            "2025": 36.95,
            "2026": 42.06,
            "2027": 48.24,
            "2028": 55.23,
            "2029": 62.68,
            "2030": 72.99,
            "2031": 81.22,
            "2032": 94.67
          },
          "cagr": 14.39,
          "market_share": 17.67
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 25.09,
            "2021": 29.05,
            "2022": 33.25,
            "2023": 37.88,
            "2024": 42.99,
            "2025": 50.48,
            "2026": 57.46,
            "2027": 65.9,
            "2028": 75.45,
            "2029": 85.63,
            "2030": 99.72,
            "2031": 110.95,
            "2032": 129.33
          },
          "cagr": 14.38,
          "market_share": 24.14
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 15.97,
            "2021": 18.49,
            "2022": 21.16,
            "2023": 24.11,
            "2024": 27.36,
            "2025": 32.13,
            "2026": 36.57,
            "2027": 41.95,
            "2028": 48.02,
            "2029": 54.5,
            "2030": 63.47,
            "2031": 70.62,
            "2032": 82.31
          },
          "cagr": 14.38,
          "market_share": 15.37
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 19.92,
            "2021": 23.05,
            "2022": 26.4,
            "2023": 30.07,
            "2024": 34.13,
            "2025": 40.06,
            "2026": 45.63,
            "2027": 52.32,
            "2028": 59.89,
            "2029": 67.98,
            "2030": 79.16,
            "2031": 88.08,
            "2032": 102.66
          },
          "cagr": 14.39,
          "market_share": 19.17
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 18.77,
            "2021": 21.72,
            "2022": 24.86,
            "2023": 28.33,
            "2024": 32.15,
            "2025": 37.75,
            "2026": 42.97,
            "2027": 49.28,
            "2028": 56.42,
            "2029": 64.03,
            "2030": 74.57,
            "2031": 82.97,
            "2032": 96.71
          },
          "cagr": 14.38,
          "market_share": 18.06
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 22.34,
            "2021": 25.86,
            "2022": 29.6,
            "2023": 33.72,
            "2024": 38.27,
            "2025": 44.93,
            "2026": 51.15,
            "2027": 58.66,
            "2028": 67.16,
            "2029": 76.22,
            "2030": 88.76,
            "2031": 98.76,
            "2032": 115.12
          },
          "cagr": 14.39,
          "market_share": 21.49
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 23.16,
            "2021": 26.81,
            "2022": 30.69,
            "2023": 34.96,
            "2024": 39.68,
            "2025": 46.59,
            "2026": 53.03,
            "2027": 60.82,
            "2028": 69.63,
            "2029": 79.03,
            "2030": 92.03,
            "2031": 102.4,
            "2032": 119.35
          },
          "cagr": 14.38,
          "market_share": 22.28
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 16.57,
            "2021": 19.18,
            "2022": 21.96,
            "2023": 25.01,
            "2024": 28.39,
            "2025": 33.33,
            "2026": 37.95,
            "2027": 43.52,
            "2028": 49.82,
            "2029": 56.54,
            "2030": 65.85,
            "2031": 73.27,
            "2032": 85.4
          },
          "cagr": 14.39,
          "market_share": 15.94
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 23.09,
            "2021": 26.73,
            "2022": 30.61,
            "2023": 34.87,
            "2024": 39.57,
            "2025": 46.46,
            "2026": 52.9,
            "2027": 60.68,
            "2028": 69.46,
            "2029": 78.83,
            "2030": 91.79,
            "2031": 102.13,
            "2032": 119.05
          },
          "cagr": 14.39,
          "market_share": 22.22
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 42.85,
            "2021": 49.6,
            "2022": 56.78,
            "2023": 64.68,
            "2024": 73.41,
            "2025": 86.19,
            "2026": 98.12,
            "2027": 112.53,
            "2028": 128.83,
            "2029": 146.21,
            "2030": 170.27,
            "2031": 189.45,
            "2032": 220.83
          },
          "cagr": 14.39,
          "market_share": 41.23
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 61.08,
            "2021": 70.7,
            "2022": 80.94,
            "2023": 92.21,
            "2024": 104.65,
            "2025": 122.87,
            "2026": 139.88,
            "2027": 160.43,
            "2028": 183.66,
            "2029": 208.44,
            "2030": 242.73,
            "2031": 270.08,
            "2032": 314.8
          },
          "cagr": 14.39,
          "market_share": 58.77
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 43.25,
            "2021": 50.06,
            "2022": 57.31,
            "2023": 65.29,
            "2024": 74.1,
            "2025": 87.0,
            "2026": 99.04,
            "2027": 113.58,
            "2028": 130.04,
            "2029": 147.58,
            "2030": 171.86,
            "2031": 191.22,
            "2032": 222.89
          },
          "cagr": 14.38,
          "market_share": 41.62
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 60.68,
            "2021": 70.24,
            "2022": 80.41,
            "2023": 91.6,
            "2024": 103.96,
            "2025": 122.06,
            "2026": 138.96,
            "2027": 159.38,
            "2028": 182.45,
            "2029": 207.07,
            "2030": 241.14,
            "2031": 268.31,
            "2032": 312.74
          },
          "cagr": 14.39,
          "market_share": 58.38
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 41.93,
            "2021": 48.54,
            "2022": 55.57,
            "2023": 63.3,
            "2024": 71.84,
            "2025": 84.35,
            "2026": 96.03,
            "2027": 110.13,
            "2028": 126.08,
            "2029": 143.09,
            "2030": 166.64,
            "2031": 185.41,
            "2032": 216.11
          },
          "cagr": 14.39,
          "market_share": 40.35
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 37.59,
            "2021": 43.51,
            "2022": 49.81,
            "2023": 56.74,
            "2024": 64.4,
            "2025": 75.61,
            "2026": 86.08,
            "2027": 98.72,
            "2028": 113.02,
            "2029": 128.27,
            "2030": 149.37,
            "2031": 166.2,
            "2032": 193.72
          },
          "cagr": 14.39,
          "market_share": 36.17
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 24.41,
            "2021": 28.25,
            "2022": 32.34,
            "2023": 36.85,
            "2024": 41.82,
            "2025": 49.1,
            "2026": 55.89,
            "2027": 64.11,
            "2028": 73.39,
            "2029": 83.29,
            "2030": 96.99,
            "2031": 107.92,
            "2032": 125.8
          },
          "cagr": 14.39,
          "market_share": 23.49
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 48.87,
            "2021": 56.57,
            "2022": 64.76,
            "2023": 73.78,
            "2024": 83.73,
            "2025": 98.31,
            "2026": 111.91,
            "2027": 128.35,
            "2028": 146.94,
            "2029": 166.77,
            "2030": 194.21,
            "2031": 216.08,
            "2032": 251.87
          },
          "cagr": 14.38,
          "market_share": 47.02
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 55.06,
            "2021": 63.73,
            "2022": 72.96,
            "2023": 83.11,
            "2024": 94.33,
            "2025": 110.75,
            "2026": 126.09,
            "2027": 144.61,
            "2028": 165.55,
            "2029": 187.88,
            "2030": 218.79,
            "2031": 243.45,
            "2032": 283.76
          },
          "cagr": 14.39,
          "market_share": 52.98
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 20.07,
            "2021": 22.98,
            "2022": 25.49,
            "2023": 27.69,
            "2024": 30.86,
            "2025": 35.13,
            "2026": 39.14,
            "2027": 43.24,
            "2028": 47.73,
            "2029": 53.91,
            "2030": 60.81,
            "2031": 66.39,
            "2032": 74.5
          },
          "cagr": 11.34,
          "market_share": 18.13
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 23.93,
            "2021": 27.41,
            "2022": 30.39,
            "2023": 33.03,
            "2024": 36.8,
            "2025": 41.89,
            "2026": 46.68,
            "2027": 51.57,
            "2028": 56.93,
            "2029": 64.29,
            "2030": 72.52,
            "2031": 79.18,
            "2032": 88.84
          },
          "cagr": 11.34,
          "market_share": 21.61
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 19.09,
            "2021": 21.86,
            "2022": 24.25,
            "2023": 26.35,
            "2024": 29.36,
            "2025": 33.42,
            "2026": 37.24,
            "2027": 41.14,
            "2028": 45.41,
            "2029": 51.29,
            "2030": 57.86,
            "2031": 63.16,
            "2032": 70.87
          },
          "cagr": 11.34,
          "market_share": 17.24
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 26.6,
            "2021": 30.46,
            "2022": 33.77,
            "2023": 36.7,
            "2024": 40.89,
            "2025": 46.55,
            "2026": 51.87,
            "2027": 57.3,
            "2028": 63.26,
            "2029": 71.44,
            "2030": 80.59,
            "2031": 87.98,
            "2032": 98.72
          },
          "cagr": 11.34,
          "market_share": 24.02
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 21.04,
            "2021": 24.09,
            "2022": 26.71,
            "2023": 29.02,
            "2024": 32.35,
            "2025": 36.83,
            "2026": 41.01,
            "2027": 45.33,
            "2028": 50.03,
            "2029": 56.51,
            "2030": 63.74,
            "2031": 69.59,
            "2032": 78.08
          },
          "cagr": 11.33,
          "market_share": 19.0
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 17.1,
            "2021": 19.58,
            "2022": 21.71,
            "2023": 23.59,
            "2024": 26.29,
            "2025": 29.93,
            "2026": 33.35,
            "2027": 36.84,
            "2028": 40.67,
            "2029": 45.93,
            "2030": 51.81,
            "2031": 56.57,
            "2032": 63.47
          },
          "cagr": 11.34,
          "market_share": 15.44
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 25.42,
            "2021": 29.11,
            "2022": 32.28,
            "2023": 35.07,
            "2024": 39.09,
            "2025": 44.49,
            "2026": 49.57,
            "2027": 54.77,
            "2028": 60.46,
            "2029": 68.28,
            "2030": 77.02,
            "2031": 84.09,
            "2032": 94.35
          },
          "cagr": 11.34,
          "market_share": 22.96
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 16.6,
            "2021": 19.01,
            "2022": 21.08,
            "2023": 22.9,
            "2024": 25.52,
            "2025": 29.05,
            "2026": 32.37,
            "2027": 35.76,
            "2028": 39.48,
            "2029": 44.59,
            "2030": 50.29,
            "2031": 54.91,
            "2032": 61.61
          },
          "cagr": 11.34,
          "market_share": 14.99
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 29.71,
            "2021": 34.02,
            "2022": 37.72,
            "2023": 40.99,
            "2024": 45.68,
            "2025": 52.0,
            "2026": 57.93,
            "2027": 64.0,
            "2028": 70.65,
            "2029": 79.8,
            "2030": 90.01,
            "2031": 98.27,
            "2032": 110.26
          },
          "cagr": 11.33,
          "market_share": 26.83
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 21.9,
            "2021": 25.08,
            "2022": 27.82,
            "2023": 30.24,
            "2024": 33.68,
            "2025": 38.35,
            "2026": 42.72,
            "2027": 47.21,
            "2028": 52.1,
            "2029": 58.84,
            "2030": 66.39,
            "2031": 72.46,
            "2032": 81.32
          },
          "cagr": 11.34,
          "market_share": 19.78
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 37.36,
            "2021": 42.78,
            "2022": 47.44,
            "2023": 51.55,
            "2024": 57.44,
            "2025": 65.39,
            "2026": 72.85,
            "2027": 80.49,
            "2028": 88.85,
            "2029": 100.35,
            "2030": 113.2,
            "2031": 123.58,
            "2032": 138.66
          },
          "cagr": 11.34,
          "market_share": 33.74
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 73.37,
            "2021": 84.02,
            "2022": 93.17,
            "2023": 101.24,
            "2024": 112.82,
            "2025": 128.43,
            "2026": 143.09,
            "2027": 158.09,
            "2028": 174.51,
            "2029": 197.09,
            "2030": 222.32,
            "2031": 242.72,
            "2032": 272.35
          },
          "cagr": 11.34,
          "market_share": 66.26
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 53.46,
            "2021": 61.22,
            "2022": 67.89,
            "2023": 73.77,
            "2024": 82.2,
            "2025": 93.57,
            "2026": 104.26,
            "2027": 115.18,
            "2028": 127.15,
            "2029": 143.6,
            "2030": 161.99,
            "2031": 176.85,
            "2032": 198.43
          },
          "cagr": 11.34,
          "market_share": 48.28
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 57.27,
            "2021": 65.58,
            "2022": 72.72,
            "2023": 79.02,
            "2024": 88.06,
            "2025": 100.25,
            "2026": 111.68,
            "2027": 123.4,
            "2028": 136.21,
            "2029": 153.84,
            "2030": 173.53,
            "2031": 189.45,
            "2032": 212.58
          },
          "cagr": 11.34,
          "market_share": 51.72
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 27.27,
            "2021": 31.22,
            "2022": 34.62,
            "2023": 37.62,
            "2024": 41.93,
            "2025": 47.73,
            "2026": 53.18,
            "2027": 58.75,
            "2028": 64.85,
            "2029": 73.24,
            "2030": 82.62,
            "2031": 90.2,
            "2032": 101.21
          },
          "cagr": 11.34,
          "market_share": 24.63
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 45.59,
            "2021": 52.21,
            "2022": 57.9,
            "2023": 62.91,
            "2024": 70.1,
            "2025": 79.8,
            "2026": 88.92,
            "2027": 98.23,
            "2028": 108.44,
            "2029": 122.47,
            "2030": 138.15,
            "2031": 150.82,
            "2032": 169.23
          },
          "cagr": 11.34,
          "market_share": 41.17
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 37.87,
            "2021": 43.37,
            "2022": 48.09,
            "2023": 52.26,
            "2024": 58.23,
            "2025": 66.29,
            "2026": 73.84,
            "2027": 81.6,
            "2028": 90.07,
            "2029": 101.73,
            "2030": 114.75,
            "2031": 125.28,
            "2032": 140.57
          },
          "cagr": 11.34,
          "market_share": 34.2
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 32.98,
            "2021": 37.77,
            "2022": 41.88,
            "2023": 45.51,
            "2024": 50.71,
            "2025": 57.73,
            "2026": 64.32,
            "2027": 71.06,
            "2028": 78.44,
            "2029": 88.59,
            "2030": 99.93,
            "2031": 109.1,
            "2032": 122.42
          },
          "cagr": 11.34,
          "market_share": 29.78
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 77.75,
            "2021": 89.03,
            "2022": 98.73,
            "2023": 107.28,
            "2024": 119.55,
            "2025": 136.09,
            "2026": 151.62,
            "2027": 167.52,
            "2028": 184.92,
            "2029": 208.85,
            "2030": 235.59,
            "2031": 257.2,
            "2032": 288.59
          },
          "cagr": 11.34,
          "market_share": 70.22
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 8.23,
            "2021": 9.09,
            "2022": 9.43,
            "2023": 10.55,
            "2024": 11.13,
            "2025": 11.99,
            "2026": 13.02,
            "2027": 13.88,
            "2028": 14.95,
            "2029": 16.07,
            "2030": 17.06,
            "2031": 18.98,
            "2032": 19.91
          },
          "cagr": 7.51,
          "market_share": 16.15
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 12.16,
            "2021": 13.42,
            "2022": 13.92,
            "2023": 15.57,
            "2024": 16.44,
            "2025": 17.71,
            "2026": 19.23,
            "2027": 20.5,
            "2028": 22.07,
            "2029": 23.73,
            "2030": 25.19,
            "2031": 28.02,
            "2032": 29.39
          },
          "cagr": 7.5,
          "market_share": 23.85
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 12.95,
            "2021": 14.3,
            "2022": 14.84,
            "2023": 16.59,
            "2024": 17.52,
            "2025": 18.87,
            "2026": 20.49,
            "2027": 21.84,
            "2028": 23.52,
            "2029": 25.28,
            "2030": 26.84,
            "2031": 29.86,
            "2032": 31.32
          },
          "cagr": 7.51,
          "market_share": 25.42
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 9.6,
            "2021": 10.59,
            "2022": 10.99,
            "2023": 12.29,
            "2024": 12.98,
            "2025": 13.98,
            "2026": 15.18,
            "2027": 16.18,
            "2028": 17.42,
            "2029": 18.73,
            "2030": 19.89,
            "2031": 22.12,
            "2032": 23.2
          },
          "cagr": 7.5,
          "market_share": 18.83
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 8.03,
            "2021": 8.85,
            "2022": 9.19,
            "2023": 10.29,
            "2024": 10.85,
            "2025": 11.7,
            "2026": 12.7,
            "2027": 13.53,
            "2028": 14.57,
            "2029": 15.67,
            "2030": 16.63,
            "2031": 18.5,
            "2032": 19.4
          },
          "cagr": 7.49,
          "market_share": 15.74
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 8.33,
            "2021": 9.19,
            "2022": 9.54,
            "2023": 10.67,
            "2024": 11.26,
            "2025": 12.13,
            "2026": 13.17,
            "2027": 14.04,
            "2028": 15.12,
            "2029": 16.25,
            "2030": 17.25,
            "2031": 19.19,
            "2032": 20.13
          },
          "cagr": 7.5,
          "market_share": 16.34
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.18,
            "2021": 13.45,
            "2022": 13.95,
            "2023": 15.6,
            "2024": 16.47,
            "2025": 17.75,
            "2026": 19.27,
            "2027": 20.54,
            "2028": 22.12,
            "2029": 23.78,
            "2030": 25.24,
            "2031": 28.08,
            "2032": 29.45
          },
          "cagr": 7.5,
          "market_share": 23.9
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 9.13,
            "2021": 10.08,
            "2022": 10.46,
            "2023": 11.7,
            "2024": 12.35,
            "2025": 13.3,
            "2026": 14.45,
            "2027": 15.4,
            "2028": 16.58,
            "2029": 17.83,
            "2030": 18.92,
            "2031": 21.05,
            "2032": 22.08
          },
          "cagr": 7.51,
          "market_share": 17.92
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 15.3,
            "2021": 16.89,
            "2022": 17.53,
            "2023": 19.6,
            "2024": 20.7,
            "2025": 22.29,
            "2026": 24.21,
            "2027": 25.8,
            "2028": 27.78,
            "2029": 29.87,
            "2030": 31.71,
            "2031": 35.28,
            "2032": 37.0
          },
          "cagr": 7.51,
          "market_share": 30.03
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 6.03,
            "2021": 6.64,
            "2022": 6.89,
            "2023": 7.72,
            "2024": 8.14,
            "2025": 8.78,
            "2026": 9.52,
            "2027": 10.15,
            "2028": 10.93,
            "2029": 11.75,
            "2030": 12.49,
            "2031": 13.88,
            "2032": 14.56
          },
          "cagr": 7.49,
          "market_share": 11.81
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 23.97,
            "2021": 26.46,
            "2022": 27.45,
            "2023": 30.71,
            "2024": 32.42,
            "2025": 34.92,
            "2026": 37.92,
            "2027": 40.42,
            "2028": 43.52,
            "2029": 46.79,
            "2030": 49.67,
            "2031": 55.26,
            "2032": 57.96
          },
          "cagr": 7.51,
          "market_share": 47.04
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 27.0,
            "2021": 29.79,
            "2022": 30.92,
            "2023": 34.58,
            "2024": 36.5,
            "2025": 39.33,
            "2026": 42.7,
            "2027": 45.51,
            "2028": 49.01,
            "2029": 52.69,
            "2030": 55.94,
            "2031": 62.22,
            "2032": 65.26
          },
          "cagr": 7.5,
          "market_share": 52.96
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 30.21,
            "2021": 33.35,
            "2022": 34.6,
            "2023": 38.7,
            "2024": 40.86,
            "2025": 44.01,
            "2026": 47.79,
            "2027": 50.94,
            "2028": 54.85,
            "2029": 58.97,
            "2030": 62.6,
            "2031": 69.64,
            "2032": 73.04
          },
          "cagr": 7.51,
          "market_share": 59.29
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 20.76,
            "2021": 22.9,
            "2022": 23.77,
            "2023": 26.59,
            "2024": 28.06,
            "2025": 30.24,
            "2026": 32.83,
            "2027": 34.99,
            "2028": 37.68,
            "2029": 40.51,
            "2030": 43.01,
            "2031": 47.84,
            "2032": 50.18
          },
          "cagr": 7.5,
          "market_share": 40.71
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 19.06,
            "2021": 21.03,
            "2022": 21.83,
            "2023": 24.41,
            "2024": 25.77,
            "2025": 27.76,
            "2026": 30.15,
            "2027": 32.13,
            "2028": 34.6,
            "2029": 37.2,
            "2030": 39.49,
            "2031": 43.93,
            "2032": 46.08
          },
          "cagr": 7.51,
          "market_share": 37.39
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 15.72,
            "2021": 17.35,
            "2022": 18.0,
            "2023": 20.14,
            "2024": 21.26,
            "2025": 22.9,
            "2026": 24.87,
            "2027": 26.51,
            "2028": 28.54,
            "2029": 30.69,
            "2030": 32.58,
            "2031": 36.24,
            "2032": 38.01
          },
          "cagr": 7.51,
          "market_share": 30.85
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 16.19,
            "2021": 17.87,
            "2022": 18.54,
            "2023": 20.74,
            "2024": 21.89,
            "2025": 23.59,
            "2026": 25.6,
            "2027": 27.29,
            "2028": 29.39,
            "2029": 31.59,
            "2030": 33.54,
            "2031": 37.31,
            "2032": 39.13
          },
          "cagr": 7.5,
          "market_share": 31.76
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 23.1,
            "2021": 25.49,
            "2022": 26.45,
            "2023": 29.58,
            "2024": 31.23,
            "2025": 33.64,
            "2026": 36.53,
            "2027": 38.94,
            "2028": 41.93,
            "2029": 45.08,
            "2030": 47.85,
            "2031": 53.23,
            "2032": 55.84
          },
          "cagr": 7.51,
          "market_share": 45.31
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 27.87,
            "2021": 30.76,
            "2022": 31.92,
            "2023": 35.71,
            "2024": 37.69,
            "2025": 40.61,
            "2026": 44.09,
            "2027": 46.99,
            "2028": 50.6,
            "2029": 54.4,
            "2030": 57.76,
            "2031": 64.25,
            "2032": 67.38
          },
          "cagr": 7.5,
          "market_share": 54.69
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 25.79,
            "2021": 28.91,
            "2022": 33.06,
            "2023": 36.74,
            "2024": 41.69,
            "2025": 47.02,
            "2026": 51.96,
            "2027": 58.4,
            "2028": 65.85,
            "2029": 73.63,
            "2030": 84.76,
            "2031": 93.81,
            "2032": 104.16
          },
          "cagr": 12.03,
          "market_share": 23.53
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 22.28,
            "2021": 24.97,
            "2022": 28.55,
            "2023": 31.73,
            "2024": 36.01,
            "2025": 40.61,
            "2026": 44.88,
            "2027": 50.44,
            "2028": 56.87,
            "2029": 63.59,
            "2030": 73.2,
            "2031": 81.02,
            "2032": 89.95
          },
          "cagr": 12.03,
          "market_share": 20.33
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 19.51,
            "2021": 21.87,
            "2022": 25.01,
            "2023": 27.79,
            "2024": 31.54,
            "2025": 35.57,
            "2026": 39.31,
            "2027": 44.18,
            "2028": 49.82,
            "2029": 55.7,
            "2030": 64.12,
            "2031": 70.96,
            "2032": 78.79
          },
          "cagr": 12.03,
          "market_share": 17.8
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 19.14,
            "2021": 21.46,
            "2022": 24.53,
            "2023": 27.26,
            "2024": 30.94,
            "2025": 34.89,
            "2026": 38.56,
            "2027": 43.34,
            "2028": 48.87,
            "2029": 54.64,
            "2030": 62.9,
            "2031": 69.61,
            "2032": 77.29
          },
          "cagr": 12.03,
          "market_share": 17.46
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 22.89,
            "2021": 25.65,
            "2022": 29.33,
            "2023": 32.61,
            "2024": 36.98,
            "2025": 41.71,
            "2026": 46.1,
            "2027": 51.81,
            "2028": 58.42,
            "2029": 65.32,
            "2030": 75.19,
            "2031": 83.23,
            "2032": 92.4
          },
          "cagr": 12.03,
          "market_share": 20.87
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 24.93,
            "2021": 27.94,
            "2022": 31.95,
            "2023": 35.51,
            "2024": 40.29,
            "2025": 45.44,
            "2026": 50.22,
            "2027": 56.44,
            "2028": 63.64,
            "2029": 71.16,
            "2030": 81.91,
            "2031": 90.66,
            "2032": 100.65
          },
          "cagr": 12.03,
          "market_share": 22.74
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 13.34,
            "2021": 14.95,
            "2022": 17.09,
            "2023": 19.0,
            "2024": 21.56,
            "2025": 24.31,
            "2026": 26.87,
            "2027": 30.2,
            "2028": 34.05,
            "2029": 38.07,
            "2030": 43.82,
            "2031": 48.5,
            "2032": 53.85
          },
          "cagr": 12.03,
          "market_share": 12.17
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 22.06,
            "2021": 24.72,
            "2022": 28.27,
            "2023": 31.42,
            "2024": 35.65,
            "2025": 40.21,
            "2026": 44.43,
            "2027": 49.94,
            "2028": 56.31,
            "2029": 62.96,
            "2030": 72.48,
            "2031": 80.22,
            "2032": 89.06
          },
          "cagr": 12.03,
          "market_share": 20.12
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 27.28,
            "2021": 30.58,
            "2022": 34.97,
            "2023": 38.86,
            "2024": 44.09,
            "2025": 49.73,
            "2026": 54.96,
            "2027": 61.77,
            "2028": 69.65,
            "2029": 77.87,
            "2030": 89.64,
            "2031": 99.21,
            "2032": 110.16
          },
          "cagr": 12.03,
          "market_share": 24.89
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 22.0,
            "2021": 24.67,
            "2022": 28.2,
            "2023": 31.34,
            "2024": 35.57,
            "2025": 40.11,
            "2026": 44.33,
            "2027": 49.82,
            "2028": 56.18,
            "2029": 62.82,
            "2030": 72.32,
            "2031": 80.04,
            "2032": 88.87
          },
          "cagr": 12.04,
          "market_share": 20.08
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 55.43,
            "2021": 62.14,
            "2022": 71.05,
            "2023": 78.96,
            "2024": 89.6,
            "2025": 101.05,
            "2026": 111.67,
            "2027": 125.51,
            "2028": 141.52,
            "2029": 158.24,
            "2030": 182.15,
            "2031": 201.6,
            "2032": 223.84
          },
          "cagr": 12.03,
          "market_share": 50.58
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 54.18,
            "2021": 60.72,
            "2022": 69.43,
            "2023": 77.17,
            "2024": 87.56,
            "2025": 98.75,
            "2026": 109.14,
            "2027": 122.66,
            "2028": 138.31,
            "2029": 154.64,
            "2030": 178.02,
            "2031": 197.03,
            "2032": 218.75
          },
          "cagr": 12.03,
          "market_share": 49.42
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 69.82,
            "2021": 78.27,
            "2022": 89.49,
            "2023": 99.46,
            "2024": 112.86,
            "2025": 127.28,
            "2026": 140.66,
            "2027": 158.09,
            "2028": 178.26,
            "2029": 199.31,
            "2030": 229.44,
            "2031": 253.94,
            "2032": 281.94
          },
          "cagr": 12.03,
          "market_share": 63.71
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 39.79,
            "2021": 44.59,
            "2022": 50.99,
            "2023": 56.67,
            "2024": 64.3,
            "2025": 72.52,
            "2026": 80.15,
            "2027": 90.08,
            "2028": 101.57,
            "2029": 113.57,
            "2030": 130.73,
            "2031": 144.69,
            "2032": 160.65
          },
          "cagr": 12.03,
          "market_share": 36.29
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 26.41,
            "2021": 29.61,
            "2022": 33.85,
            "2023": 37.62,
            "2024": 42.69,
            "2025": 48.15,
            "2026": 53.21,
            "2027": 59.8,
            "2028": 67.43,
            "2029": 75.4,
            "2030": 86.8,
            "2031": 96.06,
            "2032": 106.66
          },
          "cagr": 12.03,
          "market_share": 24.1
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 37.52,
            "2021": 42.06,
            "2022": 48.09,
            "2023": 53.44,
            "2024": 60.64,
            "2025": 68.39,
            "2026": 75.59,
            "2027": 84.95,
            "2028": 95.79,
            "2029": 107.1,
            "2030": 123.29,
            "2031": 136.46,
            "2032": 151.5
          },
          "cagr": 12.03,
          "market_share": 34.23
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 45.68,
            "2021": 51.19,
            "2022": 58.54,
            "2023": 65.07,
            "2024": 73.83,
            "2025": 83.26,
            "2026": 92.01,
            "2027": 103.42,
            "2028": 116.61,
            "2029": 130.38,
            "2030": 150.08,
            "2031": 166.11,
            "2032": 184.43
          },
          "cagr": 12.03,
          "market_share": 41.67
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 36.27,
            "2021": 40.66,
            "2022": 46.49,
            "2023": 51.66,
            "2024": 58.62,
            "2025": 66.11,
            "2026": 73.07,
            "2027": 82.12,
            "2028": 92.6,
            "2029": 103.53,
            "2030": 119.18,
            "2031": 131.91,
            "2032": 146.46
          },
          "cagr": 12.03,
          "market_share": 33.09
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 73.34,
            "2021": 82.2,
            "2022": 93.99,
            "2023": 104.47,
            "2024": 118.54,
            "2025": 133.69,
            "2026": 147.74,
            "2027": 166.05,
            "2028": 187.23,
            "2029": 209.35,
            "2030": 240.99,
            "2031": 266.72,
            "2032": 296.13
          },
          "cagr": 12.03,
          "market_share": 66.91
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 11.2,
            "2021": 12.4,
            "2022": 13.28,
            "2023": 14.41,
            "2024": 15.7,
            "2025": 16.8,
            "2026": 18.71,
            "2027": 20.17,
            "2028": 22.13,
            "2029": 23.9,
            "2030": 25.78,
            "2031": 28.26,
            "2032": 30.22
          },
          "cagr": 8.75,
          "market_share": 15.57
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 18.98,
            "2021": 21.03,
            "2022": 22.52,
            "2023": 24.43,
            "2024": 26.62,
            "2025": 28.48,
            "2026": 31.73,
            "2027": 34.2,
            "2028": 37.52,
            "2029": 40.52,
            "2030": 43.71,
            "2031": 47.91,
            "2032": 51.24
          },
          "cagr": 8.75,
          "market_share": 26.4
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 14.75,
            "2021": 16.34,
            "2022": 17.5,
            "2023": 18.98,
            "2024": 20.69,
            "2025": 22.13,
            "2026": 24.66,
            "2027": 26.58,
            "2028": 29.16,
            "2029": 31.48,
            "2030": 33.96,
            "2031": 37.23,
            "2032": 39.81
          },
          "cagr": 8.75,
          "market_share": 20.52
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 11.31,
            "2021": 12.53,
            "2022": 13.42,
            "2023": 14.55,
            "2024": 15.86,
            "2025": 16.97,
            "2026": 18.9,
            "2027": 20.38,
            "2028": 22.35,
            "2029": 24.14,
            "2030": 26.04,
            "2031": 28.54,
            "2032": 30.52
          },
          "cagr": 8.75,
          "market_share": 15.73
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 15.67,
            "2021": 17.34,
            "2022": 18.59,
            "2023": 20.16,
            "2024": 21.97,
            "2025": 23.51,
            "2026": 26.19,
            "2027": 28.23,
            "2028": 30.97,
            "2029": 33.44,
            "2030": 36.06,
            "2031": 39.54,
            "2032": 42.28
          },
          "cagr": 8.75,
          "market_share": 21.78
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 22.11,
            "2021": 24.49,
            "2022": 26.23,
            "2023": 28.45,
            "2024": 31.01,
            "2025": 33.18,
            "2026": 36.96,
            "2027": 39.84,
            "2028": 43.71,
            "2029": 47.2,
            "2030": 50.91,
            "2031": 55.81,
            "2032": 59.68
          },
          "cagr": 8.75,
          "market_share": 30.75
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 9.06,
            "2021": 10.04,
            "2022": 10.75,
            "2023": 11.66,
            "2024": 12.71,
            "2025": 13.6,
            "2026": 15.15,
            "2027": 16.33,
            "2028": 17.91,
            "2029": 19.34,
            "2030": 20.86,
            "2031": 22.87,
            "2032": 24.46
          },
          "cagr": 8.75,
          "market_share": 12.6
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 13.18,
            "2021": 14.59,
            "2022": 15.63,
            "2023": 16.96,
            "2024": 18.48,
            "2025": 19.77,
            "2026": 22.03,
            "2027": 23.74,
            "2028": 26.05,
            "2029": 28.13,
            "2030": 30.34,
            "2031": 33.26,
            "2032": 35.57
          },
          "cagr": 8.75,
          "market_share": 18.32
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 10.57,
            "2021": 11.71,
            "2022": 12.54,
            "2023": 13.6,
            "2024": 14.82,
            "2025": 15.86,
            "2026": 17.67,
            "2027": 19.05,
            "2028": 20.89,
            "2029": 22.56,
            "2030": 24.34,
            "2031": 26.68,
            "2032": 28.53
          },
          "cagr": 8.75,
          "market_share": 14.7
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 16.99,
            "2021": 18.81,
            "2022": 20.16,
            "2023": 21.86,
            "2024": 23.82,
            "2025": 25.48,
            "2026": 28.38,
            "2027": 30.6,
            "2028": 33.57,
            "2029": 36.25,
            "2030": 39.1,
            "2031": 42.86,
            "2032": 45.83
          },
          "cagr": 8.75,
          "market_share": 23.62
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 39.57,
            "2021": 43.83,
            "2022": 46.95,
            "2023": 50.92,
            "2024": 55.5,
            "2025": 59.38,
            "2026": 66.15,
            "2027": 71.3,
            "2028": 78.22,
            "2029": 84.47,
            "2030": 91.11,
            "2031": 99.88,
            "2032": 106.81
          },
          "cagr": 8.75,
          "market_share": 55.03
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 32.34,
            "2021": 35.81,
            "2022": 38.36,
            "2023": 41.61,
            "2024": 45.34,
            "2025": 48.51,
            "2026": 54.04,
            "2027": 58.26,
            "2028": 63.91,
            "2029": 69.01,
            "2030": 74.44,
            "2031": 81.6,
            "2032": 87.26
          },
          "cagr": 8.75,
          "market_share": 44.96
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 50.41,
            "2021": 55.83,
            "2022": 59.81,
            "2023": 64.87,
            "2024": 70.69,
            "2025": 75.64,
            "2026": 84.26,
            "2027": 90.83,
            "2028": 99.64,
            "2029": 107.6,
            "2030": 116.06,
            "2031": 127.23,
            "2032": 136.06
          },
          "cagr": 8.75,
          "market_share": 70.09
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 21.5,
            "2021": 23.81,
            "2022": 25.5,
            "2023": 27.66,
            "2024": 30.15,
            "2025": 32.25,
            "2026": 35.93,
            "2027": 38.73,
            "2028": 42.49,
            "2029": 45.88,
            "2030": 49.49,
            "2031": 54.25,
            "2032": 58.01
          },
          "cagr": 8.75,
          "market_share": 29.9
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 30.53,
            "2021": 33.81,
            "2022": 36.22,
            "2023": 39.29,
            "2024": 42.82,
            "2025": 45.81,
            "2026": 51.03,
            "2027": 55.01,
            "2028": 60.35,
            "2029": 65.17,
            "2030": 70.29,
            "2031": 77.06,
            "2032": 82.4
          },
          "cagr": 8.75,
          "market_share": 42.46
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 13.09,
            "2021": 14.5,
            "2022": 15.53,
            "2023": 16.85,
            "2024": 18.36,
            "2025": 19.64,
            "2026": 21.88,
            "2027": 23.59,
            "2028": 25.88,
            "2029": 27.95,
            "2030": 30.14,
            "2031": 33.04,
            "2032": 35.34
          },
          "cagr": 8.75,
          "market_share": 18.21
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 28.29,
            "2021": 31.33,
            "2022": 33.56,
            "2023": 36.39,
            "2024": 39.66,
            "2025": 42.44,
            "2026": 47.28,
            "2027": 50.96,
            "2028": 55.9,
            "2029": 60.36,
            "2030": 65.12,
            "2031": 71.38,
            "2032": 76.33
          },
          "cagr": 8.75,
          "market_share": 39.33
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 33.11,
            "2021": 36.67,
            "2022": 39.28,
            "2023": 42.6,
            "2024": 46.43,
            "2025": 49.67,
            "2026": 55.34,
            "2027": 59.65,
            "2028": 65.44,
            "2029": 70.66,
            "2030": 76.22,
            "2031": 83.56,
            "2032": 89.36
          },
          "cagr": 8.75,
          "market_share": 46.04
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 38.8,
            "2021": 42.97,
            "2022": 46.03,
            "2023": 49.93,
            "2024": 54.41,
            "2025": 58.22,
            "2026": 64.85,
            "2027": 69.91,
            "2028": 76.69,
            "2029": 82.82,
            "2030": 89.33,
            "2031": 97.92,
            "2032": 104.71
          },
          "cagr": 8.75,
          "market_share": 53.95
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 24.4,
            "2021": 26.34,
            "2022": 28.67,
            "2023": 31.64,
            "2024": 34.09,
            "2025": 36.64,
            "2026": 39.51,
            "2027": 43.11,
            "2028": 46.44,
            "2029": 50.63,
            "2030": 54.49,
            "2031": 59.83,
            "2032": 63.79
          },
          "cagr": 8.24,
          "market_share": 25.33
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 18.89,
            "2021": 20.39,
            "2022": 22.19,
            "2023": 24.5,
            "2024": 26.39,
            "2025": 28.37,
            "2026": 30.59,
            "2027": 33.37,
            "2028": 35.95,
            "2029": 39.19,
            "2030": 42.18,
            "2031": 46.32,
            "2032": 49.38
          },
          "cagr": 8.24,
          "market_share": 19.61
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 22.47,
            "2021": 24.26,
            "2022": 26.4,
            "2023": 29.14,
            "2024": 31.39,
            "2025": 33.74,
            "2026": 36.39,
            "2027": 39.7,
            "2028": 42.76,
            "2029": 46.62,
            "2030": 50.18,
            "2031": 55.1,
            "2032": 58.75
          },
          "cagr": 8.25,
          "market_share": 23.32
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 12.39,
            "2021": 13.38,
            "2022": 14.56,
            "2023": 16.07,
            "2024": 17.31,
            "2025": 18.61,
            "2026": 20.07,
            "2027": 21.89,
            "2028": 23.58,
            "2029": 25.71,
            "2030": 27.67,
            "2031": 30.39,
            "2032": 32.4
          },
          "cagr": 8.24,
          "market_share": 12.86
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 18.2,
            "2021": 19.64,
            "2022": 21.38,
            "2023": 23.59,
            "2024": 25.4,
            "2025": 27.32,
            "2026": 29.45,
            "2027": 32.15,
            "2028": 34.62,
            "2029": 37.75,
            "2030": 40.62,
            "2031": 44.61,
            "2032": 47.57
          },
          "cagr": 8.24,
          "market_share": 18.87
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 22.25,
            "2021": 24.02,
            "2022": 26.14,
            "2023": 28.85,
            "2024": 31.08,
            "2025": 33.41,
            "2026": 36.02,
            "2027": 39.31,
            "2028": 42.34,
            "2029": 46.16,
            "2030": 49.68,
            "2031": 54.55,
            "2032": 58.16
          },
          "cagr": 8.24,
          "market_share": 23.09
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 19.15,
            "2021": 20.67,
            "2022": 22.5,
            "2023": 24.84,
            "2024": 26.75,
            "2025": 28.76,
            "2026": 31.01,
            "2027": 33.83,
            "2028": 36.44,
            "2029": 39.73,
            "2030": 42.76,
            "2031": 46.96,
            "2032": 50.07
          },
          "cagr": 8.24,
          "market_share": 19.88
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 18.91,
            "2021": 20.42,
            "2022": 22.22,
            "2023": 24.53,
            "2024": 26.42,
            "2025": 28.4,
            "2026": 30.62,
            "2027": 33.42,
            "2028": 35.99,
            "2029": 39.24,
            "2030": 42.23,
            "2031": 46.38,
            "2032": 49.45
          },
          "cagr": 8.24,
          "market_share": 19.63
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 20.92,
            "2021": 22.58,
            "2022": 24.58,
            "2023": 27.12,
            "2024": 29.22,
            "2025": 31.41,
            "2026": 33.87,
            "2027": 36.95,
            "2028": 39.8,
            "2029": 43.4,
            "2030": 46.71,
            "2031": 51.29,
            "2032": 54.68
          },
          "cagr": 8.24,
          "market_share": 21.71
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 15.12,
            "2021": 16.32,
            "2022": 17.76,
            "2023": 19.6,
            "2024": 21.11,
            "2025": 22.7,
            "2026": 24.49,
            "2027": 26.71,
            "2028": 28.78,
            "2029": 31.37,
            "2030": 33.76,
            "2031": 37.07,
            "2032": 39.53
          },
          "cagr": 8.25,
          "market_share": 15.69
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 54.11,
            "2021": 58.42,
            "2022": 63.58,
            "2023": 70.17,
            "2024": 75.59,
            "2025": 81.26,
            "2026": 87.62,
            "2027": 95.6,
            "2028": 102.98,
            "2029": 112.27,
            "2030": 120.83,
            "2031": 132.69,
            "2032": 141.47
          },
          "cagr": 8.24,
          "market_share": 56.17
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 42.24,
            "2021": 45.59,
            "2022": 49.62,
            "2023": 54.77,
            "2024": 58.99,
            "2025": 63.42,
            "2026": 68.39,
            "2027": 74.62,
            "2028": 80.37,
            "2029": 87.63,
            "2030": 94.31,
            "2031": 103.56,
            "2032": 110.42
          },
          "cagr": 8.24,
          "market_share": 43.83
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 59.83,
            "2021": 64.58,
            "2022": 70.29,
            "2023": 77.58,
            "2024": 83.57,
            "2025": 89.84,
            "2026": 96.87,
            "2027": 105.7,
            "2028": 113.85,
            "2029": 124.12,
            "2030": 133.59,
            "2031": 146.69,
            "2032": 156.41
          },
          "cagr": 8.24,
          "market_share": 62.1
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 36.52,
            "2021": 39.43,
            "2022": 42.91,
            "2023": 47.36,
            "2024": 51.01,
            "2025": 54.84,
            "2026": 59.14,
            "2027": 64.52,
            "2028": 69.5,
            "2029": 75.78,
            "2030": 81.55,
            "2031": 89.56,
            "2032": 95.48
          },
          "cagr": 8.24,
          "market_share": 37.9
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 22.33,
            "2021": 24.1,
            "2022": 26.23,
            "2023": 28.95,
            "2024": 31.19,
            "2025": 33.53,
            "2026": 36.15,
            "2027": 39.45,
            "2028": 42.49,
            "2029": 46.32,
            "2030": 49.86,
            "2031": 54.75,
            "2032": 58.37
          },
          "cagr": 8.24,
          "market_share": 23.18
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 47.0,
            "2021": 50.74,
            "2022": 55.22,
            "2023": 60.95,
            "2024": 65.65,
            "2025": 70.58,
            "2026": 76.1,
            "2027": 83.04,
            "2028": 89.44,
            "2029": 97.51,
            "2030": 104.95,
            "2031": 115.25,
            "2032": 122.88
          },
          "cagr": 8.24,
          "market_share": 48.78
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 27.02,
            "2021": 29.17,
            "2022": 31.75,
            "2023": 35.04,
            "2024": 37.74,
            "2025": 40.57,
            "2026": 43.76,
            "2027": 47.73,
            "2028": 51.42,
            "2029": 56.07,
            "2030": 60.33,
            "2031": 66.25,
            "2032": 70.64
          },
          "cagr": 8.24,
          "market_share": 28.04
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 61.74,
            "2021": 66.65,
            "2022": 72.54,
            "2023": 80.06,
            "2024": 86.24,
            "2025": 92.71,
            "2026": 99.97,
            "2027": 109.08,
            "2028": 117.49,
            "2029": 128.09,
            "2030": 137.86,
            "2031": 151.38,
            "2032": 161.41
          },
          "cagr": 8.24,
          "market_share": 64.08
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 34.61,
            "2021": 37.36,
            "2022": 40.66,
            "2023": 44.88,
            "2024": 48.34,
            "2025": 51.97,
            "2026": 56.04,
            "2027": 61.14,
            "2028": 65.86,
            "2029": 71.81,
            "2030": 77.28,
            "2031": 84.87,
            "2032": 90.48
          },
          "cagr": 8.24,
          "market_share": 35.92
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 21.58,
            "2021": 24.56,
            "2022": 28.13,
            "2023": 32.12,
            "2024": 37.04,
            "2025": 41.29,
            "2026": 46.47,
            "2027": 54.38,
            "2028": 60.94,
            "2029": 69.44,
            "2030": 80.31,
            "2031": 90.11,
            "2032": 101.4
          },
          "cagr": 13.7,
          "market_share": 24.83
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 16.26,
            "2021": 18.5,
            "2022": 21.2,
            "2023": 24.2,
            "2024": 27.91,
            "2025": 31.12,
            "2026": 35.02,
            "2027": 40.98,
            "2028": 45.92,
            "2029": 52.33,
            "2030": 60.52,
            "2031": 67.9,
            "2032": 76.41
          },
          "cagr": 13.69,
          "market_share": 18.71
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 20.01,
            "2021": 22.77,
            "2022": 26.09,
            "2023": 29.78,
            "2024": 34.34,
            "2025": 38.29,
            "2026": 43.09,
            "2027": 50.43,
            "2028": 56.51,
            "2029": 64.39,
            "2030": 74.47,
            "2031": 83.55,
            "2032": 94.03
          },
          "cagr": 13.69,
          "market_share": 23.02
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 16.57,
            "2021": 18.85,
            "2022": 21.59,
            "2023": 24.65,
            "2024": 28.43,
            "2025": 31.69,
            "2026": 35.67,
            "2027": 41.74,
            "2028": 46.77,
            "2029": 53.3,
            "2030": 61.64,
            "2031": 69.16,
            "2032": 77.83
          },
          "cagr": 13.7,
          "market_share": 19.06
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 12.52,
            "2021": 14.22,
            "2022": 16.3,
            "2023": 18.62,
            "2024": 21.46,
            "2025": 23.93,
            "2026": 26.92,
            "2027": 31.51,
            "2028": 35.31,
            "2029": 40.23,
            "2030": 46.53,
            "2031": 52.21,
            "2032": 58.76
          },
          "cagr": 13.69,
          "market_share": 14.39
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 18.29,
            "2021": 20.8,
            "2022": 23.83,
            "2023": 27.21,
            "2024": 31.38,
            "2025": 34.98,
            "2026": 39.37,
            "2027": 46.07,
            "2028": 51.63,
            "2029": 58.83,
            "2030": 68.03,
            "2031": 76.34,
            "2032": 85.91
          },
          "cagr": 13.7,
          "market_share": 21.03
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 9.97,
            "2021": 11.34,
            "2022": 13.0,
            "2023": 14.84,
            "2024": 17.11,
            "2025": 19.08,
            "2026": 21.47,
            "2027": 25.13,
            "2028": 28.16,
            "2029": 32.08,
            "2030": 37.1,
            "2031": 41.63,
            "2032": 46.85
          },
          "cagr": 13.69,
          "market_share": 11.47
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 16.78,
            "2021": 19.09,
            "2022": 21.87,
            "2023": 24.97,
            "2024": 28.79,
            "2025": 32.1,
            "2026": 36.12,
            "2027": 42.27,
            "2028": 47.37,
            "2029": 53.98,
            "2030": 62.42,
            "2031": 70.04,
            "2032": 78.82
          },
          "cagr": 13.69,
          "market_share": 19.3
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 23.55,
            "2021": 26.79,
            "2022": 30.69,
            "2023": 35.04,
            "2024": 40.41,
            "2025": 45.05,
            "2026": 50.7,
            "2027": 59.33,
            "2028": 66.49,
            "2029": 75.76,
            "2030": 87.62,
            "2031": 98.31,
            "2032": 110.63
          },
          "cagr": 13.69,
          "market_share": 27.09
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 18.35,
            "2021": 20.88,
            "2022": 23.92,
            "2023": 27.31,
            "2024": 31.49,
            "2025": 35.11,
            "2026": 39.51,
            "2027": 46.24,
            "2028": 51.8,
            "2029": 59.04,
            "2030": 68.3,
            "2031": 76.61,
            "2032": 86.22
          },
          "cagr": 13.69,
          "market_share": 21.11
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 50.06,
            "2021": 56.95,
            "2022": 65.25,
            "2023": 74.5,
            "2024": 85.91,
            "2025": 95.78,
            "2026": 107.78,
            "2027": 126.14,
            "2028": 141.35,
            "2029": 161.06,
            "2030": 186.27,
            "2031": 209.0,
            "2032": 235.2
          },
          "cagr": 13.69,
          "market_share": 57.59
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 36.88,
            "2021": 41.95,
            "2022": 48.06,
            "2023": 54.87,
            "2024": 63.27,
            "2025": 70.54,
            "2026": 79.39,
            "2027": 92.9,
            "2028": 104.1,
            "2029": 118.63,
            "2030": 137.2,
            "2031": 153.93,
            "2032": 173.23
          },
          "cagr": 13.69,
          "market_share": 42.41
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 38.02,
            "2021": 43.25,
            "2022": 49.55,
            "2023": 56.57,
            "2024": 65.24,
            "2025": 72.73,
            "2026": 81.85,
            "2027": 95.79,
            "2028": 107.34,
            "2029": 122.31,
            "2030": 141.46,
            "2031": 158.71,
            "2032": 178.61
          },
          "cagr": 13.7,
          "market_share": 43.73
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 48.92,
            "2021": 55.65,
            "2022": 63.76,
            "2023": 72.8,
            "2024": 83.94,
            "2025": 93.59,
            "2026": 105.32,
            "2027": 123.25,
            "2028": 138.11,
            "2029": 157.38,
            "2030": 182.01,
            "2031": 204.22,
            "2032": 229.82
          },
          "cagr": 13.69,
          "market_share": 56.27
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 33.92,
            "2021": 38.59,
            "2022": 44.21,
            "2023": 50.47,
            "2024": 58.2,
            "2025": 64.89,
            "2026": 73.02,
            "2027": 85.46,
            "2028": 95.76,
            "2029": 109.12,
            "2030": 126.2,
            "2031": 141.6,
            "2032": 159.35
          },
          "cagr": 13.69,
          "market_share": 39.01
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 23.3,
            "2021": 26.5,
            "2022": 30.36,
            "2023": 34.67,
            "2024": 39.97,
            "2025": 44.57,
            "2026": 50.15,
            "2027": 58.69,
            "2028": 65.77,
            "2029": 74.94,
            "2030": 86.68,
            "2031": 97.25,
            "2032": 109.44
          },
          "cagr": 13.69,
          "market_share": 26.79
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 29.72,
            "2021": 33.81,
            "2022": 38.74,
            "2023": 44.23,
            "2024": 51.01,
            "2025": 56.86,
            "2026": 64.0,
            "2027": 74.89,
            "2028": 83.92,
            "2029": 95.63,
            "2030": 110.59,
            "2031": 124.08,
            "2032": 139.64
          },
          "cagr": 13.7,
          "market_share": 34.19
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 37.69,
            "2021": 42.88,
            "2022": 49.12,
            "2023": 56.09,
            "2024": 64.68,
            "2025": 72.11,
            "2026": 81.15,
            "2027": 94.96,
            "2028": 106.41,
            "2029": 121.26,
            "2030": 140.24,
            "2031": 157.35,
            "2032": 177.07
          },
          "cagr": 13.69,
          "market_share": 43.36
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 49.25,
            "2021": 56.02,
            "2022": 64.19,
            "2023": 73.28,
            "2024": 84.5,
            "2025": 94.21,
            "2026": 106.02,
            "2027": 124.08,
            "2028": 139.04,
            "2029": 158.43,
            "2030": 183.23,
            "2031": 205.58,
            "2032": 231.36
          },
          "cagr": 13.7,
          "market_share": 56.64
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 30.72,
            "2021": 34.0,
            "2022": 38.2,
            "2023": 41.74,
            "2024": 46.42,
            "2025": 51.26,
            "2026": 56.61,
            "2027": 62.69,
            "2028": 68.44,
            "2029": 75.42,
            "2030": 85.58,
            "2031": 94.76,
            "2032": 105.7
          },
          "cagr": 10.89,
          "market_share": 27.75
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 27.49,
            "2021": 30.43,
            "2022": 34.19,
            "2023": 37.36,
            "2024": 41.55,
            "2025": 45.87,
            "2026": 50.67,
            "2027": 56.11,
            "2028": 61.25,
            "2029": 67.5,
            "2030": 76.59,
            "2031": 84.81,
            "2032": 94.6
          },
          "cagr": 10.89,
          "market_share": 24.84
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 12.11,
            "2021": 13.41,
            "2022": 15.06,
            "2023": 16.46,
            "2024": 18.3,
            "2025": 20.21,
            "2026": 22.32,
            "2027": 24.72,
            "2028": 26.98,
            "2029": 29.74,
            "2030": 33.74,
            "2031": 37.36,
            "2032": 41.68
          },
          "cagr": 10.89,
          "market_share": 10.94
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 15.08,
            "2021": 16.69,
            "2022": 18.76,
            "2023": 20.49,
            "2024": 22.79,
            "2025": 25.16,
            "2026": 27.79,
            "2027": 30.78,
            "2028": 33.6,
            "2029": 37.03,
            "2030": 42.01,
            "2031": 46.52,
            "2032": 51.89
          },
          "cagr": 10.89,
          "market_share": 13.62
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 25.3,
            "2021": 27.99,
            "2022": 31.46,
            "2023": 34.38,
            "2024": 38.22,
            "2025": 42.2,
            "2026": 46.62,
            "2027": 51.61,
            "2028": 56.35,
            "2029": 62.1,
            "2030": 70.46,
            "2031": 78.03,
            "2032": 87.02
          },
          "cagr": 10.89,
          "market_share": 22.85
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 18.68,
            "2021": 20.67,
            "2022": 23.23,
            "2023": 25.38,
            "2024": 28.22,
            "2025": 31.16,
            "2026": 34.42,
            "2027": 38.12,
            "2028": 41.61,
            "2029": 45.86,
            "2030": 52.03,
            "2031": 57.61,
            "2032": 64.26
          },
          "cagr": 10.89,
          "market_share": 16.87
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 24.4,
            "2021": 27.0,
            "2022": 30.34,
            "2023": 33.16,
            "2024": 36.87,
            "2025": 40.71,
            "2026": 44.96,
            "2027": 49.79,
            "2028": 54.36,
            "2029": 59.91,
            "2030": 67.97,
            "2031": 75.27,
            "2032": 83.95
          },
          "cagr": 10.89,
          "market_share": 22.04
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 20.5,
            "2021": 22.69,
            "2022": 25.49,
            "2023": 27.85,
            "2024": 30.97,
            "2025": 34.2,
            "2026": 37.77,
            "2027": 41.83,
            "2028": 45.66,
            "2029": 50.32,
            "2030": 57.1,
            "2031": 63.23,
            "2032": 70.52
          },
          "cagr": 10.89,
          "market_share": 18.51
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 20.02,
            "2021": 22.16,
            "2022": 24.9,
            "2023": 27.21,
            "2024": 30.26,
            "2025": 33.41,
            "2026": 36.9,
            "2027": 40.87,
            "2028": 44.61,
            "2029": 49.16,
            "2030": 55.78,
            "2031": 61.77,
            "2032": 68.9
          },
          "cagr": 10.89,
          "market_share": 18.09
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 27.1,
            "2021": 30.0,
            "2022": 33.71,
            "2023": 36.83,
            "2024": 40.96,
            "2025": 45.22,
            "2026": 49.96,
            "2027": 55.3,
            "2028": 60.38,
            "2029": 66.54,
            "2030": 75.5,
            "2031": 83.6,
            "2032": 93.26
          },
          "cagr": 10.89,
          "market_share": 24.49
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 53.58,
            "2021": 59.31,
            "2022": 66.64,
            "2023": 72.82,
            "2024": 80.97,
            "2025": 89.41,
            "2026": 98.75,
            "2027": 109.36,
            "2028": 119.38,
            "2029": 131.56,
            "2030": 149.28,
            "2031": 165.3,
            "2032": 184.37
          },
          "cagr": 10.89,
          "market_share": 48.4
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 57.12,
            "2021": 63.21,
            "2022": 71.03,
            "2023": 77.61,
            "2024": 86.31,
            "2025": 95.29,
            "2026": 105.26,
            "2027": 116.55,
            "2028": 127.24,
            "2029": 140.23,
            "2030": 159.1,
            "2031": 176.18,
            "2032": 196.52
          },
          "cagr": 10.89,
          "market_share": 51.6
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 53.29,
            "2021": 58.98,
            "2022": 66.28,
            "2023": 72.42,
            "2024": 80.53,
            "2025": 88.92,
            "2026": 98.22,
            "2027": 108.76,
            "2028": 118.73,
            "2029": 130.85,
            "2030": 148.47,
            "2031": 164.4,
            "2032": 183.37
          },
          "cagr": 10.89,
          "market_share": 48.14
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 57.41,
            "2021": 63.54,
            "2022": 71.39,
            "2023": 78.01,
            "2024": 86.75,
            "2025": 95.78,
            "2026": 105.79,
            "2027": 117.15,
            "2028": 127.89,
            "2029": 140.94,
            "2030": 159.91,
            "2031": 177.08,
            "2032": 197.52
          },
          "cagr": 10.89,
          "market_share": 51.86
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 41.51,
            "2021": 45.94,
            "2022": 51.63,
            "2023": 56.41,
            "2024": 62.73,
            "2025": 69.26,
            "2026": 76.5,
            "2027": 84.71,
            "2028": 92.48,
            "2029": 101.92,
            "2030": 115.64,
            "2031": 128.05,
            "2032": 142.83
          },
          "cagr": 10.89,
          "market_share": 37.5
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 45.7,
            "2021": 50.58,
            "2022": 56.84,
            "2023": 62.11,
            "2024": 69.06,
            "2025": 76.26,
            "2026": 84.23,
            "2027": 93.27,
            "2028": 101.82,
            "2029": 112.21,
            "2030": 127.32,
            "2031": 140.99,
            "2032": 157.25
          },
          "cagr": 10.89,
          "market_share": 41.28
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 23.49,
            "2021": 26.0,
            "2022": 29.2,
            "2023": 31.91,
            "2024": 35.49,
            "2025": 39.18,
            "2026": 43.28,
            "2027": 47.93,
            "2028": 52.32,
            "2029": 57.66,
            "2030": 65.42,
            "2031": 72.44,
            "2032": 80.81
          },
          "cagr": 10.9,
          "market_share": 21.22
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 70.74,
            "2021": 78.29,
            "2022": 87.98,
            "2023": 96.13,
            "2024": 106.9,
            "2025": 118.03,
            "2026": 130.37,
            "2027": 144.37,
            "2028": 157.6,
            "2029": 173.69,
            "2030": 197.07,
            "2031": 218.22,
            "2032": 243.4
          },
          "cagr": 10.89,
          "market_share": 63.9
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 39.96,
            "2021": 44.23,
            "2022": 49.69,
            "2023": 54.3,
            "2024": 60.38,
            "2025": 66.67,
            "2026": 73.64,
            "2027": 81.54,
            "2028": 89.02,
            "2029": 98.1,
            "2030": 111.31,
            "2031": 123.26,
            "2032": 137.49
          },
          "cagr": 10.89,
          "market_share": 36.1
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 13.1,
            "2021": 15.06,
            "2022": 17.41,
            "2023": 19.53,
            "2024": 22.82,
            "2025": 25.64,
            "2026": 28.64,
            "2027": 33.25,
            "2028": 37.57,
            "2029": 42.38,
            "2030": 48.29,
            "2031": 55.06,
            "2032": 64.59
          },
          "cagr": 14.11,
          "market_share": 15.22
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 24.74,
            "2021": 28.43,
            "2022": 32.87,
            "2023": 36.88,
            "2024": 43.09,
            "2025": 48.41,
            "2026": 54.07,
            "2027": 62.78,
            "2028": 70.94,
            "2029": 80.01,
            "2030": 91.17,
            "2031": 103.96,
            "2032": 121.96
          },
          "cagr": 14.11,
          "market_share": 28.74
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 17.85,
            "2021": 20.52,
            "2022": 23.72,
            "2023": 26.61,
            "2024": 31.09,
            "2025": 34.93,
            "2026": 39.02,
            "2027": 45.31,
            "2028": 51.19,
            "2029": 57.74,
            "2030": 65.79,
            "2031": 75.02,
            "2032": 88.01
          },
          "cagr": 14.11,
          "market_share": 20.74
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 18.75,
            "2021": 21.55,
            "2022": 24.92,
            "2023": 27.96,
            "2024": 32.66,
            "2025": 36.69,
            "2026": 40.99,
            "2027": 47.59,
            "2028": 53.78,
            "2029": 60.65,
            "2030": 69.11,
            "2031": 78.81,
            "2032": 92.45
          },
          "cagr": 14.11,
          "market_share": 21.78
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 11.62,
            "2021": 13.37,
            "2022": 15.44,
            "2023": 17.33,
            "2024": 20.26,
            "2025": 22.75,
            "2026": 25.41,
            "2027": 29.51,
            "2028": 33.34,
            "2029": 37.59,
            "2030": 42.84,
            "2031": 48.87,
            "2032": 57.32
          },
          "cagr": 14.11,
          "market_share": 13.51
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 19.84,
            "2021": 22.81,
            "2022": 26.37,
            "2023": 29.58,
            "2024": 34.57,
            "2025": 38.83,
            "2026": 43.38,
            "2027": 50.37,
            "2028": 56.91,
            "2029": 64.18,
            "2030": 73.14,
            "2031": 83.4,
            "2032": 97.84
          },
          "cagr": 14.11,
          "market_share": 23.06
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.54,
            "2021": 14.42,
            "2022": 16.67,
            "2023": 18.7,
            "2024": 21.85,
            "2025": 24.55,
            "2026": 27.42,
            "2027": 31.84,
            "2028": 35.98,
            "2029": 40.57,
            "2030": 46.23,
            "2031": 52.72,
            "2032": 61.85
          },
          "cagr": 14.11,
          "market_share": 14.57
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 20.02,
            "2021": 23.01,
            "2022": 26.6,
            "2023": 29.84,
            "2024": 34.87,
            "2025": 39.17,
            "2026": 43.76,
            "2027": 50.81,
            "2028": 57.41,
            "2029": 64.74,
            "2030": 73.78,
            "2031": 84.13,
            "2032": 98.69
          },
          "cagr": 14.11,
          "market_share": 23.26
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 13.52,
            "2021": 15.55,
            "2022": 17.97,
            "2023": 20.16,
            "2024": 23.56,
            "2025": 26.47,
            "2026": 29.57,
            "2027": 34.33,
            "2028": 38.79,
            "2029": 43.75,
            "2030": 49.85,
            "2031": 56.85,
            "2032": 66.68
          },
          "cagr": 14.11,
          "market_share": 15.72
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 20.14,
            "2021": 23.14,
            "2022": 26.75,
            "2023": 30.03,
            "2024": 35.07,
            "2025": 39.4,
            "2026": 44.0,
            "2027": 51.09,
            "2028": 57.73,
            "2029": 65.13,
            "2030": 74.2,
            "2031": 84.62,
            "2032": 99.27
          },
          "cagr": 14.11,
          "market_share": 23.39
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 37.34,
            "2021": 42.92,
            "2022": 49.62,
            "2023": 55.67,
            "2024": 65.05,
            "2025": 73.07,
            "2026": 81.62,
            "2027": 94.78,
            "2028": 107.09,
            "2029": 120.78,
            "2030": 137.63,
            "2031": 156.94,
            "2032": 184.11
          },
          "cagr": 14.11,
          "market_share": 43.39
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 48.72,
            "2021": 56.01,
            "2022": 64.74,
            "2023": 72.64,
            "2024": 84.87,
            "2025": 95.35,
            "2026": 106.51,
            "2027": 123.66,
            "2028": 139.73,
            "2029": 157.59,
            "2030": 179.57,
            "2031": 204.78,
            "2032": 240.22
          },
          "cagr": 14.11,
          "market_share": 56.61
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 28.63,
            "2021": 32.91,
            "2022": 38.05,
            "2023": 42.69,
            "2024": 49.87,
            "2025": 56.03,
            "2026": 62.59,
            "2027": 72.67,
            "2028": 82.11,
            "2029": 92.61,
            "2030": 105.53,
            "2031": 120.33,
            "2032": 141.16
          },
          "cagr": 14.11,
          "market_share": 33.26
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 57.43,
            "2021": 66.02,
            "2022": 76.31,
            "2023": 85.62,
            "2024": 100.05,
            "2025": 112.39,
            "2026": 125.54,
            "2027": 145.77,
            "2028": 164.71,
            "2029": 185.76,
            "2030": 211.67,
            "2031": 241.39,
            "2032": 283.17
          },
          "cagr": 14.11,
          "market_share": 66.74
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 27.74,
            "2021": 31.89,
            "2022": 36.86,
            "2023": 41.36,
            "2024": 48.32,
            "2025": 54.28,
            "2026": 60.64,
            "2027": 70.41,
            "2028": 79.55,
            "2029": 89.72,
            "2030": 102.24,
            "2031": 116.59,
            "2032": 136.77
          },
          "cagr": 14.11,
          "market_share": 32.23
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 22.23,
            "2021": 25.55,
            "2022": 29.54,
            "2023": 33.14,
            "2024": 38.72,
            "2025": 43.5,
            "2026": 48.59,
            "2027": 56.42,
            "2028": 63.75,
            "2029": 71.9,
            "2030": 81.93,
            "2031": 93.43,
            "2032": 109.6
          },
          "cagr": 14.11,
          "market_share": 25.83
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 36.09,
            "2021": 41.49,
            "2022": 47.96,
            "2023": 53.81,
            "2024": 62.88,
            "2025": 70.64,
            "2026": 78.9,
            "2027": 91.61,
            "2028": 103.52,
            "2029": 116.75,
            "2030": 133.03,
            "2031": 151.7,
            "2032": 177.96
          },
          "cagr": 14.11,
          "market_share": 41.94
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 57.22,
            "2021": 65.78,
            "2022": 76.04,
            "2023": 85.31,
            "2024": 99.68,
            "2025": 111.98,
            "2026": 125.08,
            "2027": 145.24,
            "2028": 164.11,
            "2029": 185.09,
            "2030": 210.91,
            "2031": 240.5,
            "2032": 282.13
          },
          "cagr": 14.11,
          "market_share": 66.49
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 28.84,
            "2021": 33.15,
            "2022": 38.32,
            "2023": 43.0,
            "2024": 50.24,
            "2025": 56.44,
            "2026": 63.05,
            "2027": 73.2,
            "2028": 82.71,
            "2029": 93.28,
            "2030": 106.29,
            "2031": 121.22,
            "2032": 142.2
          },
          "cagr": 14.11,
          "market_share": 33.51
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 12.04,
            "2021": 13.22,
            "2022": 14.76,
            "2023": 16.22,
            "2024": 17.97,
            "2025": 20.24,
            "2026": 22.75,
            "2027": 25.23,
            "2028": 28.04,
            "2029": 30.76,
            "2030": 34.09,
            "2031": 37.82,
            "2032": 41.03
          },
          "cagr": 10.62,
          "market_share": 10.59
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 24.47,
            "2021": 26.87,
            "2022": 29.99,
            "2023": 32.97,
            "2024": 36.53,
            "2025": 41.13,
            "2026": 46.23,
            "2027": 51.29,
            "2028": 56.99,
            "2029": 62.52,
            "2030": 69.29,
            "2031": 76.88,
            "2032": 83.39
          },
          "cagr": 10.62,
          "market_share": 21.54
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 22.65,
            "2021": 24.87,
            "2022": 27.76,
            "2023": 30.52,
            "2024": 33.82,
            "2025": 38.08,
            "2026": 42.8,
            "2027": 47.48,
            "2028": 52.76,
            "2029": 57.88,
            "2030": 64.14,
            "2031": 71.17,
            "2032": 77.2
          },
          "cagr": 10.62,
          "market_share": 19.94
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 24.18,
            "2021": 26.55,
            "2022": 29.64,
            "2023": 32.59,
            "2024": 36.1,
            "2025": 40.65,
            "2026": 45.69,
            "2027": 50.69,
            "2028": 56.33,
            "2029": 61.8,
            "2030": 68.48,
            "2031": 75.98,
            "2032": 82.42
          },
          "cagr": 10.62,
          "market_share": 21.28
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 30.26,
            "2021": 33.23,
            "2022": 37.1,
            "2023": 40.79,
            "2024": 45.19,
            "2025": 50.88,
            "2026": 57.2,
            "2027": 63.44,
            "2028": 70.5,
            "2029": 77.35,
            "2030": 85.71,
            "2031": 95.1,
            "2032": 103.17
          },
          "cagr": 10.63,
          "market_share": 26.64
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 13.84,
            "2021": 15.2,
            "2022": 16.97,
            "2023": 18.66,
            "2024": 20.67,
            "2025": 23.27,
            "2026": 26.16,
            "2027": 29.02,
            "2028": 32.25,
            "2029": 35.38,
            "2030": 39.2,
            "2031": 43.5,
            "2032": 47.19
          },
          "cagr": 10.63,
          "market_share": 12.19
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 36.4,
            "2021": 39.97,
            "2022": 44.62,
            "2023": 49.05,
            "2024": 54.35,
            "2025": 61.19,
            "2026": 68.78,
            "2027": 76.3,
            "2028": 84.79,
            "2029": 93.02,
            "2030": 103.09,
            "2031": 114.38,
            "2032": 124.07
          },
          "cagr": 10.63,
          "market_share": 32.04
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 13.14,
            "2021": 14.43,
            "2022": 16.11,
            "2023": 17.71,
            "2024": 19.62,
            "2025": 22.09,
            "2026": 24.83,
            "2027": 27.54,
            "2028": 30.61,
            "2029": 33.58,
            "2030": 37.21,
            "2031": 41.29,
            "2032": 44.79
          },
          "cagr": 10.63,
          "market_share": 11.57
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 28.5,
            "2021": 31.29,
            "2022": 34.93,
            "2023": 38.4,
            "2024": 42.55,
            "2025": 47.91,
            "2026": 53.85,
            "2027": 59.74,
            "2028": 66.38,
            "2029": 72.83,
            "2030": 80.71,
            "2031": 89.55,
            "2032": 97.14
          },
          "cagr": 10.62,
          "market_share": 25.09
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 21.72,
            "2021": 23.85,
            "2022": 26.62,
            "2023": 29.27,
            "2024": 32.42,
            "2025": 36.52,
            "2026": 41.05,
            "2027": 45.53,
            "2028": 50.59,
            "2029": 55.5,
            "2030": 61.5,
            "2031": 68.23,
            "2032": 74.02
          },
          "cagr": 10.62,
          "market_share": 19.11
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 81.71,
            "2021": 89.73,
            "2022": 100.16,
            "2023": 110.12,
            "2024": 122.0,
            "2025": 137.37,
            "2026": 154.41,
            "2027": 171.29,
            "2028": 190.34,
            "2029": 208.82,
            "2030": 231.41,
            "2031": 256.76,
            "2032": 278.52
          },
          "cagr": 10.62,
          "market_share": 71.93
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 31.89,
            "2021": 35.01,
            "2022": 39.09,
            "2023": 42.97,
            "2024": 47.61,
            "2025": 53.61,
            "2026": 60.26,
            "2027": 66.84,
            "2028": 74.28,
            "2029": 81.49,
            "2030": 90.3,
            "2031": 100.19,
            "2032": 108.69
          },
          "cagr": 10.62,
          "market_share": 28.07
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 75.83,
            "2021": 83.27,
            "2022": 92.95,
            "2023": 102.19,
            "2024": 113.22,
            "2025": 127.48,
            "2026": 143.3,
            "2027": 158.96,
            "2028": 176.64,
            "2029": 193.79,
            "2030": 214.76,
            "2031": 238.28,
            "2032": 258.48
          },
          "cagr": 10.63,
          "market_share": 66.75
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 37.77,
            "2021": 41.47,
            "2022": 46.3,
            "2023": 50.9,
            "2024": 56.39,
            "2025": 63.5,
            "2026": 71.37,
            "2027": 79.17,
            "2028": 87.98,
            "2029": 96.52,
            "2030": 106.95,
            "2031": 118.67,
            "2032": 128.73
          },
          "cagr": 10.62,
          "market_share": 33.25
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 28.81,
            "2021": 31.63,
            "2022": 35.31,
            "2023": 38.82,
            "2024": 43.01,
            "2025": 48.43,
            "2026": 54.44,
            "2027": 60.39,
            "2028": 67.11,
            "2029": 73.62,
            "2030": 81.59,
            "2031": 90.52,
            "2032": 98.2
          },
          "cagr": 10.63,
          "market_share": 25.36
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 40.24,
            "2021": 44.19,
            "2022": 49.33,
            "2023": 54.24,
            "2024": 60.09,
            "2025": 67.66,
            "2026": 76.05,
            "2027": 84.36,
            "2028": 93.75,
            "2029": 102.85,
            "2030": 113.97,
            "2031": 126.46,
            "2032": 137.18
          },
          "cagr": 10.62,
          "market_share": 35.43
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 44.55,
            "2021": 48.92,
            "2022": 54.61,
            "2023": 60.03,
            "2024": 66.51,
            "2025": 74.89,
            "2026": 84.18,
            "2027": 93.38,
            "2028": 103.76,
            "2029": 113.84,
            "2030": 126.15,
            "2031": 139.97,
            "2032": 151.83
          },
          "cagr": 10.62,
          "market_share": 39.21
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 75.08,
            "2021": 82.44,
            "2022": 92.03,
            "2023": 101.18,
            "2024": 112.09,
            "2025": 126.21,
            "2026": 141.87,
            "2027": 157.37,
            "2028": 174.88,
            "2029": 191.86,
            "2030": 212.62,
            "2031": 235.9,
            "2032": 255.9
          },
          "cagr": 10.63,
          "market_share": 66.09
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 38.52,
            "2021": 42.3,
            "2022": 47.22,
            "2023": 51.91,
            "2024": 57.52,
            "2025": 64.77,
            "2026": 72.8,
            "2027": 80.76,
            "2028": 89.74,
            "2029": 98.45,
            "2030": 109.09,
            "2031": 121.05,
            "2032": 131.31
          },
          "cagr": 10.62,
          "market_share": 33.91
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 14.89,
            "2021": 16.07,
            "2022": 17.72,
            "2023": 19.45,
            "2024": 21.14,
            "2025": 23.04,
            "2026": 25.71,
            "2027": 28.08,
            "2028": 30.25,
            "2029": 32.82,
            "2030": 36.32,
            "2031": 39.3,
            "2032": 42.93
          },
          "cagr": 9.3,
          "market_share": 24.65
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 6.69,
            "2021": 7.23,
            "2022": 7.97,
            "2023": 8.75,
            "2024": 9.51,
            "2025": 10.36,
            "2026": 11.56,
            "2027": 12.63,
            "2028": 13.6,
            "2029": 14.76,
            "2030": 16.33,
            "2031": 17.67,
            "2032": 19.31
          },
          "cagr": 9.3,
          "market_share": 11.09
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 10.11,
            "2021": 10.91,
            "2022": 12.03,
            "2023": 13.2,
            "2024": 14.36,
            "2025": 15.65,
            "2026": 17.46,
            "2027": 19.06,
            "2028": 20.54,
            "2029": 22.28,
            "2030": 24.66,
            "2031": 26.68,
            "2032": 29.15
          },
          "cagr": 9.29,
          "market_share": 16.74
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 13.69,
            "2021": 14.77,
            "2022": 16.29,
            "2023": 17.88,
            "2024": 19.44,
            "2025": 21.19,
            "2026": 23.64,
            "2027": 25.82,
            "2028": 27.81,
            "2029": 30.18,
            "2030": 33.39,
            "2031": 36.13,
            "2032": 39.47
          },
          "cagr": 9.29,
          "market_share": 22.67
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 15.01,
            "2021": 16.2,
            "2022": 17.85,
            "2023": 19.61,
            "2024": 21.32,
            "2025": 23.23,
            "2026": 25.93,
            "2027": 28.31,
            "2028": 30.49,
            "2029": 33.09,
            "2030": 36.61,
            "2031": 39.62,
            "2032": 43.27
          },
          "cagr": 9.29,
          "market_share": 24.86
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 12.52,
            "2021": 13.51,
            "2022": 14.9,
            "2023": 16.36,
            "2024": 17.79,
            "2025": 19.38,
            "2026": 21.63,
            "2027": 23.62,
            "2028": 25.44,
            "2029": 27.61,
            "2030": 30.55,
            "2031": 33.05,
            "2032": 36.11
          },
          "cagr": 9.3,
          "market_share": 20.74
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 8.05,
            "2021": 8.69,
            "2022": 9.58,
            "2023": 10.52,
            "2024": 11.43,
            "2025": 12.46,
            "2026": 13.9,
            "2027": 15.18,
            "2028": 16.36,
            "2029": 17.75,
            "2030": 19.64,
            "2031": 21.25,
            "2032": 23.21
          },
          "cagr": 9.29,
          "market_share": 13.33
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 14.89,
            "2021": 16.07,
            "2022": 17.71,
            "2023": 19.45,
            "2024": 21.14,
            "2025": 23.04,
            "2026": 25.71,
            "2027": 28.08,
            "2028": 30.24,
            "2029": 32.82,
            "2030": 36.32,
            "2031": 39.29,
            "2032": 42.93
          },
          "cagr": 9.3,
          "market_share": 24.65
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 9.73,
            "2021": 10.5,
            "2022": 11.57,
            "2023": 12.71,
            "2024": 13.82,
            "2025": 15.06,
            "2026": 16.8,
            "2027": 18.35,
            "2028": 19.76,
            "2029": 21.44,
            "2030": 23.73,
            "2031": 25.68,
            "2032": 28.05
          },
          "cagr": 9.29,
          "market_share": 16.11
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 15.2,
            "2021": 16.41,
            "2022": 18.1,
            "2023": 19.85,
            "2024": 21.59,
            "2025": 23.53,
            "2026": 26.26,
            "2027": 28.67,
            "2028": 30.89,
            "2029": 33.51,
            "2030": 37.07,
            "2031": 40.13,
            "2032": 43.83
          },
          "cagr": 9.29,
          "market_share": 25.17
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 39.16,
            "2021": 42.27,
            "2022": 46.6,
            "2023": 51.16,
            "2024": 55.62,
            "2025": 60.62,
            "2026": 67.64,
            "2027": 73.87,
            "2028": 79.56,
            "2029": 86.34,
            "2030": 95.54,
            "2031": 103.38,
            "2032": 112.93
          },
          "cagr": 9.29,
          "market_share": 64.85
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 21.23,
            "2021": 22.91,
            "2022": 25.26,
            "2023": 27.73,
            "2024": 30.15,
            "2025": 32.85,
            "2026": 36.66,
            "2027": 40.03,
            "2028": 43.13,
            "2029": 46.79,
            "2030": 51.77,
            "2031": 56.02,
            "2032": 61.2
          },
          "cagr": 9.3,
          "market_share": 35.15
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 20.49,
            "2021": 22.11,
            "2022": 24.38,
            "2023": 26.76,
            "2024": 29.1,
            "2025": 31.71,
            "2026": 35.39,
            "2027": 38.64,
            "2028": 41.62,
            "2029": 45.17,
            "2030": 49.98,
            "2031": 54.08,
            "2032": 59.08
          },
          "cagr": 9.3,
          "market_share": 33.93
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 39.9,
            "2021": 43.07,
            "2022": 47.48,
            "2023": 52.13,
            "2024": 56.67,
            "2025": 61.76,
            "2026": 68.91,
            "2027": 75.26,
            "2028": 81.07,
            "2029": 87.96,
            "2030": 97.33,
            "2031": 105.32,
            "2032": 115.05
          },
          "cagr": 9.29,
          "market_share": 66.07
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 14.94,
            "2021": 16.12,
            "2022": 17.78,
            "2023": 19.51,
            "2024": 21.22,
            "2025": 23.12,
            "2026": 25.8,
            "2027": 28.18,
            "2028": 30.35,
            "2029": 32.93,
            "2030": 36.44,
            "2031": 39.43,
            "2032": 43.08
          },
          "cagr": 9.3,
          "market_share": 24.74
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 29.9,
            "2021": 32.27,
            "2022": 35.58,
            "2023": 39.06,
            "2024": 42.47,
            "2025": 46.28,
            "2026": 51.65,
            "2027": 56.4,
            "2028": 60.75,
            "2029": 65.92,
            "2030": 72.95,
            "2031": 78.93,
            "2032": 86.23
          },
          "cagr": 9.3,
          "market_share": 49.52
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 15.55,
            "2021": 16.79,
            "2022": 18.5,
            "2023": 20.32,
            "2024": 22.08,
            "2025": 24.07,
            "2026": 26.85,
            "2027": 29.32,
            "2028": 31.59,
            "2029": 34.28,
            "2030": 37.92,
            "2031": 41.04,
            "2032": 44.82
          },
          "cagr": 9.29,
          "market_share": 25.74
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 39.32,
            "2021": 42.44,
            "2022": 46.79,
            "2023": 51.37,
            "2024": 55.85,
            "2025": 60.87,
            "2026": 67.92,
            "2027": 74.17,
            "2028": 79.89,
            "2029": 86.69,
            "2030": 95.93,
            "2031": 103.8,
            "2032": 113.39
          },
          "cagr": 9.29,
          "market_share": 65.12
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 21.07,
            "2021": 22.74,
            "2022": 25.07,
            "2023": 27.52,
            "2024": 29.92,
            "2025": 32.6,
            "2026": 36.38,
            "2027": 39.73,
            "2028": 42.8,
            "2029": 46.44,
            "2030": 51.38,
            "2031": 55.6,
            "2032": 60.74
          },
          "cagr": 9.3,
          "market_share": 34.88
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 36.900000000000006,
            "2021": 41.13,
            "2022": 45.31,
            "2023": 50.61,
            "2024": 55.18,
            "2025": 61.03,
            "2026": 67.80000000000001,
            "2027": 76.83000000000001,
            "2028": 83.73,
            "2029": 93.72999999999999,
            "2030": 102.88,
            "2031": 112.46000000000001,
            "2032": 127.71000000000001
          },
          "cagr": 11.2,
          "market_share": 52.28
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 59.46,
            "2021": 66.31,
            "2022": 72.97,
            "2023": 80.96000000000001,
            "2024": 88.4,
            "2025": 97.5,
            "2026": 107.98,
            "2027": 122.06,
            "2028": 132.55,
            "2029": 148.27,
            "2030": 162.4,
            "2031": 176.92000000000002,
            "2032": 200.25
          },
          "cagr": 11.205,
          "market_share": 80.27
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 46.739999999999995,
            "2021": 52.07,
            "2022": 57.39,
            "2023": 64.29,
            "2024": 70.06,
            "2025": 77.55,
            "2026": 86.27000000000001,
            "2027": 97.84,
            "2028": 106.78,
            "2029": 119.56,
            "2030": 131.32999999999998,
            "2031": 143.76999999999998,
            "2032": 163.45
          },
          "cagr": 11.205,
          "market_share": 67.46000000000001
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 80.43,
            "2021": 89.66,
            "2022": 98.74000000000001,
            "2023": 110.18,
            "2024": 120.16,
            "2025": 132.84,
            "2026": 147.5,
            "2027": 167.07,
            "2028": 181.97,
            "2029": 203.67000000000002,
            "2030": 223.47,
            "2031": 244.16000000000003,
            "2032": 277.1
          },
          "cagr": 11.2,
          "market_share": 113.06
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 62.67,
            "2021": 69.85,
            "2022": 76.93,
            "2023": 85.68,
            "2024": 93.47999999999999,
            "2025": 103.24000000000001,
            "2026": 114.55,
            "2027": 129.66,
            "2028": 141.09,
            "2029": 157.89,
            "2030": 173.14,
            "2031": 188.99,
            "2032": 214.31
          },
          "cagr": 11.205,
          "market_share": 86.94
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 78.67,
            "2021": 87.66,
            "2022": 96.59,
            "2023": 107.91999999999999,
            "2024": 117.66999999999999,
            "2025": 130.14,
            "2026": 144.59,
            "2027": 163.87,
            "2028": 178.6,
            "2029": 199.93,
            "2030": 219.46,
            "2031": 239.94,
            "2032": 272.48
          },
          "cagr": 11.205,
          "market_share": 111.63
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 64.43,
            "2021": 71.85,
            "2022": 79.08,
            "2023": 87.94,
            "2024": 95.97,
            "2025": 105.94,
            "2026": 117.46000000000001,
            "2027": 132.86,
            "2028": 144.46,
            "2029": 161.63,
            "2030": 177.14999999999998,
            "2031": 193.20999999999998,
            "2032": 218.93
          },
          "cagr": 11.205,
          "market_share": 88.37
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 24.11,
            "2021": 26.88,
            "2022": 29.580000000000002,
            "2023": 32.730000000000004,
            "2024": 35.74,
            "2025": 39.36,
            "2026": 43.55,
            "2027": 49.18,
            "2028": 53.33,
            "2029": 59.64,
            "2030": 65.26,
            "2031": 70.98,
            "2032": 80.26
          },
          "cagr": 11.21,
          "market_share": 31.87
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 24.990000000000002,
            "2021": 27.84,
            "2022": 30.700000000000003,
            "2023": 34.459999999999994,
            "2024": 37.54,
            "2025": 41.599999999999994,
            "2026": 46.31,
            "2027": 52.57,
            "2028": 57.43,
            "2029": 64.32000000000001,
            "2030": 70.7,
            "2031": 77.47999999999999,
            "2032": 88.16
          },
          "cagr": 11.2,
          "market_share": 36.61
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 27.57,
            "2021": 30.73,
            "2022": 33.85,
            "2023": 37.81,
            "2024": 41.24,
            "2025": 45.6,
            "2026": 50.66,
            "2027": 57.41,
            "2028": 62.56,
            "2029": 70.03,
            "2030": 76.87,
            "2031": 84.03999999999999,
            "2032": 95.42
          },
          "cagr": 11.2,
          "market_share": 39.07
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 33.89,
            "2021": 37.78,
            "2022": 41.599999999999994,
            "2023": 46.41,
            "2024": 50.620000000000005,
            "2025": 55.96,
            "2026": 62.129999999999995,
            "2027": 70.36,
            "2028": 76.63,
            "2029": 85.75999999999999,
            "2030": 94.09,
            "2031": 102.78999999999999,
            "2032": 116.64
          },
          "cagr": 11.195,
          "market_share": 47.55
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 32.54,
            "2021": 36.28,
            "2022": 39.94,
            "2023": 44.45,
            "2024": 48.5,
            "2025": 53.56,
            "2026": 59.400000000000006,
            "2027": 67.21,
            "2028": 73.11,
            "2029": 81.81,
            "2030": 89.69,
            "2031": 97.86,
            "2032": 110.93
          },
          "cagr": 11.2,
          "market_share": 44.89
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 63.36,
            "2021": 70.63,
            "2022": 77.75,
            "2023": 86.42,
            "2024": 94.33,
            "2025": 104.1,
            "2026": 115.4,
            "2027": 130.53,
            "2028": 141.88,
            "2029": 158.74,
            "2030": 173.96,
            "2031": 189.7,
            "2032": 214.91
          },
          "cagr": 11.205,
          "market_share": 86.63
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 79.74000000000001,
            "2021": 88.88,
            "2022": 97.92,
            "2023": 109.44,
            "2024": 119.31,
            "2025": 131.98,
            "2026": 146.65,
            "2027": 166.2,
            "2028": 181.18,
            "2029": 202.82,
            "2030": 222.64999999999998,
            "2031": 243.45,
            "2032": 276.5
          },
          "cagr": 11.2,
          "market_share": 113.37
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 25.97,
            "2021": 28.93,
            "2022": 31.9,
            "2023": 35.85,
            "2024": 39.04,
            "2025": 43.269999999999996,
            "2026": 48.22,
            "2027": 54.74,
            "2028": 59.85,
            "2029": 67.03,
            "2030": 73.71000000000001,
            "2031": 80.82,
            "2032": 92.02
          },
          "cagr": 11.205,
          "market_share": 38.35
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 29.28,
            "2021": 32.629999999999995,
            "2022": 35.93,
            "2023": 40.06,
            "2024": 43.7,
            "2025": 48.29,
            "2026": 53.56999999999999,
            "2027": 60.68,
            "2028": 66.05,
            "2029": 73.92,
            "2030": 81.08,
            "2031": 88.53,
            "2032": 100.43
          },
          "cagr": 11.2,
          "market_share": 40.83
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 34.1,
            "2021": 38.02,
            "2022": 41.85,
            "2023": 46.44,
            "2024": 50.7,
            "2025": 55.93,
            "2026": 61.95,
            "2027": 70.03,
            "2028": 76.06,
            "2029": 85.09,
            "2030": 93.2,
            "2031": 101.55,
            "2032": 114.96
          },
          "cagr": 11.2,
          "market_share": 46.120000000000005
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 27.29,
            "2021": 30.42,
            "2022": 33.51,
            "2023": 37.43,
            "2024": 40.81,
            "2025": 45.13,
            "2026": 50.14,
            "2027": 56.8,
            "2028": 61.9,
            "2029": 69.29,
            "2030": 76.05,
            "2031": 83.13,
            "2032": 94.39
          },
          "cagr": 11.2,
          "market_share": 38.620000000000005
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 26.46,
            "2021": 29.509999999999998,
            "2022": 32.480000000000004,
            "2023": 36.08,
            "2024": 39.39,
            "2025": 43.46,
            "2026": 48.17,
            "2027": 54.480000000000004,
            "2028": 59.2,
            "2029": 66.22999999999999,
            "2030": 72.57,
            "2031": 79.12,
            "2032": 89.61
          },
          "cagr": 11.205,
          "market_share": 36.08
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 135.86,
            "2021": 153.26,
            "2022": 172.40000000000003,
            "2023": 190.68,
            "2024": 211.65,
            "2025": 238.49999999999997,
            "2026": 263.46000000000004,
            "2027": 294.09,
            "2028": 330.56,
            "2029": 371.69,
            "2030": 413.38,
            "2031": 466.41,
            "2032": 514.73
          },
          "cagr": 11.7425,
          "market_share": 144.67
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 106.19,
            "2021": 119.57999999999998,
            "2022": 134.27,
            "2023": 148.71,
            "2024": 164.11999999999998,
            "2025": 184.92000000000002,
            "2026": 203.97,
            "2027": 227.18,
            "2028": 254.62,
            "2029": 286.13,
            "2030": 317.49,
            "2031": 357.40000000000003,
            "2032": 394.89
          },
          "cagr": 11.7425,
          "market_share": 113.07000000000001
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 127.05000000000001,
            "2021": 143.95,
            "2022": 161.82,
            "2023": 179.17999999999998,
            "2024": 199.94,
            "2025": 225.21,
            "2026": 249.70000000000002,
            "2027": 279.18,
            "2028": 314.65,
            "2029": 353.53,
            "2030": 395.25,
            "2031": 446.5,
            "2032": 493.21999999999997
          },
          "cagr": 11.7425,
          "market_share": 142.28
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 186.55,
            "2021": 210.41,
            "2022": 237.14,
            "2023": 262.21999999999997,
            "2024": 291.16,
            "2025": 328.23,
            "2026": 362.84000000000003,
            "2027": 405.54,
            "2028": 456.12,
            "2029": 513.69,
            "2030": 571.08,
            "2031": 645.0300000000001,
            "2032": 711.97
          },
          "cagr": 11.7425,
          "market_share": 195.56
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 182.55,
            "2021": 206.38,
            "2022": 231.35,
            "2023": 256.34999999999997,
            "2024": 284.55,
            "2025": 320.40000000000003,
            "2026": 354.28999999999996,
            "2027": 394.90999999999997,
            "2028": 443.71,
            "2029": 497.65999999999997,
            "2030": 555.0400000000001,
            "2031": 625.28,
            "2032": 690.8699999999999
          },
          "cagr": 11.7425,
          "market_share": 204.44
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 168.14,
            "2021": 190.04,
            "2022": 214.13000000000002,
            "2023": 237.19,
            "2024": 263.65,
            "2025": 297.16999999999996,
            "2026": 329.28,
            "2027": 368.28,
            "2028": 414.65,
            "2029": 466.84000000000003,
            "2030": 520.48,
            "2031": 588.0799999999999,
            "2032": 650.0500000000001
          },
          "cagr": 11.7425,
          "market_share": 182.48000000000002
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 200.95999999999998,
            "2021": 226.74999999999997,
            "2022": 254.36,
            "2023": 281.38,
            "2024": 312.06,
            "2025": 351.46,
            "2026": 387.85,
            "2027": 432.1700000000001,
            "2028": 485.18,
            "2029": 544.51,
            "2030": 605.64,
            "2031": 682.23,
            "2032": 752.79
          },
          "cagr": 11.7425,
          "market_share": 217.51999999999998
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 73.8,
            "2021": 83.36,
            "2022": 93.92,
            "2023": 103.89,
            "2024": 115.65,
            "2025": 130.32,
            "2026": 144.28,
            "2027": 161.32,
            "2028": 181.7,
            "2029": 204.45999999999998,
            "2030": 227.86999999999998,
            "2031": 257.46000000000004,
            "2032": 284.21999999999997
          },
          "cagr": 11.7475,
          "market_share": 79.18
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 76.60000000000001,
            "2021": 86.28999999999999,
            "2022": 97.21000000000001,
            "2023": 107.41,
            "2024": 119.12,
            "2025": 134.29,
            "2026": 148.2,
            "2027": 165.5,
            "2028": 185.95999999999998,
            "2029": 209.39000000000001,
            "2030": 232.36999999999998,
            "2031": 262.31,
            "2032": 289.32
          },
          "cagr": 11.7425,
          "market_share": 79.01
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 88.27000000000001,
            "2021": 99.51,
            "2022": 111.71000000000001,
            "2023": 123.63,
            "2024": 136.85,
            "2025": 154.16000000000003,
            "2026": 170.11,
            "2027": 189.55,
            "2028": 212.67,
            "2029": 238.85000000000002,
            "2030": 265.39000000000004,
            "2031": 298.92,
            "2032": 330.03000000000003
          },
          "cagr": 11.7425,
          "market_share": 94.72999999999999
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 63.309999999999995,
            "2021": 71.67,
            "2022": 80.75,
            "2023": 89.67999999999999,
            "2024": 99.54999999999998,
            "2025": 112.22000000000001,
            "2026": 124.63,
            "2027": 139.46,
            "2028": 157.05,
            "2029": 176.88,
            "2030": 197.59,
            "2031": 223.24,
            "2032": 247.31
          },
          "cagr": 11.739999999999998,
          "market_share": 70.83
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 67.12,
            "2021": 75.96000000000001,
            "2022": 84.9,
            "2023": 93.96000000000001,
            "2024": 104.54,
            "2025": 117.63999999999999,
            "2026": 129.91,
            "2027": 144.62,
            "2028": 162.45,
            "2029": 181.76999999999998,
            "2030": 202.9,
            "2031": 228.38,
            "2032": 251.96000000000004
          },
          "cagr": 11.7425,
          "market_share": 76.25
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 184.67,
            "2021": 208.31,
            "2022": 234.26999999999998,
            "2023": 259.03999999999996,
            "2024": 287.56,
            "2025": 324.03,
            "2026": 357.84999999999997,
            "2027": 399.39000000000004,
            "2028": 448.87,
            "2029": 504.68,
            "2030": 561.1700000000001,
            "2031": 633.08,
            "2032": 698.5500000000001
          },
          "cagr": 11.7425,
          "market_share": 196.23000000000002
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 184.43,
            "2021": 208.48,
            "2022": 234.22,
            "2023": 259.53000000000003,
            "2024": 288.15,
            "2025": 324.6,
            "2026": 359.28,
            "2027": 401.05999999999995,
            "2028": 450.96,
            "2029": 506.67,
            "2030": 564.9499999999999,
            "2031": 637.23,
            "2032": 704.29
          },
          "cagr": 11.7425,
          "market_share": 203.76999999999998
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 61.34,
            "2021": 69.11,
            "2022": 77.44,
            "2023": 85.64,
            "2024": 94.78999999999999,
            "2025": 106.74000000000001,
            "2026": 117.58999999999999,
            "2027": 130.84,
            "2028": 146.67999999999998,
            "2029": 164.51000000000002,
            "2030": 182.66,
            "2031": 205.51,
            "2032": 226.7
          },
          "cagr": 11.7425,
          "market_share": 65.89
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 71.08,
            "2021": 80.48,
            "2022": 90.55,
            "2023": 100.58,
            "2024": 111.64999999999999,
            "2025": 125.81,
            "2026": 139.7,
            "2027": 156.19,
            "2028": 175.82,
            "2029": 197.77999999999997,
            "2030": 221.06,
            "2031": 249.59,
            "2032": 276.43
          },
          "cagr": 11.7425,
          "market_share": 80.33
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 87.45,
            "2021": 98.75,
            "2022": 111.08000000000001,
            "2023": 122.92,
            "2024": 136.52,
            "2025": 153.84,
            "2026": 170.12,
            "2027": 189.95999999999998,
            "2028": 213.64,
            "2029": 240.23,
            "2030": 267.46000000000004,
            "2031": 301.84000000000003,
            "2032": 333.3
          },
          "cagr": 11.7425,
          "market_share": 94.19
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 64.45,
            "2021": 72.87,
            "2022": 81.86,
            "2023": 90.64,
            "2024": 100.78,
            "2025": 113.52000000000001,
            "2026": 125.61,
            "2027": 140.24,
            "2028": 157.75,
            "2029": 177.19,
            "2030": 197.62,
            "2031": 222.93999999999997,
            "2032": 246.26
          },
          "cagr": 11.7425,
          "market_share": 71.14
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 84.78,
            "2021": 95.58,
            "2022": 107.56,
            "2023": 118.78999999999999,
            "2024": 131.97,
            "2025": 148.72,
            "2026": 164.10999999999999,
            "2027": 183.22,
            "2028": 205.94,
            "2029": 231.64000000000001,
            "2030": 257.32,
            "2031": 290.43,
            "2032": 320.15
          },
          "cagr": 11.7425,
          "market_share": 88.47
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 262.38,
            "2021": 286.83000000000004,
            "2022": 314.21,
            "2023": 350.08,
            "2024": 381.66999999999996,
            "2025": 424.14000000000004,
            "2026": 465.36,
            "2027": 513.73,
            "2028": 565.87,
            "2029": 623.63,
            "2030": 687.34,
            "2031": 754.5500000000001,
            "2032": 843.61
          },
          "cagr": 10.379999999999999,
          "market_share": 239.61999999999998
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 247.39999999999998,
            "2021": 271.89000000000004,
            "2022": 295.9200000000001,
            "2023": 330.88,
            "2024": 358.7,
            "2025": 398.31,
            "2026": 436.94,
            "2027": 482.95000000000005,
            "2028": 531.22,
            "2029": 584.37,
            "2030": 644.9899999999999,
            "2031": 707.63,
            "2032": 789.66
          },
          "cagr": 10.378571428571428,
          "market_share": 229.51
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 237.57000000000002,
            "2021": 261.58,
            "2022": 286.5,
            "2023": 321.03999999999996,
            "2024": 350.25000000000006,
            "2025": 390.61,
            "2026": 429.55,
            "2027": 475.69,
            "2028": 525.94,
            "2029": 581.6700000000001,
            "2030": 644.06,
            "2031": 709.31,
            "2032": 794.4000000000001
          },
          "cagr": 10.379999999999999,
          "market_share": 230.89
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 334.99,
            "2021": 368.29999999999995,
            "2022": 403.06,
            "2023": 450.93000000000006,
            "2024": 492.11,
            "2025": 548.15,
            "2026": 602.5899999999999,
            "2027": 666.56,
            "2028": 736.1300000000001,
            "2029": 813.7199999999999,
            "2030": 899.79,
            "2031": 990.72,
            "2032": 1108.99
          },
          "cagr": 10.381428571428572,
          "market_share": 322.17999999999995
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 412.35999999999996,
            "2021": 452.0,
            "2022": 493.57,
            "2023": 551.0699999999999,
            "2024": 598.51,
            "2025": 664.91,
            "2026": 729.26,
            "2027": 805.81,
            "2028": 886.9000000000001,
            "2029": 975.95,
            "2030": 1076.6,
            "2031": 1180.77,
            "2032": 1318.6800000000003
          },
          "cagr": 10.378571428571428,
          "market_share": 377.83
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 411.03000000000003,
            "2021": 449.99,
            "2022": 492.29999999999995,
            "2023": 549.08,
            "2024": 598.3,
            "2025": 665.12,
            "2026": 729.94,
            "2027": 805.72,
            "2028": 886.83,
            "2029": 977.25,
            "2030": 1077.57,
            "2031": 1183.99,
            "2032": 1323.5200000000002
          },
          "cagr": 10.379999999999999,
          "market_share": 376.56
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 336.32,
            "2021": 370.30999999999995,
            "2022": 404.33000000000004,
            "2023": 452.92,
            "2024": 492.32000000000005,
            "2025": 547.94,
            "2026": 601.9100000000001,
            "2027": 666.65,
            "2028": 736.2,
            "2029": 812.42,
            "2030": 898.8199999999999,
            "2031": 987.5000000000001,
            "2032": 1104.15
          },
          "cagr": 10.381428571428572,
          "market_share": 323.45000000000005
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 133.31,
            "2021": 146.17,
            "2022": 159.45000000000002,
            "2023": 177.93,
            "2024": 193.72000000000003,
            "2025": 215.31,
            "2026": 236.27,
            "2027": 260.79,
            "2028": 286.92,
            "2029": 316.09999999999997,
            "2030": 348.65999999999997,
            "2031": 383.27,
            "2032": 427.87
          },
          "cagr": 10.378571428571428,
          "market_share": 123.74999999999999
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 152.6,
            "2021": 167.51,
            "2022": 182.47999999999996,
            "2023": 203.98999999999998,
            "2024": 221.09,
            "2025": 245.51,
            "2026": 269.26,
            "2027": 297.58,
            "2028": 327.12,
            "2029": 359.6,
            "2030": 396.69999999999993,
            "2031": 434.97,
            "2032": 485.52000000000004
          },
          "cagr": 10.381428571428572,
          "market_share": 138.09
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 169.50000000000003,
            "2021": 186.54000000000002,
            "2022": 204.48,
            "2023": 229.19,
            "2024": 249.37,
            "2025": 277.96000000000004,
            "2026": 305.42,
            "2027": 338.65999999999997,
            "2028": 374.63,
            "2029": 413.73999999999995,
            "2030": 458.15999999999997,
            "2031": 503.23,
            "2032": 563.6800000000001
          },
          "cagr": 10.379999999999999,
          "market_share": 162.51999999999998
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 166.04,
            "2021": 182.0,
            "2022": 199.54,
            "2023": 222.84,
            "2024": 243.13,
            "2025": 270.72,
            "2026": 297.35,
            "2027": 328.56,
            "2028": 362.57000000000005,
            "2029": 400.31,
            "2030": 442.18,
            "2031": 486.34,
            "2032": 544.1700000000001
          },
          "cagr": 10.379999999999999,
          "market_share": 157.8
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 125.9,
            "2021": 138.07999999999998,
            "2022": 150.68,
            "2023": 168.05,
            "2024": 183.31,
            "2025": 203.56,
            "2026": 223.55,
            "2027": 246.78,
            "2028": 271.79,
            "2029": 299.92,
            "2030": 330.69,
            "2031": 363.68,
            "2032": 406.43
          },
          "cagr": 10.377142857142857,
          "market_share": 117.85000000000001
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 382.65,
            "2021": 420.9,
            "2022": 460.64,
            "2023": 515.71,
            "2024": 562.66,
            "2025": 626.5799999999999,
            "2026": 688.98,
            "2027": 762.89,
            "2028": 842.36,
            "2029": 931.21,
            "2030": 1029.6100000000001,
            "2031": 1133.0,
            "2032": 1269.63
          },
          "cagr": 10.379999999999999,
          "market_share": 358.45
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 364.70000000000005,
            "2021": 399.4,
            "2022": 435.98999999999995,
            "2023": 486.28999999999996,
            "2024": 527.96,
            "2025": 586.48,
            "2026": 642.87,
            "2027": 709.48,
            "2028": 780.6700000000001,
            "2029": 858.46,
            "2030": 946.7799999999999,
            "2031": 1038.49,
            "2032": 1158.04
          },
          "cagr": 10.379999999999999,
          "market_share": 341.56
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 164.98000000000002,
            "2021": 180.35999999999999,
            "2022": 196.22,
            "2023": 218.41,
            "2024": 237.31,
            "2025": 262.98,
            "2026": 288.26,
            "2027": 317.34,
            "2028": 347.65,
            "2029": 381.84,
            "2030": 419.76,
            "2031": 460.69,
            "2032": 513.45
          },
          "cagr": 10.379999999999999,
          "market_share": 145.92
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 128.85000000000002,
            "2021": 140.95,
            "2022": 154.82,
            "2023": 172.59,
            "2024": 187.89,
            "2025": 208.83,
            "2026": 229.02,
            "2027": 253.26,
            "2028": 279.52,
            "2029": 308.09,
            "2030": 340.09000000000003,
            "2031": 372.71,
            "2032": 417.17999999999995
          },
          "cagr": 10.37857142857143,
          "market_share": 121.24
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 163.48000000000002,
            "2021": 179.97000000000003,
            "2022": 197.0,
            "2023": 220.67,
            "2024": 241.18,
            "2025": 268.98,
            "2026": 295.94,
            "2027": 327.5,
            "2028": 361.96,
            "2029": 400.6,
            "2030": 443.34,
            "2031": 488.86,
            "2032": 547.51
          },
          "cagr": 10.378571428571428,
          "market_share": 157.92000000000002
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 163.45999999999998,
            "2021": 179.33999999999997,
            "2022": 195.94,
            "2023": 219.02,
            "2024": 237.27,
            "2025": 263.71000000000004,
            "2026": 289.09000000000003,
            "2027": 319.76000000000005,
            "2028": 352.44,
            "2029": 387.59000000000003,
            "2030": 428.15000000000003,
            "2031": 468.96999999999997,
            "2032": 523.56
          },
          "cagr": 10.379999999999999,
          "market_share": 154.04
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 126.58,
            "2021": 139.68,
            "2022": 152.65,
            "2023": 171.31,
            "2024": 186.97,
            "2025": 208.56,
            "2026": 229.54,
            "2027": 254.51000000000002,
            "2028": 281.46,
            "2029": 311.55,
            "2030": 345.05,
            "2031": 380.26,
            "2032": 425.96999999999997
          },
          "cagr": 10.377142857142857,
          "market_share": 120.89
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 231.71,
            "2021": 261.26,
            "2022": 288.53999999999996,
            "2023": 319.98,
            "2024": 357.53,
            "2025": 401.41999999999996,
            "2026": 447.26,
            "2027": 494.3,
            "2028": 553.62,
            "2029": 621.66,
            "2030": 694.22,
            "2031": 772.1400000000001,
            "2032": 860.1899999999999
          },
          "cagr": 11.06857142857143,
          "market_share": 245.91999999999996
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 204.13000000000002,
            "2021": 230.33999999999997,
            "2022": 254.18,
            "2023": 282.22,
            "2024": 314.76000000000005,
            "2025": 354.02,
            "2026": 394.49,
            "2027": 436.96,
            "2028": 489.7300000000001,
            "2029": 548.38,
            "2030": 613.79,
            "2031": 681.06,
            "2032": 762.33
          },
          "cagr": 11.069999999999999,
          "market_share": 221.97
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 223.76000000000002,
            "2021": 253.27,
            "2022": 280.71,
            "2023": 312.07000000000005,
            "2024": 349.39,
            "2025": 394.78999999999996,
            "2026": 440.97,
            "2027": 489.09999999999997,
            "2028": 548.93,
            "2029": 618.5400000000001,
            "2030": 693.95,
            "2031": 772.25,
            "2032": 865.3700000000001
          },
          "cagr": 11.069999999999999,
          "market_share": 232.11999999999998
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 285.77000000000004,
            "2021": 322.63,
            "2022": 356.73999999999995,
            "2023": 396.88,
            "2024": 443.54999999999995,
            "2025": 498.77,
            "2026": 557.89,
            "2027": 617.6600000000001,
            "2028": 692.71,
            "2029": 778.9,
            "2030": 871.76,
            "2031": 972.13,
            "2032": 1084.18
          },
          "cagr": 11.069999999999999,
          "market_share": 315.38
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 373.83000000000004,
            "2021": 422.23999999999995,
            "2022": 466.69000000000005,
            "2023": 517.39,
            "2024": 578.13,
            "2025": 651.46,
            "2026": 724.83,
            "2027": 802.6999999999999,
            "2028": 899.5699999999998,
            "2029": 1009.68,
            "2030": 1130.2,
            "2031": 1253.32,
            "2032": 1403.71
          },
          "cagr": 11.06857142857143,
          "market_share": 384.61
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 315.17,
            "2021": 356.62999999999994,
            "2022": 394.73,
            "2023": 438.84000000000003,
            "2024": 491.14,
            "2025": 554.9300000000001,
            "2026": 619.4,
            "2027": 686.9100000000001,
            "2028": 771.3,
            "2029": 868.5000000000001,
            "2030": 973.18,
            "2031": 1082.4,
            "2032": 1214.79
          },
          "cagr": 11.06857142857143,
          "market_share": 324.37
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 344.42999999999995,
            "2021": 388.23999999999995,
            "2022": 428.70000000000005,
            "2023": 475.42999999999995,
            "2024": 530.54,
            "2025": 595.3,
            "2026": 663.32,
            "2027": 733.45,
            "2028": 820.98,
            "2029": 920.08,
            "2030": 1028.78,
            "2031": 1143.05,
            "2032": 1273.1
          },
          "cagr": 11.068571428571428,
          "market_share": 375.62
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 126.7,
            "2021": 143.18,
            "2022": 158.71,
            "2023": 176.13,
            "2024": 197.01999999999998,
            "2025": 222.09,
            "2026": 247.81,
            "2027": 274.94,
            "2028": 308.44,
            "2029": 346.32,
            "2030": 388.71000000000004,
            "2031": 431.49,
            "2032": 483.34999999999997
          },
          "cagr": 11.070000000000002,
          "market_share": 131.60999999999999
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 128.53,
            "2021": 145.41,
            "2022": 160.46,
            "2023": 178.38,
            "2024": 199.25000000000003,
            "2025": 224.78,
            "2026": 250.99,
            "2027": 277.81,
            "2028": 311.46000000000004,
            "2029": 350.65999999999997,
            "2030": 391.99,
            "2031": 436.35999999999996,
            "2032": 488.65999999999997
          },
          "cagr": 11.06857142857143,
          "market_share": 137.15
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 139.39999999999998,
            "2021": 157.16,
            "2022": 173.53999999999996,
            "2023": 192.65999999999997,
            "2024": 215.30999999999997,
            "2025": 241.69,
            "2026": 269.72999999999996,
            "2027": 298.22,
            "2028": 334.39,
            "2029": 375.43,
            "2030": 419.19999999999993,
            "2031": 466.71,
            "2032": 520.3299999999999
          },
          "cagr": 11.067142857142857,
          "market_share": 149.57999999999998
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 141.2,
            "2021": 159.38000000000002,
            "2022": 176.01999999999998,
            "2023": 195.21,
            "2024": 217.88,
            "2025": 245.07999999999998,
            "2026": 272.82,
            "2027": 301.72,
            "2028": 337.54999999999995,
            "2029": 378.95,
            "2030": 423.98999999999995,
            "2031": 470.90999999999997,
            "2032": 525.17
          },
          "cagr": 11.069999999999999,
          "market_share": 151.77999999999997
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 123.77000000000001,
            "2021": 139.74,
            "2022": 154.70000000000002,
            "2023": 171.89000000000001,
            "2024": 192.22,
            "2025": 216.59000000000003,
            "2026": 241.37,
            "2027": 267.66999999999996,
            "2028": 300.44,
            "2029": 337.21999999999997,
            "2030": 378.07,
            "2031": 419.98,
            "2032": 470.38
          },
          "cagr": 11.069999999999999,
          "market_share": 129.85
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 370.92,
            "2021": 418.52,
            "2022": 463.1700000000001,
            "2023": 512.5799999999999,
            "2024": 572.43,
            "2025": 644.24,
            "2026": 715.48,
            "2027": 792.7299999999999,
            "2028": 887.25,
            "2029": 993.22,
            "2030": 1114.09,
            "2031": 1232.22,
            "2032": 1378.05
          },
          "cagr": 11.06857142857143,
          "market_share": 382.83
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 288.68,
            "2021": 326.35,
            "2022": 360.26,
            "2023": 401.69000000000005,
            "2024": 449.25,
            "2025": 505.99,
            "2026": 567.24,
            "2027": 627.63,
            "2028": 705.03,
            "2029": 795.36,
            "2030": 887.8700000000001,
            "2031": 993.23,
            "2032": 1109.84
          },
          "cagr": 11.068571428571428,
          "market_share": 317.16
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 140.73,
            "2021": 158.98000000000002,
            "2022": 176.17,
            "2023": 195.78000000000003,
            "2024": 219.24999999999997,
            "2025": 247.33,
            "2026": 275.63,
            "2027": 305.71999999999997,
            "2028": 343.41999999999996,
            "2029": 386.10999999999996,
            "2030": 432.86,
            "2031": 481.21,
            "2032": 539.3100000000001
          },
          "cagr": 11.069999999999999,
          "market_share": 143.76999999999998
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 135.21,
            "2021": 152.75,
            "2022": 169.04,
            "2023": 187.95000000000002,
            "2024": 210.29999999999998,
            "2025": 236.84,
            "2026": 264.88,
            "2027": 293.27,
            "2028": 329.08000000000004,
            "2029": 370.66,
            "2030": 414.59999999999997,
            "2031": 462.28000000000003,
            "2032": 516.4499999999999
          },
          "cagr": 11.065714285714284,
          "market_share": 143.68
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 117.99,
            "2021": 133.41000000000003,
            "2022": 147.46,
            "2023": 163.63,
            "2024": 182.82999999999998,
            "2025": 205.97,
            "2026": 229.97000000000003,
            "2027": 254.53,
            "2028": 285.02000000000004,
            "2029": 320.64,
            "2030": 358.98,
            "2031": 399.21000000000004,
            "2032": 445.88
          },
          "cagr": 11.067142857142857,
          "market_share": 126.04
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 126.14000000000001,
            "2021": 142.51,
            "2022": 157.51,
            "2023": 175.1,
            "2024": 195.45,
            "2025": 220.19,
            "2026": 245.67000000000002,
            "2027": 272.35,
            "2028": 305.34000000000003,
            "2029": 342.55,
            "2030": 384.05999999999995,
            "2031": 426.72999999999996,
            "2032": 477.65000000000003
          },
          "cagr": 11.068571428571428,
          "market_share": 137.73
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 139.53,
            "2021": 157.22,
            "2022": 173.25000000000003,
            "2023": 191.81,
            "2024": 213.85,
            "2025": 239.9,
            "2026": 266.57,
            "2027": 294.48999999999995,
            "2028": 329.41999999999996,
            "2029": 368.62,
            "2030": 411.4599999999999,
            "2031": 456.02,
            "2032": 508.59999999999997
          },
          "cagr": 11.06857142857143,
          "market_share": 148.75
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 80.22999999999999,
            "2021": 88.98,
            "2022": 99.69000000000001,
            "2023": 111.17999999999999,
            "2024": 124.24000000000001,
            "2025": 136.61,
            "2026": 151.04,
            "2027": 170.55,
            "2028": 187.66,
            "2029": 209.35999999999999,
            "2030": 236.34000000000003,
            "2031": 262.77,
            "2032": 291.09
          },
          "cagr": 10.946666666666665,
          "market_share": 83.44999999999999
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 97.75999999999999,
            "2021": 108.63,
            "2022": 122.07,
            "2023": 135.82999999999998,
            "2024": 152.12,
            "2025": 167.68,
            "2026": 185.67,
            "2027": 209.62,
            "2028": 230.73000000000002,
            "2029": 257.36,
            "2030": 291.7,
            "2031": 324.4,
            "2032": 360.55
          },
          "cagr": 10.94,
          "market_share": 99.69
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 116.0,
            "2021": 127.82000000000001,
            "2022": 142.42000000000002,
            "2023": 157.73000000000002,
            "2024": 174.68,
            "2025": 191.41000000000003,
            "2026": 210.48000000000002,
            "2027": 235.0,
            "2028": 257.03,
            "2029": 284.65999999999997,
            "2030": 318.95,
            "2031": 353.49,
            "2032": 389.57
          },
          "cagr": 10.94,
          "market_share": 116.85
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 157.75,
            "2021": 174.68,
            "2022": 195.46999999999997,
            "2023": 217.49,
            "2024": 242.47,
            "2025": 266.45000000000005,
            "2026": 294.15,
            "2027": 331.1,
            "2028": 363.71,
            "2029": 404.89,
            "2030": 456.38,
            "2031": 506.99,
            "2032": 561.04
          },
          "cagr": 10.94,
          "market_share": 162.16
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 136.24,
            "2021": 150.75,
            "2022": 168.71,
            "2023": 187.25,
            "2024": 208.57,
            "2025": 229.25,
            "2026": 253.04000000000002,
            "2027": 284.07,
            "2028": 311.71,
            "2029": 346.49,
            "2030": 390.61,
            "2031": 433.67,
            "2032": 480.16999999999996
          },
          "cagr": 10.94,
          "market_share": 137.84
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 142.85,
            "2021": 158.62,
            "2022": 178.06,
            "2023": 198.17000000000002,
            "2024": 221.7,
            "2025": 244.21,
            "2026": 270.25,
            "2027": 304.91999999999996,
            "2028": 335.5,
            "2029": 374.1,
            "2030": 423.47,
            "2031": 470.86,
            "2032": 522.82
          },
          "cagr": 10.94,
          "market_share": 146.03
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 151.14,
            "2021": 166.81,
            "2022": 186.12,
            "2023": 206.57,
            "2024": 229.34,
            "2025": 251.49,
            "2026": 276.94,
            "2027": 310.25,
            "2028": 339.92,
            "2029": 377.28,
            "2030": 423.52,
            "2031": 469.79999999999995,
            "2032": 518.39
          },
          "cagr": 10.943333333333333,
          "market_share": 153.97
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 60.57,
            "2021": 67.2,
            "2022": 75.39000000000001,
            "2023": 83.74,
            "2024": 93.56,
            "2025": 103.03,
            "2026": 113.96000000000001,
            "2027": 128.25,
            "2028": 140.96,
            "2029": 156.95,
            "2030": 177.56,
            "2031": 197.28,
            "2032": 219.01
          },
          "cagr": 10.943333333333333,
          "market_share": 61.28999999999999
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 53.519999999999996,
            "2021": 59.010000000000005,
            "2022": 65.84,
            "2023": 72.84,
            "2024": 80.72999999999999,
            "2025": 88.55000000000001,
            "2026": 97.44,
            "2027": 108.75,
            "2028": 118.96,
            "2029": 131.72,
            "2030": 147.82999999999998,
            "2031": 163.86,
            "2032": 180.87
          },
          "cagr": 10.94,
          "market_share": 53.39
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 59.22,
            "2021": 65.49000000000001,
            "2022": 73.2,
            "2023": 81.44,
            "2024": 90.67999999999999,
            "2025": 99.54999999999998,
            "2026": 109.81,
            "2027": 123.5,
            "2028": 135.57999999999998,
            "2029": 150.85,
            "2030": 169.74,
            "2031": 188.5,
            "2032": 208.32999999999998
          },
          "cagr": 10.943333333333333,
          "market_share": 60.99000000000001
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 64.49,
            "2021": 71.53,
            "2022": 80.16999999999999,
            "2023": 89.37,
            "2024": 99.89,
            "2025": 109.86999999999999,
            "2026": 121.47,
            "2027": 137.15,
            "2028": 150.89999999999998,
            "2029": 168.32,
            "2030": 190.11,
            "2031": 211.37,
            "2032": 234.21
          },
          "cagr": 10.94,
          "market_share": 66.89
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 56.19,
            "2021": 62.2,
            "2022": 69.58,
            "2023": 77.35,
            "2024": 86.18,
            "2025": 94.7,
            "2026": 104.50999999999999,
            "2027": 117.52,
            "2028": 129.01999999999998,
            "2029": 143.54,
            "2030": 161.75,
            "2031": 179.65,
            "2032": 198.78999999999996
          },
          "cagr": 10.94,
          "market_share": 57.44
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 123.82,
            "2021": 137.60999999999999,
            "2022": 154.54,
            "2023": 172.45999999999998,
            "2024": 193.22,
            "2025": 212.85000000000002,
            "2026": 235.7,
            "2027": 266.76,
            "2028": 293.91999999999996,
            "2029": 328.34000000000003,
            "2030": 371.82,
            "2031": 413.71000000000004,
            "2032": 459.33000000000004
          },
          "cagr": 10.943333333333333,
          "market_share": 128.66
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 170.17000000000002,
            "2021": 187.82,
            "2022": 209.64,
            "2023": 232.28,
            "2024": 257.82000000000005,
            "2025": 282.85,
            "2026": 311.49,
            "2027": 348.40999999999997,
            "2028": 381.5,
            "2029": 423.04,
            "2030": 475.17,
            "2031": 526.95,
            "2032": 581.88
          },
          "cagr": 10.94,
          "market_share": 171.34
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 76.69999999999999,
            "2021": 84.9,
            "2022": 95.0,
            "2023": 105.5,
            "2024": 117.55,
            "2025": 129.19,
            "2026": 142.58999999999997,
            "2027": 160.18,
            "2028": 175.82,
            "2029": 195.49,
            "2030": 220.38,
            "2031": 244.7,
            "2032": 270.89
          },
          "cagr": 10.943333333333333,
          "market_share": 77.91
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 56.019999999999996,
            "2021": 61.849999999999994,
            "2022": 69.14,
            "2023": 76.59,
            "2024": 85.08,
            "2025": 93.45,
            "2026": 102.99000000000001,
            "2027": 115.27,
            "2028": 126.28,
            "2029": 140.07999999999998,
            "2030": 157.61,
            "2031": 174.85,
            "2032": 193.35
          },
          "cagr": 10.94,
          "market_share": 56.11000000000001
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 44.04,
            "2021": 48.92,
            "2022": 54.91,
            "2023": 61.209999999999994,
            "2024": 68.53,
            "2025": 75.46,
            "2026": 83.53,
            "2027": 94.41,
            "2028": 103.94999999999999,
            "2029": 116.03999999999999,
            "2030": 131.32,
            "2031": 146.07,
            "2032": 162.12
          },
          "cagr": 10.943333333333333,
          "market_share": 45.54
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 54.59,
            "2021": 60.44,
            "2022": 67.55,
            "2023": 75.38,
            "2024": 84.03,
            "2025": 92.24000000000001,
            "2026": 101.80000000000001,
            "2027": 114.85,
            "2028": 126.25,
            "2029": 140.75,
            "2030": 158.39000000000001,
            "2031": 176.01,
            "2032": 194.46
          },
          "cagr": 10.943333333333333,
          "market_share": 57.28
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 62.64,
            "2021": 69.32,
            "2022": 77.58,
            "2023": 86.06,
            "2024": 95.85,
            "2025": 105.36,
            "2026": 116.28,
            "2027": 130.45999999999998,
            "2028": 143.12,
            "2029": 159.01999999999998,
            "2030": 179.29000000000002,
            "2031": 199.03,
            "2032": 220.39
          },
          "cagr": 10.94,
          "market_share": 63.16
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 96.19,
            "2021": 107.19999999999999,
            "2022": 121.07,
            "2023": 134.16,
            "2024": 151.47000000000003,
            "2025": 169.6,
            "2026": 189.93,
            "2027": 214.31,
            "2028": 238.87,
            "2029": 264.87,
            "2030": 297.1,
            "2031": 332.71,
            "2032": 374.61
          },
          "cagr": 11.339999999999998,
          "market_share": 106.89
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 71.49,
            "2021": 79.64,
            "2022": 89.95,
            "2023": 99.69000000000001,
            "2024": 112.55,
            "2025": 125.83000000000001,
            "2026": 140.88,
            "2027": 158.98000000000002,
            "2028": 177.01,
            "2029": 196.27,
            "2030": 220.26999999999998,
            "2031": 246.54000000000002,
            "2032": 278.05
          },
          "cagr": 11.34666666666667,
          "market_share": 82.33
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 92.37,
            "2021": 102.00999999999999,
            "2022": 114.45,
            "2023": 126.44,
            "2024": 141.28,
            "2025": 157.44,
            "2026": 176.29,
            "2027": 197.18,
            "2028": 218.25,
            "2029": 240.67000000000002,
            "2030": 268.85,
            "2031": 298.82,
            "2032": 333.01
          },
          "cagr": 11.343333333333334,
          "market_share": 110.78
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 158.20999999999998,
            "2021": 174.92000000000002,
            "2022": 196.38,
            "2023": 216.95000000000002,
            "2024": 242.67000000000002,
            "2025": 271.06,
            "2026": 303.67,
            "2027": 339.94,
            "2028": 376.99,
            "2029": 415.94000000000005,
            "2030": 464.58,
            "2031": 517.0799999999999,
            "2032": 575.56
          },
          "cagr": 11.339999999999998,
          "market_share": 180.17000000000002
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 101.84,
            "2021": 113.92999999999999,
            "2022": 129.09,
            "2023": 143.34,
            "2024": 162.63000000000002,
            "2025": 181.80999999999997,
            "2026": 203.43,
            "2027": 230.53,
            "2028": 257.14,
            "2029": 285.87,
            "2030": 321.64,
            "2031": 360.99,
            "2032": 410.10999999999996
          },
          "cagr": 11.343333333333334,
          "market_share": 119.83000000000001
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 135.1,
            "2021": 150.56,
            "2022": 170.09,
            "2023": 188.65,
            "2024": 213.11,
            "2025": 237.64999999999998,
            "2026": 265.82000000000005,
            "2027": 300.2,
            "2028": 333.76,
            "2029": 370.23999999999995,
            "2030": 415.95,
            "2031": 465.38,
            "2032": 526.9499999999999
          },
          "cagr": 11.339999999999998,
          "market_share": 166.06
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 124.94999999999999,
            "2021": 138.29,
            "2022": 155.38,
            "2023": 171.64,
            "2024": 192.19,
            "2025": 215.22,
            "2026": 241.28000000000003,
            "2027": 270.27,
            "2028": 300.37,
            "2029": 331.57,
            "2030": 370.27,
            "2031": 412.69,
            "2032": 458.71999999999997
          },
          "cagr": 11.34666666666667,
          "market_share": 133.94
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 57.06,
            "2021": 63.400000000000006,
            "2022": 71.47,
            "2023": 79.15,
            "2024": 89.08000000000001,
            "2025": 99.45,
            "2026": 111.31,
            "2027": 125.29,
            "2028": 139.20999999999998,
            "2029": 154.14,
            "2030": 172.76999999999998,
            "2031": 192.98000000000002,
            "2032": 217.12
          },
          "cagr": 11.339999999999998,
          "market_share": 67.67
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 56.989999999999995,
            "2021": 63.08,
            "2022": 70.87,
            "2023": 78.27,
            "2024": 87.63,
            "2025": 98.19999999999999,
            "2026": 110.10000000000001,
            "2027": 123.32,
            "2028": 137.13,
            "2029": 151.34,
            "2030": 168.95999999999998,
            "2031": 188.35,
            "2032": 209.13
          },
          "cagr": 11.343333333333334,
          "market_share": 59.94
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 46.2,
            "2021": 51.519999999999996,
            "2022": 58.24,
            "2023": 64.6,
            "2024": 73.03,
            "2025": 81.47999999999999,
            "2026": 91.17,
            "2027": 103.01,
            "2028": 114.6,
            "2029": 127.17,
            "2030": 142.89000000000001,
            "2031": 159.95,
            "2032": 181.14
          },
          "cagr": 11.34666666666667,
          "market_share": 55.989999999999995
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 51.75,
            "2021": 57.34,
            "2022": 64.47,
            "2023": 71.27000000000001,
            "2024": 79.93,
            "2025": 89.44,
            "2026": 100.22,
            "2027": 112.41999999999999,
            "2028": 124.92999999999999,
            "2029": 138.02,
            "2030": 154.29,
            "2031": 172.08,
            "2032": 191.87
          },
          "cagr": 11.339999999999998,
          "market_share": 56.92
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 48.05,
            "2021": 53.51,
            "2022": 60.42,
            "2023": 67.0,
            "2024": 75.63,
            "2025": 84.30000000000001,
            "2026": 94.30000000000001,
            "2027": 106.42999999999999,
            "2028": 118.25999999999999,
            "2029": 131.14,
            "2030": 147.31,
            "2031": 164.70999999999998,
            "2032": 186.41
          },
          "cagr": 11.34666666666667,
          "market_share": 59.48
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 88.43,
            "2021": 98.18999999999998,
            "2022": 110.60999999999999,
            "2023": 122.42999999999999,
            "2024": 137.68,
            "2025": 153.81,
            "2026": 172.23,
            "2027": 193.69,
            "2028": 215.25,
            "2029": 238.17000000000002,
            "2030": 266.76,
            "2031": 297.87,
            "2032": 334.25
          },
          "cagr": 11.343333333333334,
          "market_share": 102.29999999999998
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 171.62,
            "2021": 190.66,
            "2022": 214.85999999999999,
            "2023": 237.86,
            "2024": 267.62,
            "2025": 299.06,
            "2026": 334.87,
            "2027": 376.78000000000003,
            "2028": 418.88,
            "2029": 463.64000000000004,
            "2030": 519.46,
            "2031": 580.1999999999999,
            "2032": 651.42
          },
          "cagr": 11.343333333333334,
          "market_share": 197.7
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 40.03,
            "2021": 44.35,
            "2022": 49.89,
            "2023": 55.2,
            "2024": 61.93,
            "2025": 68.91999999999999,
            "2026": 77.1,
            "2027": 86.56,
            "2028": 95.86,
            "2029": 105.96000000000001,
            "2030": 118.69999999999999,
            "2031": 132.18,
            "2032": 148.55
          },
          "cagr": 11.343333333333334,
          "market_share": 50.46
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 56.89,
            "2021": 62.8,
            "2022": 70.39,
            "2023": 77.72999999999999,
            "2024": 86.77000000000001,
            "2025": 96.86,
            "2026": 108.53999999999999,
            "2027": 121.26,
            "2028": 134.33,
            "2029": 148.03,
            "2030": 165.16000000000003,
            "2031": 183.59,
            "2032": 203.76000000000002
          },
          "cagr": 11.343333333333334,
          "market_share": 65.00999999999999
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 56.62,
            "2021": 62.870000000000005,
            "2022": 70.85,
            "2023": 78.43,
            "2024": 88.19999999999999,
            "2025": 98.53,
            "2026": 110.32000000000001,
            "2027": 124.1,
            "2028": 137.92,
            "2029": 152.63,
            "2030": 170.98000000000002,
            "2031": 190.92000000000002,
            "2032": 214.34
          },
          "cagr": 11.339999999999998,
          "market_share": 65.73
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 50.61,
            "2021": 56.3,
            "2022": 63.510000000000005,
            "2023": 70.33,
            "2024": 79.27,
            "2025": 88.66,
            "2026": 99.28,
            "2027": 111.85,
            "2028": 124.48999999999998,
            "2029": 137.9,
            "2030": 154.59,
            "2031": 172.87,
            "2032": 194.36
          },
          "cagr": 11.339999999999998,
          "market_share": 57.42
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 55.89999999999999,
            "2021": 62.53,
            "2022": 70.83,
            "2023": 78.6,
            "2024": 89.13000000000001,
            "2025": 99.89999999999999,
            "2026": 111.86,
            "2027": 126.69999999999999,
            "2028": 141.53,
            "2029": 157.29,
            "2030": 176.79000000000002,
            "2031": 198.51,
            "2032": 224.66
          },
          "cagr": 11.343333333333334,
          "market_share": 61.370000000000005
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 530.1600000000001,
            "2021": 590.95,
            "2022": 655.02,
            "2023": 729.33,
            "2024": 806.4799999999999,
            "2025": 900.44,
            "2026": 996.9,
            "2027": 1110.3500000000001,
            "2028": 1234.4299999999998,
            "2029": 1376.07,
            "2030": 1532.25,
            "2031": 1701.3500000000001,
            "2032": 1898.9299999999998
          },
          "cagr": 11.11327380952381,
          "market_share": 562.8799999999999
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 493.23,
            "2021": 549.14,
            "2022": 607.5600000000001,
            "2023": 675.35,
            "2024": 745.36,
            "2025": 832.9300000000001,
            "2026": 922.3000000000001,
            "2027": 1025.53,
            "2028": 1138.06,
            "2029": 1267.03,
            "2030": 1408.55,
            "2031": 1563.33,
            "2032": 1741.6599999999999
          },
          "cagr": 11.112638888888888,
          "market_share": 504.19
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 495.89,
            "2021": 553.84,
            "2022": 614.3500000000001,
            "2023": 682.65,
            "2024": 757.1600000000001,
            "2025": 845.9,
            "2026": 936.5299999999999,
            "2027": 1043.8600000000001,
            "2028": 1160.6699999999998,
            "2029": 1294.35,
            "2030": 1442.48,
            "2031": 1603.37,
            "2032": 1789.3799999999999
          },
          "cagr": 11.112757936507938,
          "market_share": 518.72
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 1203.7,
            "2021": 1340.6,
            "2022": 1487.5300000000002,
            "2023": 1654.65,
            "2024": 1832.1200000000001,
            "2025": 2045.5,
            "2026": 2268.64,
            "2027": 2527.8700000000003,
            "2028": 2807.63,
            "2029": 3130.81,
            "2030": 3487.0600000000004,
            "2031": 3876.1099999999997,
            "2032": 4318.84
          },
          "cagr": 11.112321428571427,
          "market_share": 1288.51
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 503.68000000000006,
            "2021": 561.94,
            "2022": 623.15,
            "2023": 693.3,
            "2024": 767.96,
            "2025": 858.71,
            "2026": 951.83,
            "2027": 1060.53,
            "2028": 1178.5500000000002,
            "2029": 1315.23,
            "2030": 1465.28,
            "2031": 1628.45,
            "2032": 1818.11
          },
          "cagr": 11.111924603174602,
          "market_share": 535.5400000000001
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 520.6800000000001,
            "2021": 579.7,
            "2022": 642.55,
            "2023": 714.78,
            "2024": 791.0,
            "2025": 883.29,
            "2026": 978.6200000000001,
            "2027": 1089.67,
            "2028": 1209.6299999999999,
            "2029": 1348.24,
            "2030": 1502.25,
            "2031": 1666.7299999999996,
            "2032": 1859.37
          },
          "cagr": 11.110833333333332,
          "market_share": 551.77
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 453.57000000000005,
            "2021": 505.77,
            "2022": 560.22,
            "2023": 622.7,
            "2024": 690.38,
            "2025": 770.3500000000001,
            "2026": 853.04,
            "2027": 950.2299999999999,
            "2028": 1055.07,
            "2029": 1175.4,
            "2030": 1310.4099999999999,
            "2031": 1454.2600000000002,
            "2032": 1624.9
          },
          "cagr": 11.112718253968254,
          "market_share": 485.76000000000005
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 1222.23,
            "2021": 1362.2499999999998,
            "2022": 1507.9700000000003,
            "2023": 1675.88,
            "2024": 1852.4199999999998,
            "2025": 2067.35,
            "2026": 2288.7600000000007,
            "2027": 2545.65,
            "2028": 2827.11,
            "2029": 3147.4900000000002,
            "2030": 3504.18,
            "2031": 3888.48,
            "2032": 4326.08
          },
          "cagr": 11.114583333333334,
          "market_share": 1292.8700000000001
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 486.5400000000001,
            "2021": 541.88,
            "2022": 599.88,
            "2023": 667.9000000000001,
            "2024": 737.6099999999999,
            "2025": 823.4499999999999,
            "2026": 911.5899999999999,
            "2027": 1015.8500000000001,
            "2028": 1128.17,
            "2029": 1255.2700000000002,
            "2030": 1398.8600000000001,
            "2031": 1550.65,
            "2032": 1730.6799999999998
          },
          "cagr": 11.112400793650792,
          "market_share": 516.2299999999999
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 1259.3400000000001,
            "2021": 1401.5900000000001,
            "2022": 1552.8899999999996,
            "2023": 1727.0900000000001,
            "2024": 1910.1100000000001,
            "2025": 2130.96,
            "2026": 2362.4,
            "2027": 2629.56,
            "2028": 2918.2200000000003,
            "2029": 3249.99,
            "2030": 3616.88,
            "2031": 4019.55,
            "2032": 4481.97
          },
          "cagr": 11.112400793650792,
          "market_share": 1344.9
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 1250.9599999999998,
            "2021": 1393.5,
            "2022": 1545.8999999999999,
            "2023": 1719.8500000000004,
            "2024": 1905.5699999999997,
            "2025": 2129.22,
            "2026": 2359.28,
            "2027": 2629.8999999999996,
            "2028": 2920.6400000000003,
            "2029": 3256.8599999999997,
            "2030": 3630.1099999999997,
            "2031": 4030.65,
            "2032": 4510.610000000001
          },
          "cagr": 11.112678571428573,
          "market_share": 1307.13
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 843.27,
            "2021": 938.6600000000001,
            "2022": 1041.22,
            "2023": 1156.69,
            "2024": 1281.74,
            "2025": 1431.3000000000002,
            "2026": 1584.8500000000001,
            "2027": 1763.81,
            "2028": 1960.3100000000004,
            "2029": 2184.94,
            "2030": 2431.2599999999998,
            "2031": 2701.0400000000004,
            "2032": 3011.9400000000005
          },
          "cagr": 11.11295634920635,
          "market_share": 872.8299999999998
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 843.49,
            "2021": 940.7,
            "2022": 1043.29,
            "2023": 1160.75,
            "2024": 1285.6,
            "2025": 1437.01,
            "2026": 1593.26,
            "2027": 1773.99,
            "2028": 1971.58,
            "2029": 2198.63,
            "2030": 2452.39,
            "2031": 2724.14,
            "2032": 3039.0200000000004
          },
          "cagr": 11.113472222222223,
          "market_share": 900.38
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 509.75,
            "2021": 566.63,
            "2022": 626.62,
            "2023": 696.3800000000001,
            "2024": 769.8699999999999,
            "2025": 858.43,
            "2026": 949.39,
            "2027": 1055.3799999999999,
            "2028": 1169.2799999999997,
            "2029": 1300.94,
            "2030": 1448.07,
            "2031": 1605.1100000000001,
            "2032": 1790.9199999999998
          },
          "cagr": 11.114027777777778,
          "market_share": 522.3
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 1269.4899999999998,
            "2021": 1415.15,
            "2022": 1566.34,
            "2023": 1741.0799999999997,
            "2024": 1925.8700000000001,
            "2025": 2151.07,
            "2026": 2379.3999999999996,
            "2027": 2647.6800000000003,
            "2028": 2940.12,
            "2029": 3273.54,
            "2030": 3647.23,
            "2031": 4043.0199999999995,
            "2032": 4517.849999999999
          },
          "cagr": 11.11299603174603,
          "market_share": 1311.49
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 475.55,
            "2021": 530.1899999999999,
            "2022": 588.5200000000001,
            "2023": 653.5699999999999,
            "2024": 724.7700000000001,
            "2025": 809.5600000000001,
            "2026": 897.1800000000001,
            "2027": 999.77,
            "2028": 1110.5600000000002,
            "2029": 1237.6100000000001,
            "2030": 1380.83,
            "2031": 1533.46,
            "2032": 1711.83
          },
          "cagr": 11.114900793650795,
          "market_share": 495.36999999999995
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 786.43,
            "2021": 876.39,
            "2022": 969.3600000000001,
            "2023": 1078.29,
            "2024": 1190.6499999999999,
            "2025": 1328.26,
            "2026": 1469.9300000000003,
            "2027": 1637.75,
            "2028": 1815.8600000000001,
            "2029": 2020.7800000000002,
            "2030": 2250.64,
            "2031": 2493.95,
            "2032": 2785.7300000000005
          },
          "cagr": 11.113789682539682,
          "market_share": 826.84
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 1213.85,
            "2021": 1354.1599999999999,
            "2022": 1500.9799999999998,
            "2023": 1668.64,
            "2024": 1847.88,
            "2025": 2065.61,
            "2026": 2285.64,
            "2027": 2545.9900000000002,
            "2028": 2829.53,
            "2029": 3154.3600000000006,
            "2030": 3517.41,
            "2031": 3899.58,
            "2032": 4354.72
          },
          "cagr": 11.113789682539684,
          "market_share": 1255.1
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 477.33000000000004,
            "2021": 531.4599999999999,
            "2022": 589.8699999999999,
            "2023": 655.5000000000001,
            "2024": 725.39,
            "2025": 810.08,
            "2026": 898.6999999999999,
            "2027": 999.93,
            "2028": 1111.08,
            "2029": 1238.56,
            "2030": 1379.6000000000001,
            "2031": 1531.5499999999997,
            "2032": 1707.5999999999997
          },
          "cagr": 11.111686507936506,
          "market_share": 507.2
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 34.72,
            "2021": 40.019999999999996,
            "2022": 45.06,
            "2023": 52.07,
            "2024": 59.14,
            "2025": 67.22,
            "2026": 75.66999999999999,
            "2027": 86.55000000000001,
            "2028": 99.72,
            "2029": 114.92,
            "2030": 130.09,
            "2031": 145.56,
            "2032": 167.93
          },
          "cagr": 13.97,
          "market_share": 44.07
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 46.44,
            "2021": 53.53999999999999,
            "2022": 60.28,
            "2023": 69.66,
            "2024": 79.12,
            "2025": 89.92,
            "2026": 101.22999999999999,
            "2027": 115.78000000000002,
            "2028": 133.4,
            "2029": 153.74,
            "2030": 174.02,
            "2031": 194.73000000000002,
            "2032": 224.67000000000002
          },
          "cagr": 13.973333333333334,
          "market_share": 58.96
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 40.33,
            "2021": 45.879999999999995,
            "2022": 52.56,
            "2023": 60.01,
            "2024": 69.19999999999999,
            "2025": 77.15,
            "2026": 86.82,
            "2027": 101.6,
            "2028": 113.85999999999999,
            "2029": 129.74,
            "2030": 150.04000000000002,
            "2031": 168.35000000000002,
            "2032": 189.45
          },
          "cagr": 13.69,
          "market_share": 46.39
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 58.68,
            "2021": 66.75999999999999,
            "2022": 76.48,
            "2023": 87.32,
            "2024": 100.68999999999998,
            "2025": 112.26,
            "2026": 126.32999999999998,
            "2027": 147.84,
            "2028": 165.65999999999997,
            "2029": 188.78,
            "2030": 218.34000000000003,
            "2031": 244.96000000000004,
            "2032": 275.66999999999996
          },
          "cagr": 13.69,
          "market_share": 67.5
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 120.67999999999999,
            "2021": 133.73000000000002,
            "2022": 149.75,
            "2023": 166.72,
            "2024": 186.07,
            "2025": 204.57,
            "2026": 225.98,
            "2027": 254.67000000000002,
            "2028": 279.91999999999996,
            "2029": 311.86,
            "2030": 351.86,
            "2031": 391.02,
            "2032": 433.0
          },
          "cagr": 10.94,
          "market_share": 124.33
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 181.25,
            "2021": 200.93,
            "2022": 225.14000000000001,
            "2023": 250.45999999999998,
            "2024": 279.63,
            "2025": 307.6,
            "2026": 339.94,
            "2027": 382.92,
            "2028": 420.88,
            "2029": 468.81,
            "2030": 529.4200000000001,
            "2031": 588.3,
            "2032": 652.01
          },
          "cagr": 10.94111111111111,
          "market_share": 185.62
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 26.91,
            "2021": 30.39,
            "2022": 33.82,
            "2023": 38.93,
            "2024": 42.39,
            "2025": 48.84,
            "2026": 53.949999999999996,
            "2027": 60.68,
            "2028": 68.97,
            "2029": 77.05,
            "2030": 87.56,
            "2031": 97.4,
            "2032": 108.47999999999999
          },
          "cagr": 12.075,
          "market_share": 38.42
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 40.49,
            "2021": 45.730000000000004,
            "2022": 50.89,
            "2023": 58.57,
            "2024": 63.769999999999996,
            "2025": 73.49000000000001,
            "2026": 81.16999999999999,
            "2027": 91.3,
            "2028": 103.77,
            "2029": 115.91,
            "2030": 131.72,
            "2031": 146.54000000000002,
            "2032": 163.22
          },
          "cagr": 12.073333333333332,
          "market_share": 57.8
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 53.05,
            "2021": 59.04,
            "2022": 64.0,
            "2023": 69.97,
            "2024": 78.07,
            "2025": 86.53999999999999,
            "2026": 93.21000000000001,
            "2027": 101.49,
            "2028": 113.71000000000001,
            "2029": 125.89,
            "2030": 136.24,
            "2031": 149.03,
            "2032": 166.61
          },
          "cagr": 9.81,
          "market_share": 39.82
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 76.94,
            "2021": 85.61,
            "2022": 92.82,
            "2023": 101.48,
            "2024": 113.22,
            "2025": 125.50999999999999,
            "2026": 135.17000000000002,
            "2027": 147.19,
            "2028": 164.91000000000003,
            "2029": 182.57,
            "2030": 197.58,
            "2031": 216.13,
            "2032": 241.63
          },
          "cagr": 9.81,
          "market_share": 57.75
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 39.730000000000004,
            "2021": 45.989999999999995,
            "2022": 52.650000000000006,
            "2023": 59.97,
            "2024": 68.07,
            "2025": 79.92,
            "2026": 90.98,
            "2027": 104.34,
            "2028": 119.44999999999999,
            "2029": 135.57,
            "2030": 157.88,
            "2031": 175.67000000000002,
            "2032": 204.75
          },
          "cagr": 14.385000000000002,
          "market_share": 38.22
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 62.82000000000001,
            "2021": 72.72,
            "2022": 83.26,
            "2023": 94.84,
            "2024": 107.63999999999999,
            "2025": 126.38,
            "2026": 143.88,
            "2027": 165.02,
            "2028": 188.90999999999997,
            "2029": 214.39999999999998,
            "2030": 249.67000000000002,
            "2031": 277.8,
            "2032": 323.8
          },
          "cagr": 14.386666666666668,
          "market_share": 60.44
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 25.92,
            "2021": 28.79,
            "2022": 31.9,
            "2023": 36.82,
            "2024": 39.879999999999995,
            "2025": 44.67,
            "2026": 50.35,
            "2027": 57.68,
            "2028": 63.87,
            "2029": 71.7,
            "2030": 79.46000000000001,
            "2031": 88.16,
            "2032": 101.46000000000001
          },
          "cagr": 12.43,
          "market_share": 45.21
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 32.45,
            "2021": 36.04,
            "2022": 39.95,
            "2023": 46.11,
            "2024": 49.92999999999999,
            "2025": 55.910000000000004,
            "2026": 63.03,
            "2027": 72.21,
            "2028": 79.96,
            "2029": 89.76,
            "2030": 99.47000000000001,
            "2031": 110.36,
            "2032": 127.01
          },
          "cagr": 12.436666666666667,
          "market_share": 56.6
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 38.4,
            "2021": 42.93000000000001,
            "2022": 49.150000000000006,
            "2023": 53.66,
            "2024": 60.06,
            "2025": 67.93,
            "2026": 74.66,
            "2027": 84.08,
            "2028": 94.97,
            "2029": 108.12,
            "2030": 118.75,
            "2031": 135.3,
            "2032": 148.02
          },
          "cagr": 11.77,
          "market_share": 29.630000000000003
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 69.21,
            "2021": 77.36000000000001,
            "2022": 88.59,
            "2023": 96.69999999999999,
            "2024": 108.25,
            "2025": 122.43,
            "2026": 134.57,
            "2027": 151.55,
            "2028": 171.18,
            "2029": 194.86,
            "2030": 214.04000000000002,
            "2031": 243.85000000000002,
            "2032": 266.78000000000003
          },
          "cagr": 11.770000000000001,
          "market_share": 53.410000000000004
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 46.31,
            "2021": 53.03,
            "2022": 58.8,
            "2023": 63.89,
            "2024": 71.2,
            "2025": 81.05,
            "2026": 90.3,
            "2027": 99.75999999999999,
            "2028": 110.13,
            "2029": 124.39,
            "2030": 140.3,
            "2031": 153.18,
            "2032": 171.87
          },
          "cagr": 11.335,
          "market_share": 41.82
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 68.21000000000001,
            "2021": 78.11,
            "2022": 86.62,
            "2023": 94.13,
            "2024": 104.88,
            "2025": 119.4,
            "2026": 133.01999999999998,
            "2027": 146.97,
            "2028": 162.23,
            "2029": 183.23000000000002,
            "2030": 206.69,
            "2031": 225.64,
            "2032": 253.19
          },
          "cagr": 11.336666666666668,
          "market_share": 61.6
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 40.51,
            "2021": 45.269999999999996,
            "2022": 49.64,
            "2023": 54.04,
            "2024": 59.24,
            "2025": 64.85,
            "2026": 71.18,
            "2027": 79.89,
            "2028": 85.87,
            "2029": 95.87,
            "2030": 104.32,
            "2031": 112.49000000000001,
            "2032": 126.11
          },
          "cagr": 9.965,
          "market_share": 47.230000000000004
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 58.089999999999996,
            "2021": 64.89999999999999,
            "2022": 71.17,
            "2023": 77.48,
            "2024": 84.93,
            "2025": 92.97,
            "2026": 102.05000000000001,
            "2027": 114.53999999999999,
            "2028": 123.11000000000001,
            "2029": 137.45,
            "2030": 149.57,
            "2031": 161.27,
            "2032": 180.82
          },
          "cagr": 9.966666666666667,
          "market_share": 67.71000000000001
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 23.75,
            "2021": 26.3,
            "2022": 28.17,
            "2023": 30.560000000000002,
            "2024": 33.3,
            "2025": 35.629999999999995,
            "2026": 39.7,
            "2027": 42.79,
            "2028": 46.94,
            "2029": 50.69,
            "2030": 54.68,
            "2031": 59.94,
            "2032": 64.1
          },
          "cagr": 8.75,
          "market_share": 33.019999999999996
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 40.739999999999995,
            "2021": 45.11,
            "2022": 48.33,
            "2023": 52.42,
            "2024": 57.12,
            "2025": 61.11,
            "2026": 68.08,
            "2027": 73.39,
            "2028": 80.50999999999999,
            "2029": 86.94,
            "2030": 93.78,
            "2031": 102.8,
            "2032": 109.92999999999999
          },
          "cagr": 8.75,
          "market_share": 56.64
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 45.620000000000005,
            "2021": 50.64,
            "2022": 57.23,
            "2023": 65.09,
            "2024": 73.36,
            "2025": 83.51,
            "2026": 93.13,
            "2027": 103.83000000000001,
            "2028": 116.07999999999998,
            "2029": 131.17000000000002,
            "2030": 146.59,
            "2031": 164.57999999999998,
            "2032": 188.43
          },
          "cagr": 12.33,
          "market_share": 41.22
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 66.35000000000001,
            "2021": 73.65,
            "2022": 83.22,
            "2023": 94.65,
            "2024": 106.69,
            "2025": 121.44,
            "2026": 135.42,
            "2027": 151.01000000000002,
            "2028": 168.80999999999997,
            "2029": 190.75,
            "2030": 213.18,
            "2031": 239.33999999999997,
            "2032": 274.03
          },
          "cagr": 12.33,
          "market_share": 59.95
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 264.97,
            "2021": 299.12,
            "2022": 330.72,
            "2023": 367.1,
            "2024": 410.1,
            "2025": 461.67,
            "2026": 514.19,
            "2027": 569.39,
            "2028": 637.99,
            "2029": 716.17,
            "2030": 802.06,
            "2031": 890.89,
            "2032": 995.55
          },
          "cagr": 11.069999999999999,
          "market_share": 281.63
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 391.67,
            "2021": 442.3,
            "2022": 489.43000000000006,
            "2023": 543.23,
            "2024": 607.12,
            "2025": 683.76,
            "2026": 762.0,
            "2027": 844.3299999999999,
            "2028": 946.4300000000001,
            "2029": 1062.49,
            "2030": 1190.77,
            "2031": 1322.38,
            "2032": 1478.8999999999999
          },
          "cagr": 11.07,
          "market_share": 413.24
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 40.519999999999996,
            "2021": 44.85,
            "2022": 50.39,
            "2023": 55.06,
            "2024": 61.230000000000004,
            "2025": 67.61,
            "2026": 74.67,
            "2027": 82.69999999999999,
            "2028": 90.27,
            "2029": 99.47999999999999,
            "2030": 112.88,
            "2031": 125.0,
            "2032": 139.42000000000002
          },
          "cagr": 10.89,
          "market_share": 36.6
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 67.62,
            "2021": 74.85,
            "2022": 84.1,
            "2023": 91.89,
            "2024": 102.19,
            "2025": 112.83,
            "2026": 124.63,
            "2027": 138.0,
            "2028": 150.65,
            "2029": 166.01999999999998,
            "2030": 188.38,
            "2031": 208.6,
            "2032": 232.68
          },
          "cagr": 10.89,
          "market_share": 61.09
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 29.16,
            "2021": 31.8,
            "2022": 33.87,
            "2023": 37.39,
            "2024": 39.349999999999994,
            "2025": 43.120000000000005,
            "2026": 46.6,
            "2027": 50.1,
            "2028": 54.2,
            "2029": 58.14,
            "2030": 63.89,
            "2031": 69.7,
            "2032": 74.93
          },
          "cagr": 8.215,
          "market_share": 39.84
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 41.14,
            "2021": 44.870000000000005,
            "2022": 47.78,
            "2023": 52.730000000000004,
            "2024": 55.50999999999999,
            "2025": 60.82000000000001,
            "2026": 65.73,
            "2027": 70.68,
            "2028": 76.46000000000001,
            "2029": 82.01,
            "2030": 90.14,
            "2031": 98.31,
            "2032": 105.7
          },
          "cagr": 8.216666666666667,
          "market_share": 56.2
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 291.94,
            "2021": 320.08,
            "2022": 350.22,
            "2023": 390.89,
            "2024": 426.44,
            "2025": 474.28000000000003,
            "2026": 520.9000000000001,
            "2027": 575.34,
            "2028": 634.3600000000001,
            "2029": 700.23,
            "2030": 772.87,
            "2031": 850.02,
            "2032": 950.6000000000001
          },
          "cagr": 10.378571428571428,
          "market_share": 275.65000000000003
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 425.25,
            "2021": 466.25,
            "2022": 509.6700000000001,
            "2023": 568.8199999999999,
            "2024": 620.1600000000001,
            "2025": 689.59,
            "2026": 757.1700000000001,
            "2027": 836.1300000000001,
            "2028": 921.2800000000002,
            "2029": 1016.3299999999999,
            "2030": 1121.53,
            "2031": 1233.29,
            "2032": 1378.4700000000003
          },
          "cagr": 10.378571428571428,
          "market_share": 399.40000000000003
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 99.8,
            "2021": 110.85,
            "2022": 124.89,
            "2023": 138.27,
            "2024": 155.56,
            "2025": 173.74,
            "2026": 194.52,
            "2027": 218.84999999999997,
            "2028": 243.19,
            "2029": 269.15999999999997,
            "2030": 301.6,
            "2031": 336.78999999999996,
            "2032": 378.28
          },
          "cagr": 11.343333333333334,
          "market_share": 116.4
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 156.86,
            "2021": 174.25,
            "2022": 196.36,
            "2023": 217.42000000000002,
            "2024": 244.64000000000001,
            "2025": 273.19,
            "2026": 305.83000000000004,
            "2027": 344.14,
            "2028": 382.4,
            "2029": 423.29999999999995,
            "2030": 474.37,
            "2031": 529.77,
            "2032": 595.4
          },
          "cagr": 11.34222222222222,
          "market_share": 184.07
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 50.209999999999994,
            "2021": 53.2,
            "2022": 59.36,
            "2023": 64.81,
            "2024": 69.75,
            "2025": 76.53999999999999,
            "2026": 82.86,
            "2027": 91.0,
            "2028": 99.53,
            "2029": 107.59,
            "2030": 116.87,
            "2031": 124.71,
            "2032": 139.39
          },
          "cagr": 8.94,
          "market_share": 36.07
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 69.85999999999999,
            "2021": 74.03,
            "2022": 82.6,
            "2023": 90.17,
            "2024": 97.05,
            "2025": 106.50999999999999,
            "2026": 115.28999999999999,
            "2027": 126.61,
            "2028": 138.48000000000002,
            "2029": 149.71,
            "2030": 162.63,
            "2031": 173.53,
            "2032": 193.95999999999998
          },
          "cagr": 8.94,
          "market_share": 50.19
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 36.879999999999995,
            "2021": 40.82,
            "2022": 45.67,
            "2023": 50.81999999999999,
            "2024": 54.010000000000005,
            "2025": 60.94,
            "2026": 66.32,
            "2027": 72.96000000000001,
            "2028": 80.24000000000001,
            "2029": 90.23,
            "2030": 97.86,
            "2031": 108.76,
            "2032": 120.69999999999999
          },
          "cagr": 10.254999999999999,
          "market_share": 34.95
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 53.419999999999995,
            "2021": 59.11,
            "2022": 66.13,
            "2023": 73.58999999999999,
            "2024": 78.21000000000001,
            "2025": 88.24,
            "2026": 96.05,
            "2027": 105.64000000000001,
            "2028": 116.19000000000001,
            "2029": 130.67000000000002,
            "2030": 141.73,
            "2031": 157.49,
            "2032": 174.79
          },
          "cagr": 10.256666666666666,
          "market_share": 50.61
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 29.270000000000003,
            "2021": 33.589999999999996,
            "2022": 36.55,
            "2023": 40.08,
            "2024": 45.96,
            "2025": 51.33,
            "2026": 56.33,
            "2027": 62.05,
            "2028": 69.89,
            "2029": 76.31,
            "2030": 86.59,
            "2031": 96.77,
            "2032": 105.44
          },
          "cagr": 10.83,
          "market_share": 40.150000000000006
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 42.660000000000004,
            "2021": 48.949999999999996,
            "2022": 53.269999999999996,
            "2023": 58.43,
            "2024": 66.99000000000001,
            "2025": 74.8,
            "2026": 82.09,
            "2027": 90.42,
            "2028": 101.87,
            "2029": 111.22,
            "2030": 126.2,
            "2031": 141.04,
            "2032": 153.67
          },
          "cagr": 10.833333333333334,
          "market_share": 58.52000000000001
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 66.72,
            "2021": 70.83,
            "2022": 75.3,
            "2023": 80.88,
            "2024": 87.78,
            "2025": 94.7,
            "2026": 102.55,
            "2027": 109.47999999999999,
            "2028": 115.80000000000001,
            "2029": 124.33,
            "2030": 131.78,
            "2031": 143.39,
            "2032": 155.49
          },
          "cagr": 7.34,
          "market_share": 47.34
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 98.89,
            "2021": 104.96000000000001,
            "2022": 111.61,
            "2023": 119.85999999999999,
            "2024": 130.1,
            "2025": 140.35,
            "2026": 151.97,
            "2027": 162.25,
            "2028": 171.61,
            "2029": 184.25,
            "2030": 195.31,
            "2031": 212.5,
            "2032": 230.43
          },
          "cagr": 7.34,
          "market_share": 70.16
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 130.43,
            "2021": 147.63,
            "2022": 165.65,
            "2023": 183.64,
            "2024": 204.08999999999997,
            "2025": 229.86,
            "2026": 254.54,
            "2027": 284.08000000000004,
            "2028": 319.5,
            "2029": 358.65,
            "2030": 400.49,
            "2031": 451.62,
            "2032": 499.27000000000004
          },
          "cagr": 11.741249999999999,
          "market_share": 147.07999999999998
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 204.23000000000002,
            "2021": 230.99,
            "2022": 259.57,
            "2023": 287.53,
            "2024": 319.74,
            "2025": 360.18,
            "2026": 398.82,
            "2027": 445.40000000000003,
            "2028": 501.2,
            "2029": 563.1099999999999,
            "2030": 628.36,
            "2031": 709.08,
            "2032": 783.49
          },
          "cagr": 11.743333333333332,
          "market_share": 226.26
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 25.880000000000003,
            "2021": 30.29,
            "2022": 34.28,
            "2023": 39.08,
            "2024": 44.06,
            "2025": 49.66,
            "2026": 57.23,
            "2027": 64.99,
            "2028": 74.4,
            "2029": 83.99000000000001,
            "2030": 97.29,
            "2031": 110.78999999999999,
            "2032": 125.11
          },
          "cagr": 14.11,
          "market_share": 42.349999999999994
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 38.940000000000005,
            "2021": 45.57,
            "2022": 51.58,
            "2023": 58.81,
            "2024": 66.29,
            "2025": 74.71,
            "2026": 86.11,
            "2027": 97.78999999999999,
            "2028": 111.96000000000001,
            "2029": 126.36000000000001,
            "2030": 146.39000000000001,
            "2031": 166.7,
            "2032": 188.25
          },
          "cagr": 14.113333333333332,
          "market_share": 63.72
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 66.43,
            "2021": 74.06,
            "2022": 81.53999999999999,
            "2023": 90.86,
            "2024": 99.12,
            "2025": 109.52000000000001,
            "2026": 121.53,
            "2027": 137.57,
            "2028": 149.74,
            "2029": 167.57,
            "2030": 183.78,
            "2031": 200.64999999999998,
            "2032": 227.57
          },
          "cagr": 11.1975,
          "market_share": 92.44
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 90.54,
            "2021": 100.94,
            "2022": 111.11999999999999,
            "2023": 123.59,
            "2024": 134.86,
            "2025": 148.88,
            "2026": 165.07999999999998,
            "2027": 186.75,
            "2028": 203.07,
            "2029": 227.20999999999998,
            "2030": 249.04000000000002,
            "2031": 271.63,
            "2032": 307.83
          },
          "cagr": 11.201666666666668,
          "market_share": 124.31
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 24.43,
            "2021": 26.97,
            "2022": 27.990000000000002,
            "2023": 31.3,
            "2024": 33.05,
            "2025": 35.59,
            "2026": 38.66,
            "2027": 41.2,
            "2028": 44.36,
            "2029": 47.7,
            "2030": 50.63,
            "2031": 56.33,
            "2032": 59.08
          },
          "cagr": 7.51,
          "market_share": 47.95
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 30.46,
            "2021": 33.61,
            "2022": 34.88,
            "2023": 39.02,
            "2024": 41.19,
            "2025": 44.370000000000005,
            "2026": 48.17999999999999,
            "2027": 51.35,
            "2028": 55.29,
            "2029": 59.45,
            "2030": 63.120000000000005,
            "2031": 70.21,
            "2032": 73.64
          },
          "cagr": 7.503333333333333,
          "market_share": 59.760000000000005
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 49.34,
            "2021": 55.3,
            "2022": 63.239999999999995,
            "2023": 70.28,
            "2024": 79.74000000000001,
            "2025": 89.94,
            "2026": 99.39,
            "2027": 111.71000000000001,
            "2028": 125.96000000000001,
            "2029": 140.83,
            "2030": 162.12,
            "2031": 179.43,
            "2032": 199.22
          },
          "cagr": 12.03,
          "market_share": 45.010000000000005
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 71.34,
            "2021": 79.97,
            "2022": 91.44,
            "2023": 101.62,
            "2024": 115.31,
            "2025": 130.05,
            "2026": 143.72,
            "2027": 161.53,
            "2028": 182.14000000000001,
            "2029": 203.65,
            "2030": 234.44,
            "2031": 259.47,
            "2032": 288.09000000000003
          },
          "cagr": 12.033333333333331,
          "market_share": 65.09
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 39.83,
            "2021": 43.0,
            "2022": 46.8,
            "2023": 51.650000000000006,
            "2024": 55.64,
            "2025": 59.81,
            "2026": 64.49,
            "2027": 70.37,
            "2028": 75.78999999999999,
            "2029": 82.64,
            "2030": 88.94,
            "2031": 97.67,
            "2032": 104.13
          },
          "cagr": 8.24,
          "market_share": 41.34
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 54.949999999999996,
            "2021": 59.32,
            "2022": 64.56,
            "2023": 71.25,
            "2024": 76.75,
            "2025": 82.51,
            "2026": 88.97999999999999,
            "2027": 97.08000000000001,
            "2028": 104.57,
            "2029": 114.01,
            "2030": 122.69999999999999,
            "2031": 134.74,
            "2032": 143.66
          },
          "cagr": 8.243333333333334,
          "market_share": 57.03
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 41.64,
            "2021": 45.72,
            "2022": 51.04,
            "2023": 56.11,
            "2024": 62.17,
            "2025": 70.0,
            "2026": 78.68,
            "2027": 87.28,
            "2028": 96.99,
            "2029": 106.41,
            "2030": 117.91999999999999,
            "2031": 130.84,
            "2032": 141.93
          },
          "cagr": 10.625,
          "market_share": 36.66
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 63.36,
            "2021": 69.57,
            "2022": 77.66,
            "2023": 85.38,
            "2024": 94.59,
            "2025": 106.52000000000001,
            "2026": 119.73,
            "2027": 132.81,
            "2028": 147.57999999999998,
            "2029": 161.91,
            "2030": 179.42,
            "2031": 199.07,
            "2032": 215.95
          },
          "cagr": 10.623333333333333,
          "market_share": 55.769999999999996
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 28.36,
            "2021": 32.49,
            "2022": 35.87,
            "2023": 41.129999999999995,
            "2024": 46.67,
            "2025": 53.0,
            "2026": 61.95,
            "2027": 68.1,
            "2028": 77.44,
            "2029": 91.1,
            "2030": 100.21,
            "2031": 117.31,
            "2032": 129.92
          },
          "cagr": 13.67,
          "market_share": 35.79
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 41.16,
            "2021": 47.17,
            "2022": 52.08,
            "2023": 59.72,
            "2024": 67.76,
            "2025": 76.94,
            "2026": 89.95,
            "2027": 98.88,
            "2028": 112.44,
            "2029": 132.25,
            "2030": 145.49,
            "2031": 170.33,
            "2032": 188.62
          },
          "cagr": 13.67,
          "market_share": 51.96
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 974.2500000000001,
            "2021": 1085.47,
            "2022": 1202.77,
            "2023": 1337.48,
            "2024": 1481.38,
            "2025": 1653.64,
            "2026": 1831.66,
            "2027": 2039.9,
            "2028": 2264.7,
            "2029": 2523.6400000000003,
            "2030": 2812.66,
            "2031": 3120.99,
            "2032": 3484.27
          },
          "cagr": 11.111775793650793,
          "market_share": 1037.53
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 1449.8000000000002,
            "2021": 1615.6599999999999,
            "2022": 1791.29,
            "2023": 1991.05,
            "2024": 2206.15,
            "2025": 2463.2000000000003,
            "2026": 2728.84,
            "2027": 3039.67,
            "2028": 3375.26,
            "2029": 3761.2500000000005,
            "2030": 4193.49,
            "2031": 4654.45,
            "2032": 5196.1
          },
          "cagr": 11.11281746031746,
          "market_share": 1532.8999999999999
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 33.54,
            "2021": 38.56,
            "2022": 44.57,
            "2023": 50.0,
            "2024": 58.42999999999999,
            "2025": 65.64,
            "2026": 73.33,
            "2027": 85.14,
            "2028": 96.19999999999999,
            "2029": 108.49,
            "2030": 123.63,
            "2031": 140.98,
            "2032": 165.37
          },
          "cagr": 14.11,
          "market_share": 38.980000000000004
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 53.68,
            "2021": 61.7,
            "2022": 71.32,
            "2023": 80.03,
            "2024": 93.5,
            "2025": 105.03999999999999,
            "2026": 117.33,
            "2027": 136.23000000000002,
            "2028": 153.92999999999998,
            "2029": 173.62,
            "2030": 197.82999999999998,
            "2031": 225.6,
            "2032": 264.64
          },
          "cagr": 14.11,
          "market_share": 62.370000000000005
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 38.6,
            "2021": 43.2,
            "2022": 45.58,
            "2023": 51.72,
            "2024": 54.67,
            "2025": 60.35,
            "2026": 66.14,
            "2027": 73.69999999999999,
            "2028": 80.06,
            "2029": 87.03,
            "2030": 96.09,
            "2031": 104.68,
            "2032": 115.95
          },
          "cagr": 9.78,
          "market_share": 28.69
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 62.08,
            "2021": 69.47,
            "2022": 73.28999999999999,
            "2023": 83.18,
            "2024": 87.92,
            "2025": 97.06,
            "2026": 106.36,
            "2027": 118.49999999999999,
            "2028": 128.75,
            "2029": 139.96,
            "2030": 154.53,
            "2031": 168.34,
            "2032": 186.46
          },
          "cagr": 9.776666666666666,
          "market_share": 46.14
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 24.62,
            "2021": 26.57,
            "2022": 29.28,
            "2023": 32.16,
            "2024": 34.96,
            "2025": 38.1,
            "2026": 42.510000000000005,
            "2027": 46.43,
            "2028": 50.0,
            "2029": 54.260000000000005,
            "2030": 60.05,
            "2031": 64.97,
            "2032": 70.98
          },
          "cagr": 9.295,
          "market_share": 40.76
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 39.82,
            "2021": 42.980000000000004,
            "2022": 47.38,
            "2023": 52.01,
            "2024": 56.55,
            "2025": 61.63,
            "2026": 68.77000000000001,
            "2027": 75.1,
            "2028": 80.89,
            "2029": 87.77000000000001,
            "2030": 97.12,
            "2031": 105.1,
            "2032": 114.81
          },
          "cagr": 9.293333333333333,
          "market_share": 65.93
        }
      ]
    },
    "volume": {
      "geography_segment_matrix": [
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 27.62,
            "2021": 31.3,
            "2022": 35.3,
            "2023": 39.75,
            "2024": 45.69,
            "2025": 51.69,
            "2026": 58.1,
            "2027": 65.14,
            "2028": 72.8,
            "2029": 80.68,
            "2030": 91.89,
            "2031": 104.85,
            "2032": 118.2
          },
          "cagr": 12.54,
          "market_share": 25.6
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 14.0,
            "2021": 15.86,
            "2022": 17.89,
            "2023": 20.14,
            "2024": 23.15,
            "2025": 26.19,
            "2026": 29.44,
            "2027": 33.01,
            "2028": 36.89,
            "2029": 40.88,
            "2030": 46.56,
            "2031": 53.13,
            "2032": 59.89
          },
          "cagr": 12.54,
          "market_share": 12.97
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 25.83,
            "2021": 29.27,
            "2022": 33.01,
            "2023": 37.18,
            "2024": 42.73,
            "2025": 48.35,
            "2026": 54.34,
            "2027": 60.92,
            "2028": 68.09,
            "2029": 75.45,
            "2030": 85.94,
            "2031": 98.06,
            "2032": 110.55
          },
          "cagr": 12.54,
          "market_share": 23.94
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 22.64,
            "2021": 25.65,
            "2022": 28.94,
            "2023": 32.58,
            "2024": 37.45,
            "2025": 42.37,
            "2026": 47.63,
            "2027": 53.39,
            "2028": 59.68,
            "2029": 66.13,
            "2030": 75.33,
            "2031": 85.94,
            "2032": 96.89
          },
          "cagr": 12.54,
          "market_share": 20.98
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 17.8,
            "2021": 20.17,
            "2022": 22.75,
            "2023": 25.62,
            "2024": 29.47,
            "2025": 33.33,
            "2026": 37.45,
            "2027": 41.99,
            "2028": 46.93,
            "2029": 52.01,
            "2030": 59.24,
            "2031": 67.58,
            "2032": 76.2
          },
          "cagr": 12.54,
          "market_share": 16.51
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 17.67,
            "2021": 20.02,
            "2022": 22.58,
            "2023": 25.43,
            "2024": 29.23,
            "2025": 33.07,
            "2026": 37.17,
            "2027": 41.67,
            "2028": 46.57,
            "2029": 51.61,
            "2030": 58.78,
            "2031": 67.07,
            "2032": 75.61
          },
          "cagr": 12.54,
          "market_share": 16.38
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 19.94,
            "2021": 22.6,
            "2022": 25.49,
            "2023": 28.7,
            "2024": 32.99,
            "2025": 37.32,
            "2026": 41.95,
            "2027": 47.03,
            "2028": 52.57,
            "2029": 58.25,
            "2030": 66.35,
            "2031": 75.7,
            "2032": 85.35
          },
          "cagr": 12.54,
          "market_share": 18.48
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 21.04,
            "2021": 23.84,
            "2022": 26.89,
            "2023": 30.28,
            "2024": 34.8,
            "2025": 39.37,
            "2026": 44.25,
            "2027": 49.61,
            "2028": 55.45,
            "2029": 61.45,
            "2030": 69.99,
            "2031": 79.86,
            "2032": 90.03
          },
          "cagr": 12.54,
          "market_share": 19.5
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 22.56,
            "2021": 25.56,
            "2022": 28.83,
            "2023": 32.47,
            "2024": 37.32,
            "2025": 42.22,
            "2026": 47.46,
            "2027": 53.2,
            "2028": 59.47,
            "2029": 65.9,
            "2030": 75.06,
            "2031": 85.64,
            "2032": 96.55
          },
          "cagr": 12.54,
          "market_share": 20.91
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 26.68,
            "2021": 30.23,
            "2022": 34.1,
            "2023": 38.39,
            "2024": 44.15,
            "2025": 49.95,
            "2026": 56.13,
            "2027": 62.94,
            "2028": 70.33,
            "2029": 77.94,
            "2030": 88.78,
            "2031": 101.29,
            "2032": 114.19
          },
          "cagr": 12.54,
          "market_share": 24.74
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 62.57,
            "2021": 70.9,
            "2022": 79.97,
            "2023": 90.04,
            "2024": 103.51,
            "2025": 117.1,
            "2026": 131.62,
            "2027": 147.56,
            "2028": 164.92,
            "2029": 182.76,
            "2030": 208.17,
            "2031": 237.51,
            "2032": 267.76
          },
          "cagr": 12.54,
          "market_share": 57.99
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 45.32,
            "2021": 51.35,
            "2022": 57.92,
            "2023": 65.23,
            "2024": 74.98,
            "2025": 84.83,
            "2026": 95.34,
            "2027": 106.89,
            "2028": 119.47,
            "2029": 132.39,
            "2030": 150.79,
            "2031": 172.05,
            "2032": 193.97
          },
          "cagr": 12.54,
          "market_share": 42.01
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 42.49,
            "2021": 48.15,
            "2022": 54.31,
            "2023": 61.15,
            "2024": 70.3,
            "2025": 79.53,
            "2026": 89.39,
            "2027": 100.21,
            "2028": 112.01,
            "2029": 124.12,
            "2030": 141.37,
            "2031": 161.3,
            "2032": 181.85
          },
          "cagr": 12.54,
          "market_share": 39.39
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 65.4,
            "2021": 74.1,
            "2022": 83.58,
            "2023": 94.12,
            "2024": 108.19,
            "2025": 122.4,
            "2026": 137.57,
            "2027": 154.24,
            "2028": 172.38,
            "2029": 191.03,
            "2030": 217.59,
            "2031": 248.26,
            "2032": 279.88
          },
          "cagr": 12.54,
          "market_share": 60.61
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 43.6,
            "2021": 49.4,
            "2022": 55.72,
            "2023": 62.74,
            "2024": 72.12,
            "2025": 81.59,
            "2026": 91.71,
            "2027": 102.81,
            "2028": 114.91,
            "2029": 127.34,
            "2030": 145.04,
            "2031": 165.49,
            "2032": 186.57
          },
          "cagr": 12.54,
          "market_share": 40.41
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 21.75,
            "2021": 24.64,
            "2022": 27.79,
            "2023": 31.29,
            "2024": 35.97,
            "2025": 40.7,
            "2026": 45.74,
            "2027": 51.28,
            "2028": 57.32,
            "2029": 63.52,
            "2030": 72.35,
            "2031": 82.55,
            "2032": 93.06
          },
          "cagr": 12.54,
          "market_share": 20.15
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 42.54,
            "2021": 48.21,
            "2022": 54.38,
            "2023": 61.24,
            "2024": 70.4,
            "2025": 79.64,
            "2026": 89.51,
            "2027": 100.36,
            "2028": 112.16,
            "2029": 124.29,
            "2030": 141.57,
            "2031": 161.52,
            "2032": 182.1
          },
          "cagr": 12.54,
          "market_share": 39.44
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 41.91,
            "2021": 47.49,
            "2022": 53.56,
            "2023": 60.31,
            "2024": 69.33,
            "2025": 78.43,
            "2026": 88.16,
            "2027": 98.83,
            "2028": 110.46,
            "2029": 122.41,
            "2030": 139.43,
            "2031": 159.08,
            "2032": 179.34
          },
          "cagr": 12.54,
          "market_share": 38.84
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 65.98,
            "2021": 74.76,
            "2022": 84.33,
            "2023": 94.96,
            "2024": 109.16,
            "2025": 123.5,
            "2026": 138.8,
            "2027": 155.62,
            "2028": 173.93,
            "2029": 192.74,
            "2030": 219.53,
            "2031": 250.48,
            "2032": 282.39
          },
          "cagr": 12.54,
          "market_share": 61.16
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 15.69,
            "2021": 17.09,
            "2022": 18.38,
            "2023": 20.54,
            "2024": 22.41,
            "2025": 24.51,
            "2026": 27.57,
            "2027": 30.59,
            "2028": 33.69,
            "2029": 36.15,
            "2030": 40.76,
            "2031": 44.15,
            "2032": 48.53
          },
          "cagr": 10.25,
          "market_share": 24.73
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 11.11,
            "2021": 12.1,
            "2022": 13.01,
            "2023": 14.54,
            "2024": 15.87,
            "2025": 17.35,
            "2026": 19.52,
            "2027": 21.65,
            "2028": 23.86,
            "2029": 25.59,
            "2030": 28.86,
            "2031": 31.25,
            "2032": 34.36
          },
          "cagr": 10.25,
          "market_share": 17.51
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 12.43,
            "2021": 13.54,
            "2022": 14.56,
            "2023": 16.27,
            "2024": 17.75,
            "2025": 19.42,
            "2026": 21.84,
            "2027": 24.23,
            "2028": 26.69,
            "2029": 28.64,
            "2030": 32.29,
            "2031": 34.97,
            "2032": 38.44
          },
          "cagr": 10.25,
          "market_share": 19.59
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 10.24,
            "2021": 11.15,
            "2022": 11.99,
            "2023": 13.4,
            "2024": 14.63,
            "2025": 16.0,
            "2026": 17.99,
            "2027": 19.96,
            "2028": 21.99,
            "2029": 23.59,
            "2030": 26.6,
            "2031": 28.81,
            "2032": 31.67
          },
          "cagr": 10.25,
          "market_share": 16.14
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 13.97,
            "2021": 15.22,
            "2022": 16.36,
            "2023": 18.3,
            "2024": 19.96,
            "2025": 21.84,
            "2026": 24.57,
            "2027": 27.24,
            "2028": 30.01,
            "2029": 32.21,
            "2030": 36.31,
            "2031": 39.32,
            "2032": 43.23
          },
          "cagr": 10.25,
          "market_share": 22.03
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 17.51,
            "2021": 19.07,
            "2022": 20.51,
            "2023": 22.93,
            "2024": 25.02,
            "2025": 27.36,
            "2026": 30.78,
            "2027": 34.14,
            "2028": 37.61,
            "2029": 40.35,
            "2030": 45.5,
            "2031": 49.27,
            "2032": 54.17
          },
          "cagr": 10.25,
          "market_share": 27.61
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 10.21,
            "2021": 11.12,
            "2022": 11.96,
            "2023": 13.37,
            "2024": 14.59,
            "2025": 15.96,
            "2026": 17.95,
            "2027": 19.91,
            "2028": 21.93,
            "2029": 23.53,
            "2030": 26.53,
            "2031": 28.74,
            "2032": 31.59
          },
          "cagr": 10.25,
          "market_share": 16.1
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 17.99,
            "2021": 19.6,
            "2022": 21.07,
            "2023": 23.55,
            "2024": 25.7,
            "2025": 28.11,
            "2026": 31.62,
            "2027": 35.07,
            "2028": 38.64,
            "2029": 41.46,
            "2030": 46.74,
            "2031": 50.62,
            "2032": 55.65
          },
          "cagr": 10.25,
          "market_share": 28.36
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 7.15,
            "2021": 7.79,
            "2022": 8.37,
            "2023": 9.36,
            "2024": 10.21,
            "2025": 11.17,
            "2026": 12.57,
            "2027": 13.94,
            "2028": 15.36,
            "2029": 16.47,
            "2030": 18.58,
            "2031": 20.12,
            "2032": 22.12
          },
          "cagr": 10.25,
          "market_share": 11.27
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 10.58,
            "2021": 11.52,
            "2022": 12.39,
            "2023": 13.84,
            "2024": 15.1,
            "2025": 16.52,
            "2026": 18.57,
            "2027": 20.61,
            "2028": 22.7,
            "2029": 24.37,
            "2030": 27.47,
            "2031": 29.75,
            "2032": 32.7
          },
          "cagr": 10.25,
          "market_share": 16.66
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 37.74,
            "2021": 41.1,
            "2022": 44.2,
            "2023": 49.4,
            "2024": 53.9,
            "2025": 58.96,
            "2026": 66.32,
            "2027": 73.56,
            "2028": 81.04,
            "2029": 86.95,
            "2030": 98.04,
            "2031": 106.18,
            "2032": 116.72
          },
          "cagr": 10.25,
          "market_share": 59.48
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 25.7,
            "2021": 28.0,
            "2022": 30.1,
            "2023": 33.65,
            "2024": 36.72,
            "2025": 40.16,
            "2026": 45.17,
            "2027": 50.11,
            "2028": 55.2,
            "2029": 59.23,
            "2030": 66.78,
            "2031": 72.32,
            "2032": 79.51
          },
          "cagr": 10.25,
          "market_share": 40.52
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 42.34,
            "2021": 46.11,
            "2022": 49.58,
            "2023": 55.42,
            "2024": 60.48,
            "2025": 66.15,
            "2026": 74.41,
            "2027": 82.53,
            "2028": 90.92,
            "2029": 97.55,
            "2030": 109.99,
            "2031": 119.12,
            "2032": 130.95
          },
          "cagr": 10.25,
          "market_share": 66.74
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 21.1,
            "2021": 22.99,
            "2022": 24.72,
            "2023": 27.63,
            "2024": 30.14,
            "2025": 32.97,
            "2026": 37.08,
            "2027": 41.14,
            "2028": 45.32,
            "2029": 48.63,
            "2030": 54.83,
            "2031": 59.38,
            "2032": 65.28
          },
          "cagr": 10.25,
          "market_share": 33.26
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 21.09,
            "2021": 22.97,
            "2022": 24.7,
            "2023": 27.61,
            "2024": 30.12,
            "2025": 32.95,
            "2026": 37.06,
            "2027": 41.11,
            "2028": 45.29,
            "2029": 48.59,
            "2030": 54.78,
            "2031": 59.33,
            "2032": 65.23
          },
          "cagr": 10.25,
          "market_share": 33.24
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 14.5,
            "2021": 15.79,
            "2022": 16.98,
            "2023": 18.98,
            "2024": 20.71,
            "2025": 22.66,
            "2026": 25.49,
            "2027": 28.27,
            "2028": 31.14,
            "2029": 33.41,
            "2030": 37.67,
            "2031": 40.8,
            "2032": 44.85
          },
          "cagr": 10.24,
          "market_share": 22.85
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 27.85,
            "2021": 30.34,
            "2022": 32.62,
            "2023": 36.46,
            "2024": 39.79,
            "2025": 43.51,
            "2026": 48.94,
            "2027": 54.29,
            "2028": 59.81,
            "2029": 64.18,
            "2030": 72.37,
            "2031": 78.37,
            "2032": 86.15
          },
          "cagr": 10.25,
          "market_share": 43.91
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 22.07,
            "2021": 24.03,
            "2022": 25.84,
            "2023": 28.89,
            "2024": 31.52,
            "2025": 34.48,
            "2026": 38.78,
            "2027": 43.02,
            "2028": 47.39,
            "2029": 50.85,
            "2030": 57.33,
            "2031": 62.09,
            "2032": 68.25
          },
          "cagr": 10.25,
          "market_share": 34.78
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 41.37,
            "2021": 45.07,
            "2022": 48.46,
            "2023": 54.16,
            "2024": 59.1,
            "2025": 64.64,
            "2026": 72.71,
            "2027": 80.65,
            "2028": 88.85,
            "2029": 95.33,
            "2030": 107.49,
            "2031": 116.41,
            "2032": 127.98
          },
          "cagr": 10.25,
          "market_share": 65.22
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 9.34,
            "2021": 10.34,
            "2022": 11.37,
            "2023": 12.22,
            "2024": 13.09,
            "2025": 14.41,
            "2026": 15.46,
            "2027": 17.27,
            "2028": 18.48,
            "2029": 20.39,
            "2030": 22.01,
            "2031": 24.12,
            "2032": 26.19
          },
          "cagr": 8.91,
          "market_share": 12.59
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 19.57,
            "2021": 21.67,
            "2022": 23.81,
            "2023": 25.6,
            "2024": 27.43,
            "2025": 30.18,
            "2026": 32.4,
            "2027": 36.18,
            "2028": 38.71,
            "2029": 42.72,
            "2030": 46.1,
            "2031": 50.53,
            "2032": 54.88
          },
          "cagr": 8.92,
          "market_share": 26.38
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 15.55,
            "2021": 17.21,
            "2022": 18.92,
            "2023": 20.33,
            "2024": 21.79,
            "2025": 23.98,
            "2026": 25.74,
            "2027": 28.74,
            "2028": 30.75,
            "2029": 33.94,
            "2030": 36.63,
            "2031": 40.14,
            "2032": 43.59
          },
          "cagr": 8.91,
          "market_share": 20.95
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 19.29,
            "2021": 21.35,
            "2022": 23.47,
            "2023": 25.23,
            "2024": 27.03,
            "2025": 29.75,
            "2026": 31.93,
            "2027": 35.66,
            "2028": 38.15,
            "2029": 42.11,
            "2030": 45.44,
            "2031": 49.8,
            "2032": 54.09
          },
          "cagr": 8.92,
          "market_share": 25.99
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 10.46,
            "2021": 11.59,
            "2022": 12.74,
            "2023": 13.68,
            "2024": 14.66,
            "2025": 16.13,
            "2026": 17.33,
            "2027": 19.34,
            "2028": 20.7,
            "2029": 22.85,
            "2030": 24.65,
            "2031": 27.03,
            "2032": 29.34
          },
          "cagr": 8.92,
          "market_share": 14.1
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 12.64,
            "2021": 13.99,
            "2022": 15.38,
            "2023": 16.53,
            "2024": 17.71,
            "2025": 19.49,
            "2026": 20.92,
            "2027": 23.36,
            "2028": 25.0,
            "2029": 27.59,
            "2030": 29.77,
            "2031": 32.63,
            "2032": 35.43
          },
          "cagr": 8.91,
          "market_share": 17.03
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 17.52,
            "2021": 19.4,
            "2022": 21.32,
            "2023": 22.91,
            "2024": 24.55,
            "2025": 27.02,
            "2026": 29.0,
            "2027": 32.39,
            "2028": 34.65,
            "2029": 38.25,
            "2030": 41.27,
            "2031": 45.24,
            "2032": 49.13
          },
          "cagr": 8.92,
          "market_share": 23.61
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 17.0,
            "2021": 18.81,
            "2022": 20.68,
            "2023": 22.23,
            "2024": 23.82,
            "2025": 26.21,
            "2026": 28.14,
            "2027": 31.42,
            "2028": 33.62,
            "2029": 37.1,
            "2030": 40.04,
            "2031": 43.88,
            "2032": 47.66
          },
          "cagr": 8.92,
          "market_share": 22.9
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 15.91,
            "2021": 17.61,
            "2022": 19.35,
            "2023": 20.8,
            "2024": 22.29,
            "2025": 24.53,
            "2026": 26.33,
            "2027": 29.4,
            "2028": 31.46,
            "2029": 34.72,
            "2030": 37.47,
            "2031": 41.07,
            "2032": 44.6
          },
          "cagr": 8.92,
          "market_share": 21.43
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 11.14,
            "2021": 12.35,
            "2022": 13.58,
            "2023": 14.59,
            "2024": 15.63,
            "2025": 17.2,
            "2026": 18.47,
            "2027": 20.62,
            "2028": 22.06,
            "2029": 24.35,
            "2030": 26.28,
            "2031": 28.8,
            "2032": 31.27
          },
          "cagr": 8.91,
          "market_share": 15.03
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 35.82,
            "2021": 39.65,
            "2022": 43.59,
            "2023": 46.85,
            "2024": 50.19,
            "2025": 55.24,
            "2026": 59.3,
            "2027": 66.21,
            "2028": 70.85,
            "2029": 78.19,
            "2030": 84.38,
            "2031": 92.48,
            "2032": 100.43
          },
          "cagr": 8.91,
          "market_share": 48.26
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 38.39,
            "2021": 42.51,
            "2022": 46.72,
            "2023": 50.21,
            "2024": 53.81,
            "2025": 59.21,
            "2026": 63.56,
            "2027": 70.98,
            "2028": 75.94,
            "2029": 83.82,
            "2030": 90.45,
            "2031": 99.14,
            "2032": 107.66
          },
          "cagr": 8.92,
          "market_share": 51.74
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 36.39,
            "2021": 40.29,
            "2022": 44.28,
            "2023": 47.6,
            "2024": 51.0,
            "2025": 56.12,
            "2026": 60.25,
            "2027": 67.27,
            "2028": 71.98,
            "2029": 79.44,
            "2030": 85.73,
            "2031": 93.96,
            "2032": 102.04
          },
          "cagr": 8.92,
          "market_share": 49.04
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 37.82,
            "2021": 41.87,
            "2022": 46.03,
            "2023": 49.46,
            "2024": 53.0,
            "2025": 58.33,
            "2026": 62.61,
            "2027": 69.92,
            "2028": 74.81,
            "2029": 82.57,
            "2030": 89.1,
            "2031": 97.66,
            "2032": 106.05
          },
          "cagr": 8.92,
          "market_share": 50.96
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 33.15,
            "2021": 36.7,
            "2022": 40.34,
            "2023": 43.36,
            "2024": 46.46,
            "2025": 51.13,
            "2026": 54.89,
            "2027": 61.29,
            "2028": 65.58,
            "2029": 72.37,
            "2030": 78.1,
            "2031": 85.6,
            "2032": 92.96
          },
          "cagr": 8.92,
          "market_share": 44.67
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 28.0,
            "2021": 31.0,
            "2022": 34.07,
            "2023": 36.62,
            "2024": 39.24,
            "2025": 43.18,
            "2026": 46.36,
            "2027": 51.76,
            "2028": 55.39,
            "2029": 61.13,
            "2030": 65.97,
            "2031": 72.3,
            "2032": 78.52
          },
          "cagr": 8.92,
          "market_share": 37.73
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 13.06,
            "2021": 14.46,
            "2022": 15.9,
            "2023": 17.08,
            "2024": 18.3,
            "2025": 20.14,
            "2026": 21.61,
            "2027": 24.14,
            "2028": 25.82,
            "2029": 28.51,
            "2030": 30.76,
            "2031": 33.72,
            "2032": 36.61
          },
          "cagr": 8.91,
          "market_share": 17.6
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 39.03,
            "2021": 43.21,
            "2022": 47.5,
            "2023": 51.05,
            "2024": 54.7,
            "2025": 60.19,
            "2026": 64.62,
            "2027": 72.15,
            "2028": 77.2,
            "2029": 85.2,
            "2030": 91.95,
            "2031": 100.78,
            "2032": 109.44
          },
          "cagr": 8.92,
          "market_share": 52.6
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 35.18,
            "2021": 38.95,
            "2022": 42.81,
            "2023": 46.01,
            "2024": 49.3,
            "2025": 54.26,
            "2026": 58.24,
            "2027": 65.04,
            "2028": 69.59,
            "2029": 76.81,
            "2030": 82.88,
            "2031": 90.84,
            "2032": 98.65
          },
          "cagr": 8.92,
          "market_share": 47.4
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 27.06,
            "2021": 30.74,
            "2022": 34.67,
            "2023": 40.53,
            "2024": 44.99,
            "2025": 51.82,
            "2026": 60.36,
            "2027": 68.74,
            "2028": 78.38,
            "2029": 86.6,
            "2030": 102.18,
            "2031": 116.46,
            "2032": 132.5
          },
          "cagr": 14.35,
          "market_share": 22.61
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 28.37,
            "2021": 32.23,
            "2022": 36.35,
            "2023": 42.5,
            "2024": 47.17,
            "2025": 54.33,
            "2026": 63.29,
            "2027": 72.07,
            "2028": 82.18,
            "2029": 90.8,
            "2030": 107.13,
            "2031": 122.1,
            "2032": 138.92
          },
          "cagr": 14.35,
          "market_share": 23.71
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 16.59,
            "2021": 18.85,
            "2022": 21.26,
            "2023": 24.86,
            "2024": 27.59,
            "2025": 31.77,
            "2026": 37.02,
            "2027": 42.15,
            "2028": 48.06,
            "2029": 53.11,
            "2030": 62.66,
            "2031": 71.41,
            "2032": 81.25
          },
          "cagr": 14.36,
          "market_share": 13.87
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 25.62,
            "2021": 29.09,
            "2022": 32.82,
            "2023": 38.37,
            "2024": 42.59,
            "2025": 49.05,
            "2026": 57.14,
            "2027": 65.06,
            "2028": 74.2,
            "2029": 81.98,
            "2030": 96.72,
            "2031": 110.24,
            "2032": 125.42
          },
          "cagr": 14.35,
          "market_share": 21.41
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 22.02,
            "2021": 25.0,
            "2022": 28.21,
            "2023": 32.98,
            "2024": 36.6,
            "2025": 42.15,
            "2026": 49.12,
            "2027": 55.92,
            "2028": 63.79,
            "2029": 70.46,
            "2030": 83.14,
            "2031": 94.74,
            "2032": 107.79
          },
          "cagr": 14.35,
          "market_share": 18.4
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 21.18,
            "2021": 24.06,
            "2022": 27.14,
            "2023": 31.72,
            "2024": 35.21,
            "2025": 40.55,
            "2026": 47.25,
            "2027": 53.8,
            "2028": 61.35,
            "2029": 67.78,
            "2030": 79.97,
            "2031": 91.15,
            "2032": 103.7
          },
          "cagr": 14.36,
          "market_share": 17.7
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 22.73,
            "2021": 25.81,
            "2022": 29.12,
            "2023": 34.04,
            "2024": 37.78,
            "2025": 43.52,
            "2026": 50.7,
            "2027": 57.73,
            "2028": 65.83,
            "2029": 72.73,
            "2030": 85.81,
            "2031": 97.8,
            "2032": 111.27
          },
          "cagr": 14.35,
          "market_share": 18.99
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 23.84,
            "2021": 27.08,
            "2022": 30.55,
            "2023": 35.71,
            "2024": 39.64,
            "2025": 45.65,
            "2026": 53.18,
            "2027": 60.56,
            "2028": 69.06,
            "2029": 76.3,
            "2030": 90.03,
            "2031": 102.6,
            "2032": 116.74
          },
          "cagr": 14.35,
          "market_share": 19.93
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 16.89,
            "2021": 19.19,
            "2022": 21.64,
            "2023": 25.3,
            "2024": 28.09,
            "2025": 32.35,
            "2026": 37.68,
            "2027": 42.91,
            "2028": 48.93,
            "2029": 54.06,
            "2030": 63.79,
            "2031": 72.7,
            "2032": 82.71
          },
          "cagr": 14.35,
          "market_share": 14.12
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 35.02,
            "2021": 39.77,
            "2022": 44.86,
            "2023": 52.47,
            "2024": 58.22,
            "2025": 67.05,
            "2026": 78.12,
            "2027": 88.94,
            "2028": 101.44,
            "2029": 112.08,
            "2030": 132.23,
            "2031": 150.7,
            "2032": 171.46
          },
          "cagr": 14.35,
          "market_share": 29.27
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 60.0,
            "2021": 68.15,
            "2022": 76.88,
            "2023": 89.88,
            "2024": 99.76,
            "2025": 114.89,
            "2026": 133.85,
            "2027": 152.41,
            "2028": 173.8,
            "2029": 192.03,
            "2030": 226.56,
            "2031": 258.22,
            "2032": 293.78
          },
          "cagr": 14.35,
          "market_share": 50.15
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 59.66,
            "2021": 67.76,
            "2022": 76.43,
            "2023": 89.36,
            "2024": 99.18,
            "2025": 114.23,
            "2026": 133.08,
            "2027": 151.53,
            "2028": 172.81,
            "2029": 190.92,
            "2030": 225.27,
            "2031": 256.73,
            "2032": 292.1
          },
          "cagr": 14.35,
          "market_share": 49.85
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 49.67,
            "2021": 56.41,
            "2022": 63.64,
            "2023": 74.4,
            "2024": 82.58,
            "2025": 95.11,
            "2026": 110.8,
            "2027": 126.16,
            "2028": 143.87,
            "2029": 158.96,
            "2030": 187.55,
            "2031": 213.75,
            "2032": 243.19
          },
          "cagr": 14.35,
          "market_share": 41.51
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 69.99,
            "2021": 79.5,
            "2022": 89.67,
            "2023": 104.84,
            "2024": 116.36,
            "2025": 134.01,
            "2026": 156.13,
            "2027": 177.78,
            "2028": 202.74,
            "2029": 223.99,
            "2030": 264.28,
            "2031": 301.2,
            "2032": 342.69
          },
          "cagr": 14.35,
          "market_share": 58.49
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 43.84,
            "2021": 49.79,
            "2022": 56.17,
            "2023": 65.66,
            "2024": 72.88,
            "2025": 83.94,
            "2026": 97.79,
            "2027": 111.35,
            "2028": 126.98,
            "2029": 140.29,
            "2030": 165.52,
            "2031": 188.65,
            "2032": 214.63
          },
          "cagr": 14.35,
          "market_share": 36.63
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 54.48,
            "2021": 61.87,
            "2022": 69.8,
            "2023": 81.6,
            "2024": 90.57,
            "2025": 104.31,
            "2026": 121.52,
            "2027": 138.37,
            "2028": 157.8,
            "2029": 174.35,
            "2030": 205.7,
            "2031": 234.44,
            "2032": 266.73
          },
          "cagr": 14.35,
          "market_share": 45.53
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 21.34,
            "2021": 24.25,
            "2022": 27.34,
            "2023": 31.98,
            "2024": 35.49,
            "2025": 40.87,
            "2026": 47.62,
            "2027": 54.22,
            "2028": 61.83,
            "2029": 68.31,
            "2030": 80.61,
            "2031": 91.86,
            "2032": 104.52
          },
          "cagr": 14.36,
          "market_share": 17.84
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 65.28,
            "2021": 74.15,
            "2022": 83.64,
            "2023": 97.79,
            "2024": 108.54,
            "2025": 125.0,
            "2026": 145.63,
            "2027": 165.82,
            "2028": 189.1,
            "2029": 208.93,
            "2030": 246.5,
            "2031": 280.94,
            "2032": 319.64
          },
          "cagr": 14.35,
          "market_share": 54.56
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 54.38,
            "2021": 61.76,
            "2022": 69.67,
            "2023": 81.45,
            "2024": 90.4,
            "2025": 104.12,
            "2026": 121.3,
            "2027": 138.12,
            "2028": 157.51,
            "2029": 174.02,
            "2030": 205.33,
            "2031": 234.01,
            "2032": 266.24
          },
          "cagr": 14.35,
          "market_share": 45.44
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 32.65,
            "2021": 36.53,
            "2022": 40.94,
            "2023": 47.28,
            "2024": 52.61,
            "2025": 59.55,
            "2026": 66.67,
            "2027": 73.14,
            "2028": 82.34,
            "2029": 95.48,
            "2030": 106.27,
            "2031": 118.06,
            "2032": 135.37
          },
          "cagr": 12.45,
          "market_share": 27.67
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 17.07,
            "2021": 19.1,
            "2022": 21.41,
            "2023": 24.72,
            "2024": 27.51,
            "2025": 31.14,
            "2026": 34.86,
            "2027": 38.24,
            "2028": 43.05,
            "2029": 49.92,
            "2030": 55.57,
            "2031": 61.73,
            "2032": 70.78
          },
          "cagr": 12.45,
          "market_share": 14.47
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 32.54,
            "2021": 36.41,
            "2022": 40.8,
            "2023": 47.12,
            "2024": 52.44,
            "2025": 59.35,
            "2026": 66.45,
            "2027": 72.9,
            "2028": 82.07,
            "2029": 95.16,
            "2030": 105.92,
            "2031": 117.67,
            "2032": 134.92
          },
          "cagr": 12.45,
          "market_share": 27.58
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 18.53,
            "2021": 20.73,
            "2022": 23.23,
            "2023": 26.83,
            "2024": 29.86,
            "2025": 33.79,
            "2026": 37.83,
            "2027": 41.5,
            "2028": 46.72,
            "2029": 54.18,
            "2030": 60.3,
            "2031": 66.99,
            "2032": 76.81
          },
          "cagr": 12.45,
          "market_share": 15.71
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 17.19,
            "2021": 19.22,
            "2022": 21.55,
            "2023": 24.88,
            "2024": 27.7,
            "2025": 31.35,
            "2026": 35.1,
            "2027": 38.49,
            "2028": 43.35,
            "2029": 50.26,
            "2030": 55.94,
            "2031": 62.15,
            "2032": 71.26
          },
          "cagr": 12.45,
          "market_share": 14.57
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 27.0,
            "2021": 30.2,
            "2022": 33.85,
            "2023": 39.09,
            "2024": 43.51,
            "2025": 49.24,
            "2026": 55.13,
            "2027": 60.48,
            "2028": 68.09,
            "2029": 78.95,
            "2030": 87.88,
            "2031": 97.63,
            "2032": 111.94
          },
          "cagr": 12.45,
          "market_share": 22.89
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 24.76,
            "2021": 27.7,
            "2022": 31.05,
            "2023": 35.85,
            "2024": 39.9,
            "2025": 45.16,
            "2026": 50.56,
            "2027": 55.46,
            "2028": 62.44,
            "2029": 72.41,
            "2030": 80.59,
            "2031": 89.53,
            "2032": 102.66
          },
          "cagr": 12.45,
          "market_share": 20.99
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 26.8,
            "2021": 29.99,
            "2022": 33.61,
            "2023": 38.81,
            "2024": 43.19,
            "2025": 48.89,
            "2026": 54.73,
            "2027": 60.04,
            "2028": 67.59,
            "2029": 78.38,
            "2030": 87.24,
            "2031": 96.92,
            "2032": 111.12
          },
          "cagr": 12.44,
          "market_share": 22.72
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 23.63,
            "2021": 26.44,
            "2022": 29.63,
            "2023": 34.22,
            "2024": 38.08,
            "2025": 43.1,
            "2026": 48.26,
            "2027": 52.94,
            "2028": 59.6,
            "2029": 69.11,
            "2030": 76.92,
            "2031": 85.45,
            "2032": 97.98
          },
          "cagr": 12.45,
          "market_share": 20.03
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 15.79,
            "2021": 17.66,
            "2022": 19.79,
            "2023": 22.86,
            "2024": 25.44,
            "2025": 28.79,
            "2026": 32.23,
            "2027": 35.35,
            "2028": 39.81,
            "2029": 46.15,
            "2030": 51.37,
            "2031": 57.07,
            "2032": 65.44
          },
          "cagr": 12.45,
          "market_share": 13.38
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 70.65,
            "2021": 79.04,
            "2022": 88.59,
            "2023": 102.3,
            "2024": 113.85,
            "2025": 128.86,
            "2026": 144.27,
            "2027": 158.26,
            "2028": 178.17,
            "2029": 206.6,
            "2030": 229.96,
            "2031": 255.47,
            "2032": 292.92
          },
          "cagr": 12.45,
          "market_share": 59.88
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 47.33,
            "2021": 52.95,
            "2022": 59.34,
            "2023": 68.53,
            "2024": 76.27,
            "2025": 86.32,
            "2026": 96.64,
            "2027": 106.01,
            "2028": 119.36,
            "2029": 138.4,
            "2030": 154.04,
            "2031": 171.13,
            "2032": 196.22
          },
          "cagr": 12.45,
          "market_share": 40.12
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 38.27,
            "2021": 42.81,
            "2022": 47.98,
            "2023": 55.41,
            "2024": 61.67,
            "2025": 69.8,
            "2026": 78.14,
            "2027": 85.72,
            "2028": 96.51,
            "2029": 111.91,
            "2030": 124.56,
            "2031": 138.38,
            "2032": 158.66
          },
          "cagr": 12.45,
          "market_share": 32.44
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 79.71,
            "2021": 89.18,
            "2022": 99.95,
            "2023": 115.42,
            "2024": 128.45,
            "2025": 145.38,
            "2026": 162.77,
            "2027": 178.55,
            "2028": 201.02,
            "2029": 233.09,
            "2030": 259.44,
            "2031": 288.22,
            "2032": 330.48
          },
          "cagr": 12.45,
          "market_share": 67.56
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 30.92,
            "2021": 34.59,
            "2022": 38.77,
            "2023": 44.77,
            "2024": 49.82,
            "2025": 56.39,
            "2026": 63.14,
            "2027": 69.26,
            "2028": 77.97,
            "2029": 90.41,
            "2030": 100.63,
            "2031": 111.8,
            "2032": 128.19
          },
          "cagr": 12.45,
          "market_share": 26.2
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 61.06,
            "2021": 68.31,
            "2022": 76.56,
            "2023": 88.41,
            "2024": 98.39,
            "2025": 111.36,
            "2026": 124.68,
            "2027": 136.77,
            "2028": 153.97,
            "2029": 178.54,
            "2030": 198.72,
            "2031": 220.77,
            "2032": 253.14
          },
          "cagr": 12.45,
          "market_share": 51.75
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 26.0,
            "2021": 29.09,
            "2022": 32.6,
            "2023": 37.65,
            "2024": 41.91,
            "2025": 47.43,
            "2026": 53.09,
            "2027": 58.24,
            "2028": 65.59,
            "2029": 76.05,
            "2030": 84.65,
            "2031": 94.03,
            "2032": 107.81
          },
          "cagr": 12.45,
          "market_share": 22.04
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 61.14,
            "2021": 68.4,
            "2022": 76.66,
            "2023": 88.53,
            "2024": 98.53,
            "2025": 111.51,
            "2026": 124.85,
            "2027": 136.96,
            "2028": 154.19,
            "2029": 178.79,
            "2030": 199.0,
            "2031": 221.08,
            "2032": 253.49
          },
          "cagr": 12.45,
          "market_share": 51.83
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 56.84,
            "2021": 63.59,
            "2022": 71.27,
            "2023": 82.3,
            "2024": 91.59,
            "2025": 103.67,
            "2026": 116.06,
            "2027": 127.31,
            "2028": 143.34,
            "2029": 166.21,
            "2030": 185.0,
            "2031": 205.52,
            "2032": 235.65
          },
          "cagr": 12.45,
          "market_share": 48.17
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 13.7,
            "2021": 14.72,
            "2022": 16.36,
            "2023": 18.11,
            "2024": 20.27,
            "2025": 22.71,
            "2026": 24.41,
            "2027": 27.49,
            "2028": 29.51,
            "2029": 33.49,
            "2030": 36.33,
            "2031": 40.1,
            "2032": 43.59
          },
          "cagr": 9.76,
          "market_share": 18.49
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 16.96,
            "2021": 18.23,
            "2022": 20.26,
            "2023": 22.43,
            "2024": 25.1,
            "2025": 28.12,
            "2026": 30.24,
            "2027": 34.04,
            "2028": 36.54,
            "2029": 41.47,
            "2030": 44.99,
            "2031": 49.66,
            "2032": 53.98
          },
          "cagr": 9.76,
          "market_share": 22.9
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 13.53,
            "2021": 14.53,
            "2022": 16.16,
            "2023": 17.89,
            "2024": 20.02,
            "2025": 22.43,
            "2026": 24.11,
            "2027": 27.15,
            "2028": 29.14,
            "2029": 33.07,
            "2030": 35.88,
            "2031": 39.6,
            "2032": 43.05
          },
          "cagr": 9.76,
          "market_share": 18.27
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 14.11,
            "2021": 15.16,
            "2022": 16.85,
            "2023": 18.65,
            "2024": 20.87,
            "2025": 23.39,
            "2026": 25.15,
            "2027": 28.31,
            "2028": 30.39,
            "2029": 34.49,
            "2030": 37.42,
            "2031": 41.3,
            "2032": 44.89
          },
          "cagr": 9.76,
          "market_share": 19.04
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 15.77,
            "2021": 16.94,
            "2022": 18.84,
            "2023": 20.86,
            "2024": 23.33,
            "2025": 26.15,
            "2026": 28.11,
            "2027": 31.66,
            "2028": 33.99,
            "2029": 38.56,
            "2030": 41.82,
            "2031": 46.16,
            "2032": 50.19
          },
          "cagr": 9.76,
          "market_share": 21.29
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 8.47,
            "2021": 9.1,
            "2022": 10.12,
            "2023": 11.2,
            "2024": 12.53,
            "2025": 14.04,
            "2026": 15.1,
            "2027": 17.0,
            "2028": 18.25,
            "2029": 20.71,
            "2030": 22.46,
            "2031": 24.79,
            "2032": 26.95
          },
          "cagr": 9.76,
          "market_share": 11.43
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 18.62,
            "2021": 20.0,
            "2022": 22.23,
            "2023": 24.61,
            "2024": 27.54,
            "2025": 30.86,
            "2026": 33.18,
            "2027": 37.36,
            "2028": 40.1,
            "2029": 45.51,
            "2030": 49.36,
            "2031": 54.49,
            "2032": 59.23
          },
          "cagr": 9.76,
          "market_share": 25.13
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 12.39,
            "2021": 13.31,
            "2022": 14.8,
            "2023": 16.38,
            "2024": 18.33,
            "2025": 20.54,
            "2026": 22.08,
            "2027": 24.86,
            "2028": 26.69,
            "2029": 30.29,
            "2030": 32.85,
            "2031": 36.26,
            "2032": 39.42
          },
          "cagr": 9.76,
          "market_share": 16.72
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 21.51,
            "2021": 23.11,
            "2022": 25.69,
            "2023": 28.44,
            "2024": 31.82,
            "2025": 35.65,
            "2026": 38.33,
            "2027": 43.16,
            "2028": 46.33,
            "2029": 52.58,
            "2030": 57.04,
            "2031": 62.95,
            "2032": 68.43
          },
          "cagr": 9.76,
          "market_share": 29.03
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 13.08,
            "2021": 14.06,
            "2022": 15.63,
            "2023": 17.31,
            "2024": 19.37,
            "2025": 21.71,
            "2026": 23.33,
            "2027": 26.27,
            "2028": 28.2,
            "2029": 31.99,
            "2030": 34.73,
            "2031": 38.33,
            "2032": 41.67
          },
          "cagr": 9.76,
          "market_share": 17.67
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 23.98,
            "2021": 25.77,
            "2022": 28.65,
            "2023": 31.71,
            "2024": 35.48,
            "2025": 39.76,
            "2026": 42.75,
            "2027": 48.13,
            "2028": 51.67,
            "2029": 58.63,
            "2030": 63.6,
            "2031": 70.2,
            "2032": 76.32
          },
          "cagr": 9.76,
          "market_share": 32.37
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 50.09,
            "2021": 53.81,
            "2022": 59.82,
            "2023": 66.23,
            "2024": 74.11,
            "2025": 83.04,
            "2026": 89.27,
            "2027": 100.52,
            "2028": 107.9,
            "2029": 122.45,
            "2030": 132.84,
            "2031": 146.62,
            "2032": 159.38
          },
          "cagr": 9.76,
          "market_share": 67.62
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 26.13,
            "2021": 28.07,
            "2022": 31.2,
            "2023": 34.54,
            "2024": 38.65,
            "2025": 43.31,
            "2026": 46.57,
            "2027": 52.43,
            "2028": 56.28,
            "2029": 63.87,
            "2030": 69.29,
            "2031": 76.48,
            "2032": 83.13
          },
          "cagr": 9.76,
          "market_share": 35.26
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 47.94,
            "2021": 51.51,
            "2022": 57.27,
            "2023": 63.4,
            "2024": 70.94,
            "2025": 79.49,
            "2026": 85.45,
            "2027": 96.22,
            "2028": 103.29,
            "2029": 117.21,
            "2030": 127.15,
            "2031": 140.34,
            "2032": 152.57
          },
          "cagr": 9.76,
          "market_share": 64.73
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 19.75,
            "2021": 21.22,
            "2022": 23.59,
            "2023": 26.11,
            "2024": 29.22,
            "2025": 32.74,
            "2026": 35.2,
            "2027": 39.63,
            "2028": 42.55,
            "2029": 48.28,
            "2030": 52.38,
            "2031": 57.81,
            "2032": 62.85
          },
          "cagr": 9.76,
          "market_share": 26.66
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 24.62,
            "2021": 26.45,
            "2022": 29.41,
            "2023": 32.55,
            "2024": 36.43,
            "2025": 40.82,
            "2026": 43.88,
            "2027": 49.41,
            "2028": 53.04,
            "2029": 60.19,
            "2030": 65.3,
            "2031": 72.07,
            "2032": 78.35
          },
          "cagr": 9.76,
          "market_share": 33.24
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 29.7,
            "2021": 31.91,
            "2022": 35.47,
            "2023": 39.28,
            "2024": 43.94,
            "2025": 49.24,
            "2026": 52.94,
            "2027": 59.61,
            "2028": 63.98,
            "2029": 72.61,
            "2030": 78.76,
            "2031": 86.94,
            "2032": 94.5
          },
          "cagr": 9.76,
          "market_share": 40.09
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 50.21,
            "2021": 53.95,
            "2022": 59.97,
            "2023": 66.39,
            "2024": 74.29,
            "2025": 83.24,
            "2026": 89.49,
            "2027": 100.76,
            "2028": 108.17,
            "2029": 122.75,
            "2030": 133.16,
            "2031": 146.98,
            "2032": 159.77
          },
          "cagr": 9.76,
          "market_share": 67.78
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 23.86,
            "2021": 25.63,
            "2022": 28.5,
            "2023": 31.55,
            "2024": 35.3,
            "2025": 39.56,
            "2026": 42.53,
            "2027": 47.89,
            "2028": 51.4,
            "2029": 58.33,
            "2030": 63.28,
            "2031": 69.84,
            "2032": 75.93
          },
          "cagr": 9.76,
          "market_share": 32.21
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 20.95,
            "2021": 23.2,
            "2022": 25.27,
            "2023": 27.26,
            "2024": 29.81,
            "2025": 33.21,
            "2026": 35.96,
            "2027": 39.41,
            "2028": 42.79,
            "2029": 46.69,
            "2030": 51.13,
            "2031": 55.42,
            "2032": 60.41
          },
          "cagr": 8.92,
          "market_share": 17.91
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 24.98,
            "2021": 27.66,
            "2022": 30.13,
            "2023": 32.5,
            "2024": 35.54,
            "2025": 39.59,
            "2026": 42.87,
            "2027": 46.99,
            "2028": 51.02,
            "2029": 55.66,
            "2030": 60.96,
            "2031": 66.07,
            "2032": 72.03
          },
          "cagr": 8.93,
          "market_share": 21.35
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 20.87,
            "2021": 23.12,
            "2022": 25.18,
            "2023": 27.16,
            "2024": 29.7,
            "2025": 33.09,
            "2026": 35.83,
            "2027": 39.27,
            "2028": 42.63,
            "2029": 46.52,
            "2030": 50.94,
            "2031": 55.22,
            "2032": 60.19
          },
          "cagr": 8.92,
          "market_share": 17.84
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 21.97,
            "2021": 24.33,
            "2022": 26.5,
            "2023": 28.59,
            "2024": 31.26,
            "2025": 34.82,
            "2026": 37.71,
            "2027": 41.33,
            "2028": 44.87,
            "2029": 48.96,
            "2030": 53.62,
            "2031": 58.11,
            "2032": 63.35
          },
          "cagr": 8.93,
          "market_share": 18.78
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 28.2,
            "2021": 31.22,
            "2022": 34.02,
            "2023": 36.69,
            "2024": 40.14,
            "2025": 44.7,
            "2026": 48.39,
            "2027": 53.06,
            "2028": 57.59,
            "2029": 62.84,
            "2030": 68.81,
            "2031": 74.58,
            "2032": 81.31
          },
          "cagr": 8.92,
          "market_share": 24.12
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 12.6,
            "2021": 13.95,
            "2022": 15.2,
            "2023": 16.4,
            "2024": 17.93,
            "2025": 19.97,
            "2026": 21.63,
            "2027": 23.71,
            "2028": 25.74,
            "2029": 28.08,
            "2030": 30.75,
            "2031": 33.33,
            "2032": 36.33
          },
          "cagr": 8.92,
          "market_share": 10.77
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 33.2,
            "2021": 36.76,
            "2022": 40.04,
            "2023": 43.19,
            "2024": 47.24,
            "2025": 52.62,
            "2026": 56.97,
            "2027": 62.45,
            "2028": 67.8,
            "2029": 73.98,
            "2030": 81.01,
            "2031": 87.81,
            "2032": 95.72
          },
          "cagr": 8.92,
          "market_share": 28.38
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 13.32,
            "2021": 14.75,
            "2022": 16.07,
            "2023": 17.33,
            "2024": 18.95,
            "2025": 21.11,
            "2026": 22.86,
            "2027": 25.06,
            "2028": 27.21,
            "2029": 29.68,
            "2030": 32.51,
            "2031": 35.23,
            "2032": 38.41
          },
          "cagr": 8.93,
          "market_share": 11.38
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 24.21,
            "2021": 26.81,
            "2022": 29.2,
            "2023": 31.5,
            "2024": 34.45,
            "2025": 38.37,
            "2026": 41.55,
            "2027": 45.54,
            "2028": 49.44,
            "2029": 53.95,
            "2030": 59.08,
            "2031": 64.03,
            "2032": 69.81
          },
          "cagr": 8.93,
          "market_share": 20.7
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 33.64,
            "2021": 37.26,
            "2022": 40.59,
            "2023": 43.78,
            "2024": 47.88,
            "2025": 53.34,
            "2026": 57.75,
            "2027": 63.3,
            "2028": 68.71,
            "2029": 74.98,
            "2030": 82.11,
            "2031": 89.0,
            "2032": 97.02
          },
          "cagr": 8.92,
          "market_share": 28.77
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 53.73,
            "2021": 59.5,
            "2022": 64.82,
            "2023": 69.91,
            "2024": 76.46,
            "2025": 85.17,
            "2026": 92.22,
            "2027": 101.09,
            "2028": 109.74,
            "2029": 119.74,
            "2030": 131.13,
            "2031": 142.13,
            "2032": 154.94
          },
          "cagr": 8.92,
          "market_share": 45.94
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 63.24,
            "2021": 70.03,
            "2022": 76.28,
            "2023": 82.29,
            "2024": 89.99,
            "2025": 100.24,
            "2026": 108.54,
            "2027": 118.97,
            "2028": 129.16,
            "2029": 140.93,
            "2030": 154.33,
            "2031": 167.27,
            "2032": 182.35
          },
          "cagr": 8.92,
          "market_share": 54.06
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 73.03,
            "2021": 80.87,
            "2022": 88.1,
            "2023": 95.03,
            "2024": 103.92,
            "2025": 115.76,
            "2026": 125.34,
            "2027": 137.39,
            "2028": 149.16,
            "2029": 162.75,
            "2030": 178.23,
            "2031": 193.18,
            "2032": 210.59
          },
          "cagr": 8.92,
          "market_share": 62.43
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 43.94,
            "2021": 48.66,
            "2022": 53.0,
            "2023": 57.17,
            "2024": 62.53,
            "2025": 69.65,
            "2026": 75.42,
            "2027": 82.67,
            "2028": 89.74,
            "2029": 97.92,
            "2030": 107.23,
            "2031": 116.22,
            "2032": 126.7
          },
          "cagr": 8.92,
          "market_share": 37.57
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 22.75,
            "2021": 25.19,
            "2022": 27.44,
            "2023": 29.6,
            "2024": 32.37,
            "2025": 36.06,
            "2026": 39.04,
            "2027": 42.8,
            "2028": 46.46,
            "2029": 50.7,
            "2030": 55.52,
            "2031": 60.17,
            "2032": 65.6
          },
          "cagr": 8.92,
          "market_share": 19.45
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 50.4,
            "2021": 55.81,
            "2022": 60.79,
            "2023": 65.57,
            "2024": 71.71,
            "2025": 79.88,
            "2026": 86.49,
            "2027": 94.81,
            "2028": 102.93,
            "2029": 112.31,
            "2030": 122.99,
            "2031": 133.3,
            "2032": 145.32
          },
          "cagr": 8.92,
          "market_share": 43.08
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 43.82,
            "2021": 48.53,
            "2022": 52.87,
            "2023": 57.03,
            "2024": 62.37,
            "2025": 69.47,
            "2026": 75.23,
            "2027": 82.45,
            "2028": 89.51,
            "2029": 97.66,
            "2030": 106.95,
            "2031": 115.93,
            "2032": 126.37
          },
          "cagr": 8.92,
          "market_share": 37.47
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 67.61,
            "2021": 74.87,
            "2022": 81.56,
            "2023": 87.97,
            "2024": 96.21,
            "2025": 107.17,
            "2026": 116.04,
            "2027": 127.19,
            "2028": 138.09,
            "2029": 150.67,
            "2030": 165.0,
            "2031": 178.84,
            "2032": 194.96
          },
          "cagr": 8.92,
          "market_share": 57.8
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 49.36,
            "2021": 54.66,
            "2022": 59.54,
            "2023": 64.23,
            "2024": 70.24,
            "2025": 78.24,
            "2026": 84.72,
            "2027": 92.87,
            "2028": 100.81,
            "2029": 110.0,
            "2030": 120.46,
            "2031": 130.56,
            "2032": 142.33
          },
          "cagr": 8.92,
          "market_share": 42.2
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 11.75,
            "2021": 12.8,
            "2022": 13.95,
            "2023": 15.46,
            "2024": 17.39,
            "2025": 18.83,
            "2026": 20.75,
            "2027": 23.41,
            "2028": 25.32,
            "2029": 27.62,
            "2030": 31.27,
            "2031": 33.46,
            "2032": 37.94
          },
          "cagr": 10.53,
          "market_share": 22.59
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 12.12,
            "2021": 13.21,
            "2022": 14.39,
            "2023": 15.96,
            "2024": 17.94,
            "2025": 19.43,
            "2026": 21.41,
            "2027": 24.16,
            "2028": 26.12,
            "2029": 28.5,
            "2030": 32.27,
            "2031": 34.53,
            "2032": 39.15
          },
          "cagr": 10.53,
          "market_share": 23.3
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 11.39,
            "2021": 12.42,
            "2022": 13.53,
            "2023": 15.0,
            "2024": 16.87,
            "2025": 18.26,
            "2026": 20.13,
            "2027": 22.71,
            "2028": 24.56,
            "2029": 26.79,
            "2030": 30.33,
            "2031": 32.46,
            "2032": 36.8
          },
          "cagr": 10.53,
          "market_share": 21.91
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 9.45,
            "2021": 10.3,
            "2022": 11.23,
            "2023": 12.45,
            "2024": 14.0,
            "2025": 15.15,
            "2026": 16.7,
            "2027": 18.84,
            "2028": 20.38,
            "2029": 22.23,
            "2030": 25.17,
            "2031": 26.93,
            "2032": 30.53
          },
          "cagr": 10.53,
          "market_share": 18.19
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 7.28,
            "2021": 7.93,
            "2022": 8.65,
            "2023": 9.58,
            "2024": 10.78,
            "2025": 11.67,
            "2026": 12.86,
            "2027": 14.53,
            "2028": 15.7,
            "2029": 17.11,
            "2030": 19.38,
            "2031": 20.74,
            "2032": 23.51
          },
          "cagr": 10.52,
          "market_share": 14.0
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 14.2,
            "2021": 15.47,
            "2022": 16.86,
            "2023": 18.69,
            "2024": 21.02,
            "2025": 22.76,
            "2026": 25.08,
            "2027": 28.3,
            "2028": 30.6,
            "2029": 33.38,
            "2030": 37.8,
            "2031": 40.45,
            "2032": 45.86
          },
          "cagr": 10.53,
          "market_share": 27.31
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.71,
            "2021": 13.85,
            "2022": 15.09,
            "2023": 16.73,
            "2024": 18.82,
            "2025": 20.37,
            "2026": 22.45,
            "2027": 25.34,
            "2028": 27.4,
            "2029": 29.88,
            "2030": 33.84,
            "2031": 36.21,
            "2032": 41.05
          },
          "cagr": 10.53,
          "market_share": 24.45
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 11.57,
            "2021": 12.61,
            "2022": 13.74,
            "2023": 15.23,
            "2024": 17.13,
            "2025": 18.54,
            "2026": 20.43,
            "2027": 23.06,
            "2028": 24.93,
            "2029": 27.2,
            "2030": 30.8,
            "2031": 32.95,
            "2032": 37.36
          },
          "cagr": 10.53,
          "market_share": 22.25
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 7.26,
            "2021": 7.91,
            "2022": 8.62,
            "2023": 9.56,
            "2024": 10.75,
            "2025": 11.64,
            "2026": 12.82,
            "2027": 14.47,
            "2028": 15.65,
            "2029": 17.07,
            "2030": 19.32,
            "2031": 20.68,
            "2032": 23.44
          },
          "cagr": 10.52,
          "market_share": 13.96
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 6.25,
            "2021": 6.82,
            "2022": 7.44,
            "2023": 8.24,
            "2024": 9.26,
            "2025": 10.03,
            "2026": 11.07,
            "2027": 12.48,
            "2028": 13.5,
            "2029": 14.72,
            "2030": 16.66,
            "2031": 17.83,
            "2032": 20.22
          },
          "cagr": 10.53,
          "market_share": 12.03
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 26.66,
            "2021": 29.05,
            "2022": 31.66,
            "2023": 35.1,
            "2024": 39.47,
            "2025": 42.73,
            "2026": 47.09,
            "2027": 53.14,
            "2028": 57.46,
            "2029": 62.68,
            "2030": 70.97,
            "2031": 75.95,
            "2032": 86.11
          },
          "cagr": 10.53,
          "market_share": 51.27
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 25.33,
            "2021": 27.61,
            "2022": 30.09,
            "2023": 33.35,
            "2024": 37.51,
            "2025": 40.61,
            "2026": 44.76,
            "2027": 50.51,
            "2028": 54.62,
            "2029": 59.57,
            "2030": 67.45,
            "2031": 72.17,
            "2032": 81.82
          },
          "cagr": 10.53,
          "market_share": 48.73
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 25.26,
            "2021": 27.53,
            "2022": 30.0,
            "2023": 33.26,
            "2024": 37.4,
            "2025": 40.49,
            "2026": 44.63,
            "2027": 50.36,
            "2028": 54.45,
            "2029": 59.4,
            "2030": 67.25,
            "2031": 71.97,
            "2032": 81.59
          },
          "cagr": 10.53,
          "market_share": 48.58
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 26.73,
            "2021": 29.13,
            "2022": 31.75,
            "2023": 35.19,
            "2024": 39.58,
            "2025": 42.85,
            "2026": 47.22,
            "2027": 53.29,
            "2028": 57.63,
            "2029": 62.85,
            "2030": 71.17,
            "2031": 76.15,
            "2032": 86.34
          },
          "cagr": 10.53,
          "market_share": 51.42
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 17.89,
            "2021": 19.5,
            "2022": 21.25,
            "2023": 23.55,
            "2024": 26.48,
            "2025": 28.67,
            "2026": 31.6,
            "2027": 35.66,
            "2028": 38.56,
            "2029": 42.06,
            "2030": 47.62,
            "2031": 50.96,
            "2032": 57.78
          },
          "cagr": 10.53,
          "market_share": 34.4
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 14.29,
            "2021": 15.57,
            "2022": 16.97,
            "2023": 18.81,
            "2024": 21.16,
            "2025": 22.91,
            "2026": 25.25,
            "2027": 28.49,
            "2028": 30.8,
            "2029": 33.6,
            "2030": 38.05,
            "2031": 40.71,
            "2032": 46.16
          },
          "cagr": 10.53,
          "market_share": 27.49
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 19.81,
            "2021": 21.59,
            "2022": 23.53,
            "2023": 26.09,
            "2024": 29.34,
            "2025": 31.76,
            "2026": 35.0,
            "2027": 39.5,
            "2028": 42.72,
            "2029": 46.59,
            "2030": 52.75,
            "2031": 56.45,
            "2032": 63.99
          },
          "cagr": 10.53,
          "market_share": 38.11
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 24.07,
            "2021": 26.23,
            "2022": 28.59,
            "2023": 31.69,
            "2024": 35.64,
            "2025": 38.58,
            "2026": 42.52,
            "2027": 47.98,
            "2028": 51.89,
            "2029": 56.6,
            "2030": 64.08,
            "2031": 68.57,
            "2032": 77.75
          },
          "cagr": 10.53,
          "market_share": 46.3
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 27.92,
            "2021": 30.43,
            "2022": 33.16,
            "2023": 36.76,
            "2024": 41.34,
            "2025": 44.76,
            "2026": 49.33,
            "2027": 55.67,
            "2028": 60.19,
            "2029": 65.65,
            "2030": 74.34,
            "2031": 79.55,
            "2032": 90.18
          },
          "cagr": 10.52,
          "market_share": 53.7
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 29.1,
            "2021": 34.19,
            "2022": 39.32,
            "2023": 44.26,
            "2024": 50.58,
            "2025": 58.62,
            "2026": 66.38,
            "2027": 76.24,
            "2028": 88.73,
            "2029": 101.32,
            "2030": 116.05,
            "2031": 130.33,
            "2032": 153.07
          },
          "cagr": 14.7,
          "market_share": 20.07
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 36.26,
            "2021": 42.6,
            "2022": 48.99,
            "2023": 55.14,
            "2024": 63.02,
            "2025": 73.04,
            "2026": 82.7,
            "2027": 94.99,
            "2028": 110.55,
            "2029": 126.23,
            "2030": 144.6,
            "2031": 162.39,
            "2032": 190.72
          },
          "cagr": 14.7,
          "market_share": 25.01
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 34.31,
            "2021": 40.31,
            "2022": 46.36,
            "2023": 52.18,
            "2024": 59.63,
            "2025": 69.11,
            "2026": 78.26,
            "2027": 89.88,
            "2028": 104.61,
            "2029": 119.45,
            "2030": 136.82,
            "2031": 153.65,
            "2032": 180.46
          },
          "cagr": 14.7,
          "market_share": 23.66
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 25.05,
            "2021": 29.43,
            "2022": 33.84,
            "2023": 38.09,
            "2024": 43.53,
            "2025": 50.45,
            "2026": 57.13,
            "2027": 65.62,
            "2028": 76.37,
            "2029": 87.2,
            "2030": 99.88,
            "2031": 112.17,
            "2032": 131.74
          },
          "cagr": 14.7,
          "market_share": 17.27
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 20.28,
            "2021": 23.84,
            "2022": 27.41,
            "2023": 30.84,
            "2024": 35.23,
            "2025": 40.86,
            "2026": 46.25,
            "2027": 53.12,
            "2028": 61.81,
            "2029": 70.59,
            "2030": 80.86,
            "2031": 90.81,
            "2032": 106.65
          },
          "cagr": 14.69,
          "market_share": 13.98
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 32.93,
            "2021": 38.69,
            "2022": 44.49,
            "2023": 50.07,
            "2024": 57.22,
            "2025": 66.32,
            "2026": 75.1,
            "2027": 86.25,
            "2028": 100.38,
            "2029": 114.62,
            "2030": 131.3,
            "2031": 147.45,
            "2032": 173.17
          },
          "cagr": 14.7,
          "market_share": 22.71
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 26.7,
            "2021": 31.38,
            "2022": 36.08,
            "2023": 40.61,
            "2024": 46.41,
            "2025": 53.79,
            "2026": 60.91,
            "2027": 69.96,
            "2028": 81.42,
            "2029": 92.97,
            "2030": 106.49,
            "2031": 119.59,
            "2032": 140.45
          },
          "cagr": 14.7,
          "market_share": 18.42
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 23.92,
            "2021": 28.1,
            "2022": 32.32,
            "2023": 36.38,
            "2024": 41.57,
            "2025": 48.18,
            "2026": 54.56,
            "2027": 62.66,
            "2028": 72.93,
            "2029": 83.27,
            "2030": 95.38,
            "2031": 107.12,
            "2032": 125.81
          },
          "cagr": 14.7,
          "market_share": 16.5
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 34.71,
            "2021": 40.78,
            "2022": 46.9,
            "2023": 52.79,
            "2024": 60.32,
            "2025": 69.92,
            "2026": 79.17,
            "2027": 90.93,
            "2028": 105.82,
            "2029": 120.84,
            "2030": 138.41,
            "2031": 155.44,
            "2032": 182.56
          },
          "cagr": 14.69,
          "market_share": 23.94
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 26.74,
            "2021": 31.42,
            "2022": 36.13,
            "2023": 40.66,
            "2024": 46.47,
            "2025": 53.87,
            "2026": 60.98,
            "2027": 70.05,
            "2028": 81.52,
            "2029": 93.09,
            "2030": 106.63,
            "2031": 119.75,
            "2032": 140.65
          },
          "cagr": 14.69,
          "market_share": 18.44
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 62.24,
            "2021": 73.12,
            "2022": 84.09,
            "2023": 94.64,
            "2024": 108.16,
            "2025": 125.36,
            "2026": 141.95,
            "2027": 163.03,
            "2028": 189.74,
            "2029": 216.66,
            "2030": 248.17,
            "2031": 278.7,
            "2032": 327.33
          },
          "cagr": 14.7,
          "market_share": 42.92
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 82.76,
            "2021": 97.25,
            "2022": 111.83,
            "2023": 125.87,
            "2024": 143.83,
            "2025": 166.72,
            "2026": 188.77,
            "2027": 216.82,
            "2028": 252.33,
            "2029": 288.13,
            "2030": 330.04,
            "2031": 370.65,
            "2032": 435.31
          },
          "cagr": 14.69,
          "market_share": 57.08
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 66.38,
            "2021": 77.99,
            "2022": 89.69,
            "2023": 100.94,
            "2024": 115.36,
            "2025": 133.71,
            "2026": 151.4,
            "2027": 173.89,
            "2028": 202.37,
            "2029": 231.08,
            "2030": 264.7,
            "2031": 297.26,
            "2032": 349.13
          },
          "cagr": 14.7,
          "market_share": 45.78
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 78.62,
            "2021": 92.38,
            "2022": 106.23,
            "2023": 119.57,
            "2024": 136.63,
            "2025": 158.37,
            "2026": 179.32,
            "2027": 205.96,
            "2028": 239.7,
            "2029": 273.71,
            "2030": 313.51,
            "2031": 352.09,
            "2032": 413.51
          },
          "cagr": 14.7,
          "market_share": 54.22
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 37.01,
            "2021": 43.49,
            "2022": 50.01,
            "2023": 56.29,
            "2024": 64.32,
            "2025": 74.55,
            "2026": 84.42,
            "2027": 96.96,
            "2028": 112.84,
            "2029": 128.85,
            "2030": 147.59,
            "2031": 165.75,
            "2032": 194.67
          },
          "cagr": 14.7,
          "market_share": 25.52
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 48.36,
            "2021": 56.82,
            "2022": 65.34,
            "2023": 73.54,
            "2024": 84.04,
            "2025": 97.41,
            "2026": 110.29,
            "2027": 126.68,
            "2028": 147.43,
            "2029": 168.34,
            "2030": 192.83,
            "2031": 216.56,
            "2032": 254.34
          },
          "cagr": 14.69,
          "market_share": 33.35
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 59.63,
            "2021": 70.06,
            "2022": 80.57,
            "2023": 90.68,
            "2024": 103.63,
            "2025": 120.12,
            "2026": 136.01,
            "2027": 156.21,
            "2028": 181.8,
            "2029": 207.6,
            "2030": 237.79,
            "2031": 267.04,
            "2032": 313.63
          },
          "cagr": 14.69,
          "market_share": 41.12
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 80.75,
            "2021": 94.88,
            "2022": 109.11,
            "2023": 122.8,
            "2024": 140.34,
            "2025": 162.66,
            "2026": 184.18,
            "2027": 211.54,
            "2028": 246.2,
            "2029": 281.12,
            "2030": 322.02,
            "2031": 361.63,
            "2032": 424.73
          },
          "cagr": 14.7,
          "market_share": 55.69
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 64.25,
            "2021": 75.49,
            "2022": 86.81,
            "2023": 97.71,
            "2024": 111.65,
            "2025": 129.42,
            "2026": 146.54,
            "2027": 168.31,
            "2028": 195.87,
            "2029": 223.67,
            "2030": 256.19,
            "2031": 287.72,
            "2032": 337.91
          },
          "cagr": 14.69,
          "market_share": 44.31
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 20.24,
            "2021": 22.27,
            "2022": 23.98,
            "2023": 25.62,
            "2024": 28.01,
            "2025": 30.32,
            "2026": 33.04,
            "2027": 35.7,
            "2028": 39.37,
            "2029": 43.16,
            "2030": 46.87,
            "2031": 50.61,
            "2032": 56.1
          },
          "cagr": 9.19,
          "market_share": 17.58
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 27.43,
            "2021": 30.19,
            "2022": 32.51,
            "2023": 34.72,
            "2024": 37.96,
            "2025": 41.09,
            "2026": 44.78,
            "2027": 48.39,
            "2028": 53.35,
            "2029": 58.49,
            "2030": 63.52,
            "2031": 68.59,
            "2032": 76.03
          },
          "cagr": 9.19,
          "market_share": 23.82
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 19.86,
            "2021": 21.86,
            "2022": 23.54,
            "2023": 25.14,
            "2024": 27.49,
            "2025": 29.76,
            "2026": 32.43,
            "2027": 35.04,
            "2028": 38.64,
            "2029": 42.36,
            "2030": 46.0,
            "2031": 49.68,
            "2032": 55.06
          },
          "cagr": 9.19,
          "market_share": 17.25
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 26.26,
            "2021": 28.9,
            "2022": 31.12,
            "2023": 33.24,
            "2024": 36.35,
            "2025": 39.34,
            "2026": 42.87,
            "2027": 46.33,
            "2028": 51.08,
            "2029": 56.01,
            "2030": 60.82,
            "2031": 65.67,
            "2032": 72.8
          },
          "cagr": 9.19,
          "market_share": 22.81
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 21.35,
            "2021": 23.51,
            "2022": 25.32,
            "2023": 27.03,
            "2024": 29.56,
            "2025": 31.99,
            "2026": 34.87,
            "2027": 37.68,
            "2028": 41.55,
            "2029": 45.55,
            "2030": 49.46,
            "2031": 53.4,
            "2032": 59.2
          },
          "cagr": 9.19,
          "market_share": 18.55
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 20.56,
            "2021": 22.63,
            "2022": 24.37,
            "2023": 26.02,
            "2024": 28.46,
            "2025": 30.8,
            "2026": 33.56,
            "2027": 36.27,
            "2028": 39.99,
            "2029": 43.85,
            "2030": 47.61,
            "2031": 51.41,
            "2032": 56.99
          },
          "cagr": 9.19,
          "market_share": 17.86
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 25.02,
            "2021": 27.54,
            "2022": 29.65,
            "2023": 31.67,
            "2024": 34.63,
            "2025": 37.48,
            "2026": 40.85,
            "2027": 44.14,
            "2028": 48.67,
            "2029": 53.36,
            "2030": 57.95,
            "2031": 62.57,
            "2032": 69.36
          },
          "cagr": 9.19,
          "market_share": 21.73
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 25.35,
            "2021": 27.9,
            "2022": 30.04,
            "2023": 32.09,
            "2024": 35.09,
            "2025": 37.98,
            "2026": 41.39,
            "2027": 44.72,
            "2028": 49.31,
            "2029": 54.06,
            "2030": 58.71,
            "2031": 63.39,
            "2032": 70.27
          },
          "cagr": 9.19,
          "market_share": 22.02
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 12.92,
            "2021": 14.22,
            "2022": 15.32,
            "2023": 16.36,
            "2024": 17.89,
            "2025": 19.36,
            "2026": 21.1,
            "2027": 22.8,
            "2028": 25.14,
            "2029": 27.56,
            "2030": 29.93,
            "2031": 32.32,
            "2032": 35.82
          },
          "cagr": 9.19,
          "market_share": 11.23
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 31.29,
            "2021": 34.44,
            "2022": 37.09,
            "2023": 39.61,
            "2024": 43.3,
            "2025": 46.88,
            "2026": 51.09,
            "2027": 55.21,
            "2028": 60.88,
            "2029": 66.74,
            "2030": 72.47,
            "2031": 78.26,
            "2032": 86.75
          },
          "cagr": 9.19,
          "market_share": 27.17
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 64.16,
            "2021": 70.62,
            "2022": 76.04,
            "2023": 81.22,
            "2024": 88.8,
            "2025": 96.12,
            "2026": 104.75,
            "2027": 113.19,
            "2028": 124.81,
            "2029": 136.83,
            "2030": 148.59,
            "2031": 160.45,
            "2032": 177.86
          },
          "cagr": 9.19,
          "market_share": 55.72
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 50.98,
            "2021": 56.11,
            "2022": 60.43,
            "2023": 64.53,
            "2024": 70.57,
            "2025": 76.38,
            "2026": 83.24,
            "2027": 89.95,
            "2028": 99.18,
            "2029": 108.74,
            "2030": 118.08,
            "2031": 127.5,
            "2032": 141.33
          },
          "cagr": 9.19,
          "market_share": 44.28
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 62.9,
            "2021": 69.23,
            "2022": 74.55,
            "2023": 79.63,
            "2024": 87.07,
            "2025": 94.24,
            "2026": 102.7,
            "2027": 110.98,
            "2028": 122.37,
            "2029": 134.16,
            "2030": 145.69,
            "2031": 157.31,
            "2032": 174.38
          },
          "cagr": 9.19,
          "market_share": 54.63
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 52.24,
            "2021": 57.5,
            "2022": 61.92,
            "2023": 66.12,
            "2024": 72.3,
            "2025": 78.26,
            "2026": 85.29,
            "2027": 92.16,
            "2028": 101.62,
            "2029": 111.41,
            "2030": 120.98,
            "2031": 130.64,
            "2032": 144.81
          },
          "cagr": 9.19,
          "market_share": 45.37
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 40.42,
            "2021": 44.49,
            "2022": 47.9,
            "2023": 51.16,
            "2024": 55.94,
            "2025": 60.55,
            "2026": 65.99,
            "2027": 71.31,
            "2028": 78.63,
            "2029": 86.2,
            "2030": 93.61,
            "2031": 101.08,
            "2032": 112.04
          },
          "cagr": 9.19,
          "market_share": 35.1
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 34.43,
            "2021": 37.89,
            "2022": 40.8,
            "2023": 43.58,
            "2024": 47.65,
            "2025": 51.58,
            "2026": 56.21,
            "2027": 60.74,
            "2028": 66.97,
            "2029": 73.43,
            "2030": 79.74,
            "2031": 86.1,
            "2032": 95.44
          },
          "cagr": 9.19,
          "market_share": 29.9
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 40.29,
            "2021": 44.35,
            "2022": 47.77,
            "2023": 51.01,
            "2024": 55.78,
            "2025": 60.37,
            "2026": 65.79,
            "2027": 71.09,
            "2028": 78.39,
            "2029": 85.94,
            "2030": 93.32,
            "2031": 100.77,
            "2032": 111.71
          },
          "cagr": 9.19,
          "market_share": 35.0
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 39.01,
            "2021": 42.94,
            "2022": 46.24,
            "2023": 49.38,
            "2024": 54.0,
            "2025": 58.44,
            "2026": 63.69,
            "2027": 68.83,
            "2028": 75.89,
            "2029": 83.2,
            "2030": 90.35,
            "2031": 97.56,
            "2032": 108.14
          },
          "cagr": 9.19,
          "market_share": 33.88
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 76.13,
            "2021": 83.79,
            "2022": 90.23,
            "2023": 96.37,
            "2024": 105.37,
            "2025": 114.06,
            "2026": 124.3,
            "2027": 134.31,
            "2028": 148.1,
            "2029": 162.37,
            "2030": 176.32,
            "2031": 190.39,
            "2032": 211.05
          },
          "cagr": 9.19,
          "market_share": 66.12
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 25.34,
            "2021": 27.88,
            "2022": 31.46,
            "2023": 35.62,
            "2024": 40.33,
            "2025": 45.07,
            "2026": 50.7,
            "2027": 56.83,
            "2028": 65.82,
            "2029": 73.5,
            "2030": 82.13,
            "2031": 91.35,
            "2032": 103.41
          },
          "cagr": 12.6,
          "market_share": 17.86
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 23.83,
            "2021": 26.22,
            "2022": 29.59,
            "2023": 33.5,
            "2024": 37.93,
            "2025": 42.39,
            "2026": 47.68,
            "2027": 53.45,
            "2028": 61.9,
            "2029": 69.12,
            "2030": 77.24,
            "2031": 85.91,
            "2032": 97.25
          },
          "cagr": 12.59,
          "market_share": 16.8
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 35.51,
            "2021": 39.07,
            "2022": 44.09,
            "2023": 49.92,
            "2024": 56.52,
            "2025": 63.16,
            "2026": 71.05,
            "2027": 79.64,
            "2028": 92.24,
            "2029": 103.0,
            "2030": 115.11,
            "2031": 128.02,
            "2032": 144.92
          },
          "cagr": 12.6,
          "market_share": 25.03
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 42.04,
            "2021": 46.26,
            "2022": 52.2,
            "2023": 59.11,
            "2024": 66.92,
            "2025": 74.79,
            "2026": 84.13,
            "2027": 94.3,
            "2028": 109.21,
            "2029": 121.96,
            "2030": 136.29,
            "2031": 151.58,
            "2032": 171.59
          },
          "cagr": 12.6,
          "market_share": 29.63
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 15.17,
            "2021": 16.69,
            "2022": 18.83,
            "2023": 21.33,
            "2024": 24.14,
            "2025": 26.97,
            "2026": 30.36,
            "2027": 34.02,
            "2028": 39.39,
            "2029": 43.99,
            "2030": 49.17,
            "2031": 54.69,
            "2032": 61.9
          },
          "cagr": 12.6,
          "market_share": 10.69
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 24.75,
            "2021": 27.23,
            "2022": 30.73,
            "2023": 34.8,
            "2024": 39.39,
            "2025": 44.02,
            "2026": 49.52,
            "2027": 55.51,
            "2028": 64.29,
            "2029": 71.79,
            "2030": 80.23,
            "2031": 89.23,
            "2032": 101.01
          },
          "cagr": 12.6,
          "market_share": 17.44
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 24.04,
            "2021": 26.46,
            "2022": 29.85,
            "2023": 33.8,
            "2024": 38.27,
            "2025": 42.77,
            "2026": 48.11,
            "2027": 53.93,
            "2028": 62.46,
            "2029": 69.74,
            "2030": 77.94,
            "2031": 86.69,
            "2032": 98.13
          },
          "cagr": 12.6,
          "market_share": 16.95
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 34.19,
            "2021": 37.62,
            "2022": 42.45,
            "2023": 48.07,
            "2024": 54.42,
            "2025": 60.82,
            "2026": 68.42,
            "2027": 76.69,
            "2028": 88.81,
            "2029": 99.18,
            "2030": 110.84,
            "2031": 123.27,
            "2032": 139.54
          },
          "cagr": 12.6,
          "market_share": 24.1
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 37.07,
            "2021": 40.79,
            "2022": 46.03,
            "2023": 52.12,
            "2024": 59.0,
            "2025": 65.94,
            "2026": 74.18,
            "2027": 83.14,
            "2028": 96.29,
            "2029": 107.53,
            "2030": 120.16,
            "2031": 133.65,
            "2032": 151.29
          },
          "cagr": 12.6,
          "market_share": 26.12
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 21.84,
            "2021": 24.02,
            "2022": 27.11,
            "2023": 30.69,
            "2024": 34.76,
            "2025": 38.83,
            "2026": 43.69,
            "2027": 48.97,
            "2028": 56.71,
            "2029": 63.33,
            "2030": 70.77,
            "2031": 78.71,
            "2032": 89.1
          },
          "cagr": 12.6,
          "market_share": 15.39
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 68.29,
            "2021": 75.14,
            "2022": 84.79,
            "2023": 96.01,
            "2024": 108.69,
            "2025": 121.47,
            "2026": 136.64,
            "2027": 153.17,
            "2028": 177.38,
            "2029": 198.08,
            "2030": 221.36,
            "2031": 246.2,
            "2032": 278.7
          },
          "cagr": 12.6,
          "market_share": 48.13
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 73.6,
            "2021": 80.98,
            "2022": 91.38,
            "2023": 103.47,
            "2024": 117.15,
            "2025": 130.91,
            "2026": 147.28,
            "2027": 165.07,
            "2028": 191.18,
            "2029": 213.49,
            "2030": 238.58,
            "2031": 265.35,
            "2032": 300.37
          },
          "cagr": 12.6,
          "market_share": 51.87
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 72.05,
            "2021": 79.27,
            "2022": 89.45,
            "2023": 101.29,
            "2024": 114.67,
            "2025": 128.15,
            "2026": 144.16,
            "2027": 161.59,
            "2028": 187.14,
            "2029": 208.98,
            "2030": 233.54,
            "2031": 259.75,
            "2032": 294.03
          },
          "cagr": 12.6,
          "market_share": 50.77
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 69.84,
            "2021": 76.85,
            "2022": 86.72,
            "2023": 98.19,
            "2024": 111.17,
            "2025": 124.23,
            "2026": 139.76,
            "2027": 156.65,
            "2028": 181.42,
            "2029": 202.59,
            "2030": 226.4,
            "2031": 251.8,
            "2032": 285.04
          },
          "cagr": 12.6,
          "market_share": 49.23
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 35.61,
            "2021": 39.19,
            "2022": 44.22,
            "2023": 50.07,
            "2024": 56.69,
            "2025": 63.35,
            "2026": 71.26,
            "2027": 79.88,
            "2028": 92.51,
            "2029": 103.31,
            "2030": 115.45,
            "2031": 128.4,
            "2032": 145.35
          },
          "cagr": 12.6,
          "market_share": 25.1
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 66.43,
            "2021": 73.09,
            "2022": 82.48,
            "2023": 93.39,
            "2024": 105.73,
            "2025": 118.16,
            "2026": 132.92,
            "2027": 148.99,
            "2028": 172.55,
            "2029": 192.68,
            "2030": 215.33,
            "2031": 239.49,
            "2032": 271.1
          },
          "cagr": 12.6,
          "market_share": 46.82
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 39.85,
            "2021": 43.84,
            "2022": 49.47,
            "2023": 56.02,
            "2024": 63.42,
            "2025": 70.87,
            "2026": 79.74,
            "2027": 89.37,
            "2028": 103.5,
            "2029": 115.58,
            "2030": 129.16,
            "2031": 143.66,
            "2032": 162.62
          },
          "cagr": 12.6,
          "market_share": 28.08
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 78.09,
            "2021": 85.92,
            "2022": 96.96,
            "2023": 109.79,
            "2024": 124.3,
            "2025": 138.91,
            "2026": 156.26,
            "2027": 175.16,
            "2028": 202.85,
            "2029": 226.52,
            "2030": 253.15,
            "2031": 281.55,
            "2032": 318.71
          },
          "cagr": 12.6,
          "market_share": 55.04
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 63.8,
            "2021": 70.2,
            "2022": 79.21,
            "2023": 89.69,
            "2024": 101.54,
            "2025": 113.47,
            "2026": 127.66,
            "2027": 143.08,
            "2028": 165.71,
            "2029": 185.05,
            "2030": 206.79,
            "2031": 230.0,
            "2032": 260.36
          },
          "cagr": 12.6,
          "market_share": 44.96
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 11.45,
            "2021": 12.7,
            "2022": 14.98,
            "2023": 16.5,
            "2024": 18.97,
            "2025": 21.64,
            "2026": 24.62,
            "2027": 28.23,
            "2028": 31.35,
            "2029": 35.93,
            "2030": 41.24,
            "2031": 45.65,
            "2032": 52.15
          },
          "cagr": 13.39,
          "market_share": 21.65
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 6.43,
            "2021": 7.13,
            "2022": 8.41,
            "2023": 9.26,
            "2024": 10.65,
            "2025": 12.15,
            "2026": 13.82,
            "2027": 15.85,
            "2028": 17.6,
            "2029": 20.17,
            "2030": 23.15,
            "2031": 25.63,
            "2032": 29.28
          },
          "cagr": 13.39,
          "market_share": 12.15
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 11.17,
            "2021": 12.39,
            "2022": 14.61,
            "2023": 16.1,
            "2024": 18.51,
            "2025": 21.11,
            "2026": 24.02,
            "2027": 27.54,
            "2028": 30.59,
            "2029": 35.05,
            "2030": 40.23,
            "2031": 44.54,
            "2032": 50.87
          },
          "cagr": 13.39,
          "market_share": 21.13
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 10.81,
            "2021": 12.0,
            "2022": 14.15,
            "2023": 15.58,
            "2024": 17.92,
            "2025": 20.43,
            "2026": 23.25,
            "2027": 26.65,
            "2028": 29.61,
            "2029": 33.93,
            "2030": 38.94,
            "2031": 43.11,
            "2032": 49.24
          },
          "cagr": 13.39,
          "market_share": 20.45
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 13.0,
            "2021": 14.45,
            "2022": 17.03,
            "2023": 18.76,
            "2024": 21.57,
            "2025": 24.61,
            "2026": 28.0,
            "2027": 32.08,
            "2028": 35.64,
            "2029": 40.87,
            "2030": 46.88,
            "2031": 51.9,
            "2032": 59.3
          },
          "cagr": 13.39,
          "market_share": 24.62
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 7.7,
            "2021": 8.55,
            "2022": 10.08,
            "2023": 11.1,
            "2024": 12.77,
            "2025": 14.56,
            "2026": 16.57,
            "2027": 18.99,
            "2028": 21.1,
            "2029": 24.18,
            "2030": 27.75,
            "2031": 30.72,
            "2032": 35.09
          },
          "cagr": 13.39,
          "market_share": 14.57
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 17.06,
            "2021": 18.93,
            "2022": 22.32,
            "2023": 24.59,
            "2024": 28.27,
            "2025": 32.25,
            "2026": 36.69,
            "2027": 42.06,
            "2028": 46.72,
            "2029": 53.55,
            "2030": 61.45,
            "2031": 68.03,
            "2032": 77.71
          },
          "cagr": 13.39,
          "market_share": 32.26
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 8.59,
            "2021": 9.53,
            "2022": 11.24,
            "2023": 12.38,
            "2024": 14.24,
            "2025": 16.24,
            "2026": 18.48,
            "2027": 21.18,
            "2028": 23.53,
            "2029": 26.96,
            "2030": 30.94,
            "2031": 34.26,
            "2032": 39.13
          },
          "cagr": 13.39,
          "market_share": 16.25
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 6.44,
            "2021": 7.15,
            "2022": 8.43,
            "2023": 9.29,
            "2024": 10.68,
            "2025": 12.18,
            "2026": 13.86,
            "2027": 15.89,
            "2028": 17.65,
            "2029": 20.23,
            "2030": 23.21,
            "2031": 25.7,
            "2032": 29.35
          },
          "cagr": 13.39,
          "market_share": 12.19
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 13.07,
            "2021": 14.51,
            "2022": 17.11,
            "2023": 18.84,
            "2024": 21.66,
            "2025": 24.71,
            "2026": 28.11,
            "2027": 32.23,
            "2028": 35.79,
            "2029": 41.03,
            "2030": 47.09,
            "2031": 52.12,
            "2032": 59.56
          },
          "cagr": 13.39,
          "market_share": 24.72
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 24.61,
            "2021": 27.32,
            "2022": 32.22,
            "2023": 35.48,
            "2024": 40.8,
            "2025": 46.54,
            "2026": 52.95,
            "2027": 60.7,
            "2028": 67.42,
            "2029": 77.28,
            "2030": 88.68,
            "2031": 98.18,
            "2032": 112.15
          },
          "cagr": 13.39,
          "market_share": 46.56
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 28.25,
            "2021": 31.35,
            "2022": 36.96,
            "2023": 40.72,
            "2024": 46.82,
            "2025": 53.4,
            "2026": 60.76,
            "2027": 69.65,
            "2028": 77.37,
            "2029": 88.67,
            "2030": 101.76,
            "2031": 112.65,
            "2032": 128.69
          },
          "cagr": 13.39,
          "market_share": 53.44
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 29.3,
            "2021": 32.52,
            "2022": 38.35,
            "2023": 42.24,
            "2024": 48.57,
            "2025": 55.4,
            "2026": 63.04,
            "2027": 72.26,
            "2028": 80.27,
            "2029": 92.0,
            "2030": 105.57,
            "2031": 116.88,
            "2032": 133.51
          },
          "cagr": 13.39,
          "market_share": 55.43
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 23.56,
            "2021": 26.15,
            "2022": 30.83,
            "2023": 33.96,
            "2024": 39.05,
            "2025": 44.54,
            "2026": 50.67,
            "2027": 58.09,
            "2028": 64.52,
            "2029": 73.95,
            "2030": 84.87,
            "2031": 93.95,
            "2032": 107.33
          },
          "cagr": 13.39,
          "market_share": 44.57
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 18.48,
            "2021": 20.51,
            "2022": 24.18,
            "2023": 26.64,
            "2024": 30.63,
            "2025": 34.93,
            "2026": 39.75,
            "2027": 45.57,
            "2028": 50.61,
            "2029": 58.01,
            "2030": 66.57,
            "2031": 73.7,
            "2032": 84.19
          },
          "cagr": 13.39,
          "market_share": 34.96
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 12.92,
            "2021": 14.34,
            "2022": 16.92,
            "2023": 18.63,
            "2024": 21.42,
            "2025": 24.43,
            "2026": 27.8,
            "2027": 31.87,
            "2028": 35.4,
            "2029": 40.57,
            "2030": 46.56,
            "2031": 51.55,
            "2032": 58.88
          },
          "cagr": 13.39,
          "market_share": 24.45
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 21.46,
            "2021": 23.82,
            "2022": 28.08,
            "2023": 30.93,
            "2024": 35.57,
            "2025": 40.58,
            "2026": 46.16,
            "2027": 52.91,
            "2028": 58.78,
            "2029": 67.37,
            "2030": 77.31,
            "2031": 85.58,
            "2032": 97.77
          },
          "cagr": 13.39,
          "market_share": 40.6
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 27.92,
            "2021": 30.99,
            "2022": 36.55,
            "2023": 40.25,
            "2024": 46.28,
            "2025": 52.79,
            "2026": 60.07,
            "2027": 68.86,
            "2028": 76.49,
            "2029": 87.66,
            "2030": 100.6,
            "2031": 111.37,
            "2032": 127.22
          },
          "cagr": 13.39,
          "market_share": 52.82
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 24.94,
            "2021": 27.68,
            "2022": 32.63,
            "2023": 35.95,
            "2024": 41.34,
            "2025": 47.15,
            "2026": 53.64,
            "2027": 61.49,
            "2028": 68.3,
            "2029": 78.29,
            "2030": 89.84,
            "2031": 99.46,
            "2032": 113.62
          },
          "cagr": 13.39,
          "market_share": 47.18
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 13.46,
            "2021": 14.81,
            "2022": 15.94,
            "2023": 17.21,
            "2024": 18.66,
            "2025": 20.37,
            "2026": 21.71,
            "2027": 23.21,
            "2028": 25.54,
            "2029": 27.58,
            "2030": 28.91,
            "2031": 31.12,
            "2032": 33.56
          },
          "cagr": 7.39,
          "market_share": 17.56
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 17.35,
            "2021": 19.1,
            "2022": 20.55,
            "2023": 22.19,
            "2024": 24.06,
            "2025": 26.26,
            "2026": 27.99,
            "2027": 29.93,
            "2028": 32.93,
            "2029": 35.56,
            "2030": 37.28,
            "2031": 40.12,
            "2032": 43.27
          },
          "cagr": 7.4,
          "market_share": 22.64
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 21.69,
            "2021": 23.87,
            "2022": 25.69,
            "2023": 27.74,
            "2024": 30.08,
            "2025": 32.83,
            "2026": 35.0,
            "2027": 37.42,
            "2028": 41.16,
            "2029": 44.46,
            "2030": 46.6,
            "2031": 50.16,
            "2032": 54.09
          },
          "cagr": 7.39,
          "market_share": 28.31
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 14.02,
            "2021": 15.43,
            "2022": 16.6,
            "2023": 17.92,
            "2024": 19.44,
            "2025": 21.22,
            "2026": 22.62,
            "2027": 24.18,
            "2028": 26.6,
            "2029": 28.73,
            "2030": 30.11,
            "2031": 32.41,
            "2032": 34.96
          },
          "cagr": 7.39,
          "market_share": 18.29
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 10.11,
            "2021": 11.12,
            "2022": 11.97,
            "2023": 12.93,
            "2024": 14.04,
            "2025": 15.31,
            "2026": 16.31,
            "2027": 17.46,
            "2028": 19.19,
            "2029": 20.72,
            "2030": 21.73,
            "2031": 23.39,
            "2032": 25.22
          },
          "cagr": 7.39,
          "market_share": 13.21
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 10.75,
            "2021": 11.83,
            "2022": 12.73,
            "2023": 13.75,
            "2024": 14.91,
            "2025": 16.27,
            "2026": 17.35,
            "2027": 18.55,
            "2028": 20.4,
            "2029": 22.04,
            "2030": 23.1,
            "2031": 24.86,
            "2032": 26.81
          },
          "cagr": 7.4,
          "market_share": 14.03
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 22.7,
            "2021": 24.98,
            "2022": 26.88,
            "2023": 29.02,
            "2024": 31.48,
            "2025": 34.36,
            "2026": 36.62,
            "2027": 39.16,
            "2028": 43.07,
            "2029": 46.52,
            "2030": 48.76,
            "2031": 52.48,
            "2032": 56.6
          },
          "cagr": 7.39,
          "market_share": 29.62
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 11.71,
            "2021": 12.89,
            "2022": 13.87,
            "2023": 14.98,
            "2024": 16.24,
            "2025": 17.73,
            "2026": 18.89,
            "2027": 20.2,
            "2028": 22.22,
            "2029": 24.0,
            "2030": 25.16,
            "2031": 27.08,
            "2032": 29.2
          },
          "cagr": 7.39,
          "market_share": 15.28
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 16.58,
            "2021": 18.24,
            "2022": 19.63,
            "2023": 21.2,
            "2024": 22.99,
            "2025": 25.09,
            "2026": 26.75,
            "2027": 28.6,
            "2028": 31.46,
            "2029": 33.98,
            "2030": 35.62,
            "2031": 38.34,
            "2032": 41.34
          },
          "cagr": 7.39,
          "market_share": 21.63
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 14.89,
            "2021": 16.39,
            "2022": 17.64,
            "2023": 19.04,
            "2024": 20.66,
            "2025": 22.54,
            "2026": 24.02,
            "2027": 25.69,
            "2028": 28.27,
            "2029": 30.51,
            "2030": 31.99,
            "2031": 34.44,
            "2032": 37.15
          },
          "cagr": 7.4,
          "market_share": 19.44
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 28.27,
            "2021": 31.11,
            "2022": 33.47,
            "2023": 36.14,
            "2024": 39.2,
            "2025": 42.78,
            "2026": 45.6,
            "2027": 48.76,
            "2028": 53.64,
            "2029": 57.93,
            "2030": 60.72,
            "2031": 65.36,
            "2032": 70.49
          },
          "cagr": 7.39,
          "market_share": 36.89
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 48.36,
            "2021": 53.22,
            "2022": 57.28,
            "2023": 61.85,
            "2024": 67.08,
            "2025": 73.21,
            "2026": 78.03,
            "2027": 83.44,
            "2028": 91.78,
            "2029": 99.12,
            "2030": 103.91,
            "2031": 111.84,
            "2032": 120.61
          },
          "cagr": 7.39,
          "market_share": 63.12
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 46.32,
            "2021": 50.97,
            "2022": 54.84,
            "2023": 59.22,
            "2024": 64.23,
            "2025": 70.1,
            "2026": 74.72,
            "2027": 79.9,
            "2028": 87.89,
            "2029": 94.92,
            "2030": 99.49,
            "2031": 107.09,
            "2032": 115.49
          },
          "cagr": 7.39,
          "market_share": 60.44
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 30.31,
            "2021": 33.36,
            "2022": 35.91,
            "2023": 38.77,
            "2024": 42.05,
            "2025": 45.89,
            "2026": 48.91,
            "2027": 52.3,
            "2028": 57.53,
            "2029": 62.13,
            "2030": 65.14,
            "2031": 70.11,
            "2032": 75.61
          },
          "cagr": 7.39,
          "market_share": 39.57
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 30.66,
            "2021": 33.73,
            "2022": 36.3,
            "2023": 39.2,
            "2024": 42.51,
            "2025": 46.4,
            "2026": 49.46,
            "2027": 52.88,
            "2028": 58.17,
            "2029": 62.82,
            "2030": 65.85,
            "2031": 70.88,
            "2032": 76.44
          },
          "cagr": 7.39,
          "market_share": 40.0
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 15.8,
            "2021": 17.39,
            "2022": 18.71,
            "2023": 20.2,
            "2024": 21.91,
            "2025": 23.91,
            "2026": 25.49,
            "2027": 27.26,
            "2028": 29.98,
            "2029": 32.38,
            "2030": 33.94,
            "2031": 36.53,
            "2032": 39.4
          },
          "cagr": 7.4,
          "market_share": 20.62
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 30.17,
            "2021": 33.21,
            "2022": 35.74,
            "2023": 38.59,
            "2024": 41.86,
            "2025": 45.68,
            "2026": 48.68,
            "2027": 52.06,
            "2028": 57.27,
            "2029": 61.85,
            "2030": 64.84,
            "2031": 69.79,
            "2032": 75.26
          },
          "cagr": 7.39,
          "market_share": 39.39
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 47.47,
            "2021": 52.24,
            "2022": 56.21,
            "2023": 60.69,
            "2024": 65.83,
            "2025": 71.85,
            "2026": 76.58,
            "2027": 81.89,
            "2028": 90.08,
            "2029": 97.28,
            "2030": 101.97,
            "2031": 109.76,
            "2032": 118.37
          },
          "cagr": 7.39,
          "market_share": 61.95
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 29.16,
            "2021": 32.09,
            "2022": 34.54,
            "2023": 37.3,
            "2024": 40.45,
            "2025": 44.14,
            "2026": 47.05,
            "2027": 50.31,
            "2028": 55.34,
            "2029": 59.77,
            "2030": 62.66,
            "2031": 67.44,
            "2032": 72.73
          },
          "cagr": 7.39,
          "market_share": 38.06
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 14.98,
            "2021": 16.72,
            "2022": 19.56,
            "2023": 21.92,
            "2024": 25.58,
            "2025": 28.25,
            "2026": 33.0,
            "2027": 37.18,
            "2028": 41.71,
            "2029": 48.62,
            "2030": 55.55,
            "2031": 62.57,
            "2032": 71.89
          },
          "cagr": 14.27,
          "market_share": 21.95
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 16.37,
            "2021": 18.27,
            "2022": 21.37,
            "2023": 23.96,
            "2024": 27.96,
            "2025": 30.88,
            "2026": 36.07,
            "2027": 40.63,
            "2028": 45.59,
            "2029": 53.13,
            "2030": 60.71,
            "2031": 68.39,
            "2032": 78.57
          },
          "cagr": 14.27,
          "market_share": 23.99
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 10.21,
            "2021": 11.4,
            "2022": 13.34,
            "2023": 14.95,
            "2024": 17.44,
            "2025": 19.27,
            "2026": 22.5,
            "2027": 25.35,
            "2028": 28.44,
            "2029": 33.15,
            "2030": 37.88,
            "2031": 42.67,
            "2032": 49.02
          },
          "cagr": 14.27,
          "market_share": 14.96
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 10.21,
            "2021": 11.39,
            "2022": 13.33,
            "2023": 14.94,
            "2024": 17.43,
            "2025": 19.25,
            "2026": 22.49,
            "2027": 25.34,
            "2028": 28.43,
            "2029": 33.13,
            "2030": 37.86,
            "2031": 42.64,
            "2032": 48.99
          },
          "cagr": 14.28,
          "market_share": 14.96
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 16.47,
            "2021": 18.38,
            "2022": 21.5,
            "2023": 24.11,
            "2024": 28.13,
            "2025": 31.07,
            "2026": 36.3,
            "2027": 40.89,
            "2028": 45.88,
            "2029": 53.47,
            "2030": 61.1,
            "2031": 68.81,
            "2032": 79.06
          },
          "cagr": 14.27,
          "market_share": 24.14
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 7.45,
            "2021": 8.32,
            "2022": 9.73,
            "2023": 10.91,
            "2024": 12.73,
            "2025": 14.06,
            "2026": 16.42,
            "2027": 18.5,
            "2028": 20.76,
            "2029": 24.2,
            "2030": 27.65,
            "2031": 31.14,
            "2032": 35.78
          },
          "cagr": 14.27,
          "market_share": 10.92
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.84,
            "2021": 14.33,
            "2022": 16.76,
            "2023": 18.79,
            "2024": 21.93,
            "2025": 24.22,
            "2026": 28.29,
            "2027": 31.87,
            "2028": 35.76,
            "2029": 41.67,
            "2030": 47.62,
            "2031": 53.64,
            "2032": 61.62
          },
          "cagr": 14.27,
          "market_share": 18.82
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 12.07,
            "2021": 13.47,
            "2022": 15.76,
            "2023": 17.67,
            "2024": 20.62,
            "2025": 22.77,
            "2026": 26.6,
            "2027": 29.97,
            "2028": 33.62,
            "2029": 39.19,
            "2030": 44.78,
            "2031": 50.43,
            "2032": 57.94
          },
          "cagr": 14.27,
          "market_share": 17.69
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 15.48,
            "2021": 17.28,
            "2022": 20.22,
            "2023": 22.66,
            "2024": 26.44,
            "2025": 29.21,
            "2026": 34.11,
            "2027": 38.43,
            "2028": 43.12,
            "2029": 50.26,
            "2030": 57.42,
            "2031": 64.68,
            "2032": 74.31
          },
          "cagr": 14.27,
          "market_share": 22.69
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 20.4,
            "2021": 22.76,
            "2022": 26.63,
            "2023": 29.85,
            "2024": 34.82,
            "2025": 38.46,
            "2026": 44.94,
            "2027": 50.62,
            "2028": 56.79,
            "2029": 66.18,
            "2030": 75.63,
            "2031": 85.19,
            "2032": 97.88
          },
          "cagr": 14.28,
          "market_share": 29.88
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 32.78,
            "2021": 36.59,
            "2022": 42.8,
            "2023": 47.98,
            "2024": 55.99,
            "2025": 61.84,
            "2026": 72.23,
            "2027": 81.38,
            "2028": 91.3,
            "2029": 106.41,
            "2030": 121.59,
            "2031": 136.95,
            "2032": 157.34
          },
          "cagr": 14.27,
          "market_share": 48.04
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 35.46,
            "2021": 39.57,
            "2022": 46.3,
            "2023": 51.9,
            "2024": 60.55,
            "2025": 66.88,
            "2026": 78.13,
            "2027": 88.01,
            "2028": 98.75,
            "2029": 115.09,
            "2030": 131.51,
            "2031": 148.13,
            "2032": 170.19
          },
          "cagr": 14.27,
          "market_share": 51.96
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 33.87,
            "2021": 37.8,
            "2022": 44.22,
            "2023": 49.57,
            "2024": 57.84,
            "2025": 63.88,
            "2026": 74.62,
            "2027": 84.07,
            "2028": 94.32,
            "2029": 109.93,
            "2030": 125.61,
            "2031": 141.48,
            "2032": 162.54
          },
          "cagr": 14.27,
          "market_share": 49.63
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 34.37,
            "2021": 38.36,
            "2022": 44.88,
            "2023": 50.31,
            "2024": 58.7,
            "2025": 64.84,
            "2026": 75.74,
            "2027": 85.32,
            "2028": 95.73,
            "2029": 111.57,
            "2030": 127.49,
            "2031": 143.6,
            "2032": 164.99
          },
          "cagr": 14.27,
          "market_share": 50.37
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 22.45,
            "2021": 25.05,
            "2022": 29.31,
            "2023": 32.86,
            "2024": 38.33,
            "2025": 42.34,
            "2026": 49.46,
            "2027": 55.72,
            "2028": 62.51,
            "2029": 72.86,
            "2030": 83.25,
            "2031": 93.77,
            "2032": 107.74
          },
          "cagr": 14.27,
          "market_share": 32.89
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 20.2,
            "2021": 22.54,
            "2022": 26.37,
            "2023": 29.56,
            "2024": 34.49,
            "2025": 38.1,
            "2026": 44.5,
            "2027": 50.13,
            "2028": 56.25,
            "2029": 65.56,
            "2030": 74.91,
            "2031": 84.37,
            "2032": 96.94
          },
          "cagr": 14.27,
          "market_share": 29.59
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 25.59,
            "2021": 28.57,
            "2022": 33.42,
            "2023": 37.46,
            "2024": 43.72,
            "2025": 48.28,
            "2026": 56.4,
            "2027": 63.54,
            "2028": 71.29,
            "2029": 83.08,
            "2030": 94.94,
            "2031": 106.94,
            "2032": 122.85
          },
          "cagr": 14.27,
          "market_share": 37.52
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 36.19,
            "2021": 40.39,
            "2022": 47.25,
            "2023": 52.97,
            "2024": 61.8,
            "2025": 68.26,
            "2026": 79.74,
            "2027": 89.83,
            "2028": 100.78,
            "2029": 117.46,
            "2030": 134.22,
            "2031": 151.18,
            "2032": 173.69
          },
          "cagr": 14.27,
          "market_share": 53.03
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 32.05,
            "2021": 35.77,
            "2022": 41.85,
            "2023": 46.91,
            "2024": 54.74,
            "2025": 60.46,
            "2026": 70.62,
            "2027": 79.56,
            "2028": 89.27,
            "2029": 104.04,
            "2030": 118.88,
            "2031": 133.9,
            "2032": 153.84
          },
          "cagr": 14.27,
          "market_share": 46.97
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 12.59,
            "2021": 14.19,
            "2022": 15.38,
            "2023": 17.38,
            "2024": 19.24,
            "2025": 21.24,
            "2026": 23.22,
            "2027": 26.59,
            "2028": 28.68,
            "2029": 32.31,
            "2030": 36.39,
            "2031": 39.87,
            "2032": 43.06
          },
          "cagr": 10.62,
          "market_share": 16.2
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 19.48,
            "2021": 21.95,
            "2022": 23.79,
            "2023": 26.89,
            "2024": 29.77,
            "2025": 32.86,
            "2026": 35.93,
            "2027": 41.14,
            "2028": 44.37,
            "2029": 49.99,
            "2030": 56.29,
            "2031": 61.68,
            "2032": 66.62
          },
          "cagr": 10.62,
          "market_share": 25.06
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 23.45,
            "2021": 26.41,
            "2022": 28.64,
            "2023": 32.37,
            "2024": 35.83,
            "2025": 39.56,
            "2026": 43.24,
            "2027": 49.52,
            "2028": 53.4,
            "2029": 60.17,
            "2030": 67.75,
            "2031": 74.24,
            "2032": 80.19
          },
          "cagr": 10.62,
          "market_share": 30.17
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 12.28,
            "2021": 13.83,
            "2022": 14.99,
            "2023": 16.95,
            "2024": 18.76,
            "2025": 20.71,
            "2026": 22.64,
            "2027": 25.93,
            "2028": 27.96,
            "2029": 31.5,
            "2030": 35.47,
            "2031": 38.87,
            "2032": 41.98
          },
          "cagr": 10.62,
          "market_share": 15.79
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 9.94,
            "2021": 11.2,
            "2022": 12.15,
            "2023": 13.74,
            "2024": 15.18,
            "2025": 16.78,
            "2026": 18.35,
            "2027": 21.01,
            "2028": 22.65,
            "2029": 25.53,
            "2030": 28.74,
            "2031": 31.49,
            "2032": 34.03
          },
          "cagr": 10.63,
          "market_share": 12.78
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 14.97,
            "2021": 16.86,
            "2022": 18.28,
            "2023": 20.66,
            "2024": 22.87,
            "2025": 25.25,
            "2026": 27.61,
            "2027": 31.61,
            "2028": 34.09,
            "2029": 38.41,
            "2030": 43.25,
            "2031": 47.39,
            "2032": 51.19
          },
          "cagr": 10.62,
          "market_share": 19.25
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 14.58,
            "2021": 16.42,
            "2022": 17.8,
            "2023": 20.12,
            "2024": 22.27,
            "2025": 24.59,
            "2026": 26.88,
            "2027": 30.78,
            "2028": 33.19,
            "2029": 37.4,
            "2030": 42.12,
            "2031": 46.15,
            "2032": 49.85
          },
          "cagr": 10.62,
          "market_share": 18.75
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 10.31,
            "2021": 11.61,
            "2022": 12.59,
            "2023": 14.23,
            "2024": 15.75,
            "2025": 17.39,
            "2026": 19.01,
            "2027": 21.77,
            "2028": 23.47,
            "2029": 26.45,
            "2030": 29.78,
            "2031": 32.63,
            "2032": 35.24
          },
          "cagr": 10.62,
          "market_share": 13.26
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 22.55,
            "2021": 25.41,
            "2022": 27.54,
            "2023": 31.14,
            "2024": 34.46,
            "2025": 38.05,
            "2026": 41.59,
            "2027": 47.63,
            "2028": 51.36,
            "2029": 57.87,
            "2030": 65.17,
            "2031": 71.41,
            "2032": 77.13
          },
          "cagr": 10.62,
          "market_share": 29.01
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 15.33,
            "2021": 17.28,
            "2022": 18.74,
            "2023": 21.18,
            "2024": 23.43,
            "2025": 25.87,
            "2026": 28.29,
            "2027": 32.4,
            "2028": 34.95,
            "2029": 39.37,
            "2030": 44.32,
            "2031": 48.57,
            "2032": 52.47
          },
          "cagr": 10.63,
          "market_share": 19.73
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 41.91,
            "2021": 47.21,
            "2022": 51.18,
            "2023": 57.86,
            "2024": 64.04,
            "2025": 70.7,
            "2026": 77.29,
            "2027": 88.51,
            "2028": 95.45,
            "2029": 107.55,
            "2030": 121.1,
            "2031": 132.69,
            "2032": 143.33
          },
          "cagr": 10.62,
          "market_share": 53.91
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 35.83,
            "2021": 40.37,
            "2022": 43.77,
            "2023": 49.47,
            "2024": 54.74,
            "2025": 60.45,
            "2026": 66.09,
            "2027": 75.68,
            "2028": 81.61,
            "2029": 91.95,
            "2030": 103.54,
            "2031": 113.46,
            "2032": 122.55
          },
          "cagr": 10.62,
          "market_share": 46.09
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 45.47,
            "2021": 51.22,
            "2022": 55.53,
            "2023": 62.77,
            "2024": 69.47,
            "2025": 76.71,
            "2026": 83.86,
            "2027": 96.03,
            "2028": 103.56,
            "2029": 116.68,
            "2030": 131.39,
            "2031": 143.97,
            "2032": 155.51
          },
          "cagr": 10.62,
          "market_share": 58.49
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 32.27,
            "2021": 36.36,
            "2022": 39.42,
            "2023": 44.56,
            "2024": 49.31,
            "2025": 54.44,
            "2026": 59.52,
            "2027": 68.16,
            "2028": 73.5,
            "2029": 82.82,
            "2030": 93.25,
            "2031": 102.18,
            "2032": 110.37
          },
          "cagr": 10.62,
          "market_share": 41.51
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 23.48,
            "2021": 26.45,
            "2022": 28.68,
            "2023": 32.42,
            "2024": 35.88,
            "2025": 39.61,
            "2026": 43.31,
            "2027": 49.59,
            "2028": 53.48,
            "2029": 60.26,
            "2030": 67.85,
            "2031": 74.34,
            "2032": 80.3
          },
          "cagr": 10.62,
          "market_share": 30.21
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 28.1,
            "2021": 31.65,
            "2022": 34.31,
            "2023": 38.79,
            "2024": 42.93,
            "2025": 47.4,
            "2026": 51.82,
            "2027": 59.34,
            "2028": 63.99,
            "2029": 72.1,
            "2030": 81.19,
            "2031": 88.96,
            "2032": 96.09
          },
          "cagr": 10.62,
          "market_share": 36.14
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 26.16,
            "2021": 29.48,
            "2022": 31.96,
            "2023": 36.12,
            "2024": 39.97,
            "2025": 44.14,
            "2026": 48.25,
            "2027": 55.26,
            "2028": 59.59,
            "2029": 67.14,
            "2030": 75.6,
            "2031": 82.85,
            "2032": 89.49
          },
          "cagr": 10.62,
          "market_share": 33.65
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 32.55,
            "2021": 36.67,
            "2022": 39.76,
            "2023": 44.94,
            "2024": 49.74,
            "2025": 54.92,
            "2026": 60.04,
            "2027": 68.75,
            "2028": 74.14,
            "2029": 83.53,
            "2030": 94.06,
            "2031": 103.07,
            "2032": 111.33
          },
          "cagr": 10.62,
          "market_share": 41.88
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 45.19,
            "2021": 50.91,
            "2022": 55.19,
            "2023": 62.39,
            "2024": 69.04,
            "2025": 76.23,
            "2026": 83.34,
            "2027": 95.44,
            "2028": 102.92,
            "2029": 115.97,
            "2030": 130.58,
            "2031": 143.08,
            "2032": 154.55
          },
          "cagr": 10.62,
          "market_share": 58.12
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 26.77,
            "2021": 29.0,
            "2022": 32.01,
            "2023": 34.91,
            "2024": 38.37,
            "2025": 42.36,
            "2026": 45.21,
            "2027": 50.12,
            "2028": 54.79,
            "2029": 59.21,
            "2030": 65.05,
            "2031": 71.43,
            "2032": 79.76
          },
          "cagr": 9.46,
          "market_share": 28.56
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 17.29,
            "2021": 18.73,
            "2022": 20.67,
            "2023": 22.55,
            "2024": 24.78,
            "2025": 27.36,
            "2026": 29.21,
            "2027": 32.37,
            "2028": 35.39,
            "2029": 38.25,
            "2030": 42.02,
            "2031": 46.14,
            "2032": 51.53
          },
          "cagr": 9.47,
          "market_share": 18.44
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 10.07,
            "2021": 10.91,
            "2022": 12.04,
            "2023": 13.13,
            "2024": 14.43,
            "2025": 15.93,
            "2026": 17.01,
            "2027": 18.85,
            "2028": 20.61,
            "2029": 22.27,
            "2030": 24.47,
            "2031": 26.87,
            "2032": 30.0
          },
          "cagr": 9.46,
          "market_share": 10.74
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 19.79,
            "2021": 21.44,
            "2022": 23.66,
            "2023": 25.81,
            "2024": 28.36,
            "2025": 31.31,
            "2026": 33.42,
            "2027": 37.05,
            "2028": 40.5,
            "2029": 43.77,
            "2030": 48.09,
            "2031": 52.81,
            "2032": 58.97
          },
          "cagr": 9.47,
          "market_share": 21.11
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 19.82,
            "2021": 21.48,
            "2022": 23.7,
            "2023": 25.84,
            "2024": 28.41,
            "2025": 31.37,
            "2026": 33.47,
            "2027": 37.1,
            "2028": 40.55,
            "2029": 43.85,
            "2030": 48.17,
            "2031": 52.89,
            "2032": 59.05
          },
          "cagr": 9.46,
          "market_share": 21.15
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 18.27,
            "2021": 19.79,
            "2022": 21.84,
            "2023": 23.82,
            "2024": 26.18,
            "2025": 28.91,
            "2026": 30.86,
            "2027": 34.2,
            "2028": 37.39,
            "2029": 40.41,
            "2030": 44.4,
            "2031": 48.75,
            "2032": 54.44
          },
          "cagr": 9.46,
          "market_share": 19.49
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 22.97,
            "2021": 24.89,
            "2022": 27.46,
            "2023": 29.95,
            "2024": 32.92,
            "2025": 36.35,
            "2026": 38.8,
            "2027": 43.0,
            "2028": 47.01,
            "2029": 50.81,
            "2030": 55.82,
            "2031": 61.3,
            "2032": 68.44
          },
          "cagr": 9.46,
          "market_share": 24.5
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 21.27,
            "2021": 23.04,
            "2022": 25.43,
            "2023": 27.74,
            "2024": 30.48,
            "2025": 33.66,
            "2026": 35.92,
            "2027": 39.82,
            "2028": 43.53,
            "2029": 47.05,
            "2030": 51.69,
            "2031": 56.76,
            "2032": 63.38
          },
          "cagr": 9.46,
          "market_share": 22.69
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 19.87,
            "2021": 21.53,
            "2022": 23.75,
            "2023": 25.91,
            "2024": 28.48,
            "2025": 31.44,
            "2026": 33.56,
            "2027": 37.2,
            "2028": 40.66,
            "2029": 43.95,
            "2030": 48.28,
            "2031": 53.02,
            "2032": 59.2
          },
          "cagr": 9.46,
          "market_share": 21.2
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 11.36,
            "2021": 12.31,
            "2022": 13.6,
            "2023": 14.82,
            "2024": 16.29,
            "2025": 17.97,
            "2026": 19.18,
            "2027": 21.27,
            "2028": 23.25,
            "2029": 25.13,
            "2030": 27.61,
            "2031": 30.31,
            "2032": 33.85
          },
          "cagr": 9.47,
          "market_share": 12.13
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 45.06,
            "2021": 48.82,
            "2022": 53.88,
            "2023": 58.76,
            "2024": 64.59,
            "2025": 71.31,
            "2026": 76.11,
            "2027": 84.37,
            "2028": 92.23,
            "2029": 99.68,
            "2030": 109.51,
            "2031": 120.25,
            "2032": 134.28
          },
          "cagr": 9.46,
          "market_share": 48.08
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 48.68,
            "2021": 52.74,
            "2022": 58.2,
            "2023": 63.48,
            "2024": 69.76,
            "2025": 77.02,
            "2026": 82.21,
            "2027": 91.12,
            "2028": 99.61,
            "2029": 107.67,
            "2030": 118.29,
            "2031": 129.89,
            "2032": 145.03
          },
          "cagr": 9.46,
          "market_share": 51.92
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 54.0,
            "2021": 58.51,
            "2022": 64.57,
            "2023": 70.42,
            "2024": 77.4,
            "2025": 85.45,
            "2026": 91.21,
            "2027": 101.1,
            "2028": 110.52,
            "2029": 119.46,
            "2030": 131.24,
            "2031": 144.11,
            "2032": 160.91
          },
          "cagr": 9.46,
          "market_share": 57.61
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 39.74,
            "2021": 43.05,
            "2022": 47.51,
            "2023": 51.82,
            "2024": 56.95,
            "2025": 62.88,
            "2026": 67.11,
            "2027": 74.39,
            "2028": 81.32,
            "2029": 87.89,
            "2030": 96.56,
            "2031": 106.03,
            "2032": 118.4
          },
          "cagr": 9.46,
          "market_share": 42.39
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 24.02,
            "2021": 26.02,
            "2022": 28.72,
            "2023": 31.32,
            "2024": 34.42,
            "2025": 38.01,
            "2026": 40.57,
            "2027": 44.97,
            "2028": 49.16,
            "2029": 53.13,
            "2030": 58.37,
            "2031": 64.09,
            "2032": 71.57
          },
          "cagr": 9.46,
          "market_share": 25.62
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 25.35,
            "2021": 27.46,
            "2022": 30.31,
            "2023": 33.06,
            "2024": 36.33,
            "2025": 40.11,
            "2026": 42.81,
            "2027": 47.46,
            "2028": 51.88,
            "2029": 56.07,
            "2030": 61.6,
            "2031": 67.64,
            "2032": 75.53
          },
          "cagr": 9.46,
          "market_share": 27.04
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 44.37,
            "2021": 48.08,
            "2022": 53.05,
            "2023": 57.86,
            "2024": 63.6,
            "2025": 70.21,
            "2026": 74.94,
            "2027": 83.06,
            "2028": 90.8,
            "2029": 98.15,
            "2030": 107.83,
            "2031": 118.41,
            "2032": 132.21
          },
          "cagr": 9.46,
          "market_share": 47.34
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 32.92,
            "2021": 35.67,
            "2022": 39.36,
            "2023": 42.93,
            "2024": 47.18,
            "2025": 52.09,
            "2026": 55.6,
            "2027": 61.63,
            "2028": 67.38,
            "2029": 72.82,
            "2030": 80.01,
            "2031": 87.85,
            "2032": 98.1
          },
          "cagr": 9.46,
          "market_share": 35.12
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 60.82,
            "2021": 65.89,
            "2022": 72.72,
            "2023": 79.31,
            "2024": 87.17,
            "2025": 96.24,
            "2026": 102.72,
            "2027": 113.86,
            "2028": 124.46,
            "2029": 134.53,
            "2030": 147.79,
            "2031": 162.29,
            "2032": 181.21
          },
          "cagr": 9.46,
          "market_share": 64.88
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 14.58,
            "2021": 15.81,
            "2022": 17.25,
            "2023": 18.64,
            "2024": 20.58,
            "2025": 21.92,
            "2026": 24.18,
            "2027": 25.97,
            "2028": 28.57,
            "2029": 31.32,
            "2030": 32.98,
            "2031": 36.0,
            "2032": 40.42
          },
          "cagr": 9.14,
          "market_share": 16.42
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 13.96,
            "2021": 15.14,
            "2022": 16.52,
            "2023": 17.84,
            "2024": 19.7,
            "2025": 20.99,
            "2026": 23.15,
            "2027": 24.87,
            "2028": 27.36,
            "2029": 29.98,
            "2030": 31.58,
            "2031": 34.47,
            "2032": 38.7
          },
          "cagr": 9.13,
          "market_share": 15.72
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 12.81,
            "2021": 13.9,
            "2022": 15.16,
            "2023": 16.38,
            "2024": 18.08,
            "2025": 19.27,
            "2026": 21.25,
            "2027": 22.83,
            "2028": 25.11,
            "2029": 27.53,
            "2030": 28.99,
            "2031": 31.64,
            "2032": 35.53
          },
          "cagr": 9.13,
          "market_share": 14.42
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 22.63,
            "2021": 24.55,
            "2022": 26.79,
            "2023": 28.94,
            "2024": 31.95,
            "2025": 34.04,
            "2026": 37.55,
            "2027": 40.33,
            "2028": 44.37,
            "2029": 48.63,
            "2030": 51.21,
            "2031": 55.9,
            "2032": 62.77
          },
          "cagr": 9.14,
          "market_share": 25.49
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 24.82,
            "2021": 26.93,
            "2022": 29.36,
            "2023": 31.72,
            "2024": 35.03,
            "2025": 37.33,
            "2026": 41.18,
            "2027": 44.22,
            "2028": 48.66,
            "2029": 53.32,
            "2030": 56.15,
            "2031": 61.28,
            "2032": 68.82
          },
          "cagr": 9.13,
          "market_share": 27.95
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 23.19,
            "2021": 25.16,
            "2022": 27.45,
            "2023": 29.65,
            "2024": 32.74,
            "2025": 34.88,
            "2026": 38.48,
            "2027": 41.33,
            "2028": 45.47,
            "2029": 49.83,
            "2030": 52.48,
            "2031": 57.28,
            "2032": 64.32
          },
          "cagr": 9.14,
          "market_share": 26.12
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 16.52,
            "2021": 17.92,
            "2022": 19.55,
            "2023": 21.12,
            "2024": 23.32,
            "2025": 24.85,
            "2026": 27.41,
            "2027": 29.44,
            "2028": 32.39,
            "2029": 35.5,
            "2030": 37.39,
            "2031": 40.81,
            "2032": 45.82
          },
          "cagr": 9.13,
          "market_share": 18.61
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 14.87,
            "2021": 16.13,
            "2022": 17.6,
            "2023": 19.01,
            "2024": 20.99,
            "2025": 22.37,
            "2026": 24.67,
            "2027": 26.5,
            "2028": 29.15,
            "2029": 31.95,
            "2030": 33.65,
            "2031": 36.73,
            "2032": 41.24
          },
          "cagr": 9.13,
          "market_share": 16.75
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 21.61,
            "2021": 23.44,
            "2022": 25.57,
            "2023": 27.62,
            "2024": 30.5,
            "2025": 32.5,
            "2026": 35.85,
            "2027": 38.5,
            "2028": 42.36,
            "2029": 46.42,
            "2030": 48.89,
            "2031": 53.36,
            "2032": 59.92
          },
          "cagr": 9.13,
          "market_share": 24.33
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 12.61,
            "2021": 13.68,
            "2022": 14.91,
            "2023": 16.12,
            "2024": 17.79,
            "2025": 18.95,
            "2026": 20.9,
            "2027": 22.45,
            "2028": 24.7,
            "2029": 27.08,
            "2030": 28.5,
            "2031": 31.11,
            "2032": 34.94
          },
          "cagr": 9.13,
          "market_share": 14.19
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 40.0,
            "2021": 43.39,
            "2022": 47.34,
            "2023": 51.14,
            "2024": 56.46,
            "2025": 60.16,
            "2026": 66.36,
            "2027": 71.27,
            "2028": 78.41,
            "2029": 85.94,
            "2030": 90.5,
            "2031": 98.78,
            "2032": 110.92
          },
          "cagr": 9.13,
          "market_share": 45.05
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 48.8,
            "2021": 52.94,
            "2022": 57.74,
            "2023": 62.38,
            "2024": 68.88,
            "2025": 73.39,
            "2026": 80.95,
            "2027": 86.95,
            "2028": 95.66,
            "2029": 104.84,
            "2030": 110.41,
            "2031": 120.51,
            "2032": 135.32
          },
          "cagr": 9.13,
          "market_share": 54.95
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 48.59,
            "2021": 52.71,
            "2022": 57.5,
            "2023": 62.12,
            "2024": 68.59,
            "2025": 73.08,
            "2026": 80.61,
            "2027": 86.58,
            "2028": 95.25,
            "2029": 104.4,
            "2030": 109.94,
            "2031": 120.0,
            "2032": 134.75
          },
          "cagr": 9.13,
          "market_share": 54.72
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 40.21,
            "2021": 43.62,
            "2022": 47.58,
            "2023": 51.4,
            "2024": 56.75,
            "2025": 60.47,
            "2026": 66.7,
            "2027": 71.64,
            "2028": 78.82,
            "2029": 86.38,
            "2030": 90.97,
            "2031": 99.29,
            "2032": 111.49
          },
          "cagr": 9.13,
          "market_share": 45.28
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 19.88,
            "2021": 21.57,
            "2022": 23.53,
            "2023": 25.42,
            "2024": 28.07,
            "2025": 29.91,
            "2026": 32.99,
            "2027": 35.43,
            "2028": 38.98,
            "2029": 42.72,
            "2030": 44.99,
            "2031": 49.11,
            "2032": 55.14
          },
          "cagr": 9.13,
          "market_share": 22.4
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 31.07,
            "2021": 33.7,
            "2022": 36.77,
            "2023": 39.72,
            "2024": 43.85,
            "2025": 46.73,
            "2026": 51.54,
            "2027": 55.36,
            "2028": 60.9,
            "2029": 66.75,
            "2030": 70.29,
            "2031": 76.73,
            "2032": 86.15
          },
          "cagr": 9.13,
          "market_share": 34.98
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 37.85,
            "2021": 41.06,
            "2022": 44.78,
            "2023": 48.38,
            "2024": 53.42,
            "2025": 56.91,
            "2026": 62.78,
            "2027": 67.43,
            "2028": 74.19,
            "2029": 81.31,
            "2030": 85.63,
            "2031": 93.45,
            "2032": 104.95
          },
          "cagr": 9.14,
          "market_share": 42.62
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 55.26,
            "2021": 59.95,
            "2022": 65.4,
            "2023": 70.65,
            "2024": 78.01,
            "2025": 83.12,
            "2026": 91.68,
            "2027": 98.47,
            "2028": 108.34,
            "2029": 118.74,
            "2030": 125.04,
            "2031": 136.48,
            "2032": 153.25
          },
          "cagr": 9.13,
          "market_share": 62.24
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 33.54,
            "2021": 36.38,
            "2022": 39.68,
            "2023": 42.87,
            "2024": 47.33,
            "2025": 50.43,
            "2026": 55.63,
            "2027": 59.75,
            "2028": 65.73,
            "2029": 72.04,
            "2030": 75.87,
            "2031": 82.81,
            "2032": 92.99
          },
          "cagr": 9.13,
          "market_share": 37.76
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 15.4,
            "2021": 17.28,
            "2022": 19.24,
            "2023": 21.61,
            "2024": 24.04,
            "2025": 26.2,
            "2026": 29.13,
            "2027": 32.94,
            "2028": 36.79,
            "2029": 39.51,
            "2030": 44.81,
            "2031": 49.49,
            "2032": 54.83
          },
          "cagr": 11.13,
          "market_share": 14.72
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 28.76,
            "2021": 32.27,
            "2022": 35.94,
            "2023": 40.35,
            "2024": 44.91,
            "2025": 48.94,
            "2026": 54.42,
            "2027": 61.53,
            "2028": 68.72,
            "2029": 73.79,
            "2030": 83.69,
            "2031": 92.44,
            "2032": 102.4
          },
          "cagr": 11.12,
          "market_share": 27.5
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 21.99,
            "2021": 24.67,
            "2022": 27.48,
            "2023": 30.86,
            "2024": 34.34,
            "2025": 37.42,
            "2026": 41.61,
            "2027": 47.05,
            "2028": 52.55,
            "2029": 56.42,
            "2030": 63.99,
            "2031": 70.68,
            "2032": 78.3
          },
          "cagr": 11.12,
          "market_share": 21.02
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 14.51,
            "2021": 16.28,
            "2022": 18.14,
            "2023": 20.36,
            "2024": 22.66,
            "2025": 24.7,
            "2026": 27.46,
            "2027": 31.05,
            "2028": 34.68,
            "2029": 37.24,
            "2030": 42.24,
            "2031": 46.65,
            "2032": 51.68
          },
          "cagr": 11.12,
          "market_share": 13.87
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 23.93,
            "2021": 26.86,
            "2022": 29.93,
            "2023": 33.59,
            "2024": 37.38,
            "2025": 40.75,
            "2026": 45.3,
            "2027": 51.23,
            "2028": 57.21,
            "2029": 61.43,
            "2030": 69.67,
            "2031": 76.96,
            "2032": 85.23
          },
          "cagr": 11.12,
          "market_share": 22.89
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 22.89,
            "2021": 25.68,
            "2022": 28.61,
            "2023": 32.12,
            "2024": 35.74,
            "2025": 38.96,
            "2026": 43.31,
            "2027": 48.98,
            "2028": 54.7,
            "2029": 58.73,
            "2030": 66.62,
            "2031": 73.58,
            "2032": 81.51
          },
          "cagr": 11.12,
          "market_share": 21.88
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 19.01,
            "2021": 21.33,
            "2022": 23.76,
            "2023": 26.67,
            "2024": 29.68,
            "2025": 32.35,
            "2026": 35.97,
            "2027": 40.67,
            "2028": 45.42,
            "2029": 48.77,
            "2030": 55.32,
            "2031": 61.1,
            "2032": 67.68
          },
          "cagr": 11.12,
          "market_share": 18.17
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 26.18,
            "2021": 29.37,
            "2022": 32.72,
            "2023": 36.73,
            "2024": 40.88,
            "2025": 44.55,
            "2026": 49.54,
            "2027": 56.01,
            "2028": 62.56,
            "2029": 67.17,
            "2030": 76.18,
            "2031": 84.15,
            "2032": 93.21
          },
          "cagr": 11.12,
          "market_share": 25.03
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 20.08,
            "2021": 22.53,
            "2022": 25.09,
            "2023": 28.17,
            "2024": 31.35,
            "2025": 34.17,
            "2026": 37.99,
            "2027": 42.96,
            "2028": 47.98,
            "2029": 51.52,
            "2030": 58.43,
            "2031": 64.54,
            "2032": 71.49
          },
          "cagr": 11.12,
          "market_share": 19.19
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 16.43,
            "2021": 18.45,
            "2022": 20.55,
            "2023": 23.08,
            "2024": 25.68,
            "2025": 27.98,
            "2026": 31.11,
            "2027": 35.18,
            "2028": 39.29,
            "2029": 42.2,
            "2030": 47.85,
            "2031": 52.85,
            "2032": 58.55
          },
          "cagr": 11.12,
          "market_share": 15.72
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 66.9,
            "2021": 75.07,
            "2022": 83.62,
            "2023": 93.88,
            "2024": 104.47,
            "2025": 113.86,
            "2026": 126.59,
            "2027": 143.15,
            "2028": 159.87,
            "2029": 171.67,
            "2030": 194.7,
            "2031": 215.05,
            "2032": 238.22
          },
          "cagr": 11.12,
          "market_share": 63.96
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 37.69,
            "2021": 42.29,
            "2022": 47.11,
            "2023": 52.89,
            "2024": 58.86,
            "2025": 64.15,
            "2026": 71.33,
            "2027": 80.65,
            "2028": 90.08,
            "2029": 96.72,
            "2030": 109.7,
            "2031": 121.17,
            "2032": 134.22
          },
          "cagr": 11.12,
          "market_share": 36.04
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 56.69,
            "2021": 63.61,
            "2022": 70.85,
            "2023": 79.55,
            "2024": 88.52,
            "2025": 96.48,
            "2026": 107.27,
            "2027": 121.3,
            "2028": 135.47,
            "2029": 145.46,
            "2030": 164.98,
            "2031": 182.22,
            "2032": 201.86
          },
          "cagr": 11.12,
          "market_share": 54.2
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 47.9,
            "2021": 53.75,
            "2022": 59.88,
            "2023": 67.22,
            "2024": 74.81,
            "2025": 81.53,
            "2026": 90.65,
            "2027": 102.5,
            "2028": 114.48,
            "2029": 122.93,
            "2030": 139.42,
            "2031": 154.0,
            "2032": 170.58
          },
          "cagr": 11.12,
          "market_share": 45.8
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 30.69,
            "2021": 34.44,
            "2022": 38.37,
            "2023": 43.07,
            "2024": 47.93,
            "2025": 52.24,
            "2026": 58.08,
            "2027": 65.68,
            "2028": 73.35,
            "2029": 78.76,
            "2030": 89.33,
            "2031": 98.67,
            "2032": 109.3
          },
          "cagr": 11.12,
          "market_share": 29.35
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 44.37,
            "2021": 49.79,
            "2022": 55.46,
            "2023": 62.26,
            "2024": 69.29,
            "2025": 75.52,
            "2026": 83.96,
            "2027": 94.94,
            "2028": 106.04,
            "2029": 113.86,
            "2030": 129.13,
            "2031": 142.63,
            "2032": 158.0
          },
          "cagr": 11.12,
          "market_share": 42.42
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 29.53,
            "2021": 33.13,
            "2022": 36.9,
            "2023": 41.44,
            "2024": 46.11,
            "2025": 50.25,
            "2026": 55.88,
            "2027": 63.18,
            "2028": 70.56,
            "2029": 75.77,
            "2030": 85.94,
            "2031": 94.92,
            "2032": 105.14
          },
          "cagr": 11.12,
          "market_share": 28.23
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 55.13,
            "2021": 61.86,
            "2022": 68.91,
            "2023": 77.36,
            "2024": 86.09,
            "2025": 93.83,
            "2026": 104.32,
            "2027": 117.96,
            "2028": 131.74,
            "2029": 141.46,
            "2030": 160.44,
            "2031": 177.21,
            "2032": 196.31
          },
          "cagr": 11.12,
          "market_share": 52.71
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 49.46,
            "2021": 55.5,
            "2022": 61.82,
            "2023": 69.41,
            "2024": 77.24,
            "2025": 84.18,
            "2026": 93.6,
            "2027": 105.84,
            "2028": 118.21,
            "2029": 126.93,
            "2030": 143.96,
            "2031": 159.01,
            "2032": 176.13
          },
          "cagr": 11.12,
          "market_share": 47.29
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 25.0,
            "2021": 26.85,
            "2022": 30.59,
            "2023": 33.47,
            "2024": 36.94,
            "2025": 40.3,
            "2026": 44.99,
            "2027": 47.99,
            "2028": 54.44,
            "2029": 59.55,
            "2030": 65.96,
            "2031": 72.1,
            "2032": 79.82
          },
          "cagr": 10.26,
          "market_share": 17.43
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 24.63,
            "2021": 26.45,
            "2022": 30.13,
            "2023": 32.98,
            "2024": 36.39,
            "2025": 39.7,
            "2026": 44.32,
            "2027": 47.27,
            "2028": 53.63,
            "2029": 58.66,
            "2030": 64.98,
            "2031": 71.02,
            "2032": 78.63
          },
          "cagr": 10.26,
          "market_share": 17.17
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 40.67,
            "2021": 43.68,
            "2022": 49.76,
            "2023": 54.46,
            "2024": 60.1,
            "2025": 65.57,
            "2026": 73.19,
            "2027": 78.08,
            "2028": 88.57,
            "2029": 96.88,
            "2030": 107.32,
            "2031": 117.3,
            "2032": 129.87
          },
          "cagr": 10.26,
          "market_share": 28.37
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 34.95,
            "2021": 37.53,
            "2022": 42.76,
            "2023": 46.8,
            "2024": 51.64,
            "2025": 56.34,
            "2026": 62.89,
            "2027": 67.08,
            "2028": 76.1,
            "2029": 83.25,
            "2030": 92.21,
            "2031": 100.79,
            "2032": 111.59
          },
          "cagr": 10.26,
          "market_share": 24.37
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 18.15,
            "2021": 19.48,
            "2022": 22.21,
            "2023": 24.31,
            "2024": 26.81,
            "2025": 29.25,
            "2026": 32.66,
            "2027": 34.85,
            "2028": 39.54,
            "2029": 43.24,
            "2030": 47.91,
            "2031": 52.36,
            "2032": 57.96
          },
          "cagr": 10.26,
          "market_share": 12.65
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 26.18,
            "2021": 28.11,
            "2022": 32.03,
            "2023": 35.05,
            "2024": 38.68,
            "2025": 42.2,
            "2026": 47.11,
            "2027": 50.25,
            "2028": 57.01,
            "2029": 62.36,
            "2030": 69.07,
            "2031": 75.5,
            "2032": 83.59
          },
          "cagr": 10.26,
          "market_share": 18.26
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 22.05,
            "2021": 23.68,
            "2022": 26.98,
            "2023": 29.53,
            "2024": 32.58,
            "2025": 35.54,
            "2026": 39.68,
            "2027": 42.33,
            "2028": 48.02,
            "2029": 52.52,
            "2030": 58.18,
            "2031": 63.59,
            "2032": 70.4
          },
          "cagr": 10.26,
          "market_share": 15.38
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 22.19,
            "2021": 23.83,
            "2022": 27.15,
            "2023": 29.72,
            "2024": 32.79,
            "2025": 35.78,
            "2026": 39.94,
            "2027": 42.6,
            "2028": 48.33,
            "2029": 52.87,
            "2030": 58.56,
            "2031": 64.01,
            "2032": 70.87
          },
          "cagr": 10.26,
          "market_share": 15.48
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 30.77,
            "2021": 33.04,
            "2022": 37.64,
            "2023": 41.2,
            "2024": 45.46,
            "2025": 49.6,
            "2026": 55.37,
            "2027": 59.06,
            "2028": 67.0,
            "2029": 73.29,
            "2030": 81.19,
            "2031": 88.74,
            "2032": 98.24
          },
          "cagr": 10.26,
          "market_share": 21.46
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 42.21,
            "2021": 45.33,
            "2022": 51.65,
            "2023": 56.52,
            "2024": 62.37,
            "2025": 68.04,
            "2026": 75.95,
            "2027": 81.03,
            "2028": 91.92,
            "2029": 100.54,
            "2030": 111.38,
            "2031": 121.73,
            "2032": 134.77
          },
          "cagr": 10.26,
          "market_share": 29.44
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 91.53,
            "2021": 98.29,
            "2022": 111.99,
            "2023": 122.56,
            "2024": 135.24,
            "2025": 147.55,
            "2026": 164.71,
            "2027": 175.7,
            "2028": 199.32,
            "2029": 218.03,
            "2030": 241.51,
            "2031": 263.98,
            "2032": 292.25
          },
          "cagr": 10.26,
          "market_share": 63.83
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 51.87,
            "2021": 55.7,
            "2022": 63.46,
            "2023": 69.46,
            "2024": 76.64,
            "2025": 83.61,
            "2026": 93.34,
            "2027": 99.57,
            "2028": 112.96,
            "2029": 123.55,
            "2030": 136.87,
            "2031": 149.59,
            "2032": 165.62
          },
          "cagr": 10.26,
          "market_share": 36.17
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 99.13,
            "2021": 106.46,
            "2022": 121.29,
            "2023": 132.75,
            "2024": 146.48,
            "2025": 159.81,
            "2026": 178.4,
            "2027": 190.3,
            "2028": 215.89,
            "2029": 236.15,
            "2030": 261.58,
            "2031": 285.92,
            "2032": 316.54
          },
          "cagr": 10.26,
          "market_share": 69.13
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 44.27,
            "2021": 47.53,
            "2022": 54.16,
            "2023": 59.27,
            "2024": 65.4,
            "2025": 71.35,
            "2026": 79.65,
            "2027": 84.97,
            "2028": 96.39,
            "2029": 105.43,
            "2030": 116.8,
            "2031": 127.65,
            "2032": 141.33
          },
          "cagr": 10.26,
          "market_share": 30.87
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 48.79,
            "2021": 52.4,
            "2022": 59.7,
            "2023": 65.34,
            "2024": 72.1,
            "2025": 78.66,
            "2026": 87.81,
            "2027": 93.67,
            "2028": 106.26,
            "2029": 116.23,
            "2030": 128.75,
            "2031": 140.73,
            "2032": 155.8
          },
          "cagr": 10.26,
          "market_share": 34.03
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 42.2,
            "2021": 45.32,
            "2022": 51.64,
            "2023": 56.52,
            "2024": 62.36,
            "2025": 68.04,
            "2026": 75.95,
            "2027": 81.02,
            "2028": 91.91,
            "2029": 100.54,
            "2030": 111.37,
            "2031": 121.73,
            "2032": 134.76
          },
          "cagr": 10.26,
          "market_share": 29.43
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 52.41,
            "2021": 56.27,
            "2022": 64.11,
            "2023": 70.16,
            "2024": 77.42,
            "2025": 84.46,
            "2026": 94.29,
            "2027": 100.58,
            "2028": 114.11,
            "2029": 124.81,
            "2030": 138.26,
            "2031": 151.11,
            "2032": 167.31
          },
          "cagr": 10.26,
          "market_share": 36.54
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 52.05,
            "2021": 55.9,
            "2022": 63.69,
            "2023": 69.7,
            "2024": 76.91,
            "2025": 83.91,
            "2026": 93.67,
            "2027": 99.92,
            "2028": 113.35,
            "2029": 123.99,
            "2030": 137.35,
            "2031": 150.12,
            "2032": 166.2
          },
          "cagr": 10.26,
          "market_share": 36.3
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 91.35,
            "2021": 98.09,
            "2022": 111.76,
            "2023": 122.32,
            "2024": 134.97,
            "2025": 147.25,
            "2026": 164.38,
            "2027": 175.35,
            "2028": 198.93,
            "2029": 217.59,
            "2030": 241.03,
            "2031": 263.45,
            "2032": 291.67
          },
          "cagr": 10.26,
          "market_share": 63.7
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 33.41,
            "2021": 37.79,
            "2022": 43.93,
            "2023": 49.57,
            "2024": 55.74,
            "2025": 63.89,
            "2026": 72.96,
            "2027": 83.75,
            "2028": 93.51,
            "2029": 108.34,
            "2030": 120.28,
            "2031": 136.27,
            "2032": 160.0
          },
          "cagr": 14.01,
          "market_share": 23.03
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 36.7,
            "2021": 41.51,
            "2022": 48.25,
            "2023": 54.45,
            "2024": 61.22,
            "2025": 70.17,
            "2026": 80.14,
            "2027": 91.99,
            "2028": 102.71,
            "2029": 119.0,
            "2030": 132.11,
            "2031": 149.68,
            "2032": 175.75
          },
          "cagr": 14.02,
          "market_share": 25.29
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 33.82,
            "2021": 38.26,
            "2022": 44.47,
            "2023": 50.18,
            "2024": 56.42,
            "2025": 64.67,
            "2026": 73.86,
            "2027": 84.78,
            "2028": 94.66,
            "2029": 109.67,
            "2030": 121.76,
            "2031": 137.94,
            "2032": 161.97
          },
          "cagr": 14.01,
          "market_share": 23.31
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 24.13,
            "2021": 27.3,
            "2022": 31.73,
            "2023": 35.8,
            "2024": 40.26,
            "2025": 46.15,
            "2026": 52.7,
            "2027": 60.49,
            "2028": 67.54,
            "2029": 78.25,
            "2030": 86.88,
            "2031": 98.43,
            "2032": 115.57
          },
          "cagr": 14.01,
          "market_share": 16.63
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 17.04,
            "2021": 19.26,
            "2022": 22.37,
            "2023": 25.26,
            "2024": 28.4,
            "2025": 32.55,
            "2026": 37.17,
            "2027": 42.66,
            "2028": 47.64,
            "2029": 55.2,
            "2030": 61.28,
            "2031": 69.42,
            "2032": 81.53
          },
          "cagr": 14.02,
          "market_share": 11.73
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 41.07,
            "2021": 46.45,
            "2022": 53.99,
            "2023": 60.92,
            "2024": 68.5,
            "2025": 78.52,
            "2026": 89.67,
            "2027": 102.93,
            "2028": 114.92,
            "2029": 133.15,
            "2030": 147.82,
            "2031": 167.48,
            "2032": 196.65
          },
          "cagr": 14.01,
          "market_share": 28.3
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 17.54,
            "2021": 19.84,
            "2022": 23.06,
            "2023": 26.02,
            "2024": 29.26,
            "2025": 33.54,
            "2026": 38.3,
            "2027": 43.96,
            "2028": 49.09,
            "2029": 56.87,
            "2030": 63.14,
            "2031": 71.53,
            "2032": 83.99
          },
          "cagr": 14.01,
          "market_share": 12.09
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 22.82,
            "2021": 25.81,
            "2022": 30.0,
            "2023": 33.85,
            "2024": 38.06,
            "2025": 43.63,
            "2026": 49.82,
            "2027": 57.19,
            "2028": 63.85,
            "2029": 73.98,
            "2030": 82.14,
            "2031": 93.06,
            "2032": 109.26
          },
          "cagr": 14.01,
          "market_share": 15.73
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 24.84,
            "2021": 28.1,
            "2022": 32.65,
            "2023": 36.85,
            "2024": 41.43,
            "2025": 47.49,
            "2026": 54.24,
            "2027": 62.26,
            "2028": 69.51,
            "2029": 80.54,
            "2030": 89.41,
            "2031": 101.3,
            "2032": 118.94
          },
          "cagr": 14.01,
          "market_share": 17.12
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 38.83,
            "2021": 43.92,
            "2022": 51.05,
            "2023": 57.62,
            "2024": 64.79,
            "2025": 74.25,
            "2026": 84.8,
            "2027": 97.33,
            "2028": 108.69,
            "2029": 125.92,
            "2030": 139.8,
            "2031": 158.37,
            "2032": 185.98
          },
          "cagr": 14.02,
          "market_share": 26.77
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 98.47,
            "2021": 111.37,
            "2022": 129.44,
            "2023": 146.08,
            "2024": 164.25,
            "2025": 188.27,
            "2026": 215.01,
            "2027": 246.79,
            "2028": 275.56,
            "2029": 319.27,
            "2030": 354.45,
            "2031": 401.57,
            "2032": 471.51
          },
          "cagr": 14.01,
          "market_share": 67.86
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 46.63,
            "2021": 52.75,
            "2022": 61.31,
            "2023": 69.18,
            "2024": 77.79,
            "2025": 89.16,
            "2026": 101.82,
            "2027": 116.88,
            "2028": 130.5,
            "2029": 151.19,
            "2030": 167.86,
            "2031": 190.17,
            "2032": 223.31
          },
          "cagr": 14.02,
          "market_share": 32.14
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 65.04,
            "2021": 73.56,
            "2022": 85.5,
            "2023": 96.49,
            "2024": 108.49,
            "2025": 124.35,
            "2026": 142.02,
            "2027": 163.01,
            "2028": 182.01,
            "2029": 210.88,
            "2030": 234.12,
            "2031": 265.24,
            "2032": 311.44
          },
          "cagr": 14.01,
          "market_share": 44.83
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 80.06,
            "2021": 90.56,
            "2022": 105.25,
            "2023": 118.77,
            "2024": 133.55,
            "2025": 153.08,
            "2026": 174.81,
            "2027": 200.66,
            "2028": 224.05,
            "2029": 259.58,
            "2030": 288.19,
            "2031": 326.5,
            "2032": 383.38
          },
          "cagr": 14.01,
          "market_share": 55.18
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 34.71,
            "2021": 39.26,
            "2022": 45.63,
            "2023": 51.49,
            "2024": 57.9,
            "2025": 66.37,
            "2026": 75.79,
            "2027": 87.0,
            "2028": 97.14,
            "2029": 112.55,
            "2030": 124.95,
            "2031": 141.56,
            "2032": 166.22
          },
          "cagr": 14.01,
          "market_share": 23.92
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 43.16,
            "2021": 48.81,
            "2022": 56.73,
            "2023": 64.02,
            "2024": 71.99,
            "2025": 82.52,
            "2026": 94.24,
            "2027": 108.17,
            "2028": 120.77,
            "2029": 139.93,
            "2030": 155.35,
            "2031": 176.0,
            "2032": 206.66
          },
          "cagr": 14.01,
          "market_share": 29.74
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 67.23,
            "2021": 76.05,
            "2022": 88.39,
            "2023": 99.75,
            "2024": 112.15,
            "2025": 128.54,
            "2026": 146.8,
            "2027": 168.5,
            "2028": 188.15,
            "2029": 217.98,
            "2030": 242.01,
            "2031": 274.18,
            "2032": 321.94
          },
          "cagr": 14.02,
          "market_share": 46.34
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 70.51,
            "2021": 79.76,
            "2022": 92.7,
            "2023": 104.61,
            "2024": 117.63,
            "2025": 134.83,
            "2026": 153.97,
            "2027": 176.74,
            "2028": 197.33,
            "2029": 228.64,
            "2030": 253.83,
            "2031": 287.58,
            "2032": 337.67
          },
          "cagr": 14.01,
          "market_share": 48.6
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 74.59,
            "2021": 84.36,
            "2022": 98.05,
            "2023": 110.65,
            "2024": 124.41,
            "2025": 142.6,
            "2026": 162.86,
            "2027": 186.93,
            "2028": 208.73,
            "2029": 241.82,
            "2030": 268.48,
            "2031": 304.16,
            "2032": 357.15
          },
          "cagr": 14.01,
          "market_share": 51.4
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 19.25,
            "2021": 20.69,
            "2022": 22.69,
            "2023": 24.23,
            "2024": 26.95,
            "2025": 29.31,
            "2026": 31.17,
            "2027": 33.85,
            "2028": 36.83,
            "2029": 39.64,
            "2030": 43.85,
            "2031": 47.89,
            "2032": 51.85
          },
          "cagr": 8.49,
          "market_share": 20.7
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 21.94,
            "2021": 23.58,
            "2022": 25.86,
            "2023": 27.62,
            "2024": 30.71,
            "2025": 33.4,
            "2026": 35.52,
            "2027": 38.58,
            "2028": 41.97,
            "2029": 45.17,
            "2030": 49.97,
            "2031": 54.57,
            "2032": 59.08
          },
          "cagr": 8.49,
          "market_share": 23.58
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 15.0,
            "2021": 16.12,
            "2022": 17.68,
            "2023": 18.88,
            "2024": 21.0,
            "2025": 22.84,
            "2026": 24.29,
            "2027": 26.38,
            "2028": 28.7,
            "2029": 30.89,
            "2030": 34.17,
            "2031": 37.31,
            "2032": 40.4
          },
          "cagr": 8.49,
          "market_share": 16.13
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 10.94,
            "2021": 11.75,
            "2022": 12.89,
            "2023": 13.77,
            "2024": 15.31,
            "2025": 16.65,
            "2026": 17.71,
            "2027": 19.23,
            "2028": 20.93,
            "2029": 22.52,
            "2030": 24.91,
            "2031": 27.21,
            "2032": 29.46
          },
          "cagr": 8.49,
          "market_share": 11.76
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 25.9,
            "2021": 27.84,
            "2022": 30.53,
            "2023": 32.61,
            "2024": 36.25,
            "2025": 39.43,
            "2026": 41.92,
            "2027": 45.55,
            "2028": 49.57,
            "2029": 53.32,
            "2030": 59.0,
            "2031": 64.44,
            "2032": 69.76
          },
          "cagr": 8.49,
          "market_share": 27.84
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 16.86,
            "2021": 18.12,
            "2022": 19.87,
            "2023": 21.22,
            "2024": 23.6,
            "2025": 25.67,
            "2026": 27.29,
            "2027": 29.65,
            "2028": 32.26,
            "2029": 34.71,
            "2030": 38.4,
            "2031": 41.94,
            "2032": 45.41
          },
          "cagr": 8.49,
          "market_share": 18.12
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.68,
            "2021": 13.63,
            "2022": 14.94,
            "2023": 15.96,
            "2024": 17.75,
            "2025": 19.3,
            "2026": 20.53,
            "2027": 22.3,
            "2028": 24.26,
            "2029": 26.11,
            "2030": 28.88,
            "2031": 31.54,
            "2032": 34.15
          },
          "cagr": 8.49,
          "market_share": 13.63
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 20.37,
            "2021": 21.89,
            "2022": 24.01,
            "2023": 25.65,
            "2024": 28.52,
            "2025": 31.01,
            "2026": 32.98,
            "2027": 35.82,
            "2028": 38.98,
            "2029": 41.95,
            "2030": 46.4,
            "2031": 50.68,
            "2032": 54.87
          },
          "cagr": 8.49,
          "market_share": 21.9
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 22.78,
            "2021": 24.48,
            "2022": 26.85,
            "2023": 28.68,
            "2024": 31.89,
            "2025": 34.68,
            "2026": 36.88,
            "2027": 40.06,
            "2028": 43.59,
            "2029": 46.9,
            "2030": 51.89,
            "2031": 56.67,
            "2032": 61.35
          },
          "cagr": 8.49,
          "market_share": 24.49
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 20.34,
            "2021": 21.86,
            "2022": 23.98,
            "2023": 25.6,
            "2024": 28.46,
            "2025": 30.97,
            "2026": 32.93,
            "2027": 35.76,
            "2028": 38.91,
            "2029": 41.87,
            "2030": 46.33,
            "2031": 50.59,
            "2032": 54.77
          },
          "cagr": 8.49,
          "market_share": 21.86
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 39.7,
            "2021": 42.66,
            "2022": 46.79,
            "2023": 49.97,
            "2024": 55.57,
            "2025": 60.43,
            "2026": 64.27,
            "2027": 69.81,
            "2028": 75.95,
            "2029": 81.73,
            "2030": 90.42,
            "2031": 98.75,
            "2032": 106.91
          },
          "cagr": 8.49,
          "market_share": 42.67
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 53.33,
            "2021": 57.32,
            "2022": 62.86,
            "2023": 67.14,
            "2024": 74.65,
            "2025": 81.2,
            "2026": 86.34,
            "2027": 93.78,
            "2028": 102.05,
            "2029": 109.81,
            "2030": 121.48,
            "2031": 132.67,
            "2032": 143.64
          },
          "cagr": 8.49,
          "market_share": 57.33
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 63.42,
            "2021": 68.16,
            "2022": 74.75,
            "2023": 79.84,
            "2024": 88.78,
            "2025": 96.55,
            "2026": 102.68,
            "2027": 111.53,
            "2028": 121.35,
            "2029": 130.58,
            "2030": 144.46,
            "2031": 157.77,
            "2032": 170.81
          },
          "cagr": 8.49,
          "market_share": 68.18
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 29.61,
            "2021": 31.82,
            "2022": 34.9,
            "2023": 37.27,
            "2024": 41.44,
            "2025": 45.08,
            "2026": 47.93,
            "2027": 52.06,
            "2028": 56.65,
            "2029": 60.96,
            "2030": 67.44,
            "2031": 73.65,
            "2032": 79.74
          },
          "cagr": 8.49,
          "market_share": 31.82
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 28.15,
            "2021": 30.26,
            "2022": 33.18,
            "2023": 35.44,
            "2024": 39.41,
            "2025": 42.86,
            "2026": 45.58,
            "2027": 49.51,
            "2028": 53.87,
            "2029": 57.97,
            "2030": 64.13,
            "2031": 70.03,
            "2032": 75.82
          },
          "cagr": 8.49,
          "market_share": 30.26
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 25.32,
            "2021": 27.21,
            "2022": 29.84,
            "2023": 31.87,
            "2024": 35.44,
            "2025": 38.55,
            "2026": 40.99,
            "2027": 44.53,
            "2028": 48.45,
            "2029": 52.13,
            "2030": 57.67,
            "2031": 62.99,
            "2032": 68.19
          },
          "cagr": 8.49,
          "market_share": 27.22
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 39.56,
            "2021": 42.51,
            "2022": 46.63,
            "2023": 49.8,
            "2024": 55.37,
            "2025": 60.22,
            "2026": 64.04,
            "2027": 69.55,
            "2028": 75.68,
            "2029": 81.44,
            "2030": 90.1,
            "2031": 98.4,
            "2032": 106.54
          },
          "cagr": 8.49,
          "market_share": 42.52
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 39.09,
            "2021": 42.01,
            "2022": 46.07,
            "2023": 49.2,
            "2024": 54.71,
            "2025": 59.5,
            "2026": 63.28,
            "2027": 68.73,
            "2028": 74.78,
            "2029": 80.47,
            "2030": 89.03,
            "2031": 97.23,
            "2032": 105.27
          },
          "cagr": 8.49,
          "market_share": 42.01
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 53.94,
            "2021": 57.97,
            "2022": 63.58,
            "2023": 67.91,
            "2024": 75.51,
            "2025": 82.13,
            "2026": 87.33,
            "2027": 94.86,
            "2028": 103.22,
            "2029": 111.07,
            "2030": 122.87,
            "2031": 134.19,
            "2032": 145.28
          },
          "cagr": 8.49,
          "market_share": 57.99
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 12.78,
            "2021": 14.06,
            "2022": 15.41,
            "2023": 16.7,
            "2024": 18.39,
            "2025": 20.59,
            "2026": 22.43,
            "2027": 25.05,
            "2028": 27.12,
            "2029": 29.96,
            "2030": 33.6,
            "2031": 36.57,
            "2032": 40.48
          },
          "cagr": 10.14,
          "market_share": 14.71
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 10.13,
            "2021": 11.15,
            "2022": 12.22,
            "2023": 13.24,
            "2024": 14.58,
            "2025": 16.32,
            "2026": 17.79,
            "2027": 19.86,
            "2028": 21.5,
            "2029": 23.76,
            "2030": 26.64,
            "2031": 29.0,
            "2032": 32.1
          },
          "cagr": 10.15,
          "market_share": 11.66
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 24.46,
            "2021": 26.91,
            "2022": 29.5,
            "2023": 31.98,
            "2024": 35.22,
            "2025": 39.42,
            "2026": 42.95,
            "2027": 47.96,
            "2028": 51.93,
            "2029": 57.37,
            "2030": 64.34,
            "2031": 70.03,
            "2032": 77.51
          },
          "cagr": 10.14,
          "market_share": 28.17
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 19.72,
            "2021": 21.69,
            "2022": 23.78,
            "2023": 25.77,
            "2024": 28.38,
            "2025": 31.77,
            "2026": 34.62,
            "2027": 38.66,
            "2028": 41.85,
            "2029": 46.24,
            "2030": 51.86,
            "2031": 56.45,
            "2032": 62.48
          },
          "cagr": 10.14,
          "market_share": 22.7
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 19.76,
            "2021": 21.74,
            "2022": 23.82,
            "2023": 25.83,
            "2024": 28.45,
            "2025": 31.84,
            "2026": 34.68,
            "2027": 38.75,
            "2028": 41.94,
            "2029": 46.34,
            "2030": 51.96,
            "2031": 56.58,
            "2032": 62.61
          },
          "cagr": 10.14,
          "market_share": 22.76
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 17.46,
            "2021": 19.21,
            "2022": 21.05,
            "2023": 22.82,
            "2024": 25.13,
            "2025": 28.13,
            "2026": 30.65,
            "2027": 34.23,
            "2028": 37.06,
            "2029": 40.94,
            "2030": 45.92,
            "2031": 49.98,
            "2032": 55.32
          },
          "cagr": 10.14,
          "market_share": 20.1
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 10.18,
            "2021": 11.2,
            "2022": 12.27,
            "2023": 13.31,
            "2024": 14.65,
            "2025": 16.4,
            "2026": 17.87,
            "2027": 19.96,
            "2028": 21.61,
            "2029": 23.87,
            "2030": 26.77,
            "2031": 29.14,
            "2032": 32.25
          },
          "cagr": 10.14,
          "market_share": 11.72
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 20.37,
            "2021": 22.41,
            "2022": 24.56,
            "2023": 26.62,
            "2024": 29.32,
            "2025": 32.81,
            "2026": 35.75,
            "2027": 39.93,
            "2028": 43.23,
            "2029": 47.76,
            "2030": 53.56,
            "2031": 58.3,
            "2032": 64.53
          },
          "cagr": 10.15,
          "market_share": 23.45
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 21.73,
            "2021": 23.91,
            "2022": 26.2,
            "2023": 28.41,
            "2024": 31.28,
            "2025": 35.01,
            "2026": 38.15,
            "2027": 42.61,
            "2028": 46.13,
            "2029": 50.96,
            "2030": 57.15,
            "2031": 62.21,
            "2032": 68.86
          },
          "cagr": 10.15,
          "market_share": 25.02
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 17.11,
            "2021": 18.82,
            "2022": 20.65,
            "2023": 22.36,
            "2024": 24.64,
            "2025": 27.59,
            "2026": 30.05,
            "2027": 33.55,
            "2028": 36.31,
            "2029": 40.14,
            "2030": 45.0,
            "2031": 49.0,
            "2032": 54.22
          },
          "cagr": 10.13,
          "market_share": 19.71
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 46.4,
            "2021": 51.05,
            "2022": 55.95,
            "2023": 60.65,
            "2024": 66.79,
            "2025": 74.76,
            "2026": 81.46,
            "2027": 90.97,
            "2028": 98.49,
            "2029": 108.81,
            "2030": 122.02,
            "2031": 132.83,
            "2032": 147.02
          },
          "cagr": 10.14,
          "market_share": 53.42
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 40.45,
            "2021": 44.5,
            "2022": 48.78,
            "2023": 52.87,
            "2024": 58.23,
            "2025": 65.18,
            "2026": 71.01,
            "2027": 79.31,
            "2028": 85.85,
            "2029": 94.86,
            "2030": 106.38,
            "2031": 115.8,
            "2032": 128.16
          },
          "cagr": 10.14,
          "market_share": 46.58
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 39.14,
            "2021": 43.06,
            "2022": 47.19,
            "2023": 51.16,
            "2024": 56.34,
            "2025": 63.06,
            "2026": 68.71,
            "2027": 76.73,
            "2028": 83.07,
            "2029": 91.78,
            "2030": 102.92,
            "2031": 112.04,
            "2032": 124.01
          },
          "cagr": 10.14,
          "market_share": 45.06
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 47.71,
            "2021": 52.49,
            "2022": 57.54,
            "2023": 62.36,
            "2024": 68.68,
            "2025": 76.88,
            "2026": 83.76,
            "2027": 93.55,
            "2028": 101.27,
            "2029": 111.89,
            "2030": 125.48,
            "2031": 136.59,
            "2032": 151.17
          },
          "cagr": 10.14,
          "market_share": 54.94
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 17.64,
            "2021": 19.4,
            "2022": 21.26,
            "2023": 23.05,
            "2024": 25.39,
            "2025": 28.41,
            "2026": 30.96,
            "2027": 34.58,
            "2028": 37.43,
            "2029": 41.35,
            "2030": 46.38,
            "2031": 50.48,
            "2032": 55.88
          },
          "cagr": 10.15,
          "market_share": 20.31
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 42.46,
            "2021": 46.71,
            "2022": 51.19,
            "2023": 55.49,
            "2024": 61.12,
            "2025": 68.41,
            "2026": 74.53,
            "2027": 83.24,
            "2028": 90.12,
            "2029": 99.56,
            "2030": 111.65,
            "2031": 121.54,
            "2032": 134.52
          },
          "cagr": 10.14,
          "market_share": 48.89
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 26.75,
            "2021": 29.44,
            "2022": 32.28,
            "2023": 34.98,
            "2024": 38.51,
            "2025": 43.12,
            "2026": 46.98,
            "2027": 52.46,
            "2028": 56.79,
            "2029": 62.76,
            "2030": 70.37,
            "2031": 76.61,
            "2032": 84.78
          },
          "cagr": 10.14,
          "market_share": 30.8
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 47.88,
            "2021": 52.68,
            "2022": 57.74,
            "2023": 62.59,
            "2024": 68.93,
            "2025": 77.15,
            "2026": 84.06,
            "2027": 93.88,
            "2028": 101.64,
            "2029": 112.29,
            "2030": 125.93,
            "2031": 137.08,
            "2032": 151.72
          },
          "cagr": 10.14,
          "market_share": 55.14
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 38.97,
            "2021": 42.87,
            "2022": 46.99,
            "2023": 50.93,
            "2024": 56.09,
            "2025": 62.79,
            "2026": 68.41,
            "2027": 76.4,
            "2028": 82.7,
            "2029": 91.38,
            "2030": 102.47,
            "2031": 111.55,
            "2032": 123.46
          },
          "cagr": 10.14,
          "market_share": 44.86
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 24.99,
            "2021": 27.03,
            "2022": 30.44,
            "2023": 32.73,
            "2024": 36.05,
            "2025": 38.96,
            "2026": 43.27,
            "2027": 46.41,
            "2028": 49.63,
            "2029": 56.16,
            "2030": 59.88,
            "2031": 65.96,
            "2032": 71.93
          },
          "cagr": 9.15,
          "market_share": 23.73
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 21.92,
            "2021": 23.71,
            "2022": 26.71,
            "2023": 28.71,
            "2024": 31.62,
            "2025": 34.18,
            "2026": 37.96,
            "2027": 40.72,
            "2028": 43.54,
            "2029": 49.27,
            "2030": 52.53,
            "2031": 57.86,
            "2032": 63.1
          },
          "cagr": 9.15,
          "market_share": 20.81
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 13.89,
            "2021": 15.03,
            "2022": 16.92,
            "2023": 18.19,
            "2024": 20.04,
            "2025": 21.66,
            "2026": 24.05,
            "2027": 25.8,
            "2028": 27.59,
            "2029": 31.22,
            "2030": 33.29,
            "2031": 36.67,
            "2032": 39.99
          },
          "cagr": 9.15,
          "market_share": 13.19
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 18.1,
            "2021": 19.58,
            "2022": 22.05,
            "2023": 23.7,
            "2024": 26.11,
            "2025": 28.22,
            "2026": 31.34,
            "2027": 33.62,
            "2028": 35.95,
            "2029": 40.68,
            "2030": 43.37,
            "2031": 47.78,
            "2032": 52.1
          },
          "cagr": 9.15,
          "market_share": 17.19
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 26.4,
            "2021": 28.58,
            "2022": 32.18,
            "2023": 34.59,
            "2024": 38.1,
            "2025": 41.19,
            "2026": 45.73,
            "2027": 49.05,
            "2028": 52.46,
            "2029": 59.36,
            "2030": 63.28,
            "2031": 69.71,
            "2032": 76.03
          },
          "cagr": 9.15,
          "market_share": 25.08
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 22.74,
            "2021": 24.6,
            "2022": 27.71,
            "2023": 29.78,
            "2024": 32.81,
            "2025": 35.46,
            "2026": 39.38,
            "2027": 42.24,
            "2028": 45.17,
            "2029": 51.11,
            "2030": 54.5,
            "2031": 60.03,
            "2032": 65.47
          },
          "cagr": 9.15,
          "market_share": 21.6
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 25.42,
            "2021": 27.5,
            "2022": 30.97,
            "2023": 33.29,
            "2024": 36.67,
            "2025": 39.64,
            "2026": 44.01,
            "2027": 47.21,
            "2028": 50.49,
            "2029": 57.13,
            "2030": 60.91,
            "2031": 67.1,
            "2032": 73.17
          },
          "cagr": 9.15,
          "market_share": 24.14
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 16.14,
            "2021": 17.46,
            "2022": 19.66,
            "2023": 21.13,
            "2024": 23.28,
            "2025": 25.16,
            "2026": 27.94,
            "2027": 29.97,
            "2028": 32.05,
            "2029": 36.27,
            "2030": 38.67,
            "2031": 42.6,
            "2032": 46.45
          },
          "cagr": 9.15,
          "market_share": 15.32
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 15.98,
            "2021": 17.29,
            "2022": 19.47,
            "2023": 20.93,
            "2024": 23.05,
            "2025": 24.92,
            "2026": 27.67,
            "2027": 29.68,
            "2028": 31.74,
            "2029": 35.92,
            "2030": 38.3,
            "2031": 42.18,
            "2032": 46.0
          },
          "cagr": 9.15,
          "market_share": 15.17
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 25.02,
            "2021": 27.08,
            "2022": 30.49,
            "2023": 32.79,
            "2024": 36.11,
            "2025": 39.03,
            "2026": 43.35,
            "2027": 46.5,
            "2028": 49.72,
            "2029": 56.26,
            "2030": 59.97,
            "2031": 66.07,
            "2032": 72.06
          },
          "cagr": 9.15,
          "market_share": 23.77
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 38.56,
            "2021": 41.72,
            "2022": 46.99,
            "2023": 50.51,
            "2024": 55.64,
            "2025": 60.14,
            "2026": 66.78,
            "2027": 71.64,
            "2028": 76.6,
            "2029": 86.68,
            "2030": 92.42,
            "2031": 101.8,
            "2032": 111.02
          },
          "cagr": 9.15,
          "market_share": 36.62
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 66.74,
            "2021": 72.21,
            "2022": 81.31,
            "2023": 87.41,
            "2024": 96.28,
            "2025": 104.07,
            "2026": 115.57,
            "2027": 123.96,
            "2028": 132.57,
            "2029": 150.01,
            "2030": 159.93,
            "2031": 176.18,
            "2032": 192.13
          },
          "cagr": 9.15,
          "market_share": 63.38
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 44.25,
            "2021": 47.88,
            "2022": 53.92,
            "2023": 57.96,
            "2024": 63.85,
            "2025": 69.01,
            "2026": 76.63,
            "2027": 82.2,
            "2028": 87.9,
            "2029": 99.47,
            "2030": 106.05,
            "2031": 116.82,
            "2032": 127.4
          },
          "cagr": 9.15,
          "market_share": 42.03
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 61.05,
            "2021": 66.05,
            "2022": 74.38,
            "2023": 79.96,
            "2024": 88.07,
            "2025": 95.2,
            "2026": 105.72,
            "2027": 113.4,
            "2028": 121.27,
            "2029": 137.22,
            "2030": 146.3,
            "2031": 161.16,
            "2032": 175.75
          },
          "cagr": 9.15,
          "market_share": 57.97
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 51.42,
            "2021": 55.63,
            "2022": 62.65,
            "2023": 67.35,
            "2024": 74.18,
            "2025": 80.18,
            "2026": 89.04,
            "2027": 95.51,
            "2028": 102.14,
            "2029": 115.58,
            "2030": 123.22,
            "2031": 135.74,
            "2032": 148.03
          },
          "cagr": 9.15,
          "market_share": 48.83
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 27.94,
            "2021": 30.23,
            "2022": 34.04,
            "2023": 36.59,
            "2024": 40.31,
            "2025": 43.57,
            "2026": 48.38,
            "2027": 51.9,
            "2028": 55.5,
            "2029": 62.8,
            "2030": 66.95,
            "2031": 73.75,
            "2032": 80.43
          },
          "cagr": 9.15,
          "market_share": 26.53
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 25.94,
            "2021": 28.07,
            "2022": 31.61,
            "2023": 33.98,
            "2024": 37.43,
            "2025": 40.46,
            "2026": 44.93,
            "2027": 48.19,
            "2028": 51.53,
            "2029": 58.31,
            "2030": 62.18,
            "2031": 68.49,
            "2032": 74.69
          },
          "cagr": 9.15,
          "market_share": 24.64
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 58.16,
            "2021": 62.93,
            "2022": 70.87,
            "2023": 76.18,
            "2024": 83.91,
            "2025": 90.7,
            "2026": 100.72,
            "2027": 108.04,
            "2028": 115.53,
            "2029": 130.74,
            "2030": 139.39,
            "2031": 153.54,
            "2032": 167.44
          },
          "cagr": 9.15,
          "market_share": 55.23
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 47.14,
            "2021": 51.0,
            "2022": 57.43,
            "2023": 61.74,
            "2024": 68.01,
            "2025": 73.51,
            "2026": 81.63,
            "2027": 87.56,
            "2028": 93.64,
            "2029": 105.95,
            "2030": 112.96,
            "2031": 124.44,
            "2032": 135.71
          },
          "cagr": 9.15,
          "market_share": 44.77
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 13.47,
            "2021": 14.87,
            "2022": 16.7,
            "2023": 18.81,
            "2024": 20.64,
            "2025": 23.32,
            "2026": 26.03,
            "2027": 29.83,
            "2028": 32.91,
            "2029": 36.41,
            "2030": 41.0,
            "2031": 46.13,
            "2032": 52.74
          },
          "cagr": 12.36,
          "market_share": 19.01
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 12.3,
            "2021": 13.57,
            "2022": 15.25,
            "2023": 17.17,
            "2024": 18.85,
            "2025": 21.29,
            "2026": 23.77,
            "2027": 27.24,
            "2028": 30.05,
            "2029": 33.24,
            "2030": 37.43,
            "2031": 42.12,
            "2032": 48.15
          },
          "cagr": 12.37,
          "market_share": 17.36
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 20.45,
            "2021": 22.57,
            "2022": 25.36,
            "2023": 28.56,
            "2024": 31.34,
            "2025": 35.4,
            "2026": 39.53,
            "2027": 45.29,
            "2028": 49.97,
            "2029": 55.28,
            "2030": 62.24,
            "2031": 70.04,
            "2032": 80.07
          },
          "cagr": 12.37,
          "market_share": 28.86
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 11.45,
            "2021": 12.64,
            "2022": 14.2,
            "2023": 15.99,
            "2024": 17.54,
            "2025": 19.82,
            "2026": 22.13,
            "2027": 25.36,
            "2028": 27.98,
            "2029": 30.95,
            "2030": 34.85,
            "2031": 39.22,
            "2032": 44.83
          },
          "cagr": 12.37,
          "market_share": 16.15
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 13.19,
            "2021": 14.57,
            "2022": 16.38,
            "2023": 18.44,
            "2024": 20.23,
            "2025": 22.85,
            "2026": 25.52,
            "2027": 29.24,
            "2028": 32.27,
            "2029": 35.7,
            "2030": 40.18,
            "2031": 45.24,
            "2032": 51.72
          },
          "cagr": 12.38,
          "market_share": 18.63
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 13.21,
            "2021": 14.58,
            "2022": 16.38,
            "2023": 18.45,
            "2024": 20.25,
            "2025": 22.87,
            "2026": 25.54,
            "2027": 29.26,
            "2028": 32.28,
            "2029": 35.72,
            "2030": 40.21,
            "2031": 45.25,
            "2032": 51.73
          },
          "cagr": 12.37,
          "market_share": 18.65
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 9.06,
            "2021": 10.0,
            "2022": 11.24,
            "2023": 12.66,
            "2024": 13.89,
            "2025": 15.69,
            "2026": 17.52,
            "2027": 20.07,
            "2028": 22.15,
            "2029": 24.5,
            "2030": 27.58,
            "2031": 31.04,
            "2032": 35.49
          },
          "cagr": 12.37,
          "market_share": 12.79
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 20.21,
            "2021": 22.31,
            "2022": 25.06,
            "2023": 28.22,
            "2024": 30.97,
            "2025": 34.99,
            "2026": 39.06,
            "2027": 44.76,
            "2028": 49.38,
            "2029": 54.63,
            "2030": 61.51,
            "2031": 69.22,
            "2032": 79.14
          },
          "cagr": 12.37,
          "market_share": 28.52
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 19.62,
            "2021": 21.65,
            "2022": 24.33,
            "2023": 27.4,
            "2024": 30.07,
            "2025": 33.96,
            "2026": 37.92,
            "2027": 43.45,
            "2028": 47.94,
            "2029": 53.04,
            "2030": 59.72,
            "2031": 67.2,
            "2032": 76.83
          },
          "cagr": 12.37,
          "market_share": 27.69
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 8.76,
            "2021": 9.68,
            "2022": 10.88,
            "2023": 12.24,
            "2024": 13.42,
            "2025": 15.17,
            "2026": 16.94,
            "2027": 19.42,
            "2028": 21.43,
            "2029": 23.69,
            "2030": 26.68,
            "2031": 30.04,
            "2032": 34.32
          },
          "cagr": 12.37,
          "market_share": 12.36
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 38.12,
            "2021": 42.08,
            "2022": 47.28,
            "2023": 53.25,
            "2024": 58.43,
            "2025": 66.0,
            "2026": 73.69,
            "2027": 84.44,
            "2028": 93.17,
            "2029": 103.07,
            "2030": 116.04,
            "2031": 130.59,
            "2032": 149.29
          },
          "cagr": 12.37,
          "market_share": 53.8
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 32.74,
            "2021": 36.14,
            "2022": 40.61,
            "2023": 45.72,
            "2024": 50.17,
            "2025": 56.68,
            "2026": 63.29,
            "2027": 72.52,
            "2028": 80.01,
            "2029": 88.51,
            "2030": 99.66,
            "2031": 112.16,
            "2032": 128.22
          },
          "cagr": 12.37,
          "market_share": 46.2
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 36.57,
            "2021": 40.37,
            "2022": 45.36,
            "2023": 51.08,
            "2024": 56.05,
            "2025": 63.32,
            "2026": 70.69,
            "2027": 81.0,
            "2028": 89.37,
            "2029": 98.87,
            "2030": 111.32,
            "2031": 125.28,
            "2032": 143.22
          },
          "cagr": 12.37,
          "market_share": 51.61
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 34.29,
            "2021": 37.85,
            "2022": 42.53,
            "2023": 47.89,
            "2024": 52.55,
            "2025": 59.36,
            "2026": 66.29,
            "2027": 75.96,
            "2028": 83.81,
            "2029": 92.71,
            "2030": 104.38,
            "2031": 117.47,
            "2032": 134.29
          },
          "cagr": 12.37,
          "market_share": 48.39
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 20.79,
            "2021": 22.95,
            "2022": 25.79,
            "2023": 29.04,
            "2024": 31.87,
            "2025": 36.0,
            "2026": 40.19,
            "2027": 46.06,
            "2028": 50.81,
            "2029": 56.21,
            "2030": 63.29,
            "2031": 71.23,
            "2032": 81.43
          },
          "cagr": 12.37,
          "market_share": 29.35
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 16.72,
            "2021": 18.46,
            "2022": 20.74,
            "2023": 23.36,
            "2024": 25.63,
            "2025": 28.95,
            "2026": 32.33,
            "2027": 37.04,
            "2028": 40.87,
            "2029": 45.21,
            "2030": 50.91,
            "2031": 57.29,
            "2032": 65.49
          },
          "cagr": 12.37,
          "market_share": 23.6
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 33.35,
            "2021": 36.81,
            "2022": 41.36,
            "2023": 46.57,
            "2024": 51.1,
            "2025": 57.73,
            "2026": 64.46,
            "2027": 73.86,
            "2028": 81.5,
            "2029": 90.16,
            "2030": 101.5,
            "2031": 114.23,
            "2032": 130.59
          },
          "cagr": 12.37,
          "market_share": 47.05
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 29.17,
            "2021": 32.2,
            "2022": 36.18,
            "2023": 40.74,
            "2024": 44.71,
            "2025": 50.5,
            "2026": 56.39,
            "2027": 64.61,
            "2028": 71.29,
            "2029": 78.87,
            "2030": 88.8,
            "2031": 99.93,
            "2032": 114.24
          },
          "cagr": 12.37,
          "market_share": 41.17
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 41.69,
            "2021": 46.02,
            "2022": 51.71,
            "2023": 58.23,
            "2024": 63.89,
            "2025": 72.18,
            "2026": 80.59,
            "2027": 92.35,
            "2028": 101.89,
            "2029": 112.71,
            "2030": 126.9,
            "2031": 142.82,
            "2032": 163.27
          },
          "cagr": 12.37,
          "market_share": 58.83
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 23.62,
            "2021": 27.64,
            "2022": 30.92,
            "2023": 35.23,
            "2024": 41.33,
            "2025": 48.14,
            "2026": 54.0,
            "2027": 62.44,
            "2028": 71.02,
            "2029": 83.11,
            "2030": 92.53,
            "2031": 107.09,
            "2032": 123.86
          },
          "cagr": 14.45,
          "market_share": 21.54
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 28.23,
            "2021": 33.03,
            "2022": 36.95,
            "2023": 42.11,
            "2024": 49.4,
            "2025": 57.53,
            "2026": 64.53,
            "2027": 74.62,
            "2028": 84.87,
            "2029": 99.33,
            "2030": 110.58,
            "2031": 127.98,
            "2032": 148.02
          },
          "cagr": 14.45,
          "market_share": 25.74
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 19.25,
            "2021": 22.52,
            "2022": 25.2,
            "2023": 28.71,
            "2024": 33.68,
            "2025": 39.23,
            "2026": 44.0,
            "2027": 50.88,
            "2028": 57.87,
            "2029": 67.73,
            "2030": 75.4,
            "2031": 87.27,
            "2032": 100.93
          },
          "cagr": 14.45,
          "market_share": 17.55
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 22.78,
            "2021": 26.66,
            "2022": 29.83,
            "2023": 33.99,
            "2024": 39.88,
            "2025": 46.44,
            "2026": 52.09,
            "2027": 60.24,
            "2028": 68.51,
            "2029": 80.18,
            "2030": 89.26,
            "2031": 103.31,
            "2032": 119.49
          },
          "cagr": 14.45,
          "market_share": 20.78
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 15.77,
            "2021": 18.46,
            "2022": 20.65,
            "2023": 23.53,
            "2024": 27.6,
            "2025": 32.16,
            "2026": 36.06,
            "2027": 41.7,
            "2028": 47.42,
            "2029": 55.51,
            "2030": 61.79,
            "2031": 71.53,
            "2032": 82.71
          },
          "cagr": 14.45,
          "market_share": 14.38
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 28.3,
            "2021": 33.12,
            "2022": 37.05,
            "2023": 42.22,
            "2024": 49.53,
            "2025": 57.69,
            "2026": 64.7,
            "2027": 74.83,
            "2028": 85.1,
            "2029": 99.6,
            "2030": 110.88,
            "2031": 128.33,
            "2032": 148.42
          },
          "cagr": 14.45,
          "market_share": 25.81
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 26.59,
            "2021": 31.12,
            "2022": 34.81,
            "2023": 39.67,
            "2024": 46.54,
            "2025": 54.2,
            "2026": 60.79,
            "2027": 70.3,
            "2028": 79.96,
            "2029": 93.58,
            "2030": 104.18,
            "2031": 120.58,
            "2032": 139.45
          },
          "cagr": 14.45,
          "market_share": 24.25
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 24.29,
            "2021": 28.43,
            "2022": 31.8,
            "2023": 36.24,
            "2024": 42.52,
            "2025": 49.52,
            "2026": 55.54,
            "2027": 64.23,
            "2028": 73.05,
            "2029": 85.49,
            "2030": 95.17,
            "2031": 110.16,
            "2032": 127.4
          },
          "cagr": 14.45,
          "market_share": 22.16
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 13.08,
            "2021": 15.31,
            "2022": 17.12,
            "2023": 19.51,
            "2024": 22.89,
            "2025": 26.66,
            "2026": 29.9,
            "2027": 34.58,
            "2028": 39.33,
            "2029": 46.03,
            "2030": 51.24,
            "2031": 59.31,
            "2032": 68.6
          },
          "cagr": 14.46,
          "market_share": 11.93
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 17.39,
            "2021": 20.33,
            "2022": 22.77,
            "2023": 25.93,
            "2024": 30.41,
            "2025": 35.43,
            "2026": 39.75,
            "2027": 45.94,
            "2028": 52.25,
            "2029": 61.16,
            "2030": 68.09,
            "2031": 78.8,
            "2032": 91.14
          },
          "cagr": 14.45,
          "market_share": 15.85
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 38.75,
            "2021": 45.35,
            "2022": 50.73,
            "2023": 57.81,
            "2024": 67.82,
            "2025": 78.99,
            "2026": 88.59,
            "2027": 102.45,
            "2028": 116.52,
            "2029": 136.37,
            "2030": 151.81,
            "2031": 175.71,
            "2032": 203.22
          },
          "cagr": 14.45,
          "market_share": 35.34
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 70.9,
            "2021": 82.96,
            "2022": 92.82,
            "2023": 105.76,
            "2024": 124.07,
            "2025": 144.51,
            "2026": 162.09,
            "2027": 187.43,
            "2028": 213.17,
            "2029": 249.49,
            "2030": 277.75,
            "2031": 321.47,
            "2032": 371.79
          },
          "cagr": 14.45,
          "market_share": 64.66
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 47.48,
            "2021": 55.56,
            "2022": 62.16,
            "2023": 70.83,
            "2024": 83.1,
            "2025": 96.78,
            "2026": 108.55,
            "2027": 125.53,
            "2028": 142.77,
            "2029": 167.09,
            "2030": 186.02,
            "2031": 215.3,
            "2032": 249.0
          },
          "cagr": 14.45,
          "market_share": 43.31
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 62.17,
            "2021": 72.75,
            "2022": 81.39,
            "2023": 92.74,
            "2024": 108.79,
            "2025": 126.72,
            "2026": 142.13,
            "2027": 164.35,
            "2028": 186.92,
            "2029": 218.77,
            "2030": 243.54,
            "2031": 281.88,
            "2032": 326.01
          },
          "cagr": 14.45,
          "market_share": 56.69
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 25.15,
            "2021": 29.43,
            "2022": 32.93,
            "2023": 37.52,
            "2024": 44.02,
            "2025": 51.27,
            "2026": 57.5,
            "2027": 66.49,
            "2028": 75.63,
            "2029": 88.51,
            "2030": 98.53,
            "2031": 114.04,
            "2032": 131.9
          },
          "cagr": 14.45,
          "market_share": 22.94
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 47.63,
            "2021": 55.73,
            "2022": 62.35,
            "2023": 71.05,
            "2024": 83.35,
            "2025": 97.08,
            "2026": 108.88,
            "2027": 125.91,
            "2028": 143.21,
            "2029": 167.6,
            "2030": 186.59,
            "2031": 215.96,
            "2032": 249.77
          },
          "cagr": 14.45,
          "market_share": 43.44
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 36.87,
            "2021": 43.15,
            "2022": 48.27,
            "2023": 55.0,
            "2024": 64.52,
            "2025": 75.15,
            "2026": 84.3,
            "2027": 97.48,
            "2028": 110.85,
            "2029": 129.75,
            "2030": 144.44,
            "2031": 167.18,
            "2032": 193.34
          },
          "cagr": 14.45,
          "market_share": 33.62
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 62.77,
            "2021": 73.46,
            "2022": 82.18,
            "2023": 93.64,
            "2024": 109.86,
            "2025": 127.95,
            "2026": 143.52,
            "2027": 165.96,
            "2028": 188.75,
            "2029": 220.91,
            "2030": 245.93,
            "2031": 284.64,
            "2032": 329.2
          },
          "cagr": 14.45,
          "market_share": 57.25
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 46.88,
            "2021": 54.85,
            "2022": 61.37,
            "2023": 69.93,
            "2024": 82.03,
            "2025": 95.55,
            "2026": 107.16,
            "2027": 123.92,
            "2028": 140.94,
            "2029": 164.95,
            "2030": 183.63,
            "2031": 212.54,
            "2032": 245.81
          },
          "cagr": 14.45,
          "market_share": 42.75
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 18.44,
            "2021": 20.32,
            "2022": 22.12,
            "2023": 23.32,
            "2024": 25.09,
            "2025": 27.54,
            "2026": 30.47,
            "2027": 32.76,
            "2028": 34.76,
            "2029": 37.79,
            "2030": 41.86,
            "2031": 44.84,
            "2032": 48.36
          },
          "cagr": 8.38,
          "market_share": 28.88
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 12.72,
            "2021": 14.02,
            "2022": 15.26,
            "2023": 16.08,
            "2024": 17.31,
            "2025": 19.0,
            "2026": 21.02,
            "2027": 22.6,
            "2028": 23.98,
            "2029": 26.07,
            "2030": 28.88,
            "2031": 30.93,
            "2032": 33.36
          },
          "cagr": 8.37,
          "market_share": 19.92
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 10.24,
            "2021": 11.29,
            "2022": 12.29,
            "2023": 12.95,
            "2024": 13.94,
            "2025": 15.3,
            "2026": 16.93,
            "2027": 18.2,
            "2028": 19.31,
            "2029": 20.99,
            "2030": 23.26,
            "2031": 24.91,
            "2032": 26.87
          },
          "cagr": 8.38,
          "market_share": 16.05
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 7.6,
            "2021": 8.37,
            "2022": 9.11,
            "2023": 9.61,
            "2024": 10.34,
            "2025": 11.35,
            "2026": 12.56,
            "2027": 13.5,
            "2028": 14.33,
            "2029": 15.57,
            "2030": 17.25,
            "2031": 18.48,
            "2032": 19.93
          },
          "cagr": 8.38,
          "market_share": 11.9
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 14.84,
            "2021": 16.35,
            "2022": 17.79,
            "2023": 18.76,
            "2024": 20.2,
            "2025": 22.17,
            "2026": 24.52,
            "2027": 26.36,
            "2028": 27.96,
            "2029": 30.41,
            "2030": 33.67,
            "2031": 36.09,
            "2032": 38.91
          },
          "cagr": 8.37,
          "market_share": 23.25
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 15.47,
            "2021": 17.05,
            "2022": 18.55,
            "2023": 19.56,
            "2024": 21.05,
            "2025": 23.1,
            "2026": 25.56,
            "2027": 27.48,
            "2028": 29.16,
            "2029": 31.7,
            "2030": 35.11,
            "2031": 37.62,
            "2032": 40.57
          },
          "cagr": 8.38,
          "market_share": 24.23
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 12.09,
            "2021": 13.32,
            "2022": 14.5,
            "2023": 15.28,
            "2024": 16.45,
            "2025": 18.05,
            "2026": 19.98,
            "2027": 21.47,
            "2028": 22.79,
            "2029": 24.77,
            "2030": 27.44,
            "2031": 29.4,
            "2032": 31.7
          },
          "cagr": 8.38,
          "market_share": 18.93
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 8.72,
            "2021": 9.6,
            "2022": 10.45,
            "2023": 11.02,
            "2024": 11.86,
            "2025": 13.02,
            "2026": 14.4,
            "2027": 15.48,
            "2028": 16.43,
            "2029": 17.86,
            "2030": 19.79,
            "2031": 21.2,
            "2032": 22.86
          },
          "cagr": 8.37,
          "market_share": 13.65
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 17.93,
            "2021": 19.75,
            "2022": 21.5,
            "2023": 22.67,
            "2024": 24.39,
            "2025": 26.77,
            "2026": 29.62,
            "2027": 31.85,
            "2028": 33.79,
            "2029": 36.74,
            "2030": 40.69,
            "2031": 43.59,
            "2032": 47.01
          },
          "cagr": 8.38,
          "market_share": 28.07
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 9.63,
            "2021": 10.63,
            "2022": 11.57,
            "2023": 12.19,
            "2024": 13.13,
            "2025": 14.42,
            "2026": 15.94,
            "2027": 17.14,
            "2028": 18.17,
            "2029": 19.76,
            "2030": 21.89,
            "2031": 23.44,
            "2032": 25.29
          },
          "cagr": 8.36,
          "market_share": 15.11
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 38.51,
            "2021": 42.44,
            "2022": 46.19,
            "2023": 48.69,
            "2024": 52.41,
            "2025": 57.52,
            "2026": 63.64,
            "2027": 68.42,
            "2028": 72.59,
            "2029": 78.92,
            "2030": 87.42,
            "2031": 93.65,
            "2032": 101.0
          },
          "cagr": 8.37,
          "market_share": 60.32
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 25.33,
            "2021": 27.91,
            "2022": 30.38,
            "2023": 32.03,
            "2024": 34.47,
            "2025": 37.84,
            "2026": 41.86,
            "2027": 45.0,
            "2028": 47.75,
            "2029": 51.91,
            "2030": 57.5,
            "2031": 61.6,
            "2032": 66.43
          },
          "cagr": 8.37,
          "market_share": 39.68
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 38.28,
            "2021": 42.18,
            "2022": 45.91,
            "2023": 48.4,
            "2024": 52.09,
            "2025": 57.17,
            "2026": 63.26,
            "2027": 68.0,
            "2028": 72.15,
            "2029": 78.44,
            "2030": 86.89,
            "2031": 93.08,
            "2032": 100.39
          },
          "cagr": 8.38,
          "market_share": 59.96
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 25.56,
            "2021": 28.17,
            "2022": 30.66,
            "2023": 32.32,
            "2024": 34.79,
            "2025": 38.19,
            "2026": 42.24,
            "2027": 45.42,
            "2028": 48.19,
            "2029": 52.39,
            "2030": 58.03,
            "2031": 62.17,
            "2032": 67.04
          },
          "cagr": 8.37,
          "market_share": 40.04
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 18.25,
            "2021": 20.11,
            "2022": 21.89,
            "2023": 23.08,
            "2024": 24.84,
            "2025": 27.26,
            "2026": 30.16,
            "2027": 32.43,
            "2028": 34.41,
            "2029": 37.41,
            "2030": 41.43,
            "2031": 44.39,
            "2032": 47.87
          },
          "cagr": 8.38,
          "market_share": 28.59
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 26.79,
            "2021": 29.52,
            "2022": 32.13,
            "2023": 33.87,
            "2024": 36.46,
            "2025": 40.02,
            "2026": 44.27,
            "2027": 47.59,
            "2028": 50.5,
            "2029": 54.9,
            "2030": 60.81,
            "2031": 65.15,
            "2032": 70.26
          },
          "cagr": 8.37,
          "market_share": 41.97
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 18.8,
            "2021": 20.72,
            "2022": 22.55,
            "2023": 23.77,
            "2024": 25.58,
            "2025": 28.08,
            "2026": 31.07,
            "2027": 33.4,
            "2028": 35.43,
            "2029": 38.52,
            "2030": 42.68,
            "2031": 45.71,
            "2032": 49.3
          },
          "cagr": 8.37,
          "market_share": 29.44
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 40.93,
            "2021": 45.11,
            "2022": 49.09,
            "2023": 51.76,
            "2024": 55.7,
            "2025": 61.14,
            "2026": 67.65,
            "2027": 72.72,
            "2028": 77.16,
            "2029": 83.89,
            "2030": 92.92,
            "2031": 99.54,
            "2032": 107.35
          },
          "cagr": 8.37,
          "market_share": 64.11
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 22.91,
            "2021": 25.24,
            "2022": 27.48,
            "2023": 28.96,
            "2024": 31.18,
            "2025": 34.22,
            "2026": 37.85,
            "2027": 40.7,
            "2028": 43.18,
            "2029": 46.94,
            "2030": 52.0,
            "2031": 55.71,
            "2032": 60.08
          },
          "cagr": 8.37,
          "market_share": 35.89
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 70.39,
            "2021": 78.55,
            "2022": 87.0,
            "2023": 97.7,
            "2024": 110.19,
            "2025": 123.15,
            "2026": 138.45,
            "2027": 154.65,
            "2028": 171.97,
            "2029": 188.47000000000003,
            "2030": 213.94,
            "2031": 239.89000000000001,
            "2032": 268.25
          },
          "cagr": 11.395,
          "market_share": 83.35
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 64.69,
            "2021": 72.37,
            "2022": 80.42,
            "2023": 90.35,
            "2024": 102.24000000000001,
            "2025": 114.54,
            "2026": 128.76999999999998,
            "2027": 143.92000000000002,
            "2028": 160.2,
            "2029": 175.93,
            "2030": 199.82,
            "2031": 224.82,
            "2032": 251.8
          },
          "cagr": 11.395,
          "market_share": 73.65
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 36.25,
            "2021": 40.43,
            "2022": 44.769999999999996,
            "2023": 50.269999999999996,
            "2024": 56.68,
            "2025": 63.36,
            "2026": 71.23,
            "2027": 79.55,
            "2028": 88.46000000000001,
            "2029": 96.93,
            "2030": 110.02,
            "2031": 123.35,
            "2032": 137.91
          },
          "cagr": 11.39,
          "market_share": 43.0
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 100.31,
            "2021": 112.0,
            "2022": 124.17,
            "2023": 139.44,
            "2024": 157.41,
            "2025": 176.06,
            "2026": 197.94,
            "2027": 221.12,
            "2028": 245.95999999999998,
            "2029": 269.71,
            "2030": 306.21,
            "2031": 343.69,
            "2032": 384.48
          },
          "cagr": 11.395,
          "market_share": 117.47
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 71.02,
            "2021": 79.35,
            "2022": 88.02000000000001,
            "2023": 98.88,
            "2024": 111.7,
            "2025": 124.99,
            "2026": 140.51,
            "2027": 157.0,
            "2028": 174.67000000000002,
            "2029": 191.61999999999998,
            "2030": 217.57,
            "2031": 244.37,
            "2032": 273.48
          },
          "cagr": 11.395,
          "market_share": 82.53
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 86.5,
            "2021": 97.08999999999999,
            "2022": 108.3,
            "2023": 121.75,
            "2024": 138.32999999999998,
            "2025": 155.37,
            "2026": 174.64999999999998,
            "2027": 195.38,
            "2028": 217.7,
            "2029": 239.66,
            "2030": 272.42,
            "2031": 307.64,
            "2032": 345.15999999999997
          },
          "cagr": 11.395,
          "market_share": 93.87
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 84.83000000000001,
            "2021": 94.25999999999999,
            "2022": 103.89,
            "2023": 116.57,
            "2024": 130.78,
            "2025": 145.68,
            "2026": 163.8,
            "2027": 182.74,
            "2028": 202.93,
            "2029": 221.67000000000002,
            "2030": 251.36,
            "2031": 280.42,
            "2032": 312.79999999999995
          },
          "cagr": 11.395,
          "market_share": 106.13
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 37.26,
            "2021": 41.75,
            "2022": 46.49,
            "2023": 52.230000000000004,
            "2024": 59.25,
            "2025": 66.47,
            "2026": 74.7,
            "2027": 83.55,
            "2028": 93.03,
            "2029": 102.31,
            "2030": 116.25,
            "2031": 131.04000000000002,
            "2032": 146.89
          },
          "cagr": 11.395,
          "market_share": 41.4
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 30.150000000000002,
            "2021": 33.72,
            "2022": 37.45,
            "2023": 42.07,
            "2024": 47.58,
            "2025": 53.28,
            "2026": 59.900000000000006,
            "2027": 66.94,
            "2028": 74.5,
            "2029": 81.78,
            "2030": 92.88,
            "2031": 104.44,
            "2032": 116.94
          },
          "cagr": 11.395,
          "market_share": 34.58
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 35.18000000000001,
            "2021": 39.09,
            "2022": 43.09,
            "2023": 48.36,
            "2024": 54.25,
            "2025": 60.43,
            "2026": 67.95,
            "2027": 75.81,
            "2028": 84.18,
            "2029": 91.96000000000001,
            "2030": 104.28,
            "2031": 116.34,
            "2032": 129.78
          },
          "cagr": 11.395,
          "market_share": 43.989999999999995
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 29.71,
            "2021": 33.35,
            "2022": 37.199999999999996,
            "2023": 41.83,
            "2024": 47.53,
            "2025": 53.39,
            "2026": 60.03,
            "2027": 67.14,
            "2028": 74.83,
            "2029": 82.37,
            "2030": 93.64,
            "2031": 105.76,
            "2032": 118.67
          },
          "cagr": 11.395,
          "market_share": 32.18
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 39.03,
            "2021": 43.44,
            "2022": 47.96,
            "2023": 53.83,
            "2024": 60.5,
            "2025": 67.47999999999999,
            "2026": 75.87,
            "2027": 84.68,
            "2028": 94.09,
            "2029": 102.91,
            "2030": 116.72999999999999,
            "2031": 130.48,
            "2032": 145.68
          },
          "cagr": 11.395,
          "market_share": 47.86
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 107.35,
            "2021": 119.83000000000001,
            "2022": 132.79,
            "2023": 149.12,
            "2024": 168.26,
            "2025": 188.14,
            "2026": 211.51,
            "2027": 236.27,
            "2028": 262.78,
            "2029": 288.07,
            "2030": 327.02,
            "2031": 366.89,
            "2032": 410.37
          },
          "cagr": 11.395,
          "market_share": 126.38
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 63.98,
            "2021": 71.52000000000001,
            "2022": 79.4,
            "2023": 89.2,
            "2024": 100.85,
            "2025": 112.91,
            "2026": 126.94,
            "2027": 141.85,
            "2028": 157.85,
            "2029": 173.26,
            "2030": 196.76,
            "2031": 221.17000000000002,
            "2032": 247.59
          },
          "cagr": 11.395,
          "market_share": 73.62
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 43.31,
            "2021": 48.39,
            "2022": 53.67999999999999,
            "2023": 60.29,
            "2024": 68.1,
            "2025": 76.2,
            "2026": 85.67,
            "2027": 95.73,
            "2028": 106.49,
            "2029": 116.83000000000001,
            "2030": 132.65,
            "2031": 149.0,
            "2032": 166.73000000000002
          },
          "cagr": 11.395,
          "market_share": 50.33
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 31.770000000000003,
            "2021": 35.39,
            "2022": 39.11,
            "2023": 43.92,
            "2024": 49.43,
            "2025": 55.17,
            "2026": 62.02,
            "2027": 69.23,
            "2028": 76.94,
            "2029": 84.22,
            "2030": 95.55000000000001,
            "2031": 106.9,
            "2032": 119.43
          },
          "cagr": 11.395,
          "market_share": 38.540000000000006
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 32.88,
            "2021": 36.8,
            "2022": 40.93,
            "2023": 45.98,
            "2024": 52.080000000000005,
            "2025": 58.37,
            "2026": 65.62,
            "2027": 73.35,
            "2028": 81.67,
            "2029": 89.72,
            "2030": 101.93,
            "2031": 114.75,
            "2032": 128.56
          },
          "cagr": 11.395,
          "market_share": 37.120000000000005
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 38.26,
            "2021": 42.81,
            "2022": 47.57,
            "2023": 53.45,
            "2024": 60.48,
            "2025": 67.77000000000001,
            "2026": 76.18,
            "2027": 85.15,
            "2028": 94.78,
            "2029": 104.09,
            "2030": 118.22999999999999,
            "2031": 133.03,
            "2032": 148.99
          },
          "cagr": 11.395,
          "market_share": 43.53
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 25.11,
            "2021": 27.96,
            "2022": 30.9,
            "2023": 34.68,
            "2024": 39.019999999999996,
            "2025": 43.540000000000006,
            "2026": 48.96,
            "2027": 54.66,
            "2028": 60.75,
            "2029": 66.47,
            "2030": 75.42,
            "2031": 84.38,
            "2032": 94.25
          },
          "cagr": 11.395,
          "market_share": 30.480000000000004
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 90.1,
            "2021": 99.71,
            "2022": 111.31,
            "2023": 125.99000000000001,
            "2024": 139.64,
            "2025": 157.68,
            "2026": 175.26,
            "2027": 196.20999999999998,
            "2028": 217.22,
            "2029": 245.48000000000002,
            "2030": 274.78000000000003,
            "2031": 306.55,
            "2032": 343.44
          },
          "cagr": 11.37,
          "market_share": 97.57
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 127.66000000000001,
            "2021": 142.3,
            "2022": 158.87,
            "2023": 179.89999999999998,
            "2024": 198.38,
            "2025": 224.2,
            "2026": 251.01999999999998,
            "2027": 281.53,
            "2028": 313.08,
            "2029": 351.35,
            "2030": 396.63,
            "2031": 443.86,
            "2032": 498.63
          },
          "cagr": 11.37,
          "market_share": 134.16000000000003
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 168.16,
            "2021": 187.63,
            "2022": 209.84,
            "2023": 239.18,
            "2024": 264.63,
            "2025": 299.67,
            "2026": 336.44,
            "2027": 376.30999999999995,
            "2028": 420.2,
            "2029": 474.21,
            "2030": 535.6899999999999,
            "2031": 599.5799999999999,
            "2032": 676.74
          },
          "cagr": 11.37,
          "market_share": 168.25
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 190.45,
            "2021": 212.61000000000004,
            "2022": 237.71,
            "2023": 270.73999999999995,
            "2024": 299.28,
            "2025": 338.75,
            "2026": 380.16999999999996,
            "2027": 425.01,
            "2028": 474.49,
            "2029": 535.45,
            "2030": 604.5,
            "2031": 676.3700000000001,
            "2032": 763.45
          },
          "cagr": 11.367499999999998,
          "market_share": 190.66
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 195.47,
            "2021": 217.03000000000003,
            "2022": 242.31,
            "2023": 274.33,
            "2024": 303.37,
            "2025": 342.8,
            "2026": 382.55,
            "2027": 429.03999999999996,
            "2028": 476.01,
            "2029": 535.59,
            "2030": 602.6,
            "2031": 673.62,
            "2032": 755.36
          },
          "cagr": 11.37,
          "market_share": 209.33
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 235.45999999999998,
            "2021": 262.06,
            "2022": 292.91999999999996,
            "2023": 333.12,
            "2024": 368.75,
            "2025": 417.21,
            "2026": 466.96,
            "2027": 522.47,
            "2028": 581.86,
            "2029": 656.86,
            "2030": 739.9699999999999,
            "2031": 827.4200000000001,
            "2032": 931.79
          },
          "cagr": 11.37,
          "market_share": 241.74
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 150.46,
            "2021": 167.57999999999998,
            "2022": 187.1,
            "2023": 211.95,
            "2024": 233.9,
            "2025": 264.34,
            "2026": 295.76,
            "2027": 331.58,
            "2028": 368.64,
            "2029": 414.18,
            "2030": 467.13000000000005,
            "2031": 522.5699999999999,
            "2032": 587.02
          },
          "cagr": 11.37,
          "market_share": 158.25
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 75.03,
            "2021": 83.84,
            "2022": 93.85999999999999,
            "2023": 107.23,
            "2024": 118.66,
            "2025": 134.75,
            "2026": 152.14999999999998,
            "2027": 171.18,
            "2028": 191.51,
            "2029": 214.57000000000002,
            "2030": 244.60999999999999,
            "2031": 274.9,
            "2032": 309.84000000000003
          },
          "cagr": 11.367499999999998,
          "market_share": 75.35
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 83.63000000000001,
            "2021": 92.91,
            "2022": 103.72,
            "2023": 117.41000000000001,
            "2024": 129.76999999999998,
            "2025": 146.56,
            "2026": 163.44,
            "2027": 182.94,
            "2028": 203.01999999999998,
            "2029": 228.89999999999998,
            "2030": 257.03000000000003,
            "2031": 287.06,
            "2032": 322.29
          },
          "cagr": 11.37,
          "market_share": 88.71999999999998
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 69.29,
            "2021": 77.35,
            "2022": 86.49000000000001,
            "2023": 98.54,
            "2024": 108.96000000000001,
            "2025": 123.32,
            "2026": 138.4,
            "2027": 154.64,
            "2028": 172.69,
            "2029": 195.03,
            "2030": 220.08,
            "2031": 246.2,
            "2032": 278.02
          },
          "cagr": 11.37,
          "market_share": 69.05000000000001
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 77.94,
            "2021": 86.35,
            "2022": 96.31,
            "2023": 108.75999999999999,
            "2024": 120.28,
            "2025": 135.63,
            "2026": 150.59999999999997,
            "2027": 168.41,
            "2028": 186.32,
            "2029": 210.46999999999997,
            "2030": 235.22,
            "2031": 262.17,
            "2032": 293.72
          },
          "cagr": 11.37,
          "market_share": 84.61
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 80.03,
            "2021": 89.19,
            "2022": 99.64,
            "2023": 113.13,
            "2024": 124.98,
            "2025": 141.29,
            "2026": 158.13,
            "2027": 176.88,
            "2028": 196.96,
            "2029": 222.07,
            "2030": 250.16,
            "2031": 279.65999999999997,
            "2032": 314.94
          },
          "cagr": 11.3675,
          "market_share": 82.27
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 170.26,
            "2021": 189.93,
            "2022": 212.25,
            "2023": 241.31,
            "2024": 266.59,
            "2025": 301.61,
            "2026": 338.13,
            "2027": 378.36,
            "2028": 421.84,
            "2029": 475.37,
            "2030": 536.49,
            "2031": 600.21,
            "2032": 676.47
          },
          "cagr": 11.37,
          "market_share": 173.22
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 215.66,
            "2021": 239.71000000000004,
            "2022": 267.77,
            "2023": 303.76,
            "2024": 336.06,
            "2025": 379.94,
            "2026": 424.59000000000003,
            "2027": 475.69,
            "2028": 528.66,
            "2029": 595.67,
            "2030": 670.61,
            "2031": 749.7800000000001,
            "2032": 842.3399999999999
          },
          "cagr": 11.37,
          "market_share": 226.77
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 82.75,
            "2021": 92.33,
            "2022": 103.33999999999999,
            "2023": 118.14,
            "2024": 130.96,
            "2025": 148.49,
            "2026": 166.9,
            "2027": 186.64,
            "2028": 208.70999999999998,
            "2029": 235.96,
            "2030": 266.79,
            "2031": 298.74,
            "2032": 337.65
          },
          "cagr": 11.367499999999998,
          "market_share": 81.36
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 65.44,
            "2021": 72.75,
            "2022": 81.34,
            "2023": 92.39999999999999,
            "2024": 102.29,
            "2025": 115.78,
            "2026": 129.65999999999997,
            "2027": 145.41,
            "2028": 161.83,
            "2029": 182.13,
            "2030": 205.54999999999998,
            "2031": 230.07999999999998,
            "2032": 258.58
          },
          "cagr": 11.37,
          "market_share": 68.36
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 77.55,
            "2021": 86.33,
            "2022": 96.37,
            "2023": 109.07999999999998,
            "2024": 120.35000000000001,
            "2025": 135.98000000000002,
            "2026": 152.04999999999998,
            "2027": 170.53,
            "2028": 189.45999999999998,
            "2029": 212.76000000000002,
            "2030": 239.88,
            "2031": 268.33,
            "2032": 301.21
          },
          "cagr": 11.37,
          "market_share": 82.15
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 78.21000000000001,
            "2021": 87.0,
            "2022": 97.14,
            "2023": 110.2,
            "2024": 121.83999999999999,
            "2025": 137.53,
            "2026": 153.32,
            "2027": 170.94000000000003,
            "2028": 190.01999999999998,
            "2029": 215.27999999999997,
            "2030": 241.08999999999997,
            "2031": 268.82,
            "2032": 302.81
          },
          "cagr": 11.37,
          "market_share": 80.67
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 81.97,
            "2021": 91.23,
            "2022": 101.83,
            "2023": 115.25,
            "2024": 127.21000000000001,
            "2025": 143.76999999999998,
            "2026": 160.79000000000002,
            "2027": 180.53,
            "2028": 200.48,
            "2029": 224.91,
            "2030": 253.79,
            "2031": 284.02,
            "2032": 318.56
          },
          "cagr": 11.37,
          "market_share": 87.46000000000001
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 255.02999999999997,
            "2021": 285.4,
            "2022": 318.03000000000003,
            "2023": 350.35,
            "2024": 391.96999999999997,
            "2025": 438.85,
            "2026": 486.61000000000007,
            "2027": 543.5899999999999,
            "2028": 611.97,
            "2029": 682.59,
            "2030": 762.12,
            "2031": 839.22,
            "2032": 951.35
          },
          "cagr": 10.958571428571428,
          "market_share": 259.77
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 202.82,
            "2021": 226.1,
            "2022": 251.3,
            "2023": 276.51,
            "2024": 308.94,
            "2025": 344.51,
            "2026": 381.52,
            "2027": 425.06,
            "2028": 477.78000000000003,
            "2029": 531.95,
            "2030": 592.21,
            "2031": 650.94,
            "2032": 736.0699999999999
          },
          "cagr": 10.959999999999999,
          "market_share": 214.53
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 242.63,
            "2021": 270.90999999999997,
            "2022": 302.01,
            "2023": 333.71999999999997,
            "2024": 373.62000000000006,
            "2025": 418.28,
            "2026": 464.45,
            "2027": 518.84,
            "2028": 586.0600000000001,
            "2029": 653.3100000000001,
            "2030": 729.44,
            "2031": 804.24,
            "2032": 910.64
          },
          "cagr": 10.959999999999999,
          "market_share": 225.70999999999998
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 327.96,
            "2021": 365.86,
            "2022": 407.09000000000003,
            "2023": 448.5,
            "2024": 501.58,
            "2025": 560.17,
            "2026": 621.2,
            "2027": 693.08,
            "2028": 780.1899999999999,
            "2029": 869.1999999999999,
            "2030": 969.6200000000001,
            "2031": 1066.97,
            "2032": 1207.5800000000002
          },
          "cagr": 10.959999999999999,
          "market_share": 327.42999999999995
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 372.52,
            "2021": 416.55000000000007,
            "2022": 464.25,
            "2023": 512.08,
            "2024": 572.95,
            "2025": 641.47,
            "2026": 711.38,
            "2027": 794.4099999999999,
            "2028": 895.62,
            "2029": 998.65,
            "2030": 1114.15,
            "2031": 1227.4299999999998,
            "2032": 1390.48
          },
          "cagr": 10.958571428571428,
          "market_share": 372.58
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 325.24,
            "2021": 364.03,
            "2022": 406.36,
            "2023": 448.96999999999997,
            "2024": 503.31000000000006,
            "2025": 563.79,
            "2026": 626.5899999999999,
            "2027": 701.12,
            "2028": 792.16,
            "2029": 884.5600000000001,
            "2030": 989.3,
            "2031": 1090.96,
            "2032": 1239.3399999999997
          },
          "cagr": 10.959999999999999,
          "market_share": 321.95
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 375.24,
            "2021": 418.38,
            "2022": 464.98,
            "2023": 511.61,
            "2024": 571.22,
            "2025": 637.85,
            "2026": 705.99,
            "2027": 786.37,
            "2028": 883.65,
            "2029": 983.29,
            "2030": 1094.4699999999998,
            "2031": 1203.4399999999998,
            "2032": 1358.7199999999998
          },
          "cagr": 10.959999999999999,
          "market_share": 378.06
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 147.71999999999997,
            "2021": 164.86,
            "2022": 183.11,
            "2023": 200.86,
            "2024": 223.98999999999998,
            "2025": 250.2,
            "2026": 276.71,
            "2027": 307.93,
            "2028": 345.38,
            "2029": 384.4,
            "2030": 427.72,
            "2031": 470.10999999999996,
            "2032": 530.45
          },
          "cagr": 10.959999999999999,
          "market_share": 145.96
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 161.42999999999998,
            "2021": 179.9,
            "2022": 199.90999999999997,
            "2023": 219.61,
            "2024": 245.12,
            "2025": 273.64,
            "2026": 302.59999999999997,
            "2027": 337.03999999999996,
            "2028": 377.54,
            "2029": 420.0,
            "2030": 467.44,
            "2031": 513.38,
            "2032": 579.02
          },
          "cagr": 10.959999999999999,
          "market_share": 171.81
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 123.49,
            "2021": 138.35,
            "2022": 154.46,
            "2023": 170.82999999999998,
            "2024": 191.7,
            "2025": 214.70000000000002,
            "2026": 238.81,
            "2027": 267.58,
            "2028": 302.5,
            "2029": 337.94000000000005,
            "2030": 378.5400000000001,
            "2031": 417.45000000000005,
            "2032": 475.25999999999993
          },
          "cagr": 10.961428571428572,
          "market_share": 124.69
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 139.19,
            "2021": 155.9,
            "2022": 174.13,
            "2023": 192.81999999999996,
            "2024": 216.08000000000004,
            "2025": 242.50000000000003,
            "2026": 269.43,
            "2027": 301.37,
            "2028": 341.45,
            "2029": 381.1600000000001,
            "2030": 425.72999999999996,
            "2031": 470.15999999999997,
            "2032": 533.61
          },
          "cagr": 10.958571428571428,
          "market_share": 129.77
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 128.65,
            "2021": 143.39999999999998,
            "2022": 159.73000000000002,
            "2023": 176.45999999999998,
            "2024": 197.64000000000004,
            "2025": 220.6,
            "2026": 245.03000000000003,
            "2027": 273.57,
            "2028": 308.94000000000005,
            "2029": 344.34999999999997,
            "2030": 384.34000000000003,
            "2031": 423.29999999999995,
            "2032": 479.71999999999997
          },
          "cagr": 10.961428571428572,
          "market_share": 127.78
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 335.56,
            "2021": 374.34000000000003,
            "2022": 416.12,
            "2023": 458.01,
            "2024": 511.93,
            "2025": 571.24,
            "2026": 633.24,
            "2027": 706.04,
            "2028": 794.32,
            "2029": 884.8,
            "2030": 986.5999999999999,
            "2031": 1085.1200000000001,
            "2032": 1228.1799999999998
          },
          "cagr": 10.957142857142857,
          "market_share": 336.53000000000003
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 364.91999999999996,
            "2021": 408.07000000000005,
            "2022": 455.21999999999997,
            "2023": 502.57,
            "2024": 562.6,
            "2025": 630.4,
            "2026": 699.3400000000001,
            "2027": 781.4499999999999,
            "2028": 881.4900000000001,
            "2029": 983.05,
            "2030": 1097.1699999999998,
            "2031": 1209.28,
            "2032": 1369.88
          },
          "cagr": 10.959999999999999,
          "market_share": 363.47999999999996
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 132.29000000000002,
            "2021": 147.85,
            "2022": 164.89999999999998,
            "2023": 181.93,
            "2024": 203.75,
            "2025": 228.06,
            "2026": 253.16,
            "2027": 283.03,
            "2028": 318.92,
            "2029": 355.79999999999995,
            "2030": 397.6,
            "2031": 437.93999999999994,
            "2032": 496.63999999999993
          },
          "cagr": 10.959999999999999,
          "market_share": 135.22
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 115.39,
            "2021": 128.76,
            "2022": 143.23,
            "2023": 157.16,
            "2024": 175.46,
            "2025": 196.11,
            "2026": 217.04000000000002,
            "2027": 241.95000000000002,
            "2028": 270.87,
            "2029": 301.6700000000001,
            "2030": 336.29,
            "2031": 369.51,
            "2032": 417.09000000000003
          },
          "cagr": 10.957142857142857,
          "market_share": 119.17000000000002
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 149.60000000000002,
            "2021": 166.65,
            "2022": 185.64000000000001,
            "2023": 204.98000000000002,
            "2024": 229.42000000000002,
            "2025": 256.20000000000005,
            "2026": 284.40999999999997,
            "2027": 317.25,
            "2028": 358.12,
            "2029": 399.02,
            "2030": 444.83,
            "2031": 489.98,
            "2032": 554.21
          },
          "cagr": 10.961428571428572,
          "market_share": 145.42
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 154.79999999999998,
            "2021": 173.04000000000002,
            "2022": 193.0,
            "2023": 213.24,
            "2024": 238.8,
            "2025": 267.32,
            "2026": 296.71999999999997,
            "2027": 331.50000000000006,
            "2028": 374.42999999999995,
            "2029": 417.63,
            "2030": 466.03000000000003,
            "2031": 513.73,
            "2032": 582.39
          },
          "cagr": 10.959999999999999,
          "market_share": 155.13
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 148.39999999999998,
            "2021": 166.10999999999999,
            "2022": 184.57,
            "2023": 203.26999999999998,
            "2024": 227.10000000000002,
            "2025": 253.95000000000002,
            "2026": 281.25,
            "2027": 313.76,
            "2028": 353.47,
            "2029": 393.73,
            "2030": 439.02,
            "2031": 483.24,
            "2032": 547.7299999999999
          },
          "cagr": 10.961428571428572,
          "market_share": 145.07000000000002
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 283.14,
            "2021": 312.64,
            "2022": 352.60999999999996,
            "2023": 391.16999999999996,
            "2024": 436.39,
            "2025": 482.78999999999996,
            "2026": 539.34,
            "2027": 601.55,
            "2028": 668.69,
            "2029": 748.24,
            "2030": 830.21,
            "2031": 921.8600000000001,
            "2032": 1043.89
          },
          "cagr": 11.27,
          "market_share": 272.24
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 204.02,
            "2021": 225.19,
            "2022": 253.94,
            "2023": 281.92,
            "2024": 314.63,
            "2025": 347.14,
            "2026": 388.01000000000005,
            "2027": 432.06,
            "2028": 480.87999999999994,
            "2029": 536.51,
            "2030": 597.49,
            "2031": 662.27,
            "2032": 746.07
          },
          "cagr": 11.267142857142858,
          "market_share": 198.42000000000002
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 234.45000000000002,
            "2021": 259.27,
            "2022": 291.59000000000003,
            "2023": 323.92999999999995,
            "2024": 361.24,
            "2025": 398.42,
            "2026": 444.82,
            "2027": 496.42,
            "2028": 551.74,
            "2029": 614.8100000000001,
            "2030": 683.84,
            "2031": 758.06,
            "2032": 854.13
          },
          "cagr": 11.267142857142858,
          "market_share": 229.34000000000003
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 416.65,
            "2021": 460.74,
            "2022": 520.25,
            "2023": 578.26,
            "2024": 645.04,
            "2025": 713.69,
            "2026": 798.3000000000001,
            "2027": 891.1699999999998,
            "2028": 992.1399999999999,
            "2029": 1108.55,
            "2030": 1233.36,
            "2031": 1369.27,
            "2032": 1547.8500000000001
          },
          "cagr": 11.267142857142858,
          "market_share": 390.72999999999996
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 304.96,
            "2021": 336.36,
            "2022": 377.89,
            "2023": 418.76,
            "2024": 467.22,
            "2025": 514.66,
            "2026": 573.8699999999999,
            "2027": 638.86,
            "2028": 709.17,
            "2029": 791.01,
            "2030": 878.1800000000001,
            "2031": 972.92,
            "2032": 1096.24
          },
          "cagr": 11.268571428571429,
          "market_share": 309.27
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 318.82000000000005,
            "2021": 353.22999999999996,
            "2022": 398.67999999999995,
            "2023": 443.34999999999997,
            "2024": 495.46999999999997,
            "2025": 548.59,
            "2026": 614.1800000000001,
            "2027": 687.64,
            "2028": 764.29,
            "2029": 856.5999999999999,
            "2030": 952.6799999999998,
            "2031": 1059.25,
            "2032": 1200.54
          },
          "cagr": 11.267142857142858,
          "market_share": 311.4
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 402.79,
            "2021": 443.87,
            "2022": 499.46,
            "2023": 553.67,
            "2024": 616.79,
            "2025": 679.7600000000001,
            "2026": 757.99,
            "2027": 842.39,
            "2028": 937.02,
            "2029": 1042.96,
            "2030": 1158.8600000000001,
            "2031": 1282.94,
            "2032": 1443.55
          },
          "cagr": 11.267142857142858,
          "market_share": 388.61
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 157.17000000000002,
            "2021": 173.73000000000002,
            "2022": 197.13,
            "2023": 219.19,
            "2024": 245.17000000000002,
            "2025": 271.52,
            "2026": 305.17,
            "2027": 340.28,
            "2028": 379.59,
            "2029": 426.42,
            "2030": 475.09,
            "2031": 528.13,
            "2032": 598.44
          },
          "cagr": 11.272857142857143,
          "market_share": 147.86
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 125.50999999999999,
            "2021": 138.41,
            "2022": 155.37,
            "2023": 172.20000000000002,
            "2024": 191.95999999999998,
            "2025": 211.43999999999997,
            "2026": 235.32999999999998,
            "2027": 262.04999999999995,
            "2028": 290.88,
            "2029": 323.54,
            "2030": 359.59,
            "2031": 398.12,
            "2032": 447.79999999999995
          },
          "cagr": 11.267142857142858,
          "market_share": 126.32000000000001
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 154.01999999999998,
            "2021": 170.37,
            "2022": 191.93,
            "2023": 213.13,
            "2024": 237.44000000000003,
            "2025": 262.78,
            "2026": 293.46000000000004,
            "2027": 327.8,
            "2028": 364.34000000000003,
            "2029": 407.09000000000003,
            "2030": 451.29,
            "2031": 501.12,
            "2032": 567.48
          },
          "cagr": 11.26857142857143,
          "market_share": 144.22
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 155.20000000000002,
            "2021": 171.32999999999998,
            "2022": 192.46,
            "2023": 213.54999999999998,
            "2024": 238.12000000000003,
            "2025": 262.46,
            "2026": 292.71000000000004,
            "2027": 326.03999999999996,
            "2028": 361.99,
            "2029": 403.85,
            "2030": 448.78999999999996,
            "2031": 497.05000000000007,
            "2032": 559.23
          },
          "cagr": 11.267142857142858,
          "market_share": 155.0
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 129.71,
            "2021": 143.26,
            "2022": 161.25,
            "2023": 178.95,
            "2024": 199.57,
            "2025": 220.15,
            "2026": 245.5,
            "2027": 273.86,
            "2028": 304.51000000000005,
            "2029": 338.66,
            "2030": 376.78,
            "2031": 417.77,
            "2032": 471.14
          },
          "cagr": 11.267142857142858,
          "market_share": 126.63000000000001
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 387.0,
            "2021": 426.9,
            "2022": 481.07,
            "2023": 533.86,
            "2024": 594.9,
            "2025": 657.39,
            "2026": 733.15,
            "2027": 816.73,
            "2028": 908.25,
            "2029": 1012.9200000000001,
            "2030": 1126.5900000000001,
            "2031": 1248.7,
            "2032": 1407.54
          },
          "cagr": 11.267142857142858,
          "market_share": 370.11999999999995
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 334.60999999999996,
            "2021": 370.2,
            "2022": 417.06999999999994,
            "2023": 463.16,
            "2024": 517.36,
            "2025": 570.96,
            "2026": 639.02,
            "2027": 713.3,
            "2028": 793.0600000000001,
            "2029": 886.64,
            "2030": 984.95,
            "2031": 1093.49,
            "2032": 1236.5500000000002
          },
          "cagr": 11.267142857142858,
          "market_share": 329.88000000000005
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 142.73000000000002,
            "2021": 157.64,
            "2022": 177.95999999999998,
            "2023": 197.5,
            "2024": 220.49,
            "2025": 244.15999999999997,
            "2026": 272.69,
            "2027": 304.53999999999996,
            "2028": 338.49,
            "2029": 378.86,
            "2030": 421.02,
            "2031": 467.73,
            "2032": 529.78
          },
          "cagr": 11.270000000000001,
          "market_share": 138.31
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 130.17,
            "2021": 143.59,
            "2022": 161.22,
            "2023": 178.57,
            "2024": 199.34,
            "2025": 219.10000000000002,
            "2026": 244.43,
            "2027": 271.96,
            "2028": 302.13,
            "2029": 336.03999999999996,
            "2030": 373.02,
            "2031": 413.21000000000004,
            "2032": 465.67999999999995
          },
          "cagr": 11.27,
          "market_share": 133.29
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 138.5,
            "2021": 152.32,
            "2022": 171.4,
            "2023": 189.60000000000002,
            "2024": 211.06,
            "2025": 232.5,
            "2026": 259.15,
            "2027": 287.27,
            "2028": 319.58,
            "2029": 355.77,
            "2030": 393.96,
            "2031": 436.09000000000003,
            "2032": 491.55
          },
          "cagr": 11.271428571428572,
          "market_share": 132.22
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 153.02,
            "2021": 169.23,
            "2022": 190.89000000000001,
            "2023": 212.33,
            "2024": 236.64,
            "2025": 261.69,
            "2026": 292.66,
            "2027": 326.46000000000004,
            "2028": 363.34000000000003,
            "2029": 406.09000000000003,
            "2030": 452.15999999999997,
            "2031": 501.34000000000003,
            "2032": 564.88
          },
          "cagr": 11.267142857142858,
          "market_share": 142.99
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 157.19,
            "2021": 174.32,
            "2022": 196.67,
            "2023": 219.01999999999998,
            "2024": 244.73,
            "2025": 270.9,
            "2026": 303.24,
            "2027": 339.8,
            "2028": 377.77,
            "2029": 422.79999999999995,
            "2030": 471.38000000000005,
            "2031": 523.8199999999999,
            "2032": 592.2
          },
          "cagr": 11.27,
          "market_share": 153.17
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 92.25,
            "2021": 100.02000000000001,
            "2022": 110.52,
            "2023": 118.75999999999999,
            "2024": 131.31,
            "2025": 143.8,
            "2026": 155.95000000000002,
            "2027": 170.2,
            "2028": 184.0,
            "2029": 202.51,
            "2030": 222.65,
            "2031": 243.5,
            "2032": 266.01
          },
          "cagr": 9.26,
          "market_share": 97.96000000000001
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 97.21000000000001,
            "2021": 105.28999999999999,
            "2022": 117.09,
            "2023": 125.83999999999999,
            "2024": 138.98000000000002,
            "2025": 151.45,
            "2026": 165.57999999999998,
            "2027": 179.60000000000002,
            "2028": 193.44,
            "2029": 214.89999999999998,
            "2030": 233.73,
            "2031": 256.25,
            "2032": 279.73
          },
          "cagr": 9.263333333333334,
          "market_share": 99.4
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 95.72,
            "2021": 104.15,
            "2022": 115.07,
            "2023": 123.95,
            "2024": 136.87,
            "2025": 150.53,
            "2026": 163.9,
            "2027": 179.67,
            "2028": 194.07,
            "2029": 214.49,
            "2030": 236.26999999999998,
            "2031": 258.28,
            "2032": 283.14
          },
          "cagr": 9.26,
          "market_share": 102.64
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 124.66,
            "2021": 135.43,
            "2022": 149.73000000000002,
            "2023": 161.13,
            "2024": 178.0,
            "2025": 195.32999999999998,
            "2026": 212.51,
            "2027": 232.42000000000002,
            "2028": 251.04,
            "2029": 277.22,
            "2030": 304.86,
            "2031": 333.38,
            "2032": 364.95
          },
          "cagr": 9.26,
          "market_share": 132.71
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 160.51999999999998,
            "2021": 174.02999999999997,
            "2022": 192.95,
            "2023": 207.42,
            "2024": 229.16,
            "2025": 250.45,
            "2026": 272.92,
            "2027": 297.05,
            "2028": 320.46999999999997,
            "2029": 354.68,
            "2030": 387.79,
            "2031": 424.65,
            "2032": 463.92999999999995
          },
          "cagr": 9.26,
          "market_share": 167.29
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 138.37,
            "2021": 150.36,
            "2022": 166.82,
            "2023": 179.58999999999997,
            "2024": 198.19,
            "2025": 217.16,
            "2026": 237.41,
            "2027": 259.01,
            "2028": 279.19,
            "2029": 310.07,
            "2030": 339.22,
            "2031": 371.4,
            "2032": 406.65999999999997
          },
          "cagr": 9.26,
          "market_share": 144.73
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 146.81,
            "2021": 159.1,
            "2022": 175.86,
            "2023": 188.96,
            "2024": 208.97,
            "2025": 228.62,
            "2026": 248.01999999999998,
            "2027": 270.46,
            "2028": 292.32,
            "2029": 321.83000000000004,
            "2030": 353.43,
            "2031": 386.63,
            "2032": 422.22
          },
          "cagr": 9.26,
          "market_share": 155.27
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 62.47,
            "2021": 67.75999999999999,
            "2022": 75.11999999999999,
            "2023": 80.75,
            "2024": 89.21000000000001,
            "2025": 97.59,
            "2026": 106.33000000000001,
            "2027": 115.81,
            "2028": 124.94,
            "2029": 138.26999999999998,
            "2030": 151.3,
            "2031": 165.66,
            "2032": 181.05
          },
          "cagr": 9.256666666666668,
          "market_share": 65.34
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 48.28,
            "2021": 52.33,
            "2022": 58.18,
            "2023": 62.56,
            "2024": 69.07,
            "2025": 75.34,
            "2026": 82.41,
            "2027": 89.47,
            "2028": 96.36000000000001,
            "2029": 107.11000000000001,
            "2030": 116.56,
            "2031": 127.78,
            "2032": 139.57
          },
          "cagr": 9.26,
          "market_share": 49.49
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 57.06,
            "2021": 61.93,
            "2022": 68.63,
            "2023": 73.82,
            "2024": 81.54,
            "2025": 89.25999999999999,
            "2026": 97.32,
            "2027": 106.12,
            "2028": 114.49,
            "2029": 126.76,
            "2030": 138.82,
            "2031": 151.95,
            "2032": 166.2
          },
          "cagr": 9.26,
          "market_share": 59.82
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 60.49000000000001,
            "2021": 65.68,
            "2022": 72.52,
            "2023": 78.02000000000001,
            "2024": 86.22,
            "2025": 94.61,
            "2026": 102.7,
            "2027": 112.35,
            "2028": 121.46,
            "2029": 133.78,
            "2030": 147.33999999999997,
            "2031": 161.06,
            "2032": 176.21
          },
          "cagr": 9.263333333333334,
          "market_share": 64.67999999999999
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 56.88,
            "2021": 61.76,
            "2022": 68.23,
            "2023": 73.39999999999999,
            "2024": 81.12,
            "2025": 88.98,
            "2026": 96.66999999999999,
            "2027": 105.72,
            "2028": 114.25999999999999,
            "2029": 125.98000000000002,
            "2030": 138.63,
            "2031": 151.57999999999998,
            "2032": 165.85000000000002
          },
          "cagr": 9.263333333333334,
          "market_share": 60.669999999999995
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 140.05,
            "2021": 151.84,
            "2022": 168.0,
            "2023": 180.58,
            "2024": 199.61,
            "2025": 218.43,
            "2026": 237.37,
            "2027": 258.82,
            "2028": 279.56,
            "2029": 308.4,
            "2030": 338.3,
            "2031": 370.18,
            "2032": 404.45000000000005
          },
          "cagr": 9.26,
          "market_share": 147.62
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 145.13,
            "2021": 157.62,
            "2022": 174.68,
            "2023": 187.97000000000003,
            "2024": 207.55,
            "2025": 227.35000000000002,
            "2026": 248.06,
            "2027": 270.65000000000003,
            "2028": 291.95000000000005,
            "2029": 323.5,
            "2030": 354.35,
            "2031": 387.85,
            "2032": 424.43
          },
          "cagr": 9.26,
          "market_share": 152.38
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 57.019999999999996,
            "2021": 61.78,
            "2022": 68.54,
            "2023": 73.66,
            "2024": 81.39,
            "2025": 88.86,
            "2026": 96.87,
            "2027": 105.31,
            "2028": 113.58000000000001,
            "2029": 125.75999999999999,
            "2030": 137.33,
            "2031": 150.42000000000002,
            "2032": 164.26
          },
          "cagr": 9.26,
          "market_share": 59.14
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 72.06,
            "2021": 78.16,
            "2022": 86.53,
            "2023": 93.03,
            "2024": 102.80000000000001,
            "2025": 112.46,
            "2026": 122.32999999999998,
            "2027": 133.35,
            "2028": 143.97,
            "2029": 159.01999999999998,
            "2030": 174.24,
            "2031": 190.73,
            "2032": 208.4
          },
          "cagr": 9.26,
          "market_share": 75.68
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 48.76,
            "2021": 53.019999999999996,
            "2022": 58.72,
            "2023": 63.239999999999995,
            "2024": 69.8,
            "2025": 76.64,
            "2026": 83.67,
            "2027": 91.50999999999999,
            "2028": 98.73,
            "2029": 109.44,
            "2030": 120.13999999999999,
            "2031": 131.44,
            "2032": 144.04
          },
          "cagr": 9.26,
          "market_share": 51.650000000000006
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 53.35,
            "2021": 58.06,
            "2022": 64.1,
            "2023": 69.05,
            "2024": 76.25999999999999,
            "2025": 83.92,
            "2026": 91.29,
            "2027": 100.14,
            "2028": 108.22,
            "2029": 119.47999999999999,
            "2030": 131.8,
            "2031": 144.01,
            "2032": 157.9
          },
          "cagr": 9.26,
          "market_share": 57.489999999999995
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 53.99,
            "2021": 58.44,
            "2022": 64.78999999999999,
            "2023": 69.57,
            "2024": 76.91,
            "2025": 83.9,
            "2026": 91.27000000000001,
            "2027": 99.16,
            "2028": 107.00999999999999,
            "2029": 118.20000000000002,
            "2030": 129.14,
            "2031": 141.43,
            "2032": 154.28
          },
          "cagr": 9.263333333333334,
          "market_share": 56.05
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 89.02,
            "2021": 100.68,
            "2022": 112.17999999999999,
            "2023": 125.33999999999999,
            "2024": 141.2,
            "2025": 160.95999999999998,
            "2026": 179.82999999999998,
            "2027": 204.74,
            "2028": 227.78,
            "2029": 258.43,
            "2030": 288.62,
            "2031": 327.12,
            "2032": 373.23
          },
          "cagr": 11.729999999999999,
          "market_share": 110.10999999999999
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 64.19,
            "2021": 72.49,
            "2022": 80.61,
            "2023": 89.64,
            "2024": 100.73,
            "2025": 114.53000000000002,
            "2026": 127.85,
            "2027": 144.98,
            "2028": 160.85,
            "2029": 182.13,
            "2030": 203.25,
            "2031": 229.66000000000003,
            "2032": 261.2
          },
          "cagr": 11.733333333333334,
          "market_share": 80.88000000000001
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 91.13999999999999,
            "2021": 103.71,
            "2022": 115.22,
            "2023": 128.28,
            "2024": 145.44,
            "2025": 166.05,
            "2026": 185.48,
            "2027": 210.54,
            "2028": 234.58,
            "2029": 267.71,
            "2030": 298.31,
            "2031": 338.4,
            "2032": 385.52
          },
          "cagr": 11.729999999999999,
          "market_share": 109.00999999999999
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 115.38,
            "2021": 129.87,
            "2022": 144.2,
            "2023": 159.75,
            "2024": 178.66,
            "2025": 202.51000000000002,
            "2026": 225.92000000000002,
            "2027": 255.31,
            "2028": 282.28,
            "2029": 318.36,
            "2030": 355.27000000000004,
            "2031": 399.95000000000005,
            "2032": 453.51
          },
          "cagr": 11.729999999999999,
          "market_share": 149.46
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 128.97000000000003,
            "2021": 147.01,
            "2022": 163.81,
            "2023": 183.51000000000002,
            "2024": 208.71,
            "2025": 239.03,
            "2026": 267.24,
            "2027": 304.95,
            "2028": 340.93,
            "2029": 389.90999999999997,
            "2030": 434.90999999999997,
            "2031": 495.23,
            "2032": 566.44
          },
          "cagr": 11.729999999999999,
          "market_share": 150.54
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 122.02000000000001,
            "2021": 138.76999999999998,
            "2022": 154.58,
            "2023": 172.95,
            "2024": 196.13,
            "2025": 224.26999999999998,
            "2026": 250.66000000000003,
            "2027": 285.73,
            "2028": 318.92,
            "2029": 363.87,
            "2030": 405.94999999999993,
            "2031": 461.52000000000004,
            "2032": 527.3399999999999
          },
          "cagr": 11.729999999999999,
          "market_share": 145.12
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 122.33,
            "2021": 138.11,
            "2022": 153.43,
            "2023": 170.31,
            "2024": 191.23999999999998,
            "2025": 217.26999999999998,
            "2026": 242.5,
            "2027": 274.53,
            "2028": 304.29,
            "2029": 344.40000000000003,
            "2030": 384.23,
            "2031": 433.66,
            "2032": 492.61
          },
          "cagr": 11.733333333333334,
          "market_share": 154.88
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 35.78,
            "2021": 40.64,
            "2022": 45.22,
            "2023": 50.36,
            "2024": 56.96,
            "2025": 65.02,
            "2026": 72.63,
            "2027": 82.5,
            "2028": 91.85000000000001,
            "2029": 104.61,
            "2030": 116.66000000000001,
            "2031": 132.28,
            "2032": 150.75
          },
          "cagr": 11.726666666666667,
          "market_share": 43.32
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 47.739999999999995,
            "2021": 54.440000000000005,
            "2022": 60.550000000000004,
            "2023": 67.61,
            "2024": 76.88,
            "2025": 87.94,
            "2026": 98.29,
            "2027": 111.84,
            "2028": 124.89999999999998,
            "2029": 142.85,
            "2030": 159.2,
            "2031": 181.02,
            "2032": 206.64
          },
          "cagr": 11.733333333333334,
          "market_share": 55.97
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 56.980000000000004,
            "2021": 64.75,
            "2022": 71.97999999999999,
            "2023": 80.23,
            "2024": 90.83,
            "2025": 103.66,
            "2026": 115.80000000000001,
            "2027": 131.57,
            "2028": 146.54,
            "2029": 167.01999999999998,
            "2030": 186.2,
            "2031": 211.20000000000002,
            "2032": 240.71999999999997
          },
          "cagr": 11.733333333333334,
          "market_share": 68.69
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 50.63,
            "2021": 56.71,
            "2022": 62.95,
            "2023": 69.58,
            "2024": 77.35,
            "2025": 87.39,
            "2026": 97.44,
            "2027": 109.88,
            "2028": 121.06,
            "2029": 135.81,
            "2030": 151.65,
            "2031": 170.10000000000002,
            "2032": 192.44
          },
          "cagr": 11.736666666666666,
          "market_share": 67.69
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 53.22,
            "2021": 60.339999999999996,
            "2022": 67.31,
            "2023": 75.48,
            "2024": 85.35000000000001,
            "2025": 97.53,
            "2026": 109.0,
            "2027": 124.47000000000001,
            "2028": 138.86,
            "2029": 157.98000000000002,
            "2030": 176.47,
            "2031": 200.57999999999998,
            "2032": 229.40000000000003
          },
          "cagr": 11.729999999999999,
          "market_share": 64.33
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 111.47999999999999,
            "2021": 126.11,
            "2022": 140.56,
            "2023": 157.12,
            "2024": 177.10000000000002,
            "2025": 201.95000000000002,
            "2026": 225.6,
            "2027": 256.96999999999997,
            "2028": 286.01,
            "2029": 324.59999999999997,
            "2030": 362.53,
            "2031": 411.07,
            "2032": 469.16
          },
          "cagr": 11.729999999999999,
          "market_share": 137.47
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 132.87,
            "2021": 150.76999999999998,
            "2022": 167.45000000000002,
            "2023": 186.14,
            "2024": 210.26999999999998,
            "2025": 239.58999999999997,
            "2026": 267.56000000000006,
            "2027": 303.28999999999996,
            "2028": 337.20000000000005,
            "2029": 383.66999999999996,
            "2030": 427.65000000000003,
            "2031": 484.11,
            "2032": 550.79
          },
          "cagr": 11.729999999999999,
          "market_share": 162.53
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 55.53,
            "2021": 62.83,
            "2022": 69.74000000000001,
            "2023": 77.35999999999999,
            "2024": 87.06,
            "2025": 99.0,
            "2026": 110.5,
            "2027": 125.03,
            "2028": 138.69,
            "2029": 157.31,
            "2030": 175.39,
            "2031": 198.06,
            "2032": 224.95999999999998
          },
          "cagr": 11.729999999999999,
          "market_share": 69.42999999999999
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 43.8,
            "2021": 49.38,
            "2022": 54.82,
            "2023": 60.730000000000004,
            "2024": 68.03,
            "2025": 77.18,
            "2026": 86.1,
            "2027": 97.3,
            "2028": 107.65,
            "2029": 121.62,
            "2030": 135.64,
            "2031": 152.86,
            "2032": 173.34
          },
          "cagr": 11.733333333333333,
          "market_share": 56.26
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 41.830000000000005,
            "2021": 47.669999999999995,
            "2022": 53.14,
            "2023": 59.59,
            "2024": 67.76,
            "2025": 77.60999999999999,
            "2026": 86.78,
            "2027": 99.1,
            "2028": 110.82000000000001,
            "2029": 126.70000000000002,
            "2030": 141.36,
            "2031": 161.01,
            "2032": 184.25
          },
          "cagr": 11.733333333333334,
          "market_share": 48.83
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 49.940000000000005,
            "2021": 56.38,
            "2022": 62.85,
            "2023": 70.22,
            "2024": 78.96,
            "2025": 89.92999999999999,
            "2026": 100.46000000000001,
            "2027": 114.37,
            "2028": 127.15,
            "2029": 144.0,
            "2030": 160.9,
            "2031": 182.22,
            "2032": 207.87
          },
          "cagr": 11.733333333333334,
          "market_share": 62.459999999999994
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 53.25,
            "2021": 60.620000000000005,
            "2022": 67.46000000000001,
            "2023": 75.36,
            "2024": 85.56,
            "2025": 97.82,
            "2026": 109.32,
            "2027": 124.46000000000001,
            "2028": 138.9,
            "2029": 158.64,
            "2030": 176.89,
            "2031": 201.03,
            "2032": 229.53000000000003
          },
          "cagr": 11.729999999999999,
          "market_share": 63.019999999999996
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Chemotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Chemotherapy",
            "level_3": "Chemotherapy",
            "level_4": "Chemotherapy"
          },
          "time_series": {
            "2020": 496.02000000000004,
            "2021": 551.8399999999999,
            "2022": 616.58,
            "2023": 684.9100000000001,
            "2024": 764.72,
            "2025": 854.15,
            "2026": 951.74,
            "2027": 1063.52,
            "2028": 1184.74,
            "2029": 1325.8,
            "2030": 1479.21,
            "2031": 1644.2600000000002,
            "2032": 1857.46
          },
          "cagr": 10.998055555555558,
          "market_share": 510.46000000000004
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Immunotherapy",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Immunotherapy",
            "level_3": "Immunotherapy",
            "level_4": "Immunotherapy"
          },
          "time_series": {
            "2020": 496.74,
            "2021": 551.7099999999999,
            "2022": 615.18,
            "2023": 681.4600000000002,
            "2024": 760.38,
            "2025": 848.2,
            "2026": 941.9699999999999,
            "2027": 1050.28,
            "2028": 1167.1999999999998,
            "2029": 1304.1799999999998,
            "2030": 1452.7,
            "2031": 1611.8,
            "2032": 1812.2599999999998
          },
          "cagr": 10.997579365079366,
          "market_share": 526.89
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "EGFR Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "EGFR Inhibitors",
            "level_3": "EGFR Inhibitors",
            "level_4": "EGFR Inhibitors"
          },
          "time_series": {
            "2020": 519.91,
            "2021": 578.68,
            "2022": 646.2199999999999,
            "2023": 717.15,
            "2024": 800.53,
            "2025": 893.8799999999999,
            "2026": 994.8299999999999,
            "2027": 1112.37,
            "2028": 1238.38,
            "2029": 1384.75,
            "2030": 1545.6399999999999,
            "2031": 1717.92,
            "2032": 1936.55
          },
          "cagr": 10.99829365079365,
          "market_share": 535.2500000000001
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Route of Administration",
          "segment": "Intravenous (IV)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Intravenous (IV)",
            "level_3": "Intravenous (IV)",
            "level_4": "Intravenous (IV)"
          },
          "time_series": {
            "2020": 1275.4099999999999,
            "2021": 1416.5100000000002,
            "2022": 1583.15,
            "2023": 1757.8200000000002,
            "2024": 1959.97,
            "2025": 2186.51,
            "2026": 2436.04,
            "2027": 2718.11,
            "2028": 3026.0999999999995,
            "2029": 3378.4900000000002,
            "2030": 3773.82,
            "2031": 4189.63,
            "2032": 4721.820000000001
          },
          "cagr": 10.996607142857142,
          "market_share": 1308.46
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "Multikinase Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Multikinase Inhibitors",
            "level_3": "Multikinase Inhibitors",
            "level_4": "Multikinase Inhibitors"
          },
          "time_series": {
            "2020": 489.12,
            "2021": 542.79,
            "2022": 606.2,
            "2023": 672.47,
            "2024": 750.47,
            "2025": 837.3000000000001,
            "2026": 931.6799999999998,
            "2027": 1039.01,
            "2028": 1158.3799999999999,
            "2029": 1293.41,
            "2030": 1442.1,
            "2031": 1601.6000000000001,
            "2032": 1803.82
          },
          "cagr": 10.998531746031745,
          "market_share": 497.38999999999993
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy b",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy b"
          },
          "time_series": {
            "2020": 513.1600000000001,
            "2021": 569.32,
            "2022": 635.57,
            "2023": 704.56,
            "2024": 785.5800000000002,
            "2025": 875.98,
            "2026": 972.9100000000001,
            "2027": 1085.19,
            "2028": 1207.11,
            "2029": 1347.4399999999998,
            "2030": 1502.37,
            "2031": 1666.2999999999997,
            "2032": 1873.88
          },
          "cagr": 10.998452380952381,
          "market_share": 533.9300000000001
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy a",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": "Targeted Therapy a"
          },
          "time_series": {
            "2020": 487.52,
            "2021": 541.39,
            "2022": 604.1200000000001,
            "2023": 671.2499999999999,
            "2024": 749.1600000000001,
            "2025": 836.03,
            "2026": 930.1999999999999,
            "2027": 1039.18,
            "2028": 1157.62,
            "2029": 1291.95,
            "2030": 1443.11,
            "2031": 1603.37,
            "2032": 1806.73
          },
          "cagr": 10.997400793650796,
          "market_share": 509.53999999999996
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Gender",
          "segment": "Male",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Male",
            "level_3": "Male",
            "level_4": "Male"
          },
          "time_series": {
            "2020": 1282.4599999999998,
            "2021": 1421.3000000000002,
            "2022": 1584.72,
            "2023": 1753.07,
            "2024": 1952.9,
            "2025": 2173.52,
            "2026": 2414.06,
            "2027": 2688.0699999999997,
            "2028": 2988.85,
            "2029": 3328.33,
            "2030": 3709.4799999999996,
            "2031": 4109.66,
            "2032": 4616.92
          },
          "cagr": 10.997579365079366,
          "market_share": 1341.2000000000003
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "VEGF/Angiogenesis Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "VEGF/Angiogenesis Inhibitors",
            "level_3": "VEGF/Angiogenesis Inhibitors",
            "level_4": "VEGF/Angiogenesis Inhibitors"
          },
          "time_series": {
            "2020": 527.58,
            "2021": 586.5200000000001,
            "2022": 655.5500000000001,
            "2023": 728.49,
            "2024": 812.98,
            "2025": 908.1599999999999,
            "2026": 1010.6300000000001,
            "2027": 1128.5600000000002,
            "2028": 1257.94,
            "2029": 1406.5700000000002,
            "2030": 1570.2099999999998,
            "2031": 1743.15,
            "2032": 1964.8400000000001
          },
          "cagr": 10.997579365079366,
          "market_share": 542.27
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Sales Channel",
          "segment": "Offline",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Offline",
            "level_3": "Offline",
            "level_4": "Offline"
          },
          "time_series": {
            "2020": 1257.1699999999996,
            "2021": 1397.8899999999999,
            "2022": 1561.59,
            "2023": 1732.8000000000002,
            "2024": 1934.6899999999998,
            "2025": 2161.15,
            "2026": 2405.51,
            "2027": 2686.23,
            "2028": 2990.21,
            "2029": 3345.79,
            "2030": 3731.49,
            "2031": 4145.68,
            "2032": 4671.58
          },
          "cagr": 10.99702380952381,
          "market_share": 1308.66
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Gender",
          "segment": "Female",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Gender",
            "level_2": "Female",
            "level_3": "Female",
            "level_4": "Female"
          },
          "time_series": {
            "2020": 1226.41,
            "2021": 1365.54,
            "2022": 1527.6599999999996,
            "2023": 1699.7299999999998,
            "2024": 1900.1800000000003,
            "2025": 2126.3900000000003,
            "2026": 2370.45,
            "2027": 2651.35,
            "2028": 2954.12,
            "2029": 3311.62,
            "2030": 3699.54,
            "2031": 4118.1900000000005,
            "2032": 4650.83
          },
          "cagr": 10.99702380952381,
          "market_share": 1258.81
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By End User",
          "segment": "Research Institute",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Research Institute",
            "level_3": "Research Institute",
            "level_4": "Research Institute"
          },
          "time_series": {
            "2020": 879.93,
            "2021": 977.0,
            "2022": 1091.65,
            "2023": 1209.3099999999997,
            "2024": 1350.7,
            "2025": 1507.23,
            "2026": 1675.44,
            "2027": 1870.94,
            "2028": 2081.63,
            "2029": 2325.72,
            "2030": 2592.32,
            "2031": 2878.1400000000003,
            "2032": 3246.1700000000005
          },
          "cagr": 10.997261904761904,
          "market_share": 921.0
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By End User",
          "segment": "Speciality Center",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Speciality Center",
            "level_3": "Speciality Center",
            "level_4": "Speciality Center"
          },
          "time_series": {
            "2020": 868.35,
            "2021": 966.1,
            "2022": 1078.5,
            "2023": 1199.33,
            "2024": 1338.48,
            "2025": 1496.31,
            "2026": 1666.3200000000002,
            "2027": 1861.3300000000002,
            "2028": 2075.11,
            "2029": 2321.46,
            "2030": 2593.57,
            "2031": 2881.9100000000003,
            "2032": 3248.08
          },
          "cagr": 10.996190476190476,
          "market_share": 877.9499999999999
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "PD-1/PD-L1 Inhibitors",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "PD-1/PD-L1 Inhibitors",
            "level_3": "PD-1/PD-L1 Inhibitors",
            "level_4": "PD-1/PD-L1 Inhibitors"
          },
          "time_series": {
            "2020": 513.63,
            "2021": 570.82,
            "2022": 638.16,
            "2023": 708.88,
            "2024": 791.75,
            "2025": 884.77,
            "2026": 985.7900000000001,
            "2027": 1100.28,
            "2028": 1224.88,
            "2029": 1370.5199999999998,
            "2030": 1530.7799999999997,
            "2031": 1701.8899999999999,
            "2032": 1920.02
          },
          "cagr": 10.997083333333334,
          "market_share": 533.79
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Route of Administration",
          "segment": "Oral",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Route of Administration",
            "level_2": "Oral",
            "level_3": "Oral",
            "level_4": "Oral"
          },
          "time_series": {
            "2020": 1233.46,
            "2021": 1370.33,
            "2022": 1529.23,
            "2023": 1694.98,
            "2024": 1893.1100000000001,
            "2025": 2113.4,
            "2026": 2348.4700000000003,
            "2027": 2621.31,
            "2028": 2916.87,
            "2029": 3261.4599999999996,
            "2030": 3635.2,
            "2031": 4038.2200000000003,
            "2032": 4545.93
          },
          "cagr": 10.99702380952381,
          "market_share": 1291.54
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 2",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 2",
            "level_4": "Targeted Therapy 2"
          },
          "time_series": {
            "2020": 515.43,
            "2021": 572.58,
            "2022": 640.9300000000001,
            "2023": 710.62,
            "2024": 793.24,
            "2025": 885.55,
            "2026": 987.69,
            "2027": 1101.25,
            "2028": 1226.3,
            "2029": 1370.58,
            "2030": 1531.63,
            "2031": 1702.12,
            "2032": 1917.42
          },
          "cagr": 10.996448412698413,
          "market_share": 519.2300000000001
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By End User",
          "segment": "Hospital",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By End User",
            "level_2": "Hospital",
            "level_3": "Hospital",
            "level_4": "Hospital"
          },
          "time_series": {
            "2020": 760.5900000000001,
            "2021": 843.74,
            "2022": 942.23,
            "2023": 1044.16,
            "2024": 1163.9,
            "2025": 1296.37,
            "2026": 1442.7499999999998,
            "2027": 1607.15,
            "2028": 1786.2299999999998,
            "2029": 1992.77,
            "2030": 2223.13,
            "2031": 2467.8,
            "2032": 2773.5
          },
          "cagr": 10.99813492063492,
          "market_share": 801.04
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Sales Channel",
          "segment": "Online",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Sales Channel",
            "level_2": "Online",
            "level_3": "Online",
            "level_4": "Online"
          },
          "time_series": {
            "2020": 1251.7,
            "2021": 1388.9499999999998,
            "2022": 1550.79,
            "2023": 1720.0,
            "2024": 1918.3899999999999,
            "2025": 2138.76,
            "2026": 2379.0,
            "2027": 2653.19,
            "2028": 2952.76,
            "2029": 3294.16,
            "2030": 3677.5299999999997,
            "2031": 4082.17,
            "2032": 4596.17
          },
          "cagr": 10.996547619047618,
          "market_share": 1291.34
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Drug Class",
          "segment": "Others (including pipeline and emerging drugs)",
          "segment_level": "leaf",
          "segment_hierarchy": {
            "level_1": "By Drug Class",
            "level_2": "Others (including pipeline and emerging drugs)",
            "level_3": "Others (including pipeline and emerging drugs)",
            "level_4": "Others (including pipeline and emerging drugs)"
          },
          "time_series": {
            "2020": 458.63,
            "2021": 508.03,
            "2022": 566.25,
            "2023": 625.8100000000001,
            "2024": 697.3499999999999,
            "2025": 775.8000000000002,
            "2026": 861.58,
            "2027": 959.1999999999999,
            "2028": 1063.39,
            "2029": 1184.6999999999998,
            "2030": 1320.29,
            "2031": 1463.29,
            "2032": 1642.52
          },
          "cagr": 10.997579365079362,
          "market_share": 491.3
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 38.27,
            "2021": 42.12,
            "2022": 45.36,
            "2023": 48.45,
            "2024": 52.980000000000004,
            "2025": 57.339999999999996,
            "2026": 62.49,
            "2027": 67.52,
            "2028": 74.45,
            "2029": 81.62,
            "2030": 88.64,
            "2031": 95.71000000000001,
            "2032": 106.09
          },
          "cagr": 9.19,
          "market_share": 33.25
        },
        {
          "geography": "Italy",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 69.56,
            "2021": 76.56,
            "2022": 82.45,
            "2023": 88.06,
            "2024": 96.28,
            "2025": 104.22,
            "2026": 113.58000000000001,
            "2027": 122.72999999999999,
            "2028": 135.33,
            "2029": 148.36,
            "2030": 161.11,
            "2031": 173.97000000000003,
            "2032": 192.84
          },
          "cagr": 9.19,
          "market_share": 60.42
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 42.1,
            "2021": 46.32,
            "2022": 50.76,
            "2023": 55.03,
            "2024": 60.6,
            "2025": 67.82,
            "2026": 73.9,
            "2027": 82.53999999999999,
            "2028": 89.36,
            "2029": 98.72,
            "2030": 110.71000000000001,
            "2031": 120.50999999999999,
            "2032": 133.39
          },
          "cagr": 10.15,
          "market_share": 48.47
        },
        {
          "geography": "Israel",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 59.21,
            "2021": 65.14,
            "2022": 71.41,
            "2023": 77.39,
            "2024": 85.24000000000001,
            "2025": 95.41,
            "2026": 103.95,
            "2027": 116.08999999999999,
            "2028": 125.67,
            "2029": 138.86,
            "2030": 155.71,
            "2031": 169.51,
            "2032": 187.60999999999999
          },
          "cagr": 10.143333333333333,
          "market_share": 68.18
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 117.37,
            "2021": 127.44,
            "2022": 140.75,
            "2023": 151.42000000000002,
            "2024": 167.34,
            "2025": 183.59,
            "2026": 199.37,
            "2027": 218.07,
            "2028": 235.71999999999997,
            "2029": 259.76,
            "2030": 285.96999999999997,
            "2031": 312.64,
            "2032": 342.06000000000006
          },
          "cagr": 9.263333333333334,
          "market_share": 125.35
        },
        {
          "geography": "Middle East",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 179.84,
            "2021": 195.2,
            "2022": 215.87,
            "2023": 232.17000000000002,
            "2024": 256.55,
            "2025": 281.18,
            "2026": 305.70000000000005,
            "2027": 333.88,
            "2028": 360.65999999999997,
            "2029": 398.03,
            "2030": 437.27,
            "2031": 478.29999999999995,
            "2032": 523.1100000000001
          },
          "cagr": 9.261111111111111,
          "market_share": 190.69
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 71.25999999999999,
            "2021": 78.41,
            "2022": 88.48,
            "2023": 100.19,
            "2024": 113.42,
            "2025": 126.75999999999999,
            "2026": 142.60000000000002,
            "2027": 159.82999999999998,
            "2028": 185.10000000000002,
            "2029": 206.71,
            "2030": 231.0,
            "2031": 256.92,
            "2032": 290.83
          },
          "cagr": 12.6,
          "market_share": 50.22
        },
        {
          "geography": "Spain",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 93.1,
            "2021": 102.42999999999999,
            "2022": 115.59,
            "2023": 130.88,
            "2024": 148.18,
            "2025": 165.58999999999997,
            "2026": 186.29000000000002,
            "2027": 208.79999999999998,
            "2028": 241.81000000000003,
            "2029": 270.04,
            "2030": 301.77,
            "2031": 335.63,
            "2032": 379.92999999999995
          },
          "cagr": 12.6,
          "market_share": 65.61
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 32.86,
            "2021": 37.019999999999996,
            "2022": 40.129999999999995,
            "2023": 45.370000000000005,
            "2024": 50.21,
            "2025": 55.44,
            "2026": 60.60000000000001,
            "2027": 69.4,
            "2028": 74.83,
            "2029": 84.32,
            "2030": 94.95,
            "2031": 104.03999999999999,
            "2032": 112.37
          },
          "cagr": 10.62,
          "market_share": 42.27
        },
        {
          "geography": "Japan",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 48.19,
            "2021": 54.3,
            "2022": 58.86999999999999,
            "2023": 66.55000000000001,
            "2024": 73.64,
            "2025": 81.31,
            "2026": 88.89000000000001,
            "2027": 101.80000000000001,
            "2028": 109.78,
            "2029": 123.69,
            "2030": 139.27,
            "2031": 152.60999999999999,
            "2032": 164.84
          },
          "cagr": 10.623333333333333,
          "market_share": 62.0
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 41.14,
            "2021": 44.57,
            "2022": 49.18,
            "2023": 53.65,
            "2024": 58.96,
            "2025": 65.1,
            "2026": 69.48,
            "2027": 77.02000000000001,
            "2028": 84.19,
            "2029": 91.0,
            "2030": 99.97,
            "2031": 109.78,
            "2032": 122.58000000000001
          },
          "cagr": 9.46,
          "market_share": 43.89
        },
        {
          "geography": "India",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 52.5,
            "2021": 56.88,
            "2022": 62.78,
            "2023": 68.47,
            "2024": 75.25,
            "2025": 83.07,
            "2026": 88.66,
            "2027": 98.29,
            "2028": 107.44,
            "2029": 116.13,
            "2030": 127.58,
            "2031": 140.09,
            "2032": 156.43
          },
          "cagr": 9.463333333333333,
          "market_share": 56.02
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 25.14,
            "2021": 27.39,
            "2022": 29.439999999999998,
            "2023": 32.91,
            "2024": 35.91,
            "2025": 39.28,
            "2026": 44.19,
            "2027": 49.01,
            "2028": 54.0,
            "2029": 57.93,
            "2030": 65.32,
            "2031": 70.74,
            "2032": 77.77
          },
          "cagr": 10.25,
          "market_share": 39.629999999999995
        },
        {
          "geography": "Canada",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 35.72,
            "2021": 38.91,
            "2022": 41.83,
            "2023": 46.75,
            "2024": 51.01,
            "2025": 55.8,
            "2026": 62.76,
            "2027": 69.62,
            "2028": 76.7,
            "2029": 82.3,
            "2030": 92.78999999999999,
            "2031": 100.49,
            "2032": 110.47
          },
          "cagr": 10.25,
          "market_share": 56.28999999999999
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 50.43,
            "2021": 56.43,
            "2022": 63.239999999999995,
            "2023": 73.03,
            "2024": 81.27,
            "2025": 91.99000000000001,
            "2026": 102.99,
            "2027": 112.97999999999999,
            "2028": 127.19,
            "2029": 147.49,
            "2030": 164.16,
            "2031": 182.37,
            "2032": 209.10000000000002
          },
          "cagr": 12.445,
          "market_share": 42.75
        },
        {
          "geography": "Mexico",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 66.22,
            "2021": 74.09,
            "2022": 83.03,
            "2023": 95.89,
            "2024": 106.71,
            "2025": 120.78,
            "2026": 135.22,
            "2027": 148.32999999999998,
            "2028": 167.0,
            "2029": 193.64000000000001,
            "2030": 215.53,
            "2031": 239.44,
            "2032": 274.54
          },
          "cagr": 12.446666666666667,
          "market_share": 56.13
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 36.48,
            "2021": 39.57,
            "2022": 43.17,
            "2023": 46.63,
            "2024": 51.489999999999995,
            "2025": 54.870000000000005,
            "2026": 60.52,
            "2027": 65.0,
            "2028": 71.50999999999999,
            "2029": 78.37,
            "2030": 82.53999999999999,
            "2031": 90.09,
            "2032": 101.16
          },
          "cagr": 9.13,
          "market_share": 41.08
        },
        {
          "geography": "Australia",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 49.089999999999996,
            "2021": 53.25,
            "2022": 58.08,
            "2023": 62.75,
            "2024": 69.28,
            "2025": 73.82000000000001,
            "2026": 81.42,
            "2027": 87.45,
            "2028": 96.21,
            "2029": 105.45,
            "2030": 111.03999999999999,
            "2031": 121.2,
            "2032": 136.1
          },
          "cagr": 9.13,
          "market_share": 55.269999999999996
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 43.599999999999994,
            "2021": 49.4,
            "2022": 55.72,
            "2023": 62.75,
            "2024": 72.12,
            "2025": 81.59,
            "2026": 91.71000000000001,
            "2027": 102.81,
            "2028": 114.92,
            "2029": 127.35000000000001,
            "2030": 145.05,
            "2031": 165.5,
            "2032": 186.57999999999998
          },
          "cagr": 12.54,
          "market_share": 40.41
        },
        {
          "geography": "U.S.",
          "geography_level": "country",
          "parent_geography": "North America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 70.28,
            "2021": 79.63,
            "2022": 89.82,
            "2023": 101.14,
            "2024": 116.27000000000001,
            "2025": 131.54000000000002,
            "2026": 147.84,
            "2027": 165.75,
            "2028": 185.25,
            "2029": 205.29000000000002,
            "2030": 233.83,
            "2031": 266.79,
            "2032": 300.77
          },
          "cagr": 12.54,
          "market_share": 65.14999999999999
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 47.66,
            "2021": 53.91,
            "2022": 62.65,
            "2023": 70.7,
            "2024": 79.49000000000001,
            "2025": 91.12,
            "2026": 104.06,
            "2027": 119.44999999999999,
            "2028": 133.36,
            "2029": 154.52,
            "2030": 171.55,
            "2031": 194.36,
            "2032": 228.2
          },
          "cagr": 14.01,
          "market_share": 32.85
        },
        {
          "geography": "Rest of Asia Pacific",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 86.49,
            "2021": 97.83,
            "2022": 113.69999999999999,
            "2023": 128.32,
            "2024": 144.28000000000003,
            "2025": 165.37,
            "2026": 188.86,
            "2027": 216.77999999999997,
            "2028": 242.05,
            "2029": 280.44,
            "2030": 311.35,
            "2031": 352.73,
            "2032": 414.17999999999995
          },
          "cagr": 14.013333333333334,
          "market_share": 59.620000000000005
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 28.29,
            "2021": 31.13,
            "2022": 33.5,
            "2023": 36.18,
            "2024": 39.23,
            "2025": 42.82,
            "2026": 45.64,
            "2027": 48.8,
            "2028": 53.68,
            "2029": 57.98,
            "2030": 60.78,
            "2031": 65.42,
            "2032": 70.54
          },
          "cagr": 7.39,
          "market_share": 36.91
        },
        {
          "geography": "Rest of Europe",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 43.18,
            "2021": 47.519999999999996,
            "2022": 51.14,
            "2023": 55.22,
            "2024": 59.89,
            "2025": 65.36,
            "2026": 69.66,
            "2027": 74.49,
            "2028": 81.95,
            "2029": 88.49,
            "2030": 92.77,
            "2031": 99.86,
            "2032": 107.69
          },
          "cagr": 7.3933333333333335,
          "market_share": 56.349999999999994
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 284.91,
            "2021": 314.59,
            "2022": 353.71000000000004,
            "2023": 392.5,
            "2024": 437.69000000000005,
            "2025": 482.61,
            "2026": 538.21,
            "2027": 599.9,
            "2028": 666.5,
            "2029": 742.51,
            "2030": 825.5699999999999,
            "2031": 914.82,
            "2032": 1030.37
          },
          "cagr": 11.267142857142858,
          "market_share": 281.63
        },
        {
          "geography": "Asia Pacific",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 442.08000000000004,
            "2021": 488.32,
            "2022": 550.84,
            "2023": 611.69,
            "2024": 682.8600000000001,
            "2025": 754.13,
            "2026": 843.3800000000001,
            "2027": 940.18,
            "2028": 1046.09,
            "2029": 1168.93,
            "2030": 1300.6599999999999,
            "2031": 1442.95,
            "2032": 1628.81
          },
          "cagr": 11.269047619047619,
          "market_share": 429.49
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 32.120000000000005,
            "2021": 34.75,
            "2022": 39.129999999999995,
            "2023": 42.06,
            "2024": 46.33,
            "2025": 50.08,
            "2026": 55.61,
            "2027": 59.65,
            "2028": 63.78999999999999,
            "2029": 72.19,
            "2030": 76.97,
            "2031": 84.78,
            "2032": 92.45
          },
          "cagr": 9.15,
          "market_share": 30.490000000000002
        },
        {
          "geography": "Rest of Middle East",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 57.14,
            "2021": 61.83,
            "2022": 69.61999999999999,
            "2023": 74.85,
            "2024": 82.44,
            "2025": 89.11,
            "2026": 98.96000000000001,
            "2027": 106.15,
            "2028": 113.50999999999999,
            "2029": 128.45,
            "2030": 136.94,
            "2031": 150.85,
            "2032": 164.51
          },
          "cagr": 9.15,
          "market_share": 54.260000000000005
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 18.83,
            "2021": 20.52,
            "2022": 22.36,
            "2023": 24.79,
            "2024": 27.88,
            "2025": 30.18,
            "2026": 33.25,
            "2027": 37.53,
            "2028": 40.58,
            "2029": 44.269999999999996,
            "2030": 50.120000000000005,
            "2031": 53.63,
            "2032": 60.8
          },
          "cagr": 10.524999999999999,
          "market_share": 36.21
        },
        {
          "geography": "Germany",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 25.08,
            "2021": 27.34,
            "2022": 29.8,
            "2023": 33.03,
            "2024": 37.14,
            "2025": 40.21,
            "2026": 44.32,
            "2027": 50.010000000000005,
            "2028": 54.08,
            "2029": 58.989999999999995,
            "2030": 66.78,
            "2031": 71.46000000000001,
            "2032": 81.02
          },
          "cagr": 10.526666666666666,
          "market_share": 48.24
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 267.84000000000003,
            "2021": 299.29999999999995,
            "2022": 333.86,
            "2023": 369.28,
            "2024": 413.7200000000001,
            "2025": 463.1,
            "2026": 514.46,
            "2027": 574.94,
            "2028": 650.3900000000001,
            "2029": 725.51,
            "2030": 810.0699999999999,
            "2031": 893.4599999999999,
            "2032": 1013.3299999999999
          },
          "cagr": 10.96,
          "market_share": 257.55
        },
        {
          "geography": "Europe",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 415.56,
            "2021": 464.15999999999997,
            "2022": 516.97,
            "2023": 570.14,
            "2024": 637.71,
            "2025": 713.3,
            "2026": 791.1700000000001,
            "2027": 882.8700000000001,
            "2028": 995.7700000000001,
            "2029": 1109.9099999999999,
            "2030": 1237.79,
            "2031": 1363.57,
            "2032": 1543.78
          },
          "cagr": 10.96,
          "market_share": 403.51
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 103.85,
            "2021": 117.05,
            "2022": 130.26,
            "2023": 145.06,
            "2024": 162.7,
            "2025": 184.92000000000002,
            "2026": 206.44,
            "2027": 234.35000000000002,
            "2028": 259.92,
            "2029": 293.79,
            "2030": 328.12,
            "2031": 370.68,
            "2032": 421.84000000000003
          },
          "cagr": 11.733333333333333,
          "market_share": 132.01999999999998
        },
        {
          "geography": "Africa",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 139.63,
            "2021": 157.69,
            "2022": 175.48,
            "2023": 195.42000000000002,
            "2024": 219.66,
            "2025": 249.94,
            "2026": 279.07,
            "2027": 316.85,
            "2028": 351.77000000000004,
            "2029": 398.40000000000003,
            "2030": 444.78000000000003,
            "2031": 502.96000000000004,
            "2032": 572.59
          },
          "cagr": 11.73111111111111,
          "market_share": 175.33999999999997
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 37.53,
            "2021": 41.56,
            "2022": 45.269999999999996,
            "2023": 48.83,
            "2024": 53.400000000000006,
            "2025": 59.48,
            "2026": 64.41,
            "2027": 70.6,
            "2028": 76.65,
            "2029": 83.63,
            "2030": 91.59,
            "2031": 99.25999999999999,
            "2032": 108.22
          },
          "cagr": 8.93,
          "market_share": 32.08
        },
        {
          "geography": "U.K.",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 71.17,
            "2021": 78.82,
            "2022": 85.86,
            "2023": 92.61,
            "2024": 101.28,
            "2025": 112.82,
            "2026": 122.16,
            "2027": 133.89999999999998,
            "2028": 145.36,
            "2029": 158.61,
            "2030": 173.7,
            "2031": 188.26,
            "2032": 205.24
          },
          "cagr": 8.926666666666668,
          "market_share": 60.849999999999994
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 40.730000000000004,
            "2021": 46.269999999999996,
            "2022": 52.19,
            "2023": 61.010000000000005,
            "2024": 67.73,
            "2025": 78.0,
            "2026": 90.86,
            "2027": 103.47,
            "2028": 117.99000000000001,
            "2029": 130.36,
            "2030": 153.82,
            "2031": 175.3,
            "2032": 199.45
          },
          "cagr": 14.35,
          "market_share": 34.05
        },
        {
          "geography": "Argentina",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 75.75,
            "2021": 86.03999999999999,
            "2022": 97.05,
            "2023": 113.48,
            "2024": 125.95,
            "2025": 145.05,
            "2026": 168.98000000000002,
            "2027": 192.41,
            "2028": 219.43,
            "2029": 242.44,
            "2030": 286.04999999999995,
            "2031": 326.0,
            "2032": 370.90999999999997
          },
          "cagr": 14.35,
          "market_share": 63.31999999999999
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 32.91,
            "2021": 36.42,
            "2022": 40.03,
            "2023": 43.03,
            "2024": 46.11,
            "2025": 50.74,
            "2026": 54.47,
            "2027": 60.82,
            "2028": 65.08,
            "2029": 71.82,
            "2030": 77.50999999999999,
            "2031": 84.95,
            "2032": 92.25999999999999
          },
          "cagr": 8.92,
          "market_share": 44.33
        },
        {
          "geography": "Brazil",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 44.05,
            "2021": 48.77,
            "2022": 53.61,
            "2023": 57.620000000000005,
            "2024": 61.74,
            "2025": 67.94,
            "2026": 72.94,
            "2027": 81.44,
            "2028": 87.14,
            "2029": 96.16999999999999,
            "2030": 103.78999999999999,
            "2031": 113.75,
            "2032": 123.52999999999999
          },
          "cagr": 8.916666666666666,
          "market_share": 59.36
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 15.030000000000001,
            "2021": 16.68,
            "2022": 19.67,
            "2023": 21.67,
            "2024": 24.92,
            "2025": 28.419999999999998,
            "2026": 32.34,
            "2027": 37.07,
            "2028": 41.18,
            "2029": 47.19,
            "2030": 54.150000000000006,
            "2031": 59.959999999999994,
            "2032": 68.48
          },
          "cagr": 13.39,
          "market_share": 28.439999999999998
        },
        {
          "geography": "Russia",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 28.1,
            "2021": 31.189999999999998,
            "2022": 36.78,
            "2023": 40.510000000000005,
            "2024": 46.58,
            "2025": 53.129999999999995,
            "2026": 60.45,
            "2027": 69.3,
            "2028": 76.97,
            "2029": 88.22,
            "2030": 101.24000000000001,
            "2031": 112.07999999999998,
            "2032": 128.04000000000002
          },
          "cagr": 13.39,
          "market_share": 53.16
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 157.97,
            "2021": 175.54,
            "2022": 195.95,
            "2023": 221.89,
            "2024": 245.26,
            "2025": 276.91999999999996,
            "2026": 308.72999999999996,
            "2027": 345.28999999999996,
            "2028": 383.28,
            "2029": 432.53999999999996,
            "2030": 485.38,
            "2031": 541.8299999999999,
            "2032": 608.6600000000001
          },
          "cagr": 11.368749999999999,
          "market_share": 166.88
        },
        {
          "geography": "Latin America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 233.0,
            "2021": 259.38,
            "2022": 289.80999999999995,
            "2023": 329.12,
            "2024": 363.91999999999996,
            "2025": 411.66999999999996,
            "2026": 460.87999999999994,
            "2027": 516.47,
            "2028": 574.79,
            "2029": 647.11,
            "2030": 729.99,
            "2031": 816.7299999999999,
            "2032": 918.5000000000001
          },
          "cagr": 11.368333333333332,
          "market_share": 242.23
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 33.900000000000006,
            "2021": 36.42,
            "2022": 40.49,
            "2023": 44.82,
            "2024": 50.15,
            "2025": 56.19,
            "2026": 60.41,
            "2027": 68.02,
            "2028": 73.02,
            "2029": 82.87,
            "2030": 89.89,
            "2031": 99.21000000000001,
            "2032": 107.85000000000001
          },
          "cagr": 9.76,
          "market_share": 45.75
        },
        {
          "geography": "Rest of Latin America",
          "geography_level": "country",
          "parent_geography": "Latin America",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 46.980000000000004,
            "2021": 50.480000000000004,
            "2022": 56.120000000000005,
            "2023": 62.129999999999995,
            "2024": 69.52,
            "2025": 77.9,
            "2026": 83.74,
            "2027": 94.28999999999999,
            "2028": 101.22,
            "2029": 114.86,
            "2030": 124.62,
            "2031": 137.54000000000002,
            "2032": 149.52
          },
          "cagr": 9.76,
          "market_share": 63.42
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 68.74000000000001,
            "2021": 76.78999999999999,
            "2022": 85.16,
            "2023": 95.66,
            "2024": 108.03,
            "2025": 120.86999999999999,
            "2026": 135.9,
            "2027": 151.82,
            "2028": 168.92000000000002,
            "2029": 185.28,
            "2030": 210.37,
            "2031": 236.24,
            "2032": 264.35
          },
          "cagr": 11.395,
          "market_share": 80.03999999999999
        },
        {
          "geography": "North America",
          "geography_level": "region",
          "parent_geography": "Global",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 106.0,
            "2021": 118.53999999999999,
            "2022": 131.65,
            "2023": 147.89,
            "2024": 167.28,
            "2025": 187.33999999999997,
            "2026": 210.60000000000002,
            "2027": 235.37,
            "2028": 261.95000000000005,
            "2029": 287.59000000000003,
            "2030": 326.62,
            "2031": 367.28000000000003,
            "2032": 411.24
          },
          "cagr": 11.395000000000001,
          "market_share": 121.44
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 46.26,
            "2021": 51.900000000000006,
            "2022": 57.81,
            "2023": 64.9,
            "2024": 72.23,
            "2025": 78.72,
            "2026": 87.53,
            "2027": 98.97,
            "2028": 110.53999999999999,
            "2029": 118.69,
            "2030": 134.61,
            "2031": 148.69,
            "2032": 164.7
          },
          "cagr": 11.12,
          "market_share": 44.22
        },
        {
          "geography": "South Korea",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 62.69,
            "2021": 70.35000000000001,
            "2022": 78.36,
            "2023": 87.98,
            "2024": 97.91,
            "2025": 106.7,
            "2026": 118.64,
            "2027": 134.15,
            "2028": 149.82999999999998,
            "2029": 160.89,
            "2030": 182.46,
            "2031": 201.54,
            "2032": 223.25
          },
          "cagr": 11.12,
          "market_share": 59.94
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 52.96,
            "2021": 56.87,
            "2022": 64.78999999999999,
            "2023": 70.92,
            "2024": 78.25,
            "2025": 85.38,
            "2026": 95.31,
            "2027": 101.66,
            "2028": 115.33,
            "2029": 126.16,
            "2030": 139.75,
            "2031": 152.75,
            "2032": 169.11
          },
          "cagr": 10.26,
          "market_share": 36.94
        },
        {
          "geography": "ASEAN",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 95.17,
            "2021": 102.19999999999999,
            "2022": 116.44,
            "2023": 127.44,
            "2024": 140.62,
            "2025": 153.42000000000002,
            "2026": 171.26,
            "2027": 182.69,
            "2028": 207.25,
            "2029": 226.7,
            "2030": 251.13,
            "2031": 274.48,
            "2032": 303.88
          },
          "cagr": 10.26,
          "market_share": 66.38
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 43.150000000000006,
            "2021": 46.370000000000005,
            "2022": 50.86,
            "2023": 54.33,
            "2024": 60.41,
            "2025": 65.69,
            "2026": 69.86,
            "2027": 75.88,
            "2028": 82.57,
            "2029": 88.85,
            "2030": 98.28999999999999,
            "2031": 107.35,
            "2032": 116.22
          },
          "cagr": 8.49,
          "market_share": 46.39
        },
        {
          "geography": "GCC",
          "geography_level": "country",
          "parent_geography": "Middle East",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 63.49000000000001,
            "2021": 68.23,
            "2022": 74.84,
            "2023": 79.93,
            "2024": 88.87,
            "2025": 96.66,
            "2026": 102.78999999999999,
            "2027": 111.63999999999999,
            "2028": 121.47999999999999,
            "2029": 130.72,
            "2030": 144.62,
            "2031": 157.94,
            "2032": 170.99
          },
          "cagr": 8.49,
          "market_share": 68.25
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 37.37,
            "2021": 43.74,
            "2022": 48.92,
            "2023": 55.75,
            "2024": 65.41,
            "2025": 76.18,
            "2026": 85.44,
            "2027": 98.81,
            "2028": 112.38,
            "2029": 131.51999999999998,
            "2030": 146.41,
            "2031": 169.47,
            "2032": 196.0
          },
          "cagr": 14.455,
          "market_share": 34.09
        },
        {
          "geography": "Central Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 54.76,
            "2021": 64.07,
            "2022": 71.69,
            "2023": 81.68,
            "2024": 95.82,
            "2025": 111.61000000000001,
            "2026": 125.19,
            "2027": 144.75,
            "2028": 164.63,
            "2029": 192.67999999999998,
            "2030": 214.5,
            "2031": 248.26999999999998,
            "2032": 287.14
          },
          "cagr": 14.453333333333333,
          "market_share": 49.940000000000005
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 27.55,
            "2021": 30.75,
            "2022": 35.98,
            "2023": 40.33,
            "2024": 47.06,
            "2025": 51.980000000000004,
            "2026": 60.71,
            "2027": 68.4,
            "2028": 76.74,
            "2029": 89.44999999999999,
            "2030": 102.2,
            "2031": 115.11000000000001,
            "2032": 132.25
          },
          "cagr": 14.27,
          "market_share": 40.38
        },
        {
          "geography": "China",
          "geography_level": "country",
          "parent_geography": "Asia Pacific",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 47.95,
            "2021": 53.510000000000005,
            "2022": 62.61,
            "2023": 70.18,
            "2024": 81.88,
            "2025": 90.44,
            "2026": 105.65,
            "2027": 119.02000000000001,
            "2028": 133.53,
            "2029": 155.63,
            "2030": 177.82999999999998,
            "2031": 200.3,
            "2032": 230.13
          },
          "cagr": 14.273333333333333,
          "market_share": 70.26
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 1000.6800000000001,
            "2021": 1110.71,
            "2022": 1239.69,
            "2023": 1375.81,
            "2024": 1534.7400000000002,
            "2025": 1712.01,
            "2026": 1903.1100000000001,
            "2027": 2124.37,
            "2028": 2364.7299999999996,
            "2029": 2639.39,
            "2030": 2945.4799999999996,
            "2031": 3269.6699999999996,
            "2032": 3680.61
          },
          "cagr": 10.997926587301588,
          "market_share": 1043.47
        },
        {
          "geography": "Global",
          "geography_level": "global",
          "parent_geography": null,
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 1516.1100000000001,
            "2021": 1683.29,
            "2022": 1880.6200000000001,
            "2023": 2086.43,
            "2024": 2327.9800000000005,
            "2025": 2597.56,
            "2026": 2890.8,
            "2027": 3225.62,
            "2028": 3591.0299999999997,
            "2029": 4009.97,
            "2030": 4477.11,
            "2031": 4971.789999999999,
            "2032": 5598.030000000001
          },
          "cagr": 10.997433862433864,
          "market_share": 1562.7000000000003
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 39.83,
            "2021": 43.959999999999994,
            "2022": 49.39,
            "2023": 55.62,
            "2024": 61.04,
            "2025": 68.95,
            "2026": 76.98,
            "2027": 88.21000000000001,
            "2028": 97.32,
            "2029": 107.67,
            "2030": 121.22999999999999,
            "2031": 136.42000000000002,
            "2032": 155.97
          },
          "cagr": 12.37,
          "market_share": 56.21
        },
        {
          "geography": "North Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 48.589999999999996,
            "2021": 53.63999999999999,
            "2022": 60.27,
            "2023": 67.86,
            "2024": 74.46,
            "2025": 84.12,
            "2026": 93.92,
            "2027": 107.63000000000001,
            "2028": 118.75,
            "2029": 131.36,
            "2030": 147.91,
            "2031": 166.46,
            "2032": 190.29
          },
          "cagr": 12.37,
          "market_share": 68.57
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 58.63,
            "2021": 68.88,
            "2022": 79.22,
            "2023": 89.17,
            "2024": 101.89,
            "2025": 118.1,
            "2026": 133.73000000000002,
            "2027": 153.59,
            "2028": 178.75,
            "2029": 204.11,
            "2030": 233.79,
            "2031": 262.56,
            "2032": 308.37
          },
          "cagr": 14.695,
          "market_share": 40.44
        },
        {
          "geography": "France",
          "geography_level": "country",
          "parent_geography": "Europe",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 85.37,
            "2021": 100.3,
            "2022": 115.35,
            "2023": 129.82999999999998,
            "2024": 148.36,
            "2025": 171.97,
            "2026": 194.71,
            "2027": 223.64,
            "2028": 260.27,
            "2029": 297.20000000000005,
            "2030": 340.41999999999996,
            "2031": 382.31,
            "2032": 449.02
          },
          "cagr": 14.693333333333333,
          "market_share": 58.879999999999995
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy 1",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy 1",
            "level_4": ""
          },
          "time_series": {
            "2020": 26.65,
            "2021": 29.35,
            "2022": 31.95,
            "2023": 33.69,
            "2024": 36.25,
            "2025": 39.79,
            "2026": 44.02,
            "2027": 47.33,
            "2028": 50.22,
            "2029": 54.6,
            "2030": 60.48,
            "2031": 64.79,
            "2032": 69.87
          },
          "cagr": 8.375,
          "market_share": 41.72
        },
        {
          "geography": "South Africa",
          "geography_level": "country",
          "parent_geography": "Africa",
          "segment_type": "By Therapy Type",
          "segment": "Targeted Therapy",
          "segment_level": "parent",
          "segment_hierarchy": {
            "level_1": "By Therapy Type",
            "level_2": "Targeted Therapy",
            "level_3": "Targeted Therapy",
            "level_4": ""
          },
          "time_series": {
            "2020": 36.28,
            "2021": 39.980000000000004,
            "2022": 43.519999999999996,
            "2023": 45.879999999999995,
            "2024": 49.38,
            "2025": 54.21,
            "2026": 59.96,
            "2027": 64.47,
            "2028": 68.39,
            "2029": 74.36,
            "2030": 82.37,
            "2031": 88.23,
            "2032": 95.16
          },
          "cagr": 8.37,
          "market_share": 56.83
        }
      ]
    }
  }
}